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1. General Introduction 
 
Molecular chirality plays a key role in science and technology.1  Many organic 
compounds are chiral and many enantiomerically pure compounds are widely used in the 
preparation of cosmetics, flavours, pesticides, vitamins and pharmaceuticals.2  There are many 
examples which stress the necessity for preparing enantiomerically pure compounds.  For 
example, the market for single enantiomer drugs in 1996 was $ 73 billion, which increased to 
$ 96 billion in 1998 and to $ 123 billion in 2000.  The market for enantiopure materials 
continues to increase3; hence the search for efficient ways to access enantiomerically enriched 
compounds is still an active area of research to synthetic organic chemists.4 
 
 To access enantiomerically pure compounds there are four main approaches. 
1. Resolution of a racemic mixture 
 2. Synthesis from a chiral pool and synthesis using a chiral auxiliary5 
3. Synthesis using biocatalysts (enzymes, cell cultures and antibody)6  
 4. Asymmetric catalysis using a man made chiral catalyst. 
 
Among this variety of methods, asymmetric catalysis has proved to be an ideal method 
to prepare naturally and nonnaturally occurring chiral compounds in large quantities by using 
small amounts of chiral catalyst. 
 
In the past three decades, many metal complexes using various chiral ligands have 
been found that catalyze various reactions with impressive enantioselectivities.  However, 
despite the impressive progress in this area, the design of suitable chiral ligands for a 
particular application remains a formidable task.7  Hence the design of new chiral ligands for 
                                                 
1
  Noyori, R. Adv. Synth. Catal. 2003, 345, 15. 
2
  a) Gawley, R. E.; Aube, J. Principles of Asymmetric Synthesis; 1996, Pergamon: Oxford, p 1 b) Chirality in 
Industry: The Commercial Manufacture and Applications of Optically Active Compounds; Collins, A. N., 
Sheldrake, G. N., Crosby, G., Eds.; Wiley-Interscience: New York, 1992. c) Sheldon, R. A. Chirotechnology. 
Industrial Synthesis of Optically Active Compounds; Dekker, M., Ed.; New York, 1993. d) Scott, J. W. In Topics 
in Stereochemistry; Eliel, E. L., Allinger, N. L., Eds.; Wiley-Interscience: New York, 1991, Vol. 19, p 209-226. 
e) Crossley, R. Tetrahedron 1992, 48, 8155. 
3
 a) Stinson, S. C. Chem. Eng. News 1999, 77, 101. (b) Stinson, S. C. Chem. Eng. News 2001, 79, 45. 
4
 McCarthy, M.; Guiry, P. J. Tetrahedron, 2001, 57, 3809. 
5
 Aitken, R. A.; Kilenyi, S. N. Asymmetric synthesis; Blackie: London, 1994. 
6
 Wong, C.-H.; Whitesides, G. M. Enzymes in Synthetic Organic Chemsitry; Pergamon: Oxford, 1994. 
7
 Pfaltz, A.; Drury, W. J., III; Proc. Nat. Acad. Sci. 2004, 101, 5723. 
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asymmetric catalysis is a highly active field of research8 that concentrates especially, on chiral 
P,P and P,N-ligands, since this type of ligands plays a wide role in transition-metal-catalyzed 
asymmetric reactions. 
 
1.1 Chiral P,P-ligands 
The concept of C2-symmetry in ligands was first introduced when Kagan developed 
the ligand DIOP.9  The main advantage of having a C2-symmetrical axis in ligands is that it 
reduces the number of possible competing, diastereomeric transition states.10  In 1980, Noyori 
reported an axially chiral ligand, BINAP, which expanded the scope of transition-metal-
catalyzed asymmetric hydrogenations.11,12  Since then many chiral P,P-ligands have been 
prepared and have played a successful role in transition-metal-catalyzed asymmetric 
reactions.  BPPM13 (Achiwa), CHIRAPHOS14 (Bosnich), DuPHOS15 (Burk), BICP16 (Zhang), 
PHANEPHOS17 (Rossen), PENNPHOS18 (Zhang), BIPHEMP19 (Schönholzer), P-PHOS20 
(Chan), SEGPHOS21 (Mikami) and TANGPHOS22 (Zhang) are some of the successful 
examples in this field (Figure 1).  
 
 
                                                 
8
 a) Noyori, R. Asymmetric Catalysis in Organic Synthesis; Wiely: New york, 1994. b) Ohkuma, T.; Kitamura, 
M.; Noyori, R. In Catalytic Asymmetric Synthesis; Ojima, I., Ed.; Wiley-VCH: Weinheim, 2000, p 1. c) Splinder, 
F.; Blaser, H.-U. In Transition Metals for Organic Synthesis, 2nd ed.; Beller, M., Bolm, c., Eds.; Wiley-VCH: 
Weinheim, 2004, Vol. 2, p 113-123. d) Blaser, H.-U.; Splider, F. In Comprehensive Asymmetric Catalysis; 
Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Berlin, 1999, Vol. 1, pp 247-265. 
9
 Kagan, H. B.; Dang, T. P. J. Am. Chem. Soc. 1972, 94, 6429. 
10
 Whitesell, J. K. Chem. Rev. 1989, 89, 1581. 
11
 a) Miyashita, A.; Yasuda, A.; Takaya, H.; Toriumi, K.; Ito, T.; Souchi, T.; Noyori, R. J. Am. Chem. Soc. 1980, 
102, 7932. b) Noyori, R.; Takaya, H. Acc. Chem. Res. 1990, 23, 345. 
12
 a) Ohta, T.; Takaya, H.; Kitamura, M.; Nagai, K.; Noyori, R. J. Org. Chem. 1987, 52, 3174. b) Noyori, R.; 
Ohkuma, T.; Kitamura, M.; Takaya, H.; Sayo, N.; Kumobayashi, H.; Akutagawa, S. J. Am. Chem. Soc. 1987, 
109, 5856. c) Noyori, R.; Ohkuma, T. Angew. Chem, Int. Ed. 2001, 40, 40. 
13
 Achiwa, K. J. J. Am. Chem. Soc. 1976, 98, 8256. 
14
 Fryzuk, M. D.; Bosnich, B. J. J. Am. Chem. Soc. 1977, 99, 6262. 
15
 Burk, M. J. J. Am. Chem. Soc. 1991, 113, 8518. 
16
 Zhu, G.; Cao, P.; Jiang, Q.; Zhang, Q. J. Am. Chem. Soc. 1997, 119, 1799. 
17
 Pye, P. J.; Rossen, K.; Reaner, R. A.; Tsou, N. N.; Volante, R. P.; Reider, P. J. J. Am. Chem. Soc. 1997, 119, 
6207. 
18
 Jiang, Q.; Jiang, Y.; Xiao, D.; Cao, P.; Zhang, X. Angew. Chem. Int. Ed. 1998, 37, 1100. 
19
 Schmid, R.; Cereghetti, M.; Heiser, B.; Schönholzer, P. Helv. Chim. Acta 1998, 71, 897. 
20
 Pai, C.; Lin, C.; Chen, C.; Chan, A. S. C. J. Am. Chem. Soc. 2000, 122, 11513. 
21
 Hatano, M.; Terada, M.; Mikami, K. Angew. Chem. Int. Ed. 2001, 40, 249. 
22
 Tang, W.; Zhang, X. Angew. Chem. Int. Ed. 2002, 41, 1612. 
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Figure 1. Chiral diphosphine ligands  
 
These ligands were extensively employed in Rh-catalyzed asymmetric hydrogenation 
of enamides giving rise to the corresponding amino acid derivatives with high 
enantioselectivities (Scheme 1).23  
 
COOR2
NHAcR1
COOR2
NHAcR1
[Rh/L*],  H2 *
96-100% ee
R1 = Ph, H
R2 = H, Me
 
Scheme 1. Asymmetric hydrogenation of enamides using chiral diphosphine ligands 
 
One of the outstanding industrial achievements using these chiral ligands in 
asymmetric catalysis is the widely known Takasago’s industrial synthesis of (−)-menthol (4) 
starting from myrcene.  The crucial step is asymmetric isomerization of diethylgeranylamine 
(1) to 3-(R)-citronellal enamine (3) using the catalyst [(S)-BINAP]2Ru+ClO4- (2) (Scheme 2).24 
 
                                                 
23
 Ojima, I. Catalytic Asymmetric Synthesis, 2nd ed.; Wiley-VCH: Weinhem, 2000. 
24
 a) Tani, T.; Yamagata, T.; Akutagawa, S.; Kumobayashi, H.; Taketomi, T.; Takaya, H.; Miyashita, A.; Noyori, 
R.; Otsuka, T. J. Am. Chem. Soc. 1984, 106, 5208.  
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CH3
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Scheme 2. Takasago’s industrial synthesis of (−)-menthol using (S)-Binap. 
 
1.1.1 Ferrocenyl P,P-ligands 
Since the discovery of ferrocene in 1951,25 its fascinating sandwich structure has 
caught the attention of chemists as a potential platform for the preparation of new ligands for 
asymmetric catalysis.26  A very interesting structural feature in ferrocene chemistry is planar 
chirality.  This means that compounds substituted at positions 1 and 2 with different groups 
are chiral because of the loss of plane of symmetry (Figure 2). 
 
R2
R1
FeFe
R1
R2
R1 > R2
(SFc)-configuration
R1 > R2
(RFc)-configuration
 
Figure 2. Planar chirality in 1,2-disubstituted ferrocene 
 
The pioneering work of Ugi27 et al. on the C2-functionalization of enantiopure N,N-
dimethyl-1-ferrocenylethylamine, in which planar chirality was introduced into the ferrocene 
backbone using a diastereoselective ortho lithiation with an appropriate chiral ortho-directing 
group and subsequent in situ trapping with an electrophile has become a standard 
methodology for the preparation of such compounds.  In 1974 Hayashi reported the first 
example of a planar-chiral enantiopure ferrocenyl phosphine by introducing the ligand PPFA 
(N,N-dimethyl-1-[2-(diphenylphosphino)ferrocenyl]ethylamine.28  Its high reactivity was a 
                                                 
25
 Kelay, T. J.; Pauson, P. J. Nature 1951, 168, 1039. 
26
 For reviews see a) Hayashi, T. In Organic Synthesis: An Interdisciplinary Challenges; Streith, J., Prinzbach, 
H., Schill, G., Eds.; Blackwell: London, 1985, p 35-42. b) Hayashi, T.; Kumada, M. Acc. Chem. Res. 1982, 15, 
395. c) Colacot, T. J. Chem. Rev. 2003, 103, 3101. d) Arrayás, R. G.; Adiro, J.; Carretero, J. C. Angew. Chem. 
Int. Ed. 2006, 45, 7674. 
27
 Markarding, D.; Klusacek, H.; Gokel, G.; Hoffmann, P.; Ugi, I. J. Am. Chem. Soc. 1970, 92, 5389. 
28
 Hayashi, T.; Yamamoto, K.; Kumada, M. Tetrahedron Lett. 1974, 4405. 
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landmark in the development of chiral ferrocene ligands for asymmetric catalysis.  Josiphos,29 
Taniaphos,30 Walphos31 and Bophoz32 are some successful examples (Figure 3). 
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NMe2
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Fe Fe Fe
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Figure 3. Chiral ferrocenyl P,P-ligands. 
 
These ligands were successfully applied in Rh, Ru, Ir, and Pd-catalyzed asymmetric 
reactions providing high enantioselectivities and also noteworthy applications in industrial 
chemistry.26c  One of the intensive application to mention here is the preparation of (+)−Biotin 
(Lonza AG)33,34 and (S)-Metolachlor® (Syngenta)33,35 using Josiphos by transition-metal-
catalyzed hydrogenation reactions (Scheme 3). 
 
                                                 
29
 Togni, A.; Breutel, C.; Schnyder, A.; Spindler, F.; Landert, H.; Tijani, A. J. Am. Chem. Soc. 1994, 116, 4062.  
30
 Ireland, T. Grossheimann, G.; Wiesser-Jeunesse, C.; Knochel, P. Angew. Chem. Int. Ed. 1999, 38, 3212. 
31
 Sturm, T.; Weissensteiner, W.; Spindler, F. Adv. Synth. Catal. 2003, 345, 160. 
32
 Boaz, N. W.; Debenham, S. D.; Mackeniz, E. B.; Large, S. E: Org. Lett. 2002, 4, 2421. 
33
  Togni, A. Angew. Chem. Int. Ed. 1996, 35, 1475.  
34
 McGarrity, J.; Spindler, F.; Fuchs, R.; Eyer, M (Lonza AG), EP-A624587A2, 1995, [Chem. ABstr. 1995, 
122P8111369q]. 
35
 Spindler, F.; Pugin, B.; Jalett, H.-P.; Buser, U. P.; Blaser, H.-U. In Catalysis of Organic Reactions, Malz, Jr., 
R. E. Ed.; Dekker: New York, 1996, Vol. 68, p 153. 
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Scheme 3. Industrial preparation of (−)-Biotin and (S)-Metolachlor® using ferrocenyl P,P-
ligand Josiphos. 
 
Another very successful ferrocenyl ligand, reported by Knochel et al,30 which has found 
broad applications in transition-metal-catalyzed asymmetric catalysis, is Taniaphos (5).  This 
ligand was prepared via diastereoselective ortho-lithiation using Ugi’s amine (Scheme 4). 
 
BrOAc
BrO BrOH
PAr2NMe2
PAr2
BrNMe2
Fe
Br
Cl
O
Fe
AlCl3,      78%
Ac2O, pyr R2NH
CH3CN
Fe
Fe
N
B O
Ph
Ph
Me
BH3.SMe2
Fe
Fe
 93%, 96% ee
> 99% ee after recrystallisation
quant.
1) t-BuLi (3.5 equiv.)
2) ClPAr2 (2.5 equiv.)
5: 33-85%
Taniaphos
 77-95%
 
Scheme 4. Preparation of Taniaphos 
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The second generation of Taniaphos was later prepared by replacing the dimethylamino 
group with a methoxy group at the α-position.  This was prepared via diastereoselective 
ortho-lithiation using a sulfoxide (Scheme 5)36. 
 
PPh2OH
Fe Fe
S
O
:
1. LDA, THF, -78 °C
2.
PPh2
CHO
- 78 °C, to rt
SOTol
PPh2OH
SOTol
Fe
45% 37%
PPh2OH
SOTol
Fe
1. KH, THF, 0 °C
2. MeI, 0 °C, to rt
PPh2OMe
SOTol
Fe
1. tBuLi, THF, - 78 °C
2. ClPPh2, -78 °C to rt
PPh2OMe
PPh2
Fe
76% 76%
PPh2OH
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PPh2OMe
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PPh2OMe
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Fe Fe Fe
1. KH, THF, 0 °C
2. MeI, 0 °C, to rt
1. tBuLi, THF, - 78 °C
2. ClPPh2, -78 °C to rt
88% 68%
5b: Taniaphos derivative
5b: Taniaphos derivative
 
Scheme 5. Synthesis of second generation Taniaphos via sulfoxide approach 
 
Taniaphos has been successfully applied in Rh and Ru-catalyzed hydrogenation of 
olefins, β-keto esters,37 Cu-catalyzed 1,4-addition of cyclic and acyclic unsaturated ketones38, 
and aldol, Mannich-type reactions (Scheme 6).39 
 
                                                 
36
 Lotz, M.; Polborn, K.; Knochel, P. Angew. Chem. Int. Ed. 2002, 41, 4708. 
37
 Ireland, T.; Tappe, K.; Grossheimann, G.; Knochel, P. Chem. Eur. J. 2002, 8, 843. 
38
 a) Feringa, B. L.; Badorrey, R.; Pena, Diego.; Harutyunyan, S. R.; Minnaard, A. J. Proc. Natl. Acad. Sci. 
2004, 101, 5834. b) Spindler, F.; Malan, C.; Lotz, M.; Kesselgruber, M.; Pittelkow, U.; Rivas-Nass, A.; Briel, 
O.; Blaser, H.-U. Tetrahedron: Asymmetry, 2004, 15, 2299. c) Kreis, M.; Friedmann, C. J.; Braese, S. Chem. 
Eur. J. 2005, 11, 7387. d) Llamas, T.; Gomez-Arrayas, R.; Carretero, J. C. Org. Lett. 2006, 8, 1795. e) Lopez, F.; 
Van Zijl, A. W.; Minnaard, A. J.; Feringa, B. L. Chem. Commun. 2006, 409. f) Zhao, D.; Oisaki, K.; Kanai, M.; 
Shibasaki, M. J. Am. Chem. Soc. 2006, 128, 14440. g) Geurts, K.; Fletcher, S. P.; Feringa, B. L. J. Am. Chem. 
Soc. 2006, 128, 15572. h) Chuzel, O.; Deschamp, J.; Chausteur, C.; Riant, O. Org. Lett. 2006, 8, 5943. 
39
 Oisaki, K.; Zhao, D.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2006, 128, 7164. 
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Scheme 6. Application of Taniaphos in asymmetric catalysis. 
 
1.2 Chiral P,N-ligands 
P,N-ligands are another important class in chiral ligands.  To date, many P,N-ligands 
have been prepared and successfully applied in asymmetric catalysis.40  The success of these 
mixed donor ligands in metal-catalyzed asymmetric catalysis arises from the fact that they are 
a class of hemi labile ligands possessing a combination of hard and soft donor atoms.41  
Therefore, the different features associated with each donor atom provide a unique reactivity 
to their metal complexes.42  Axially chiral aminophosphines such as Quinap,43 MAP,44 
PINAP45, Pyphos46, phosphoryloxazolines such as PHOX47, iminophosphine ligands48 such as 
VALAP49 and phosphinoarylpyridine ligands50 such as PINPHOS, CANPHOS,51 are 
representative examples of the variety of classes in this area (Figure 4). 
                                                 
40
 Nishiyama, H. Comprehensive Asymmetric Catalysis; Jacobsen, E. N., Pfaltz, A., Yamamoto, H., Eds.; 
Springer: New York, 1999, Vols. 1-3. 
41
 Chelucci, G.; Orrù, G.; Pinna, G. A. Tetrahedron 2003, 59, 9471. 
42
 a) Espinet, P.; Soulantica, K. Coord. Chem. Rev. 1999, 193-195, 499. b) Molina, P.; Arques, A.; García, A.; 
Ramríez de Arellano, M. C. Eur. J. Inorg. Chem. 1998, 1359 and references therein. 
43
 Alcock, N. W.; Brown, J. M. Tetrahedron Asymmetry: 1993, 4, 743. 
44
 Vyskočil, S.; Cisarova, I.; Sejbal, J.; Tislerova, I.; Smrcina, M.; Lloyd-Jones, G. C.; Stephen, S. C.; Butts, C. 
P.; Murray, M.; Langer, V. J. Am. Chem. Soc. 1999, 121, 7714. 
45
 Knöpfel, T. F.; Aschwanden, P.; Ichikawa, T.; Watanabe, T.; Carreira, E. M. Angew. Chem. Int. Ed. 2004, 43, 
5971. 
46
 Kwong, F. Y.; Yang, Q.; Mak, T. C. W.; Chan, A. S. C.; Chan, K. S. J. Org. Chem. 2002, 67, 2729. 
47
 Helmchen, G.; Pfaltz, A. Acc. Chem. Res. 2000, 33, 336. 
48
 a) Hird, A. W.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 1276. b) Hiroi, K.; Watanabe, K.; 
Tetrahedron: Asymmetry 2001, 12, 3067. 
49
 a) Saitoh, A.; Achiwa, K.; Tanaka, K.; Morimoto, T.; J. Org. Chem. 2000, 65, 4227. b) Saitoh, A.; Morimoto, 
T.; Achiwa, K. Tetrahedron: Asymmetry 1997, 8, 3567. 
50
 a) Bunlaksananusorn, T.; Polborn, K.; Knochel, P. Angew. Chem. Int. Ed. 2003, 42, 3941. b) Kasier, S.; Smidt, 
S. P.; Pfaltz, A. Angew. Chem. Int. Ed. 2006, 45, 5194. 
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Figure 4. Chiral P, N-ligands 
 
These chiral P,N-ligands have been successfully applied in Pd-catalyzed asymmetric 
alkylations52 and asymmetric Heck reactions,53 Rh-catalyzed asymmetric hydroboration 
reactions,54 Cu-catalyzed conjugated addition of dialkylzinc species to enones55 and Ir-
catalyzed asymmetric hydrogenation reactions.56 Among these chiral P,N-ligands, 
phosphanyloxazolines (6) have proved to be the most efficient chiral ligands for metal-
catalyzed asymmetric reactions.  The syntheses of chiral phosphinoxazolines were reported 
independently, by Helmchen,57 Pflatz,58 and Williams59.  The synthesis of PHOX ligands 
reported by Pfaltz et al. is shown in scheme 7. 
                                                                                                                                                        
51
 a) Malkov, A. V.; Bella M. Stará, I. G. Kočovský, P. Tetrahedron Lett. 2001, 42, 3045. b) Chelucci, G.; Saba, 
A.; Soccolini, F. Tetrahedron 2001, 57, 9989. 
52
 Lautens, M. A.; Pfaltz, A.; Allylic Substitution Reactions:. Comprehensive Asymmetric Catalysis; Jacobsen, E. 
N., Pfaltz, A., Yamamoto, H., Eds.; Springer: Heidelberg, 1999; Vol. 2, Chapter 24. 
53
 a) de Meijere, A.; Meyer, F. E. Angew. Chem. Int. Ed. 1994, 33, 3279. b) Loiseleur, O.; Meier, P.; Pfaltz, A. 
Angew. Chem. Int. Ed. 1996, 35, 200. c) Ripa, L.; Hallberg, A. J. Org. Chem. 1997, 62, 595. d) Shibasaki, M.; 
Vogel, E. M.; Ohshima, T. Adv. Synth. Catal. 2004, 346, 1533. 
54
 Carroll, A.-M.; O’Sullivan, T. P.; Guiry, P. J. Adv. Synth. Catal. 2005, 347, 609. 
55
 a) Mizutani, H.; Degrado, S. J.; Hoveyda, A. H. J. Am. Chem. Soc. 2002, 124, 779. b) Degrado, S. J.; 
Mizutani, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2002, 124, 13362. 
56
 Källström, K.; Munslow, I.; Andersson, P. G. Chem. Eur. J. 2006, 12, 3194. 
57
 a) Spring. J.; Helmchen, G. Tetrahedron Lett. 1993, 34, 1769. b) Helmchen, G.; Kudis, S.; Sennhenn, P.; 
Steinhagen, H. Pure Appl. Chem. 1997, 69, 513. 
58
 a) von Matt, P.; Pflatz, A. Angew. Chem. Int. Ed. 1993, 32, 566. b) Pfaltz, A. Acta Chem. Scand. B 1996, 50, 
189. 
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Scheme 7. Synthesis of PHOX-ligands by Pfaltz’s method 
 
1.2.1 Chiral Ferrocenyl P,N-ligands 
Similar to the chiral ferrocenyl P,P-ligands, many chiral P,N-ligands based on the 
ferrocene backbone have been prepared and found successful applications in asymmetric 
catalysis.26  Ferrcocenyl oxazolinylphosphine (Fc-PHOX) its analogues,60 PPFA, 28,40  and 
PPFA-type ligands61 have proved to be the most successful ligands for asymmetric catalysis.  
Fc-PHOX ligands have been successfully applied in an amazing variety of enatioselective 
processes.  Some of the successful applications to mention here are Pd-catalyzed asymmetric 
Heck reactions,62 Cu-catalyzed asymmetric 1,3-dipolar addition reactions,63 Ru and Ir-
catalyzed hydrogenation reactions (Scheme 8).64 
                                                                                                                                                        
59
 a) Dawson, G. J.; Frost, C. G.; Williams, J. M. J.; Coote, S. J. Tetrahedron Lett. 1993, 34, 3149. b) Williams, 
J. M. J. Synlett 1996, 705. 
60
 Sutcliffe, O. B.; Bryce, M. R. Tetrahedron: Asymmetry 2003, 14, 2297. 
61
 a) Chen, W.; Mbafor, W.; Roberts, S. M.; Whittall, J. Tetrahedron: Asymmetry 2006, 17, 550. b) Cammidge, 
A. N.; Crépy, K. V. L. Tetrahedron 2004, 60, 4377. c) Bringmann, G.; Hamm, A.; Schraut, M. Org. Lett. 2003, 
5, 2805. d) Böttcher, A.; Schmalz, H.-G. Synlett 2003, 1595. e) Wang, M.-C.; Liu, L.-T.; Hua, Y.-Z.; Zhang, J.-
S.; Shi, Y.-Y.; Wang, D.-K. Tetrahedron: Asymmetry 2005, 16, 2531. f) Matsumura, S.; Maeda, Y.; Nishimura, 
T.; Uemura, S. J. Am. Chem. Soc. 2003, 125, 8862. 
62
 a) Deng, W.-P.; Hou, X.-L.; Dai, L.-X.; Dong, X.-W. Chem. Commun. 2000, 1483. b) Tu.; T.; Deng, W.-P.; 
Hou, X.-L.; Dai, X.-L.; Dong, X.-C. Chem. Eur. J. 2003, 9, 3073. c) Kiely, D. Guiry, P. J. J. Organomet. Chem. 
2003, 687, 545. d) Tu, T.; Hou, X.-L.; Dai, X.-L. Org. Lett. 2003, 5, 3651. 
63
 a) Gao, W.; Zhang, X.; Raghunath, M. Org. Lett. 2005, 7, 4241. b) Yan, X.-X.; Peng, Q.; Zhang, Y.; Zhang, 
K.; Hong, W.; Hou, X.-L.; Wu, Y.-D. Angew. Chem. Int. Ed. 2006, 45, 1979. 
64
 Ru-catalyzed reactions a) Naud, F.; Malan, C.; Splinder, F.; Rüggeberg, C.; Schmidt, T. Blaser, H.-U. Adv. 
Synth. Catal. 2006, 348, 47. b) Tellers, D. M.; Bio, M.; Song, Z. J.; McWilliams, J. C.; Sun, Y. Tetrahedron: 
Asymmetry 2006, 17, 550. c) Nishibayashi, Y.; Yamauchi, A.; Onodera, G.; Uemura, S. J. Org. Chem. 2003, 68, 
5875. Ir-catalyzed reactions d) Lu, S.-M.; Han, X.-W.; Zhou, Y.-G. Adv. Synth. Catal. 2004, 346, 909. e) 
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Scheme 8. Applications of Fc-PHOX ligands in asymmetric catalysis  
 
 
2. Objectives 
 
As shown in the previous section, Taniaphos and its analogues compounds are 
important ligands in asymmetric catalysis.  To further explore this class of compounds, the 
main objectives of this work were firstly the development of new chiral P,P- or P,N-ligands 
based on the Taniaphos structure, and secondly to study their applications in transition-metal-
catalyzed asymmetric reactions. 
 
2.1 Ferrocenyl P,P-ligands  
The first objective of this work was to prepare the new chiral ferrocenyl P,P-ligand 8 
(Figure 5) in enantiomerically pure form and use this ligand in asymmetric catalysis.   
 
                                                                                                                                                        
Giernoth, R.; Krumn, M. S. Adv. Synth. Catal. 2004, 346, 989. f) Onodera, G.; Nishibayashi, Y.; Uemura, S. 
Angew. Chem. Int. Ed. 2006, 45, 3819. 
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Figure 5. New chiral ferrocenyl P,P-ligand 8 
 
2.2 Chiral Ferrocenyl P,N-ligand 
Based on the progress in the synthesis of new chiral P,N-ligands and their successful 
applications in asymmetric catalysis, it was of interest to prepare chiral P,N-ligands based on 
the Taniaphos structure.  The objectives of this work were to synthesize new chiral ferrocenyl 
P,N-ligands 9 and 10 (Figure 6) by replacing one of the phosphines by a N-donor group such 
as pyridine in Taniaphos and to test their efficiency in asymmetric catalysis. 
 
PPh2
PPh2
OMe
N
PAr2
OMe
R N
PAr2
OR1
R
Fe Fe Fe
9 105b: Taniaphos derivative
 
Figure 6. New chiral ferrocenyl P,N-ligands 9 and 10 
 
2.3 Bis-ferrocenyl P,P-ligands 
The third objective of this work was to prepare the new ferrocenyl ligand 11 (Figure 
7), which bares structural similarities to Taniaphos and to apply this ligand in metal-catalyzed 
asymmetric reactions. 
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Figure 7. New chiral bis-ferrocenyl P,P-ligand 11 
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2.4. Chiral Paracyclophane P,P-ligands 
The final objective was to synthesize new paracyclophane diphosphines of type 12, 
(Figure 8) bearing two different kinds of phosphines and test their efficiency in asymmetric 
catalysis.  
PR12
PR22
12
R1 = Ph
R2 = 4-F-C6H4
      = 3,5-(CF3)2-C6H3
      = 3,5-(CH3)2-C6H3
 
Figure 8. New paracyclophane diphosphines of type 12 
 
 
 
Results and Discussion 
 
1. Synthesis of Planar Chiral Ferrocenyl P,P-ligand and their 
applications in asymmetric catalysis 
 
1.1. Introduction 
 
1.1.1 Chiral ferrocenyl ligands with planar chirality 
In recent years many chiral ferrocenyl ligands have been prepared and have found 
broad applications in asymmetric catalysis.  Many of the chiral ferrocenyl ligands developed, 
possess both planar and central chiralities, although there are some examples such as 
Fesulphos65, MOPF66 and Taniaphos derivatives37, showing only planar chirality.  Fesulphos 
is a bidentate P,S-ligand and has been successfully applied in asymmetric catalysis.  Whereas, 
Mopf (monophosphine) and Taniaphos derivative 5b (bisphosphine) have found limited 
applications in asymmetric catalysis due to the moderate selectivities observed (Scheme 9). 
 
                                                 
65
 García Mancheño, O.; Priego, J.; Cabrera, S.; Gómez Arrayás, R.; Llamas, T.; Carretero, J, C. J. Org. Chem. 
2003, 68, 3679. 
66
 a) Jensen, J. F.; Johannsen, M. Org.Lett. 2003, 5, 3025. b) Jensen, J. F.; Søtofte, I.; Sørensen, H. O.; 
Johannsen, M. J. Org. Chem. 2003, 68, 1258. 
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Scheme 9. Applications of Fesulphos, MOPF and Taniaphos-derivative 5c in asymmetric 
catalysis. 
 
In order to further explore planar chiral ferrocenyl ligands such as 5c, our goal was to prepare 
ligand 8 (Figure 9) and investigate its properties in asymmetric catalysis. 
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Figure 9. New chiral ferrocenyl ligand 8 for asymmetric catalysis 
 
1.1.2. Synthesis of 1,2-disubstituted ferrocenes via diastereoselective ortho-metallation 
Chiral 1,2-disubstituted ferrocenes have found much attention since these building 
blocks have emerged as a premiere structural ligand motif in metal-catalyzed asymmetric 
reactions.67  In 1970, Ugi reported the first example of diastereoselective ortho-lithiation on 
                                                 
67
 Richards, C. J.; Locke, A. J. Tetrahedron: Asymmetry 1998, 9, 2377. 
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N,N-dimethylamino-1-ferrocenylethylamine using the N,N-dimethylamino group as an ortho-
directing group (Scheme 10).68 
 
NMe2
Me
PPh2
NMe2
Me
Fe
BuLi, THF, -78 °C
PPh2Cl
Fe
(R,SFc)-PPFA
 
Scheme 10. Diastereoselective ortho-lithiation on Ugi amine.  
 
In addition to Ugi’s amine, a large number of other chiral ortho-directing groups have been 
described such as sulfoxides,69 acetals,70 oxazolines,71 azepines,72 pyrrolidines,73 
hydrazones,74 sulfoximines,75 imidazolines76 and phosphine oxides.77  Among these, the Ugi 
amine method, the oxazoline approach, and the sulfoxide approach are the most widely used 
strategies for the preparation of chiral 1,2-ferrocenes (Figure 10). 
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Figure 10. Directing groups for the diastereoselective ortho-lithiation on ferrocenes. 
 
The Kagan sulfoxide approach has significantly enlarged the possibilities for preparing 
structurally diverse 1,2-substituted ferrocenes.  The major advantage of this method is that, 
after a diastereoselective ortho-lithiation and substitution, the sulfoxide group can be removed 
                                                 
68
 Gokel, G.; Marquarding, D.; Ugi, I. J. J. Org. Chem. 1972, 37, 3052. 
69
 Rebière, F.; Riant, O.; Ricard, L.; Kagan, H. B. Angew. Chem. Int. Ed. 1993, 32, 568. 
70
 Riant, O.; Samuel, O.; Kagan, H. B. J. Am. Chem. Soc. 1993, 115, 5835. 
71
 a) Richards, C. J.; Damalidis, T.; Hibbis, D. E.; Hursthouse, M. B. Synlett 1995, 74. b) Sammakia, T.; Latham, 
H. A.; Schaad, D. R. J. Org. Chem. 1995, 60, 10. 
72
 Wildhalm, M.; Mereiter, K.; Bourghida, M. Tetrahedron: Asymmetry 1998, 9, 2983. 
73
 Farrell, Y.; Goddard, R.; Guiry, P. J. J. Org. Chem. 2002, 67, 4209. 
74
 Enders, D.; Peters, R.; Lochtman, R.; Raabe, G. Angew. Chem. Int. Ed. 1999, 38, 2421. 
75
 Bolm, C.; Kesselgruber, M.; Muñiz, K.; Raabe, G. Organometallics 2000, 19, 1648. 
76
 Peters, R.; Fischer, D. F. Org. Lett. 2005, 7, 4137. 
77
 Nettekoven, U.; Widhalm, M.; Kamer, P. C. J.; Van Leeuwen, P. W. N. M.; Mereiter, K. Lutz, M. 
Organometallics 2000, 19, 2299. 
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by tert-butyllithium mediated C-S cleavage and the resulting ferrocenyllithium can be reacted 
with an electrophile (Scheme 11).78 
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E1
Fe
E2t-BuLi, THF, -78 °C
E2+
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Scheme 11. Preparation of 1,2-disubstituted ferrocenes via Kagan sulfoxide approach 
 
Ligand 8 could therefore be formed in enantiomerically pure form using Kagan’s sulfoxide as 
shown retrosynthetically in scheme 12. 
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Scheme 12. Synthetic approach to chiral ferrocenyl P,P-ligand 8  
 
The diphosphine 8 can be prepared by the consecutive, onepot exchange of bromine and 
sulfoxide on 16, followed by the addition of chlorodiphenylphosphine.  Substrate 16 can be 
prepared via the diastereoselective lithiation of 14.  
 
1.2. Synthesis of Chiral Planar Ferrocenyl P,P-ligand 8 
 
1.2.1. Diastereoselective ortho-lithiation  
 
The diastereoselective ortho-lithiation on the Kagan sulfoxide 14 using LDA proceeded with 
>98% de.  The resulting ferrocenyllithium was reacted with 1579 at -78 °C to furnish the 
corresponding ferrocenyl silane compound 16 in 93% yield and 98% de (Scheme 13). 
 
                                                 
78
 a) Guillaneux, D.; Kagan, H. B. J. Org. Chem. 1995, 60, 2502. b) Riant, O. ; Argouarch, G. ; Guillaneux, D. ; 
Samuel, D. ; Kagan, H. B. J. Org. Chem. 1998, 63, 3511. 
79
 Acemoglu, M. J. Lable Compd. Radiopharm. 2002, 45, 361. 
Results and Discussion   17
Si
Br
SOTol
MeMe
S
O
:
FeFe
Si Cl
MeMe
14: >99% ee
15
16: 93%; 98% deBr
1. LDA (1.1 equiv), 
THF, -78 °C, 30 min
2.
-78 °C, 1 h;
  rt, 1 h
 
Scheme 13.Diasteroselective ortho-lithiaton of 14 and reaction with electrophile 15 
 
Treatment of 16 with t-BuLi (4.2 equiv) in THF at -78 °C, followed by the addition of 
chlorodiphenylphosphine led to a mixture of compounds that contained mono and 
disubstituted phosphines as well as the protolysis product (Scheme 14).  
 
Si
Br
SOTol
MeMe
Si
PPh2
PPh2
MeMe
Si
PPh2
H
MeMe
Si
H
PPh2
MeMe
Si
H
H
MeMe
Fe Fe
Fe
Fe
Fe
16
1. t-BuLi (4.0 equiv), 
THF, -78 °C, 10 min
2. PPh2Cl, -78 °C
1 h; rt, 2 h
21% 30%
10% 10%
 
Scheme 14. Exchange of sulfoxide and bromine using t-BuLi 
 
1.2.2. Optimization for selective Sulfoxide-Lithium exchange 
Since we are obtaining a complex mixture with the simultaneous exchange on 16 using tBuLi, 
we decided to perform a stepwise exchange of the sulfoxide and bromine.  We screened some 
organomagnesium reagents and organolithium reagents for a selective exchange of the 
sulfoxide.  For this study we have chosen the (RFc,S)-(p-tolylsulfinyl)-2-bromoferrocene 17 as 
a test substrate.  The bromoferrocene 17 can be synthesized via diastereoselective ortho-
lithiation of sulfoxide 14, followed by the addition of 1,1,2,2-tetrafluoro-1,2-dibromoethane 
(Scheme 15).  
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14 17: 88%; 98% de
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Scheme 15. Preparation of bromo-sulfoxide 17 
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With the test substrate in hand, we screened several organomagnesium and lithium reagents, 
the results are summarized in Table 1. 
 
Table 1. Screening of organometallic reagents for a selective sulfoxide-lithium exchange on 
17 
SOTol
Fe
17
1. RM, THF, -78 °C
2. H3O+
Br
H
Fe
Br
SOTol
Fe
H
+ HFe
H
+
18a 18b 18c
 
 
Product (%)a Entry Organometallic reagent (RM) 
18a 18b 18c 
1 t-BuLi (2.2 equiv) 
− − 
45 
2 n-BuLi (1.1 equiv) 
− 
75 <5 
3 i-PrMgCl (1.1equiv) 25 5 Traces 
4 PhMgCl (1.1 equiv) 
− − − 
5 PhLi (1.1 equiv) 75 4 <1 
a yields refers to the isolated products 
 
Sulfoxide/lithium-exchange using t-BuLi (-78 °C, 10 min) on 17 led to complete exchange of 
both the bromine and the sulfoxide and gave product 18c in 90% yield (entry 1).  Whereas, n-
BuLi (-78 °C, 15 min) selectively exchanged the bromine, providing the product 18b in 75% 
yield (entry 2).  Very poor exchange rate was observed with i-PrMgCl (-50 °C, 1 day), but, 
after long reaction times, we also observed the partial exchange of bromine (entry 3).  No 
exchange (neither bromine nor sulfoxide) was observed with PhMgCl (entry 4).  Exchange of 
sulfoxide using PhLi80 (-78 °C, 10 min) proceeded selectively and afforded the desired 
product 18a in 75% yield. We also noticed a partial exchange of bromine and also traces of 
product 18c (entry 5). 
 
Although exchange of the sulfoxide using PhLi proceeded selectively, the stability of the α-
bromoferrocenyllithium species to racemization was unknown.  Quenching of the 
ferrocenyllithium species 19 with diphenyldisulfide as an electrophile using various reaction 
times gave the ferrocenyl sulfide 20a in 30-72% yield.  Measurement of the enantiopurity of 
the sulfone 21 formed via oxidation with m-CPBA gave an indication of the stability of 
bromo-lithium species 19 (Table 2). 
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 Kloetzing, R.J.; Knochel, P. Tetrahedron: Asymmetry 2006, 17, 116. 
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Table 2. Verifying the configurational stability of α-bromoferrocenyllithium species 19 
 
SOTol
Br
Li
Br
SPh
Br
SO2Ph
Br
Fe
Et2O, t min
19
Fe
20a
Fe
21
Fe
17
mCPBA, rt
PhLi (1.2 equiv),
 -78 °C PhSSPh, THF,
-78 °C, 30 min;
rt, 1.5 h
CH2Cl2, 1 h
 
 
 
Product 20a Product 21 Entry Quenching the 
lithium species at t 
(min) yield(%)
a
 yield(%)a ee(%)b 
1 5 72 90 97 
2 10 70 91 86 
3 15 66 90 64 
4 20 50 85 49 
5 60 30 92 Rac 
a
 isolated yield of analytically pure sample. b enantioselectivity was measured by chiral  
HPLC using a chiralcel OD-H column 
 
As the time before the bromo-lithium species was quenched with the electrophile was 
increased (5 to 60 min), the enantioselectivity of the desired product 21 dropped.  It may be 
that 19 was undergoing a halogen dance81 and thus led to racemization of the product.  A 
possible disadvantage of this method is that the lithium species 19 must be quenched with 
very reactive electrophiles.  To examine the scope of this method, the lithium species 19 was 
quenched with a variety of electrophiles to form 20a-e in 69-79% yield (Scheme 16).  
Compound 20c is an especially interesting building block for many cross-coupling reactions 
and can be accessed only by using this method. 
 
SOTol
Br
Li
Br
E
Br
Fe Et2O, 5 min
19
Fe
20a-e
Fe
17
PhLi (1.2 equiv), 
-78 °C E+
-78 °C, 30 min;
rt, 1-2 h
20a: E = SPh      72%
20b: E = CHO     69%
20c: E = I           70%
20d: E = SiMe3     70%
20e: E = P(S)Ph2 79%
 
Scheme 16. Preparation of bromoferrocenes of type 20 by the reaction of the lithium species 
19 with various electrophiles 
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Application of these findings to silyl ferrocene derivative 16, phenyllithium proved to be the 
appropriate reagent for the selective sulfoxide/lithium-exchange (Scheme 17).  The 
sulfoxide/lithium-exchange on 16 using PhLi, followed by the addition of 
chlorodiphenylphosphine and in situ protection of the resulting phosphine with sulfur (S8, 
BuNH2), provided the thionophosphine compound 22 in 88% yield (Scheme 17). 
 
Si
Br
SOTol
MeMe Si
Br
PPh2
MeMe
Si
Br
I
MeMe
Fe Fe Fe
16 22: 88%
1. PhLi, Et2O, -78 °C
    5-10 min
2. PPh2Cl, THF, -78 °C
    45 min; rt, 2 h
3. S8, BuNH2, rt, 12 h
1. PhLi, Et2O, -78 °C
    5-10 min
2. I2, THF, -78 °C, 
    30 min; rt, 1.5 h
23: 89%
S
 
Scheme 17. Selective sulfoxide/lithium exchange on the substrate 16 using phenyllithium 
 
Further, bromine/lithium-exchange on 22 using n-BuLi, followed by reaction with 
chlorodiphenylphosphine and protection of the phosphine with sulfur, provided the air-stable 
diphosphine disulfide 24 in 89% yield.  Deprotection of diphosphine disulfide 24 was 
smoothly accomplished using Raney-Ni82 in methanol, leading to the diphosphine 8 in 92% 
yield (Scheme 18). 
 
Si
Br
SOTol
MeMe Si
Br
PPh2
MeMe
S
Si
PPh2
PPh2
MeMe
S
S
Si
PPh2
PPh2
MeMe
Fe
Fe
Fe
Fe
16 22: 88%
1. PhLi, Et2O, -78 °C
    5-10 min
2. PPh2Cl, THF, -78 °C
    45 min; rt, 2 h
3. S8, BuNH2, rt, 12 h
1. n-BuLi, THF, -78 °C
    15 min
2. PPh2Cl, THF, -78 °C
    45 min; rt, 2 h
3. S8, BuNH2, rt, 12 h
24: 89% (SFc)-8: 92%
Raney-Ni, MeOH
rt, 12 h
 
Scheme 18. Preparation of chiral ferrocenyl P,P-ligand 8 
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1.3. Applications in asymmetric catalysis 
 
1.3.1. Rh-catalyzed hydrogenation of olefins 
Exploration of the efficiency of this new chiral ferrocenyl P,P-ligand 8 in the Rh-
catalyzed hydrogenation of α-acetamidocinnamate 25 to phenylalanine derivative 26 was 
conducted.  Despite the hydrogenation reaction being quantitative, no selectivity was 
observed in the desired product 26 (Scheme 19). 
 
Ph
CO2Me
NHAc Ph
CO2Me
NHAc
H
[Rh(nbd)2]BF4 
(1 mol%)
 Tol:MeOH (1:1)
H2, 10 bar, rt, 4 h
26: >95%; rac.25
 
Scheme 19. Application of 8 in Rh-catalyzed hydrogenation of 25 
 
1.3.2. Pd-catalyzed asymmetric allylic alkylations 
The application of 8 in Pd(0)-catalyzed allylic substitution reactions of racemic 1,3-
diphenylprop-2-en-1-yl acetate (±)-27 with dimethylmalonate employing Trost’s procedure83 
was investigated.  [Pd(C3H5)Cl]2 was used as the catalyst precursor in the presence of a 
mixture of dimethyl malonate, N,O-bis(trimethylsilyl)acetamide (BSA) and potassium acetate 
in CH2Cl2. Reaction at -20 °C using the ligand 8 provided the desired compound 28 in 90% 
yield and 30% ee (Scheme 20). 
 
Ph Ph
OAc
Ph Ph
MeO2C CO2Me
27 28: 90%; 30% ee
[Pd(C3H5)Cl]2 (1 mol%)
  8 (2 mol%)
CH2(CO2Me)2, KOAc (5 mol%)
BSA (3 equiv), CH2Cl2, -20 °C, 10 h
 
Scheme 20. Pd-catalyzed allylic alkylation using ferrocenyl ligand 8 
 
1.4. Conclusion 
In conclusion, the synthesis of the chiral P,P-ligand 8 was achieved.  We have shown that 
phenyllithium is the most efficient reagent for a selective sulfoxide/lithium-exchange on 
bromoferrocenyl sulfoxide 17.  Furthermore, we have applied this methodology to the 
synthesis of various ferrocene derivatives of type 20.  The ligand 8 was applied to Rh-
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catalyzed asymmetric hydrogenations and Pd-catalyzed allylic alkylations and very poor 
selectivities were observed.  One of the possible reasons for the poor enantioselectivity using 
ligand 8 is that the C-Si bond is so long that the two donor phosphines are too far away from 
each other to form a favourable bite angle in the complex with the transition metal. 
 
 
 
2. Synthesis of Chiral Ferrocenyl P,N-ligands and their 
Application in Asymmetric Catalysis. 
 
2.1 Introduction  
 
Chiral P,N-ligands are one of the most important classes of chiral ligands because they have 
proved to be efficient in transition-metal-catalyzed asymmetric reactions, particularly in areas 
where C2-symmetrical ligands failed.84  During the past two decades an increasing number of 
P,N-ligands and their catalysts were reported for a wide range of asymmetric reactions and 
improved the efficiency of existing processes.  2-Phosphinylphenyloxazoline ligands, one of 
the most successful chiral P,N-ligands, were reported by Pfaltz et al.7  These ligands have 
proved to be especially efficient in Ir-catalyzed asymmetric hydrogenation reactions of olefins 
(Scheme 21).85 
 
[Ir(cod)(L)]BARF 
(1 mol %)
H2, 50 bar, CH2Cl2
>99%; 99% ee
L =
O
N
tBu
P(o-Tol)2
 
Scheme 21. Asymmetric hydrogenation of olefins using Pflatz’s chiral phospineoxazoline 
ligand 
 
In addition to this Ir-catalyzed hydrogenation of olefins, Knochel et al. have demonstrated the 
iridium catalyzed hydrogenation of enamides such as 25 to amino acid derivatives 26 using a 
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chiral terpene-derived P,N-ligand.  This is of interest as it allows for the potential Ir-catalyzed 
formation of highly enantiomerically pure nonnatural α-amino acid derivatives, which have 
previously been extensively studied using Rh and Ru-catalysts (Scheme 22). 
 
CO2Me
NHAc
PPh2
N
CO2Me
NHAc
[Ir(cod)(L)]BARF
H2, 1 bar, CH2Cl2, 50 °C
26: >99%; 96% ee
L =
25
 
Scheme 22. Ir-catalyzed reduction of enamide 25 using the chiral terpene-derived P,N-ligand 
 
Recently, our group reported a ferrocenyl P,N-ligand with both planar and central chiralities 
and found very good applications in Rh-catalyzed hydroboration reactions and Pd-catalyzed 
asymmetric allylic alkylation reactions (Scheme 23).86 
 
PPh2
N
OAc
OH
CH(CO2Me)2
OH
Fe
L =
[Pd(C3H5)Cl]2 (1 mol%)
  L (4 mol%)
CH2(CO2Me)2, KOAc (4.6 mol%)
BSA (2 equiv), CH2Cl2, rt, 20 h 76%; 91% ee
+
1. Catecholborane, THF, -45 °C
[Rh(cod)2]BF4 (1 mol%)
 L ( 2 mol%)
2. NaOH, H2O2 64:36
92% ee
 
Scheme 23. Ferrocenyl P,N-ligands for asymmetric catalysis. 
 
This impressive progress on the successful applications of P,N-ligands in asymmetric 
catalysis encouraged us to design and synthesize a new chiral P,N-ligand for asymmetric 
catalysis.  The aim of this work was to synthesize chiral P,N-ligands analogous to Taniaphos, 
which possess both planar and central chirality elements and have a –NMe2 or a –OMe group 
in the side chain. The ligand structure is described in figure 11. 
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PPh2
PPh2
OMe
N
PAr2
OMe
R N
PAr2
OR1
R
Fe Fe Fe
5b: Taniaphos derivative 9 10R = H, Ph, tBu
R1 = Bn, H
 
Figure 11. New ferrocenyl P,N-ligands 9-10 
 
2.2. Synthesis of P,N-ligands 9 and 10 
 
2.2.1 Synthesis of ferrocenyl ligands 9 and 10 with a pyridine ring as a N-donor 
 
Initially we tried to synthesize the P,N-ligands 9-10 via a classical route.36  The phosphines 
9a-b can be prepared by the deprotection of the corresponding sulfides.  The phosphine 
sulfides can be prepared via the sulfoxide-lithium exchange of the corresponding ferrocenyl 
sulfoxide.  The methyl ether can be prepared through the O-methylation of the corresponding 
alcohol which can be prepared by through the diastereoselective ortho-lithiation of the 
sulfoxide 14 (Scheme 24). 
 
SOTol
N
OH
PPh2
N
OMe
PPh2
N
OMe
S
S :
O
SOTol
N
OMe
PPh2
N
OMe
PPh2
N
OMe
S
SOTol
N
OMe
SOTol
N
OH
Fe
Fe Fe
Fe
Fe
Fe
Fe
Fe Fe
N
CHO
+
14
9a
9b
 
Scheme 24. Classical approach to the P,N-ligands 9a-b 
 
Thus, treating the Kagan sulfoxide 14 with LDA at -78 °C for 30 min, followed by the 
addition of 2-pyridinecarboxaldehyde, resulted in the alcohol 29 (Scheme 25).  This alcohol 
was quite unstable at room temperature and turned black immediately after isolation. 
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S
O
:
SOTol
N
OH
Fe
Fe
29
1) LDA, THF, 
-78 °C, 30 min
2) 2-PyrCHO, -78 °C, 1 h; 
  to RT, 1.5 h
(S)-14 : >99% ee
 
 
Scheme 25. Preparation of pyridyl alcohol 29 
 
Because we met the difficulties to isolate 29, we changed our synthetic pathway towards the 
P,N-ligands of type 9 and 10.  Our new synthetic approach is outlined in the Scheme 26. 
 
Ph2P
S
S
O
Tol
:
N
OR1Ph2P
R N
OHPh2P
S
R
N
OR1Ph2P
S
RN
OR1Ph2P
R
S :
O
N
OHPh2P
S
R
Fe
Fe Fe
Fe
Fe
Fe
Fe
N
OR1Ph2P
S
R
Fe
9a-10a
9b-10b
30
14
32a-33a
32b-33b
31a
31b
 
Scheme 26. Novel synthetic approach to the chiral ferrocenyl P,N-ligands 9-10 
 
The phosphine sulfides 32a-33a and 32b-33b could be prepared by O-alkylation of the 
alcohols 31a-b.  These alcohols can be synthesized through the sulfoxide-lithium exchange on 
30, followed by the addition of the 2-pyridinecarboxaldehydes.  Phosphine sulfide 30 can be 
prepared via the diastereoselective ortho-metallation of Kagan sulfoxide 14.  Deprotection of 
phosphine sulfides 32a-33b will furnish chiral P,N-ligands 9-10.   
 
The diastereoselective lithiation of 14 using LDA, followed by the addition of 
chlorodiphenylphosphine, led to an air sensitive phosphine, which was in situ protected with 
sulfur leading to the thianophosphinyl ferrocene 30 in 88% yield.  Performance of a 
sulfoxide/lithium-exchange using phenyllithium, followed by the addition of 2-
pyridinecarboxaldehyde, led to a 3:2 mixture of diastereomeric ferrocenyl alcohols 31a and 
31b as 31 in 72% yield (Scheme 27).  
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S
O
:
S
OPh2P
S
N
OHPh2P
S
Fe Fe Fe
1) LDA, THF, 
-78 °C, 30 min
2) PPh2Cl, -78 °C, 1 h; 
  to RT, 1.5 h
3) S8, BuNH2, RT, 
2 - 4 h(S)-14 : >99% ee 30: 88%
1) PhLi, THF, 
      -78 °C, 10 min
2) 2-PyrCHO, 
   -78 °C, 1.5 h; 
     to RT, 1.5 h
31: 72% (dr: 3:2)
 
Scheme 27. Preparation of pyridyl alcohol 31 
 
This inseparable mixture of alcohols 31 was alkylated with MeI leading to the separable 
ferrocenyl methyl ethers 32a and 32b in 54% and 35% yield respectively (Scheme 28).  In a 
similar manner, the alcohol mixture 31 was benzylated using KH and benzyl bromide, leading 
to separable benzyl ethers 33a and 33b in 56% and 36% yield respectively (Scheme 28). 
 
N
ORPh2P
S
N
ORPh2P
S
N
OHPh2P
S
Fe Fe Fe
31
+
1) KH, THF, 0 °C; to  RT, 
1 h
2) RX, 0 °C, 15 min;  to RT, 
30  min
(RFc,S)-32a : R = Me; 54%
(RFc,S)-33a : R = Bn; 56%
(RFc,R)-32b : R = Me; 35%
(RFc,R)-33b : R = Bn; 36%
 
Scheme 28. Preparation of protected ferrocenyl ligands 32a-33b 
 
The stereochemistry of the two ferrocenyl ethers 32a and 32b at the α-centre was determined 
by X-ray analysis of the phosphine sulfide 32b as shown in figure 12.87   
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C10 C6
C9
C7
C8
S1
C20
C19
C12
Fe1
C21
C18
O1
P1 C11
C1 C2
C22
C5
C23
C3
C4
C29
C24 C13
C14
C28
N1
C25
C15
C27
C17
C26
C16
 
N
OMePh2P
S
Fe
(RFc,R)-32b
 
Figure 12. ORTEP drawing of 32b. 
 
The reduction of the phosphine sulfides 32a-33b was achieved smoothly with Raney-Ni in 
MeOH at 25 °C for 12 h, to furnish the air-stable chiral P,N-ligands 9a-10b in 82-88% yield 
(Scheme 29).  These ligands are quite stable towards air. 
 
N
ORPh2P
S
N
ORPh2P
S
N
ORPh2P
N
ORPh2P
Fe Fe
Fe Fe
Raney Ni, MeOH
RT, 12 h
32a : R = Me 
33a : R = Bn
(RFc,S)-9a:  R = Me; 84%
(RFc,S)-10a: R = Bn; 88%
Raney Ni, MeOH
RT, 12 h
32b : R = Me 
33b : R = Bn
(RFc,R)-9b:  R = Me; 82%
(RFc,R)-10b: R = Bn;  86%
 
Scheme 29.  Deprotection of phosphine sulfides 32a-b and 33a-b  
 
Furthermore, we have prepared the ferrocenyl P,N-ligands of type 9c-d and 10c-d by 
changing the aromatic group on the phosphorus (Scheme 32).  Thus, treating the sulfoxide 14 
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with LDA, followed by the addition of chlorobis(3,5-dimethylphenyl)phosphine, led to the 
sulfoxide 34 in 85% yield.  Performing the sulfoxide-lithium exchange with PhLi, followed 
by the addition of 2-pyridinecarboxaldehyde, provided the mixture of diastereomeric alcohols 
35 in 3:7 ratio ((RFc,S):(RFc,R)).  On the other side, the diastereoselectivity of the alcohols 
changed to 1:1, when we performed the sulfoxide-lithium exchange using tBuLi, followed by 
the addition of pyridine-2-carboxaldehyde (Scheme 30). 
 
S
O
:
S
OXyl2P
S
N
OHXyl2P
S
Fe Fe Fe
1) LDA, THF, 
-78 °C, 30 min
2) PXyl2Cl, -78 °C, 1 h; 
  to RT, 1.5 h
3) S8, BuNH2, RT, 
2 - 4 h(S) - 14 : >99 % ee 34: 85%
1) RLi, THF, 
      -78 °C, 10 min
2) 2-PyrCHO, 
   -78 °C, 1.5 h; 
     to RT, 1.5 h
35: 70% (dr: 3:7) using PhLi
35:  65% (dr: 1:1) using tBuLi
 
Scheme 30. Preparation of ferrocenyl alcohol 35 
O-alkylation of the alcohol mixture 35 using KH and CH3I or PhCH2Br led to the 
corresponding separable methyl ethers 36a (45%), 36b (44%) and benzyl ethers 37a (46%), 
37b (44%) respectively (Scheme 31). 
 
N
ORXyl2P
S
N
ORXyl2P
S
N
OHXyl2P
S
Fe Fe Fe
35
+
1) KH, THF, 0 °C; to  RT, 
1 h
2) RX, 0 °C, 15 min;  to RT, 
30  min
(RFc,S)-36a : R = Me; 45%
(RFc,S)-37a : R = Bn; 46%
(RFc,R)-36b : R = Me; 44%
(RFc,R)-37b : R = Bn; 44%
 
Scheme 31. Preparation of ferrocenyl ethers 36a-b and 37a-b 
 
Reduction of the phosphine sulfides 36a-b and 37a-b using Raney-Ni in methanol furnished 
the corresponding phosphine 9c-d and 10c-d in 80-90% yield (Scheme 32). 
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N
ORXyl2P
S
N
ORXyl2P
S
N
ORXyl2P
N
ORXyl2P
Fe
Fe Fe
Fe
Raney Ni, MeOH
RT, 12 h
36a : R = Me  
37a : R = Bn
(RFc,S)-9c:   R = Me; 90%
(RFc,S)-10c: R = Bn; 87%
Raney Ni, MeOH
RT, 12 h
36b : R = Me  
37b : R = Bn
(RFc,R)-9d:  R = Me; 89%
(RFc,R)-10d: R = Bn;  80%
 
Scheme 32. Preparation of the P,N-ligands 9c-d and 10c-d 
 
 
2.2.2. Synthesis of ferrocenyl P,N-ligands 9-10 with substituted pyridine as a N-
donor 
In addition, we directed our attention towards the preparation of chiral P,N-ligands having 
substituted pyridines as a N-donor group.  We synthesized some 2-pyridine aldehydes with 
various substituents at the 6-position. 
 
Treating 2,6-dibromopyridine with a fourfold excess of 2:1 PhMgCl⋅LiCl/CuCN mixture 
provided 6-phenyl-2-bromopyridine 39a in 82% yield.88  In a similar manner, reacting 2,6-
dibromopyridine with tBuMgCl⋅LiCl, afforded 6-tbutyl-2-bromopyridine 39b in 68% yield.  
The bromine-lithium exchange on substrates 39a and 39b using nBuLi, followed by the 
addition of DMF, furnished the 2-pyridine aldehydes 40a and 40b in 43% and 82% yield, 
respectively (Scheme 33).89 
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N BrBr
N RBr N ROHC
N RBr
1. CuCN, THF -78 °C
2. RMgCl.LiCl, THF, 
    -78 °C, 15 min; RT
     10 h 39a : R = Ph;  82%
39b : R = tBu; 68%
1. nBuLi, THF, -78 °C
    20 min
2. DMF, -78 °C, 1 h;
    RT, 1 h
39a : R = Ph
39b : R = tBu
40a : R = Ph;  43%
40b : R = tBu; 85%
38
 
Scheme 33.  Synthesis of 6-substittuted 2-pyridine aldehydes. 
 
With the precursors in hands, we started our investigation towards the preparation of the new 
P,N-ligand derivatives of type 9 and 10 with substituted pyrdines as N-donors.  Exchange of 
the sulfoxide on substrate 30 using PhLi at -78 °C, followed by the addition of 40a, led to the 
two diastereomeric alcohols 41a and 41b as an inseparable diastereomeric mixture 41 in 64% 
yield.  The diastereomeric mixture 41 was treated with KH and CH3I, to afford the readily 
separable methyl ethers 42a and 42b in 55% and 34% yield, respectively (Scheme 34). 
 
S
OPh2P
S
N
OHPh2P
S
Ph
N
OMePh2P
S
Ph N
OMePh2P
S
Ph
Fe
Fe
Fe
Fe
1) PhLi, THF, 
      -78 °C, 10 min
2) 40a,  -78 °C, 1.5 h; 
     to RT, 1.5 h
41: 64% (dr: 3:2)
+
1) KH, THF, 0 °C; to  RT, 
1 h
2) MeI, 0 °C, 15 min;  to RT, 
30  min
41
42a: 55% 42b: 34%
30
 
Scheme 34.  Preparation of 6-phenylpyridyl-substituted P,N-ligands 42a-b. 
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The deprotection of the two phosphine sulfides 42a and 42b was performed using Raney-Ni 
in MeOH at room temperature overnight, furnishing the corresponding phosphines 9e and 9f 
in 80-84% yield (Scheme 35). 
 
Fe Fe
Fe Fe
N
OMePh2P
S
Ph N
OMePh2P
Ph
N
OMePh2P
S
Ph N
OMePh2P
Ph
Raney Ni, MeOH
RT, overnight
Raney Ni, MeOH
RT, overnight
42a (RFc,S)-9e: 84%
42b (RFc,R)-9f: 80%
 
 
Scheme 35.  Preparation of the chiral P,N-ligands 9e and 9f 
 
Surprisingly, when we treated the ferrocenylsulfoxide 30 with PhLi at -78 °C, followed by the 
addition of 6-tbutyl-2-pyridinecarboxaldehyde 40b, we obtained the two diastereomeric 
alcohols 43a and 43b as separable compounds in 27% and 47% yield respectively (Scheme 
35).  Furthermore, the diastereoselectivity of the reaction was opposite to the other analogues 
31a-b, 35a-b and 41a-b (Scheme 27 and 31).  The (RFc,R) compound was obtained as the 
major diastereomeres and the (RFc,S)-compound as the minor one (Scheme 36).  This change 
in the diastereoselectivity may be because of the sterical hindrance of the t-butyl group. 
 
N
OHPh2P
S
S
OPh2P
S
N
OHPh2P
S
Fe Fe Fe
1) PhLi, THF, 
      -78 °C, 10 min
2) 40b, -78 °C
1.5 h ; to RT,
  1.5 h
+
30 43a: 27% 43b: 47%
tBu tBu
 
Scheme 36. Preparation of the phosphine sulfide 43a-b 
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Treating the two ferrocenyl alcohols 43a and 43b individually with KH and MeI or BnBr 
provided the corresponding methyl ethers 44a and 44b in 80% and 82% yield and benzyl 
ethers 45a-b in 85% yield respectively (Scheme 37).  The stereochemistry of both 
diastereomers was deduced from their 1H, 13C NMR data when compared to that of 
compounds 32a and 32b. 
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ORPh2P
S
N
OHPh2P
S
N
ORPh2P
S
N
OHPh2P
S
Fe
Fe
Fe
Fe
1) KH, THF, 0 °C; 
to  RT, 1 h
2) RX, 0 °C, 15 min; 
RT, 30  min
1) KH, THF, 0 °C; 
to  RT, 1 h
2) RX, 0 °C, 15 min; 
RT, 30  min
44a: R = Me; 80%
45a: R = Bn; 85%
44b: R = Me; 82%
45b: R = Bn; 85%
43a
43b
tBu tBu
tButBu
 
Scheme 37. Synthesis of phosphine sulfides 44a-b and 45a-b 
 
Desulfurization of the compounds 44a-b and 45a-b was smoothly accomplished using Raney-
Ni in MeOH, furnishing the chiral phosphines 9g-h and 10e-f in 80-89% yield (Scheme 38).  
We then investigated the reduction of the phosphine sulfides of the ferrocenyl alcohols 43a 
and 43b.  For this reason, we subjected the two ferrocenyl alcohols 43a-b under similar 
conditions (Raney-Ni, MeOH, rt, overnight) and obtained the corresponding phosphines 10g 
and 10h in 85% and 80% yields, respectively (Scheme 38). 
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Scheme 38. Preparation of phosphines 9g-h and 10e-h 
 
 
2.3. Applications in asymmetric catalysis 
For clarity, the structure of the chiral P,N-lignads 9a-h and 10a-h is depicted in Scheme 39. 
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Scheme 39. Overview of novel chiral P,N-ligands 9a-h and 10a-h 
 
2.3.1. Pd-catalyzed asymmetric allylic alkylation 
With the novel chiral ligands 9a-h and 10a-h in hand, we examined their applications in 
Pd(0)-catalyzed allylic substitution reactions of racemic 1,3-diphenylprop-2-en-1-yl acetate 
(±)-27 with dimethylmalonate, employing [Pd(C3H5)Cl]2 as the catalyst precursor in the 
presence of a mixture of dimethylmalonate, N,O-bis(trimethylsilyl)acetamide (BSA), and 
potassium acetate in a solvent.  The results are summarized in Table 3. 
 
Table 3. Pd(0)-catalyzed asymmetric allylic substitution of 27 with dimethyl malonate. 
 
Ph
OAc
Ph
27 28
PhPh
MeO2C CO2Me[Pd(C3H5)Cl]2 (0.5 mol%), L* (1.0 mol%)
CH2(CO2Me)2, KOAc (1.0 mol%)
BSA (3.0 equiv), solvent, 25 °C, 2-12 h
*
 
 
Entry L* Solvent T[h] Yield (%)a eeb 
1 (RFc,S)-9a THF 6 89 70(R) 
2 (RFc,S)-9a  toluene 4 94 79(R) 
3 (RFc,S)-9a  CH2Cl2 6 90 89(R) 
 4c (RFc,S)-9a CH2Cl2 12 90 97(R) 
5 (RFc,S)-10a CH2Cl2 6 90 82(R) 
6 (RFc,S)-9c CH2Cl2 6 91 89(R) 
7 (RFc,S)-10c CH2Cl2 6 87 85(R) 
8 (RFc,R)-9b CH2Cl2 8 69 25(S) 
9 (RFc,R)-10b CH2Cl2 8 60 20(S) 
10 (RFc,R)-9d CH2Cl2 8 65 25 (S) 
11 (RFc,R)-10d CH2Cl2 8 55 28(S) 
12 (RFc,S)-9e CH2Cl2 10 90 78(R) 
13 (RFc,R)-9f CH2Cl2 10 85 30(S) 
14 (RFc,S)-9g CH2Cl2 1 73 65(R) 
15 (RFc,S)-10e CH2Cl2 1 75 64(R) 
16 (RFc,S)-10g CH2Cl2 2 58 35(R) 
17 (RFc,R)-9h CH2Cl2 1 92 94(S) 
18 (RFc,R)-10f CH2Cl2 1 94 94(S) 
19 (RFc,R)-10h CH2Cl2 2 90 66(S) 
a
 Isolated yields of analytically pure product. b Enantioselectivity was determined  
by HPLC using a chiralcel OD-H column. c Reaction was performed at -20 °C 
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The results can be summarized as follows: high conversions and enantioselectivities were 
achieved in dichloromethane.  Ligands bearing (S)-configuration at the α-centre, generally 
provided good reaction rates and enantioselectivities (entries 1-7 and 12).  Exceptionally, in 
the case of P,N-ligands with a t-butyl group on the pyridine ring the (R)-isomers provided 
higher enantioselectivities compared to (S)-isomers (up to 94% ee; entries 14-19).  The P,N-
ligands bearing an alcohol group at the α-centre, such as 10g and 10h, provided mediocre 
results compared to the corresponding alkyl ethers 9g-h and 10g-h (entries 16 and 19).  These 
results show the necessity of O-alkyl groups in creating a sterical environment capable of 
providing high enantioselectivities. The difference in the reactivity of both diastereomers 
(RFc,S) and (RFc,R), is clearly supporting the concept of substrate and catalyst matched and 
mismatched interactions. 
 
2.3.2. Ir-catalyzed asymmetric hydrogenation of olefins 
 
With encouraging results from the Pd(0)-catalyzed asymmetric allylic alkylation reactions 
with the P,N-ligands 9a-h and 10a-h, we then tested the efficiency of these new P,N-ligands 
in the Ir-catalyzed asymmetric hydrogenation of olefins.   
Following, Pfaltz’s procedure,90 iridium complexes 46a-46g and 47a-47g were readily 
prepared by reacting a solution of [Ir(cod)Cl]2 and the (RFc,S)-P,N-ligand or (RFc,R)-P,N-
ligand in CH2Cl2 at room temperature for 1 h.  The chloride ion was exchanged with 
tetrakis[3,5-bis(trifluoromethyl)phenyl]borate using NaBARF in a biphasic CH2Cl2-H2O 
system.  The resulting orange BARF salts can be purified by silica gel column 
chromatography.  These complexes were stable towards oxygen and moisture.  The iridium-
complexes 46a-g were prepared by using [Ir(cod)Cl]2 and the (RFc,S)-P,N-ligand (Scheme 40 
and Table 4) 
 
                                                 
90
 Lightfoot, A.; Schnider, P.; Pfaltz, A. Angew. Chem. Int. Ed. 1998, 37, 2897. 
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N
OR1R
2
2P
R N
OR1R
2
2P
Ir(COD)
R
Fe Fe
BARF
1) [Ir(cod)Cl]2, CH2Cl2, 
    RT, 1 h
2) NaBARF, H2O, 30 min
R = H, Ph, tBu
R2 = Ph, Xyl
R1 = Me, Bn
46a-g
 
Scheme 40. Preparation of iridium complexes 46a-g 
 
Table 4. Preparation of Ir-catalysts 46a-g using the (RFc,S)-P,N-ligands. 
 
Entry Ligand R R1 R2 Yielda Product 
1 9a H Me Ph 90 46a 
2 10a H Bn Ph 90 46b 
3 9c H Me (3,5-dimethylphenyl) 92 46c 
4 10c H Bn (3,5-dimethylphenyl) 89 46d 
5 9e Ph Me Ph 82 46e 
6 9g tBu Me Ph 89 46f 
7 10e tBu Bn Ph 88 46g 
               
a
 Isolated yield of analytically pure product. 
 
Using the similar procedure mentioned above, iridium complexes 47a-g were prepared by 
using (RFc,R)-P,N-ligand (Scheme 41 and Table 5). 
 
N
OR1R
2
2P
R N
OR1R
2
2P
Ir(COD)
R
Fe Fe
BARF
1) [Ir(cod)Cl]2, CH2Cl2, 
    RT, 1 h
2) NaBARF, H2O, 30 min
R = H, Ph, tBu
R1 = Me, Bn
R2 = Ph, Xyl
47a-g
 
Scheme 41. Preparation of iridium complexes 47a-g 
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Table 5. Preparation of Ir-catalysts 46a-g using the (RFc,R)-P,N-ligands. 
 
Entry Ligand R R1 R2 Yielda Product 
1 9b H Me Ph 89 47a 
2 10b H Bn Ph 88 47b 
3 9d H Me (3,5-dimethylphenyl) 93 47c 
4 10d H Bn (3,5-dimethylphenyl) 90 47d 
5 9f Ph Me Ph 80 47e 
6 9h tBu Me Ph 88 47f 
7 10f tBu Bn Ph 80 47g 
               
a
 Isolated yield of analytically pure product. 
 
Applying these iridium complexes 46a-g and 47a-g in the asymmetric hydrogenation of olefin 
48 gave disappointing results giving only traces of the product even at high hydrogen 
pressures and in different solvent systems (e.g. methanol, toluene, CH2Cl2, DMF etc) (Scheme 
42). 
 
46a-g or 47a-g
(1 mol%)
H2, 80 bar, toluene
49: traces48
 
Scheme 42. Asymmetric hydrogenation of olefin 48 using the iridium complex 46a 
 
2.3.3. Ir-catalyzed asymmetric imine hydrogenation 
Asymmetric synthesis of chiral amines is an important synthetic task since these 
structural units are widely used in pharmaceutical and agrochemical substances.91  Recently, 
the catalytic asymmetric hydrogenation of imines has drawn much attention since it proves to 
be one of the most efficient ways to form chiral amines.  In the past decade, many efficient 
catalysts using different transition metals, such as Ti,92 Rh,93 and Ru94 were developed for the 
highly enantioselective imine hydrogenation.  Although many efficient catalysts have been 
developed for the asymmetric imine hydrogenation, most of them were suitable only for 
                                                 
91
 a) Kobayashi, S.; Ishitani, H. Chem. Rev. 1999, 99, 1069. b) Tang, W.; Zhang, X. Chem. Rev. 2003, 103, 3029. 
c) Blaser, H.-U.; Malan, C.; Pugin, B.; Spinder, F.; Steiner, H.; Studer, M. Adv. Synth. Catal. 2003, 345, 103. 
92
 a) Verdaguer, X.; Lange, U. E. W.; Reding, M. T.; Buchwald, S. L. J. Am. Chem. Soc. 1996, 118, 6784. b) 
Willoughby, C. A.; Buchwald, S. L. J. Am. Chem. Soc. 1994, 116, 8952. c) Willoughby, C. A.; Buchwald, S. L. 
J. Am. Chem. Soc. 1992, 114, 7562. d) Hanson, M. C.; Buchwald, S. L. Org. Lett. 2000, 2, 713.  
93
 a) Mao, J.; Baker, D. C. Org. Lett. 1999, 1, 841. b) Xiao, D. Zhang, X. Org. Lett, 1999, 1679. c) Becalski, A. 
G.; Cullen, W. R.; Fryzuk, M. D.; James, B. R.; Kang, G.-J.; Rettig, S. R. Inorg. Chem. 1991, 30, 5002. 
94
 a) Uematsu, N.; Fujii, A.; Hashiguchi, S.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1996, 118, 4916. b) 
Cobley, C. J.; Henschke, J. P. Adv. Synth. Catal. 2003, 345, 195. c) Oppolzer, W.; Wills, M.; Starkemann, M.; 
Bernardinelli, G. Tetrahedron Lett. 1990, 31, 4117. 
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cyclic substrates.  The reduction of acyclic imines with high enantioselectivities is still a 
major challenge in this field.95  Chiral iridium complexes based on P,P or P,N-ligands have 
been successfully applied as catalysts for the highly enantioselective hydrogenation of 
imines.96  One of the most notable examples was reported by Zhang et al. in the 
hydrogenation of acyclic imines that gave up to 99% ee using Ir/F-Binaphane catalysts.97  
Furthermore, Bolm et al. reported a highly enantioselective Ir-catalyzed hydrogenation of N-
aryl ketimines using sulfoximine ligands (P,N-ligands) with I2 as an additive98 (Scheme 43). 
 
P
P
Me
N
Me
Me
Me
N
OMe
Me
HN
Me
Me
Me
HN
OMe
PPh2NS
But
O
Ph
Fe
*
*
Binaphane ( 1 mol%), rt,
[Ir(cod)Cl]2 (0.5 mol%)
H2, 70 bar, 44 h,  CH2Cl2,
sulfoximine ( 1 mol%),  rt,
[Ir(cod)Cl]2 (0.5 mol%)
H2, 20 bar, 4 h, CH2Cl2,
I2 (10 mol%); >99% conversion  >99% ee Binaphane
I2 (2 mol%); >99% conversion  96% ee
(S)-sulfoximine ligand
 
Scheme 43. Ir-catalyzed asymmetric reduction of N-aryl ketimines  
 
We investigated the efficiency of the new iridium complexes 46a-46g and 47a-47g in 
asymmetric imine hydrogenation.  For this purpose, N-Phenylethylidene amine 50a was 
                                                 
95
 Ohkuma, T.; Kitamura, M.; Noyori, R. In Catalytic Asymmetric Synthesis; Ojima, I., Ed.; Wiley-VCH: 
Weinheim, 2000, p 1. 
96
 a) Trifonova, A.; Diesen, J. S.; Chapman, C. J.; Anderson, P. G. Org. Lett. 2004, 6, 3825. b) Olinas, M.; 
Pfaltz, A.; Cozzi, P. G.; Leitner, W. J. Am. Chem. Soc. 2004, 126, 16142. c) Iwadate, N.; Yoshida, K.; Imamoto, 
T. Org. Lett. 2006, 8, 2289. d) Guiu, E.; Aghmiz, M.; Diaz, Y.; Claver, C.; Meseguer, B.; Militzer, C.; Castillon, 
S. Eur. J. Org. Chem. 2006, 627. d) Spindler, F.; Blaser, H.-U. Adv. Synth. Catal. 2001, 343, 68. e) Schnider, P.; 
Koch, G.; Prétôt, R.; Wang, G.; Bohnen, F. M.; Krüger, C.; Pfaltz, A. Chem. Eur. J. 1997, 3, 887. f) Jiang, X.-B.; 
Minnaard, A. J.; Hessen, B.; Feringa, B. L.; Duchateau, A. L. L.; Andrien, J. G. O.; Boogers, J. A. F.; Vries, d. J. 
G. Org. Lett. 2003, 5, 1503. g) Kainz, S.; Brinkmann, A.; Leitner, W.; Pfaltz, A. J. Am. Chem. Soc. 1999, 121, 
6421. h)Wang, W.-B.; Lu, S.-M.; Yang, P.-Y.; Han, X.-W.; Zhou, Y.-G. J. Am. Chem. Soc. 2003, 125, 10536. i) 
Dervisi, A.; Carcedo, C.; Ooi, L.-L. Adv. Synth. Catal. 2006, 348, 175. j) Vargas, S.; Rubio, M.; Suárez, A.; Río, 
D. D.; Álvarez, E.; Pizzano, A. Organometallics 2006, 25, 961. k). Zhu, G.; Zhang, X. Tetrahedron: Asymmetry 
1998, 9, 2415. 
97
 Xiao, D.; Zhang, X. Angew. Chem. Int. Ed. 2001, 40, 3425. 
98
 Moessner, C.; Bolm, C. Angew. Chem. Int. Ed. 2005, 44, 7564. 
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chosen as the test substrate and hydrogenation reaction was performed at 60 bar pressure 
using 1 mol% of 47a as the standard catalyst.  The results are summarized in Table 6. 
 
Table 6. Asymmetric hydrogenation of imine 50a using catalyst 47a and testing the effect of 
solvents 
 
N HN
solvent, 60 bar, H2,
12 h, 25 °C
50a 51a
47a (1mol%)
 
 
Entry Solvent Conversion (%)a ee(%)
b,c
 
1 toluene 96 11 
2 CH2Cl2 55 6 
3 MeOH 23 39 
4 Tol:MeOH (4:1) 72 67 
5 Tol:MeOH (1:1) 63 56 
6 Tol:MeOH (10:1) 80 23 
7 Tol:iPrOH (4:1) 89 2 
8 Tol:tBuOH (4:1) 63 56 
a
 Conversion was measured by chiral GC or by 1H NMR. b  
Enantioselectivity was determined by chiral GC using a DEX-CB column. 
c
 Configuration was assigned by comparing the literature values. 
 
Hydrogenation of imine 50a in toluene provided the corresponding amine 51a in 96% 
conversion, but only in 11% ee (entry 1).  We also noticed that very polar solvents (e.g. 
methanol) or less polar solvents (e.g. CH2Cl2) tremendously decreased the reaction rate and 
enantioselectivity (entries 2-3).  Interestingly, performing the hydrogenation of imine 50a in a 
mixed solvent system such as toluene:methanol (4:1) showed a remarkable improvement in 
enantioselectivity from 11 to 67% ee but decreased the conversion of the amine 51a (entry 4).  
Increasing the portion of methanol in the solvent mixture of toluene/methanol or replacing the 
methanol by 2-propanol or t-butanol led to only mediocre conversions and poor 
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enantioselectivities of the amine 51a (entries 5-8).  It turned out that a toluene:methanol (4:1) 
mixture only provided the improved selectivities in the hydrogenation of imine 50a. 
 
For a systematic approach, we initially tested all the iridium complexes 47a-47g in the 
hydrogenation of imine 50a using the reaction conditions from the above screenings.  We 
conducted the hydrogenation of 50a in toluene:methanol (4:1) at 60 bar pressure using the 
catalysts 47a-g (Table 7). 
 
Table 7. Ir-catalyzed enantioselective hydrogenation of imine 50a using 47a-g  
 
N HN
Ir-catalyst
Tol, 60 bar, H2,
50a 51a
25 °C, 12 h
 
 
 
Entry Catalyst Conv(%)a ee(%)b,c 
1 47a 72 67 
2 47b 75 65 
3 47c 70 65 
4 47d 79 65 
5 47e 20 10 
6 47f 40 18 
7 47g 34 18 
                                  a
 Conversion was measured by 1H-NMR analysis or by chiral GC.b  
                         Enantioselectivity was determined by chiral GC using a DEX-CB column.  
                          
c
 Configuration was assigned by comparing the literature values 
 
Ir-complexes 47a-47d which have no substitution on the pyridine ring of the P,N-ligand 
provided better enantioselectivities and moderate conversions in the hydrogenation of imine 
50a (entries 1-4).  Ir-complexes 47e-47g with substitution on the pyridine ring of P,N-ligands 
provided poor conversions and selectivities (entries 5-7).  Under similar conditions 
(toluene/methanol (4:1), H2, 60 bar, rt), we examined the efficiency of Ir-catalysts 46a-46g in 
the hydrogenation of imine 50a (Table 8). 
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Table 8. Ir-catalyzed enantioselective hydrogenation of imine 50a using 46a-g. 
 
N HN
Ir-catalyst
Tol, 60 bar, H2,
12 h, 25 °C50a 51a
 
 
Entry Catalyst Conv(%)a ee(%)b,c 
1 46a 100 82 
2 46b 100 82 
3 46c 100 80 
4 46d 100 80 
5 46e 50 26 
6 46f 21 6 
7 46g 30 5 
                                  a
 Conversion was measured by 1H-NMR analysis or by chiral GC.b  
                         Enantioselectivity was determined by chiral GC using a DEX-CB column.  
                          
c
 Configuration was assigned by comparing the literature values 
 
Ir-catalysts with (S)-configuration at the α-center and no substitution on the pyridine ring of 
the P,N-ligand, provided improved results in the reduction of imine 50a.  Reduction of imine 
50a using the iridium catalysts 46a-d proceeded quantitatively and provided the amine 51a in 
80-82% ee (entries 1-4), whereas the Ir-catalysts 46e-f with substitutions on the pyridine ring 
of P,N-ligands provided low selectivities and conversions (entries 5-7). 
 
To trace out the most efficient reaction conditions for the imine hydrogenation, we performed 
the hydrogenation of imine 50a using the catalyst 46a at low hydrogen pressures and low 
catalyst loadings (Table 9).  Decreasing the hydrogen pressure from 60 to 10 bar didn’t effect 
the conversion; it rather improved the enantioselectivity of amine 51a from 82 to 84% ee 
(entries 1-5).  Hydrogenation at 1 bar hydrogen pressure resulted in long reaction timings 
(entry 5).  Decreasing the catalyst loading from 1 mol% to 0.5 mol% increased the reaction 
time but retained the enantioselectivity at 84% ee (entry 6).  We observed a decrease in 
enantioselectivity when the catalyst loading was lower to 0.25 mol% (entry 7). 
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Table 9. Effect of the catalyst loading and hydrogen pressure on the hydrogenation of imine 
50a using the catalyst 46a 
 
N HN
Tol:MeOH (4:1), H2,
50a 51a
46a, 25 °C
 
 
Entry 
Catalyst 
loading 
(mol  %) 
Pressure 
(bar) 
Time 
[h] 
Conversion 
[%]a ee(%)
b
 
1 1 60 2 100 82 
2 1 40 2 100 83 
3 1 20 2 100 84 
4 1 10 2 100 84 
5 1 1 21 75 84 
6 0.5 10 3 100 84 
7 0.25 10 12 100 80 
 
                 a
 Conversion was measured by chiral GC or 1H NMR. b. Enantioselectivity was  
            determined by chiral GC using a DEX-CB column. 
 
Among all catalysts 46a-g, 47a-g the iridium catalysts 46a, 46b, 46c and 46d provided better 
results under optimized conditions (toluene:MeOH (4:1), 10 bar H2, 2 h; 80-84% ee).  In order 
to further improve this asymmetric imine hydrogenation, we performed the hydrogenation of 
various imines with different aryl substituents attached to the nitrogen atom of the imine, 
using the catalysts 46a-46b (Table 10).  We noticed that reduction of imines with electron-
rich aromatic groups on the imine nitrogen proceeded well and provided improved 
enantioselectivities (entries 2-6).  Imines having ortho-substituted aromatic groups on the 
nitrogen atom gave mediocre conversions and enantioselectivities (entries 8-9).  Interestingly, 
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the hydrogenation of the imine 52a (R = 3,5-dimethyl) gave the best results, providing the 
corresponding secondary amine (R)-53a99 in 93-94% ee (entry 10). 
 
Table 10. Asymmetric hydrogenation of imines 50a-h and 52a using the Ir-complexes 46a 
and 46b 
 
N HN
L (1 mol %)
Tol:MeOH (4:1), 
  H2, 10 bar, rt, 2 h
RR
50a-h, 51a-h,
*
>99% conversion
 
 
 
ee (%)b 
Entry Imine R Producta
 L = 46a L = 46b 
1 50a H 51a 84(R) 84(R) 
2 50b 4-MeO 51b 88(R) 88(R) 
3 50c 4-Me 51c 84 84 
4 50d 3,4-dioxymethylene 51d 90 90 
5 50e 3,4,5-trimethoxy 51e 89 87 
6 50f 3,4-dimethyl 51f 90 89 
7 50g 3,4-dimethoxy 51g 81 80 
8c 50h 2,4-dimethyl 51h 83 80 
9d 50i 2-MeO 51i 54 50 
10 52 3,5-dimethyl 53a 94(R) 93(R) 
a In all cases full conversion was achieved in 2-4 h. b Enantioselectivity was determined by HPLC (chiracel OD-
H) or by GC using a chiral Dex-CB column. c Reaction time is 10 h; isolated yield is 84% d Reaction time is 12 
h; isolated yield is 50%. 
 
To envisage the effect of functional groups on the imine hydrogenation, we investigated the 
hydrogenation on a series of imines of type 52 using the catalysts 46a and 46b (Table 11).  
Imines 52b-52h were smoothly reduced under the optimized conditions and provided the 
corresponding secondary amines 53b-53h in 84-94% ee (Table 9).  Imines with electron 
donating groups (entries 2, 3, 4 and 7) provided better enantioselectivities compared to 
electron withdrawing groups (entry 5).  Reduction of the imine 52h which was derived from 
                                                 
99
 Kwong, F. Y.; Buchwald, S. L. Org Lett. 2003, 5, 793. 
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tetralone also proceeded well and the corresponding amine 53h was obtained in 84% ee (entry 
8). 
 
Table 11. Asymmetric hydrogenation of imines 52a-h using the Ir-complexes 46a and 47a 
 
R1
N
R1
HNL (1 mol %)
Tol:MeOH (4:1), 
  H2, 10 bar, rt, 2 h
52a-h, 53a-h,> 99.5% conversion
R R
 
 
 
ee(%)b 
Entry Imine R R1 Producta 
L = 46a L = 46b 
1 52a H Me 53a 94 93 
2 52b 4-MeO Me 53b 94 93 
3 52c 4-Me Me 53c 93 92 
4 52d 3-OMe Me 53d 94 89 
5 52e 4-Cl Me 53e 91 88 
6 52f 4-Ph Me 53f 88 82 
7 52g H Et 53g 94 94 
8 52h -(CH2)3- Me 53h 84 84 
a
 In all cases full conversion was achieved. b enantioselectivity was determined by HPLC  
using a chiralcel OD-H column or by AD-column.  
 
Although high enantioselectivities were achieved in the hydrogenation of imines of type 52, 
the removal of the 3,5-dimethylphenyl group from the amine 53 was difficult.  In general, 
secondary amines with 4-methoxy or 2-methoxyphenyl on the nitrogen atom of the amine can 
be cleaved under practical conditions to provide chiral primary amines.100  Since the imines 
with N-(4-methoxyphenyl) group 50b, 50e, 50g and N-(2-methoxyphenyl) group 50i provided 
the corresponding amines in moderate enantioselectivities (entries 2; 5, 7, and 9 of Table 10), 
we searched for another substrate.  We thought that N-aryl imine 56a with a 3,5-dimethyl-4-
methoxyphenyl group on the imine nitrogen could also be the ideal substrate for the 
                                                 
100
 For the cleavage of 4-methoxy N-phenyl groups see a) Shang, G.; Yang, Q.; Zhang, X. Angew. Chem. Int. Ed. 
2006, 45, 5194. b) Palacios, F.; Aparicio, D.; García, J.; Rodríguez, E. Eur. J. Org. Chem. 1998, 1413. c) 
Taniyama, D.; Hasegawa, M.; Tomika, K. Tetrahedron Lett. 2006, 47, 821. for the cleavage of 2-methoxy N-
phenyl groups see ref 15  
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deprotection to provide primary amines.  Imine 56a was synthesized as showed in the 
following scheme (Scheme 44). 
 
OMe
MeMe MeMe
OMe
NH2
55 56a
Me
N
Me
OMe
Me1.HNO3:H2SO4, Ac2O,
0 °C, 2 h; 91%
2. N2H4.H2O, FeCl3.6H2O,
    Charcoal, MeOH,
    100 °C, 12 h; 96%
PhCOMe, Tol, 110 °C
MS 4 Å, 12 h; 75%
54
 
Scheme 44. Synthesis of the imine 56a 
 
To our delight, imine 56a could be smoothly reduced using the Ir-catalysts 46a and 46b, 
furnishing the corresponding secondary amine 57a in 92-94% ee.  As we anticipated, 
deprotection of the 3,5-dimethyl-4-methoxyphenyl group on the amine 57a was accomplished 
by using cerium ammonium nitrate (CAN; Ce(NH4)2(NO3)6) in MeOH:H2O (6:1), providing 
the chiral primary amine (R)-58 in 85% yield and 94% ee (Scheme 45). 
 
Me
N
Me
OMe
Me
56a (R)-57a
Me
HN
Me
OMe
Me
(R)-58
Me
NH2
L* (1 mol%), H2, 10 bar
Tol:MeOH (4:1), 2 h, 25 °C
CAN (4 equiv), 25 °C
MeOH:H2O (6:1), 12 h
L * = 46a: 96%; 94% ee
L * = 46b:  95%; 92% ee
 85%; 94% ee
Scheme 45. Asymmetric hydrogenation of imine 56a using the Ir-catalysts 46a and 46b and 
subsequent deprotection to primary amine 58  
 
To extend the scope of this asymmetric imine hydrogenation, we examined the reduction of 
various imines of type 56 using the Ir-catalysts 46a and 46b (Table 12).  The results are 
summarized as follows.  Both electron donating (entries 2, 3, 4, 7, 8, 12 and 13) and electron 
withdrawing substituents (entries 5, 6, 9, 10, 11 and 14) provided high enantioselectivities 
(80-94% ee; Table 10) in hydrogenation.  Imines with electron withdrawing groups on the 
aromatic ring provided higher enantioselectivities compared to electron donating groups.  
Among the electron-rich imines, imines with meta- and ortho-substitution provided better 
enantioselectivities compared to para-substitution (entries 2, 4, 8 and 3, 7).  Reduction of the 
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imine derived from tetralone 56o provided the secondary amine in 84% ee, whereas the 
indanone derived imine 56p provided the corresponding amine only in 70% ee  
 
Table 12. Asymmetric hydrogenation of imines 56a-p using the Ir-complex 46a and 46b 
 
N
OMe
Me
Me
Ar R Ar R
HN
OMe
Me
Me
L* (1 mol %)
Tol:MeOH (4:1), 
H2, 10 bar, RT
56a-p 57a-p
68 - 94% ee
>96% yield
 
 
ee(%)b 
Entry Imine Ar R Product time[h]a 46a 46b 
1 56a Ph Me 57a 2 94 92 
2 56b 4-Me-C6H4 Me 57b 2 86 85 
3 56c 3-MeC6H4 Me 57c 2 94 93 
4 56d 2-Me-C6H4 Me 57d 6 94 94 
5 56e 4-MeCO2-C6H4 Me 57e 4 94 92 
6 56f 4-CF3-C6H4 Me 57f 2 89 88 
7 56g 4-MeO-C6H4 Me 57g 2 85 84 
8 56h 3-MeO-C6H4 Me 57h 2 86 82 
9 56i 3-F-C6H4 Me 57i 2 93 91 
10 56j 4-Cl-C6H4 Me 57j 4 92 92 
11 56k 3-Cl-C6H4 Me 57k 2 90 90 
12 56l 4-Ph-C6H4 Me 57l 2 92 90 
13 56m 2-naphthyl Me 57m 2 93 93 
14 56n 3-CH3CO-C6H4 Me 57n 2 80 80 
15 56o Ph -(CH2)3- 57o 2 84 84 
16c 56p Ph -(CH2)2- 57p 12 70 68 
a
 Time to achieve full conversion. b Enatioselectivity was determined by HPLC using chiracel OD-H column 
or AD-column. c Only 70% conversion was achieved even after 12 h at rt.  
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The asymmetric imine hydrogenation with catalysts 46a and 46b can also be applied to 
various kinds of imines bearing a side-chain at the α−position.  Thus, imines 56q-s underwent 
a smooth hydrogenation and the respective secondary amines 57q-s were obtained in 92-95% 
ee (Scheme 46).   
 
N
R
OMe
Me
Me HN
R
Me
OMe
Me
1. L *  (1 mol%), H2, 10 bar
Tol:MeOH (4:1), 25 °C, 4-5 h
56q  : R = Et
56r   : R = Pent
56s   : R = (CH2)2Ph
R= Et;            57q         L * = 46a: 96%; 94% ee
                                      L*  = 46b: 95%; 92% ee
R = Pent;        57r         L * = 46a: 98%; 95% ee
                                      L*  = 46b: 95%; 94% ee
R = (CH2)2Ph; 57s       L * = 46a: 98%; 95% ee
                                      L*  = 46b: 95%; 95% ee
 
Scheme 46. Reduction of imines 56q, 56r and 56s with side-chains at the α-position using the 
catalysts 46a and 46b 
 
Interestingly, reduction of the imine 56t bearing a remote keto group proceeded chemo-
selectively and quantitatively, yielding the corresponding amine 57t in 99% ee (Scheme 47). 
No over-reduction of the ketone functionality was observed in this reaction. 
 
N
OMe
Me
COPh
Me HN
OMe
Me
COPh
Me
                              L * = 46a:  95%; 99% ee
                               L*  = 46b:   95%; 98% ee
 L *  (1 mol%), H2, 10 bar
Tol:MeOH (4:1), 25 °C, 6 h
56t (R)-(-)-57t
 
Scheme 47. Chemoselective hydrogenation of imine 56t using the Ir-catalysts 46a and 46b 
 
Deprotection of the functionalized amines of type 56 was also accomplished by using CAN to 
furnish the corresponding (R)-primary amines in good yields (Scheme 48). 
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N
R1
OMe
Me
Me NH2
R1
R
CAN (4equiv), 25 °C
MeOH:H2O (6:1), 12 h R
(R)-59: R = Cl,         R1 = Me: 82%; 92% ee
(R)-60: R = CO2Me R1 = Me: 87%; 94% ee
(R)-61: R = H           R1 = Et:  80%; 94% ee
(R)-62: R = H           R1 = Pent 78%; 95% ee
 
Scheme 48. Preparation of chiral primary amine 59-62 
 
Furthermore, we extended this protocol to the asymmetric synthesis of chiral γ- and δ-
lactams.101-102  Thus, the imines 56u and 56v bearing a remote ester group were subjected to 
the asymmetric hydrogenation, and after subsequent deprotection of the N-aromatic group, the 
5-phenyl-2-pyrrolidinone 63 and 6-phenyl-2-piperidinone 64 were obtained in 74% yield, 
92% ee and 78% yield, 97% ee respectively (Scheme 49). 
 
N
OMe
Me
Me
O
OMe
HN
O
1. L *  (1 mol%), H2, 10 bar
Tol:MeOH (4:1), 25 °C, 6 h
2. CAN (4 equiv), H2O:MeOH (1:6)
    25 °C, 12 h56u : n = 1
 56v : n = 2
n
n = 1; (R)-(+)-63           L * = 46a: 74%; 92% ee
                                     L*  = 46b: 72%; 90% ee
n = 2; (R)-(+)-64           L * = 46a: 78%; 97% ee
                                     L*  = 46b: 72%; 96% ee
n
 
Scheme 49. Synthesis of γ- and δ-lactams 63 and 64 
 
Hydrogenation of disubstituted imines 56w-y under optimized reaction conditions was then 
investigated (Scheme 50).  Unlike the mono substituted imines, disubstituted imines with 
electron donating groups provided improved enantioselectivities compared to the electron 
withdrawing imine (Scheme 50). 
 
                                                 
101
 for the asymmetric synthesis of γ-lactams, a) Ramachnadran, P. V.; Burghardt, T. E. Chem. Eur. J. 2005, 11, 
4387. b) Vivienne, B. C.; Page, M. I.; Korn, S. R.; Monteith, M. Chem. Commun. 1999, 8, 721. c) Ward, B. D.; 
Risler, H.; Weitershaus, K.; Bellemin-Laponnaz, S.; Wadepohl, H.; Gade, L. H. Inorg. Chem. 2000, 45, 7777. 
102
 for the asymmetric synthesis of δ-lactams, a) Burke, A. J.; Davies, S. G.; Garner, A. C.; McCarthy, T. D.; 
Roberts, P. M.; Smith, A. D.; Rodriguez-Solla, H.; Vickers, R. J. Org. Biomol. Chem. 2004, 2, 1387. b) Davis, F. 
A.; Chao, B.; Fang, T.; Szewczyk, J. M. Org. Lett. 2000, 2, 1041. c) Davis, F. A.; Szewczyk, J. M. Tetrahedron 
Lett. 1998, 39, 5951. 
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N
OMe
Me
Me
R
R
HN
Me
OMe
Me
R
R
 46a   (1 mol%), H2, 10 bar
Tol:MeOH (4:1), 25 °C, 6 h
*
57w: R = Cl:     96%; 87% ee
57x: R = OMe 96%; 92% ee
57y: R = Me    98%; 94% ee
56w:   R = Cl:     
56x:  R = OMe
56y:   R = Me
 
 
Scheme 50. Hydrogenation of disubstituted imines 56w-y 
 
 
2.4. Conclusion  
In conclusion, the novel synthesis of P,N-ligands 9a-g and 10a-g in high yields was achieved.  
Their iridium complexes 46a-g and 47a-g were prepared and applied in asymmetric imine 
hydrogenation.  Various N-arylketimines were reduced using the Ir-catalysts 46a and 46b in 
high conversions and enantioselectivities (up to 99% ee).  We also described the synthesis of 
chiral primary amines and γ- and δ-lactams via this asymmetric imine hydrogenation.   
 
 
3. Preparation of bis-ferrocenyl P,P ligands and their applications 
in asymmetric catalysis 
 
3.1. Introduction 
Although many chiral ferrocene ligands have been prepared for various transition-metal-
catalyzed asymmetric reactions, only few ligands with two ferrocenyl groups (bis-ferrocenyl 
ligands) have been reported.  Trap,103 Pigiphos,104 and Trost’s chiral pocket ligand105 are the 
only reported examples in this category.  Among these bis-ferrocenyl P,P-ligands, ligand 
TRAP proved to be a very efficient ligand for asymmetric catalysis.  Trap has been 
successfully applied in Rh-catalyzed asymmetric hydrogenation of indoles106 and 
                                                 
103
 Sawamura, M.; Hamashima, H.; Sugawara, M.; Kuwano, R.; Ito, Y. Organometallics 1995, 14, 4549. 
104
 a) Barbaro, P.; Togni, A. Organometallics 1995, 14, 3570. b) Ladini, L.; Togni, A. Chem Commun. 2003, 30. 
c) Sadow, A. D.; Togni, A. J. Am. Chem. Soc. 2005, 127, 17012. 
105
 a) Trost, B. M.; Schroeder, G. M. J. Am. Chem. Soc. 1999, 121, 6759. b) Yan, X.-X.; Liang, C.-G.; Zhang, Y.; 
Hong, W.; Cao, B.-X.; Dai, L.-X.; Hou, X.-L. Angew. Chem. Int. Ed. 2005, 44, 4435. 
106
 Kuwano, R.; Sato, K.; Kurokawa, T.; Karube, T.; Ito, Y. J. Am. Chem. Soc. 2000, 122, 7614. b) Kuwano, R.; 
Kaneda, K.; Ito, T.; Sato, K.; Kurokawa, T.; Ito, Y. Org. Lett. 2004, 6, 2213. 
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hydrosilylation of prochiral ketones,107 and Rh and Pd-catalyzed asymmetric allylic 
alkylations108 (Scheme 51). 
 
N
Ts
R
Fe
Ph2P
PPh2
Fe
Ph-TRAP
N
Ts
R
[Rh(nbd)2]SbF6/Ph-TRAP (1 mol%)
Cs2CO3 (10 mol%)
H2, (50 atm), iPrOH, 80 °C
R = (CH2)2OTBS: 94%; 98% ee
 
Scheme 51. Applications of Trap in asymmetric catalysis. 
 
Based on this successful work, we decided to design a bis-ferrocenyl ligand for asymmetric 
catalysis.  The ligand structure is shown in figure 13.  The α-carbon in the ligand structure is a 
chirotopic center. 
 
Fe
OMe
Ph2P
Ph2P
Fe
11
 
Figure 13. Structure of new bis-ferrocenyl ligands 11 
 
3.2. Synthesis of bis-ferrocenyl P,P-ligand 11 
 
The synthetic approach for the ligand 11 is shown in the scheme 52.  The bis-ferrocenyl 
phosphine 11 can be prepared through the reduction of the corresponding phosphine sulfides.  
The phosphine sulfides can be prepared via the sulfoxide-lithium exchange on 67, followed 
by the addition of chlorodiarylphosphines.  The methyl ether can be prepared by O-
methylation of the corresponding alcohol 66 which can be prepared via the diastereoselective 
ortho-lithiation of 14, followed by the addition of 65. 
 
                                                 
107
 Kuwano, R.; Uemura, T.; Saitoh, M.; Ito, Y. Tetrahedron: Asymmetry 2004, 15, 2263. 
108
 a) Sawamura, M.; Sudoh, M.; Itoh, Y. J. Am. Chem. Soc. 1996, 118, 3309. b) Nowicki, A.; Mortreux, A.; 
Agbossou-Niedercorn, F. Tetrahedron: Asymmetry 2005, 16, 1295. 
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CHO
SOTol
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OH
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Fe
Fe
OMe
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FeFe
OMe
PPh2
PPh2
Fe
S
S
Fe
OMe
PPh2
PPh2
Fe
 
Scheme 52. Synthetic approach to the bis-ferrocenyl ligand 11 
 
Diastereoselective ortho-lithiation on sulfoxide 14, followed by the addition of DMF, led to 
the aldehyde 65 in 80% yield.  Addition of this aldehyde 65 to the lithiated species generated 
from the diastereoselective metallation of 14, provided the bis-ferrocenyl alcohol 66 in 60% 
yield.  O-methylation of 66 using KH and MeI led to the bis-ferrocenyl ether 67 in 85% yield 
(Scheme 53). 
 
S
O
CHO
SOTol
S
O
Fe
Fe
Fe
OH
SOTol
SOTol
Fe
Fe
Fe
OMe
SOTol
SOTol
Fe
(S)-65: 80%
1. LDA, THF, -78 °C, 
30 min
2. 65, -78 °C, 1.5 h; 
    rt, 1 h
KH, 0 °C, rt, 1 h
MeI, 0 °C, 30 min,  
    rt, 1 h
1. LDA, THF, -78 °C, 30 min
2. DMF, -78 °C, 2 h; rt, 1 h
(SFc,SFc)-66: 60%
(S)-14
(SFc,SFc)-67: 85%
 
Scheme 53. Preparation of bis-ferrocenyl ether 67 
 
Exchange of the sulfoxide using phenyllithium or tert-butyllithium, followed by the addition 
of chlorodiphenylphosphine led to an inseparable mixture of mono and disubstituted 
phosphines (Scheme 54). 
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Fe
OMe
SOTol
SOTol
Fe Fe
OMe
PPh2
PPh2
Fe
(SFc,SFc)-67
1. PhLi, Et2O, -78 °C, 20 min
2. PPh2Cl, -78 °C, 1 h; rt, 2 h
unseparable mixture of mono
and diphosphines
 
Scheme 54. Performance of sulfoxide/lithium exchange on 67 
 
Since compound 67 provided an inseparable mixture in the reaction with ClPPh2 after the 
sulfoxide/lithium exchange, we changed our synthetic approach to ligand 11.  Starting our 
synthesis from the sulfoxide 30, performance of sulfoxide-lithium exchange of 30 using PhLi, 
followed by the addition of DMF, furnished the ferrocenyl aldehyde 68 in 65% yield.  
Sulfoxide-lithium exchange on 30 using PhLi, followed by the addition of 68 led to the bis-
ferrocenyl alcohol 69 in 55% yield (Scheme 55). 
 
PPh2
SOTol
S
PPh2
CHO
S
PPh2
SOTol
S
Fe
Fe
Fe
(RFc)-68: 65%
1. PhLi, Et2O, -78 °C, 10 min
2. DMF, -78 °C, 2 h; rt, 1 h
(RFc,RFc)-69: 55%
(S)-30
1. PhLi, Et2O, -78 °C, 10 min
2.68, -78 °C, 1.5  h; rt, 2 h
(S)-30
Fe
OH
Ph2P
Ph2P
S
S
Fe
 
Scheme 55. Preparation of bis-ferrocenyl alcohol 69 
 
We couldn’t accomplish the O-methylation of the alcohol 69 under any known reaction 
conditions.  In addition, attempted deprotection on the bisphosphine sulfide 69 using Raney-
Ni in MeOH resulted in no conversion (Scheme 56). 
 
Fe
OH
Ph2P
Ph2P
Fe Fe
OH
Ph2P
Ph2P
S
S
Fe Fe
OMe
Ph2P
Ph2P
S
S
Fe
69
KH, THF, 0 °C, rt, 1 h
MeI, rt, 1 h
Raney Ni, MeOH
rt, 12 h
 
Scheme 56. Attempts to prepare the bis-ferrocenyl ether from 69 
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Keeping these problems from the above two synthetic approaches in mind, the following 
synthesis was attempted.  Sulfoxide-lithium exchange on the substrate 30, followed by the 
addition of bromoferrocenyl aldehyde 20b, led to the bis-ferrocenyl alcohol 70 in 58% yield.  
O-methylation of 70 using KH and MeI led to the bis-ferrocenyl ether 71 in 84% yield 
(Scheme 57). 
 
PPh2
SOTol
S
Br
CHO
Fe
Fe
20b
1. PhLi, Et2O, -78 °C, 10 min
2.
(RFc,RFc)-70: 58%(S)-30
1. KH, THF, 0 °C, 1 h
78 °C, 1 h;
  rt, 2 h 2. MeI, 0 °C, 30 min;
    rt, 1 h
(RFc,RFc)-71: 84%
Fe
OH
Ph2P
Br
S
Fe Fe
OMe
Ph2P
Br
S
Fe
 
Scheme 57. Preparation of bis-ferrocenyl ether 71 
 
The bromine-lithium exchange on 71 using n-BuLi, followed by the addition of 
chlorodiphenylphosphine or bis-2-furyl phosphine, gave the bis-ferrocenyl phosphine sulfides 
72 and 73 in 76 and 80% yields, respectively (Scheme 58). 
 
Fe
OMe
Ph2P
Br
S
Fe Fe
OMe
Ph2P
Ar2P
S
S
Fe
71
1. n-BuLi, THF, -78 °C, 
10 min
2. ClPAr2, -78 °C, 1 h;
    rt, 1 h
(RFc,RFc)-72:  Ar = Ph;      76%
(RFc,RFc)-73:  Ar = 2-furyl; 80%
3. S8, BuNH2, rt, 12 h
 
Scheme 58. Preparation of bis-ferrocenyl phosphine sulfides 72 and 73 
 
Deprotection of the phosphine sulfides 72 and 73 using Raney-Ni in methanol provided the 
corresponding bisphosphines 11a-b in 76-80% yield, respectively (Scheme 59) 
 
Fe
Ph2P
Ar2P
S
OMe
S
Fe Fe
OMe
Ph2P
Ar2P
Fe
72: R = Ph
73: R = 2-furyl
Rane Ni, MeOH
rt, 12 h
(RFc,RFc)-11a:  Ar = Ph;  86%
(RFc,RFc)-11b:  Ar = 2-furyl; 85%
 
Scheme 59. Preparation of bis-ferrocenyl phosphines 11a and 11b 
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3.3 Applications in asymmetric catalysis 
 
3.3.1 Rh-catalyzed hydrogenation of olefins 
With the two bis-ferrocenyl ligands 11a-11b in hand, we applied them in Rh-catalyzed 
hydrogenation of α-acetamidocinnamate 25 to yield the phenylalanine derivative 26.  
Hydrogenation of 25 using 11a proceeded quantitatively, but racemic product was obtained 
(Scheme 60). 
 
Ph
CO2Me
NHAc Ph
CO2Me
NHAc
[Rh(nbd)2]BF4/11a 
(1 mol%)
 Tol:MeOH (1:1)
H2, 1 bar, rt, 1 h
26: >95%; rac.25
H
 
Scheme 60. Application of 11a in Rh-catalyzed hydrogenation of 25 
 
We also tested the efficiency of 11a in the Rh-catalyzed hydrogenation of dimethyl itaconate 
74.  The desired product 75 was obtained quantitatively but only in 18% ee (Scheme 61). 
 
[Rh(nbd)2]BF4/11a 
(1 mol%)
 MeOH, H2, 
 1 bar, rt, 1 h
75: 90%; 18% ee
OMe
OMe
O
O
OMe
OMe
O
O
74
 
Scheme 61. Rh-catalyzed hydrogenation of dimethyl itaconate 75 
 
Application of ligand 11b in the above reactions resulted in no reactions. 
 
3.3.2. Pd-catalyzed asymmetric allylic alkylation  
We then examined the efficiency of new ferrocenyl ligand 11a in Pd(0)-catalyzed asymmetric 
alkylation on the racemic substrate 27 using dimethylmalonate as a nuecleophile.  We 
observed complete conversion in 5 minutes, however, a very low selectivity was achieved 
(Scheme 62). 
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Ph Ph
OAc
Ph Ph
MeO2C CO2Me
27 28: 90%; 26% ee
[Pd(C3H5)Cl]2 (1 mol%)
  11a (2 mol%)
CH2(CO2Me)2, KOAc (5 mol%)
BSA (3 equiv), CH2Cl2, -20 °C, 5 min
 
Scheme 62. Asymmetric allylic alkylation using the ligand 11a 
 
3.4. Conclusion 
In conclusion, we prepared the new bis-ferrocenyl ligands 11 in good yields.  Although the 
ligands formed very active catalysts, as shown by quantitative conversions and low reaction 
times, low enantioselectivities were observed.   
 
 
4. Synthesis of new paracyclophane phosphines and their 
applications in asymmetric catalysis 
 
4.1 Introduction  
The [2,2]paracyclophane backbone serves as a powerful tool to develop new and efficient 
ligands for the asymmetric catalysis.109  The chiral [2,2]phanephos 13, a C2 symmetric 
bisphosphine, is one of the most successful chiral ligands with a rigid paracyclophane 
backbone (Scheme 63).  It has been efficiently used in Rh-catalyzed hydrogenation of 
dehydroamino acids,17 allylic acids,110 Ru-catalyzed hydrogenation of β-ketoesters,111 
aromatic ketones112 and Pd-catalyzed amination reactions.113  The chiral C2-symmetrical 
phosphinites based on the paracyclophane backbone have also proved to be very efficient 
catalysts for Rh-catalyzed hydrogenation of N-acetyl dehydroamino acids and esters (Scheme 
63).114   
 
                                                 
109
 Gibson, S. E.; Knight, J. D. Org. Biomol. Chem. 2003, 1, 1256. 
110
 Boulton, L. T.; Lennon, I. C. ; McCague, R. Org. Biomol. Chem. 2003, 1, 1094. 
111
 Pye, P. J.; Rossen, K. ; Reamer, R. A.; Volante, R. P; Reider, P. J. Tetrahedron Lett. 1998, 39, 4441. 
112
 Burk, M. J.; Hems, W. P.; Herzburg, D.; Malan, C.; Zanotti-Gerosa, A. Org. Lett. 2000, 2, 4173. 
113
 Rossen, K.; Pye, P. J.; Maliakal, A. Volante, R. P. J. Org. Chem. 1997, 62, 6462. 
114
 Zanotti-Gerosa, A.; Malan, C.; Herzburg, D. Org. Lett. 2001, 3, 3687. 
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L* = =
*
97-98 % ee
          Phanephos
(R)-13a: Ar = Ph
(R)-13b: Ar = 3,5-(CH3)2-C6H3
 
Scheme 63. Applications of C2-symmetrical paracyclophane phosphines in asymmetric 
catalysis 
 
Hems et al. prepared various non-C2-symmetrical paracyclophane phosphines by introducing 
substituents on one of the aromatic ring of Phanephos 12.  These ligands showed an 
indistinguishable performance to the original Phanephos 12 in Rh-catalyzed hydrogenation of 
dehydroamino acids and Ru-catalyzed hydrogenation of acetophenone (Scheme 63).115   
 
CO2Me
NHAc
O OH
CO2Me
NHAc
PPh2
PPh2
HO
Rh(nbd)2BF4 (1mol%)
L*, MeOH, rt, H2, 5 bar
97% ee
[L*RuCl2(diamine)]
H2, 10 bar, iPrOH
L* =
25 °C, tBuOK,
s/c 10,000, 1 h 99% ee
 
Scheme 63. Applications of non-C2-symmetrical paracyclophane phosphines in Rh and Ru-
catalyzed hydrogenation reactions 
 
4.2 Synthesis of new paracyclophane phosphines 
                                                 
115
 Dominguez, B.; Canotti-Gerosa, A.; Hems, W. Org. Lett. 2004, 6, 1927.  
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However, apart from this fascinating work, paracyclophane phosphines bearing two different 
kinds of aryl phosphines have not been synthesized until now.  Our aims of this work were to 
synthesize the new diphosphines of type 12 based on the paracyclophane backbone and test 
their efficiency in asymmetric catalysis.  This work also allows us to study the electronic 
properties of different phosphines to elucidate the effect of the phosphines on asymmetric 
catalysis.  The new ligands structure is depicted in Figure 14. 
 
PPh2
PAr2
12
 
Figure 14. New paracyclophane phosphines of type 12 
 
The corresponding monometallation on chiral dibromide 76116 using n-BuLi for 2 h at -78 °C, 
followed by the addition of chlorodiphenylphosphine led to an air sensitive diphenyphosphine 
derivative which was in situ protected with sulfur leading to the air stable phosphine sulfide 
77 in 85% yield. Bromine/lithium-exchange on substrate 77 using n-BuLi at -78 °C for 1 h, 
followed by reaction with various chlorodiarylphosphines and in situ protection the resulting 
phosphine with sulfur, provided the bisphosphine sulfides 78a-78c in 50-86% yields.  The 
deprotection of the phosphine sulfides was accomplished using Raney-Ni in MeOH (25 °C, 
12 h) to obtain the diphosphines 12a-c in 20-66% yields (Scheme 65).117 
 
                                                 
116
 a) For the preparation of the dibromide see the ref. (109) and for the preparation of racemic dibromide see b) 
Reich, H. J.; Cram, D. J. J. Am. Chem. Soc. 1969, 91, 3527. 
117
 Ph. D thesis, Maud gayral, Oxford University. 
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S
PPh2
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S
PPh2
PAr2
CF3
CF3
12c
O
12a
F
12b
1. n-BuLi, THF, -78 °C
    1 h
2. ClPAr2, -78 °C, 1 h
     RT, 1.5 h
3. S8, RT, 12 h
Raney-Ni, MeOH
RT, 12 h
78a-c (R)-12a-c
1. n-BuLi, THF, -78 °C
   2 h
2. ClPPh2, -78 °C, 1 h,
  RT, 1.5 h
3. S8, RT, 12 h
Ar =
(R)-76 77
 
Scheme 65. Preparation of new paracyclophane based ligands 12a-c. 
 
In addition, we required also a mixed bisphosphine bearing an electron-rich aromatic group on 
the phosphorous such as 3,5-dimethylphenyl group.  Thus, we prepared the diphosphine 12d, 
in the similar way to the synthesis as described in Scheme 65.  The bromine-lithium exchange 
on substrate 77, using n-BuLi, followed by reaction with chlorobis(3,5-
dimethylphenyl)phosphine and in situ protection with sulfur, provided the bisphosphinesulfide 
78d in 86% yield.  The deprotection of 78d was performed by using Raney-Ni in MeOH at 
room temperature, and provided the phosphine 12d in 92% yield (Scheme 66). 
 
PPh2
Br
S
PPh2
PXyl2
S
S
PPh2
PXyl21. BuLi, THF, -78 °C
    1 h
2. ClPXyl2, -78 °C, 1 h
     RT, 1.5 h
3. S8, RT, 12 h
Raney-Ni, MeOH
RT, 12 h
78d: 87% (R)-12d: 92%77
 
Scheme 66. Preparation of the paracyclophane phosphine 12d 
 
4.3 Applications in asymmetric catalysis. 
For clarity, the structure of chiral P,P-ligands 12a-d are shown in Scheme 67. 
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Scheme 67. Overview of new chiral paracyclophane based P,P-ligands 12a-d 
 
4.3.1 Rh-catalyzed asymmetric hydrogenation reactions 
Having these P,P-ligands in hand, we sought to investigate their efficiency in Rh-catalyzed 
asymmetric hydrogenation of N-acetyl methyl cinnamate 25.  Since ligand 12a is very 
unstable and oxidized rapidly, we couldn’t apply this ligand in asymmetric catalysis.  The 
ligands 12b-d gave mixed results in asymmetric hydrogenation of cinnamate 25. The ligand 
12d proved to be efficient for the hydrogenation of 25 and gave the desired compound 26 in 
quantitative yield and 90% ee (Scheme 68). 
 
CO2Me
NHAc
25 26
CO2Me
NHAc
HRh(nbd)2BF4 (1mol%)
L* (1mol%), H2, 1 bar
Tol:MeOH (1:1)
L * = 12b : 60%; 18% ee
L * = 12c : 95%; 30% ee
L*  = 12d : 95%; 90% ee
 
Scheme 68.  Rh-catalyzed hydrogenation of N-acetyl dehydroamino acids using the ligands 
12b-d 
 
Applying these ligands in Rh-catalyzed hydrogenation of dimethylitaconate, also resulted in 
moderate enantioselectivities (Scheme 69). 
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Scheme 69. Rh-catalyzed hydrogenation of dimethyl itaconate using the ligands 12c and 12d. 
 
4.3.2 Ru-Catalyzed Hydrogenation of Prochiral Ketones 
Enantiomerically pure alcohols serve as important intermediates in drug design.  A direct 
approach to single enantiomer alcohols through catalytic reduction of ketones is most 
attractive, and various methods have been introduced.118  Owing to the inherent atom-
economical nature of the hydrogenation reactions, hydrogenation of prochiral ketones is one 
of the most facile routes for generating single enantiomer alcohols.  Recently, a ground-
breaking discovery by Noyori and co-workers, found that phosphine-ruthenium-diamine 
complexes are very effective catalysts for the hydrogenation of ketones and aldehydes.119  
Significantly, this method allowed the development of many efficient catalysts for highly 
enantioselective hydrogenation of a wide range of prochiral ketones.120  Thus, we sought to 
investigate the efficiency of these new ligands 12b-d in ruthenium catalyzed hydrogenation of 
prochiral ketones.  We prepared various phosphine-ruthenium-diamine complexes 79a-c and 
                                                 
118
 Hydroboration: a) Itsuno, S.; Nakano, M.; Miyazaki, K.; Masuda, H.; Ito, K.; Hirao, A.; Nakahama, S. J. 
Chem. Soc., Perkin Trans. 1 1985, 2039. b) Corey, E. J.; Bakshi, R. K.; Shibata, S. J. Am. Chem. Soc. 1987, 109, 
5551. c) Singh, V. K. Synthesis 1991, 605. d) Hayashi, T.; Matsumoto, Y.; Ito, Y. J. Am. Chem. Soc. 1989, 111, 
3426. e) Brown, J. M.; Hulmes, D. I.; Layzell, T. P. J. Chem. Soc., Chem. Commun. 1993, 1673  
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80a-c using chiral 1,2-diphenylethylenediamines. The ruthenium complexes were prepared 
analogous to the literature procedure.113  Heating a mixture of diphosphine 12b-d and 
[RuCl2(C6H6)]2 in toluene/DMF for 4 h at 115 °C, followed by the addition of chiral diamine 
and heating the mixture for 2 h at 115 °C provided the ruthenium complexes 79a-c and 80a-c 
in quantitative yields (Table 11).  Catalysts 79a-c were prepared using (R,R)-1,2-
diphenylethylenediamine, whereas the catalysts 80a-c were prepared by using (S,S)-1,2-
diphenylethylenediamine. 
 
Table. 13 Preparation of Ru-complexes using the chiral diamine and the ligands 79a-c and 
80a-c. 
 
PPh2
PAr2
P
Ph2
Ar2
P
Ru
H2
N
N
H2
Cl
Cl
R1
R2
R3
R4
1.  [RuCl2(C6H6)]2, Tol/DMF,
      115 °C, 4 h
2.  DPEN, 115 °C
     2 h; RT, 12 h
quant.
 
 
Entry Ar Ligand Diaminea Productb 
1 4-F-C6H4 12b (R,R)-DPEN 79a 
2 4-F-C6H4 12b (S,S)-DPEN 80a 
3 3,5-(CF3)2-C6H3 12c (R,R)-DPEN 79b 
4 3,5-(CF3)2-C6H3 12c (S,S)-DPEN 80b 
5 3,5-(CH3)2-C6H3 12d (R,R)-DPEN 79c 
6 3,5-(CH3)2-C6H3 12d (S,S)-DPEN 80c 
                               a
 DPEN = Diphenylethylenediamine. b all product was obtained in quantitative yield. 
 
We started our investigation on the ketone hydrogenation using the novel ruthenium 
complexes 79a-c and 8a-0c and acetophenone as the model substrate under standard reaction 
conditions (i-PrOH solvent, 10 bar H2, t-BuOK/Ru : 25/1, 1.0-2.0 M solutions)120-121 (Table 
14).  Preliminary results indicate that the hydrogenation of acetophenone 81a using ruthenium 
complexes 79a-c led to poor conversions and enantioselectivities (entries 1-3).  On the other 
hand the ruthenium complexes 80a-c provided better enantioselectivities in the hydrogenation 
of acetophenone 81a (entries 4-6).  Among the ruthenium precatalysts 80a-c, catalyst 80c 
proved to be the most efficient catalyst for the asymmetric hydrogenation of acetophenone 
81a and furnished the corresponding alcohol 82a in 97% ee (entry 6-10). 
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Table 14. Hydrogenation of acetophenone 81a using the ruthenium precatalysts 79a-80ca. 
 
O
L*, t-BuOK, 25 °C
H2, 10 bar
OH
81a 82a
*
 
 
Entry Catalyst S/Ca Time[h] Conv(%)b eec 
1 79a 500 12 45 14(S) 
2 79b 500 12 54 22(S) 
3 79c 500 12 55 25(S) 
4 80a 500 12 50 43(R) 
5 80b 500 12 70 80(R) 
6 80c 500 1 100 97(R) 
7 80c 1000 1 100 97(R) 
8 80c 2000 1 100 97(R) 
9 80c 5000 1.5 100 97(R) 
10 80c 10000 2 100 95(R) 
a S/C: Substrate/Catalyst b Conversion was measured by chiral GC or by 1H-  
NMR.c Enantioselectivity was determined using chiral GC-DEX-CB column  
 
These results indicated that the stereochemistry of the diamine played a major role in 
providing high conversions and enantioselectivities in ketone hydrogenation.  The efficiency 
of this ruthenium-complex 80c in ketone hydrogenation was investigated by decreasing the 
catalyst loadings.  Increasing the ratio of substrate/catalyst to 10000 provided the alcohol 82a 
in quantitative yield but diminished the enantioselectivity to 95% ee (entries 7-10 of Table 
14). 
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Then we investigated the scope of ketone substrates for the asymmetric hydrogenation using 
the Ru-catalyst 80c.  Various types of substituted acetophenones were reduced in high 
conversions providing the corresponding chiral alcohols in high enantioselectivities.  The 
results are listed in Table 15. 
 
Table 15. Asymmetric hydrogenation of substituted acetophenones using the Ru-catalyst 80ca 
 
O
R
80c, t-BuOK, 25 °C
H2, 10 bar, S/C 2000,
OH
R
81a-l 82a-l100% conversion
 
 
Entry Substrate Time[h] Productb ee(%)c 
1 
O
 
81a 
1 82a 97 
2 
O
MeO
 
81b 
1.5 82b 96 
3 
O
H3C
 
81c 
1 82c 97 
4 
OCH3
 
81d 
2 82d 94 
5 
O
MeO
 
81e 
1.5 82e 97 
6 
O
Cl
 
81f 
1.5 82f 97 
7 
O
Cl
 
81g 
1 82g 96 
8 
O
F3C
 
81h 
1 82h 94 
Results and Discussion   64
9 
O
F
 
81i 
1 82i 96 
10 
O
 
81j 
2 82j 97 
11 
O
 
81k 
2 82k 97 
12 
O
Ph
 
81l 
2 82l 94 
a
 Reactions were performed with 1M solution of ketone in i-PrOH at S/C 2000/1 and t-BuOK 
(base/Ru = 25/1). b In all cases full conversion was achieved. c Enantiomeric excess was  
determined by chiral GC or chiral HPLC. 
 
In order to further explore the substrate scope, we investigated the asymmetric hydrogenation 
of ketones bearing different types of side-chains at the α-position.  Elongation of the side 
chain of the ketone from methyl to ethyl, n-butyl, n-pentyl or benzyl doesn’t affect the 
reactivity and provided the corresponding secondary alcohols in 90-97% ee (entries 1-4 of 
Table 16).  Introducing branching at the α-position of the ketone led to long reaction times 
and poor selectivities (entry 5).  Furthermore, we examined the chemoselective hydrogenation 
of α,β-unsaturated ketones of type 85a-b (entries 6-7; Table 16).  Ketone 85a was smoothly 
reduced to afford the allylic alcohol 86a in 95% ee (entry 6) whereas the ketone 85b furnished 
the secondary alcohol 86b in 37% ee (entry 7).  We also extended the hydrogenation of 
ketones using the Ru-catalyst 80c to hetero-aromatic ketones 87, 88 and 91 and obtained the 
corresponding alcohols in excellent enantioselectivities (entries 8-10; Table 16). 
 
Table 16. Asymmetric hydrogenation of aryl and heteroaryl ketones using the Ru-catalyst 
80c.a 
 
Ar R
O
80c, t-BuOK, 25 °C
H2, 10 bar, S/C 2000,
Ar R
OH
100% conversion
 
 
Results and Discussion   65
Entry Substrate Time[h] Productb ee(%)c 
1 
O
 
83a 
1.5 84a 97 
2 nBu
O
 
83b 
1.5 84b 97 
3 nPent
O
 
83c 
1.5 84c 94 
4 
O
Ph
 
83d 
2 84d 90 
5 
O
 
83e 
5 84e 38 
6 
O
 
85a 
1 86a 94 
7 
O
 
85b 
2 86b 37 
8 
N
O
 
87 
3 88 96 
9 S
O
 
89 
2.5 90 93 
10 
CH3
O
Fe
 
91 
4 92 92 
a
 Reactions were performed with 1M solution of ketone in i-PrOH at S/C 2000/1 and t-BuOK 
(base/Ru = 25/1). b In all cases full conversion was achieved. c Enantiomeric excess was  
determined by chiral GC or chiral HPLC. 
 
 
To broaden the application of this ruthenium catalyzed hydrogenation using the catalyst 80c, 
we performed the hydrogenation on disubstituted acetophenones 93a-d and obtained the 
respective alcohols 94a-d in good enantioselectivities.  Reduction of the ketone 93d bearing 
Results and Discussion   66
two methoxy groups on 3,4 positions of the aromatic ring was accomplished smoothly 
providing the alcohol 94d in 94% ee, which is a precursor for the synthesis of (−)-Salsolidine 
(Scheme 70).121 
 
R
R
CH3
O
Cl
Cl
CH3
OH
O
O
CH3
OH
H3C
H3C
CH3
OH
R
R
CH3
OH
CH3
OH
MeO
MeO
80c, t-BuOK, 25 °C
H2, 10 bar, 2-4 h, 
S/C: 2000
94a : 96% ee 94b : 90% ee 94c : 97% ee 94d : 94% ee
93a-d 94a-d>96% yield
 
Scheme 70. Asymmetric hydrogenation of disubstituted acetophenone using the Ru-catalyst 
80c 
 
4.4. Conclusion 
In conclusion, we have synthesized new paracyclophane based diphosphine ligands 12a-d.  
By tuning the electronic properties of the phosphines, we were able to demonstrate the ligand 
12d as the more efficient one for transition-metal catalyzed asymmetric reactions.  The 
possible reason for the difference in the reactivity of the ligands 12c and 12d in asymmetric 
catalysis could be that the (3,5-trifluoromethylphenyl) group on the phosphine of the ligand 
12c is an electron poor group.  This may lead to an increase in the Lewis acidity on the 
transition metal, thereby decreasing the reactivity and selectivities in the asymmetric 
reactions.  The ruthenium complex 80c which was derived from 12d and (S,S)-1,2-DPEN 
provided high enantioselectivities in hydrogenation of aromatic and hetero-aromatic ketones, 
quite comparable to the C2-symmetrical dixylylphosphine 13b. 
 
 
 
 
 
 
 
                                                 
121
 Ponzo, V. L.; Kaufman, T. S. Tetrahedron Lett. 1995, 36, 9105. 
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5. Summary and Outlook 
This work focused on the preparation of new chiral ligands and studies concerning their 
applications in asymmetric catalysis. 
 
In the first project, we described the synthesis of a chiral planar ferrocenyl P,P-ligand 8 
through the selective sulfoxide-lithium exchange.  Performing the sulfoxide-lithium exchange 
on 1,2-bromo-ferrocenyl sulfoxide 17 using PhLi, followed by the addition of several 
electrophiles led to the bromo substituted 1,2-chiral ferrocenes of type 20 (Scheme 71).   
 
SOTol
Br
Li
Br
E
Br
Fe Et2O, 5 min
19
Fe Fe
17
PhLi, -78 °C E+,
-78 °C, 30 min;
rt, 1-2 h
20a-e
20a: E = SPh;     72%
20b: E = CHO;    69%
20c: E = I;           70%
20d: E = SiMe3;   70%
20e: E = P(S)Ph2;  79%
Si
Br
SOTol
MeMe Si
Br
PPh2
MeMe
S
Si
PPh2
PPh2
MeMe
S
S
Si
PPh2
PPh2
MeMe
Fe
FeFe
Fe
16 22: 88%
1. PhLi, Et2O, 
-78 °C, 5-10 min
2. PPh2Cl, THF, 
-78 °C, 45 min; rt, 2 h
3. S8, BuNH2, rt, 12 h
1. n-BuLi, THF, 
-78 °C, 15 min
2. PPh2Cl, THF, 
-78 °C, 45 min; rt, 2 h
3. S8, BuNH2, rt, 12 h 24: 89%
(SFc)-8: 92%
Raney-Ni, MeOH
rt, 12 h
 
Scheme 71. Preparation of bromo ferrocenes of type 20 and chiral planar ferrocenyl ligand 8 
through selective sulfoxide-lithium exchange using PhLi 
 
The ferrocenyllithium species 19 was unstable and undergoes racemization for long reaction 
times.  We extended this selective-sulfoxide lithium exchange to synthesize the chiral planar 
ferrocenyl P,P-ligand 8.  This ligand gave poor enantioselecetivities in Pd(0)-catalyzed 
asymmetric allylic alkylation (Scheme 72). 
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Ph Ph
OAc
Ph Ph
MeO2C CO2Me
27 28: 90%; 30% ee
[Pd(C3H5)Cl]2 (1 mol%)
  8 (2 mol%)
CH2(CO2Me)2, KOAc (5 mol%)
BSA (3 equiv), CH2Cl2, -20 °C, 10 h
Si
PPh2
PPh2
MeMe
Fe
8
 
 
Scheme 72. Application of ferrocenyl P,P-ligand 8 in Pd(0)-catalyzed allylic alkylation 
 
In the second project, the synthesis of various novel chiral P,N-ligands of type 9-10 was 
demonstrated.  Various chiral P,N-ligands with or without substitutions on the pyridine ring 
were described (Figure 15). 
 
N
PAr2
OMe
N
PAr2
OR1
R
Fe Fe
9a-h 10a-h
R
R = H, tBu, Ph
R1 = Bn, H
R = H, tBu, Ph
Ar = Ph, Xyl
 
Figure 15. New ferrocenyl P,N-ligands of type 9 and 10 for asymmetric catalysis. 
 
The P,N-ligands of type 9 and 10 were synthesized via the diastereoselective ortho-lithiation 
of ferrocenyl sulfoxide 14 (Scheme 73). 
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S
OPh2P
S
N
OHPh2P
S
N
OR1Ph2P
S
N
OR1Ph2P
S
Fe
Fe
Fe
Fe
1) PhLi, THF, 
      -78 °C, 10 min
2) 2-PyrCHO,  
-78 °C, 1.5 h; 
     to RT, 1.5 h
31: 72% (dr: 3:2)
+
1) KH, THF, 0 °C; 
to  RT, 1 h
2) RX, 0 °C, 15 min;  
to RT, 30  min
30: 88%
Fe
(S)-14: >99% ee
S
O
: 1) LDA, THF, 
  -78 °C, 30 min
2) PPh2Cl, -78 °C, 1 h;
      to RT, 1.5 h
3) S8, BuNH2, RT, 
   2 - 4 h
31
(RFc,S)-32a: R1 = Me; 54%
(RFc,S)-33a: R1= Bn; 56%
(RFc,R)-32b: R1 = Me; 35%
(RFc,R)-33b: R1 = Bn; 36%
Raney-Ni, MeOH
RT, 12 h
Raney-Ni, MeOH
RT, 12 h
N
OR1Ph2P
N
OR1Ph2P
Fe Fe
9a:   R1 = Me; 84%
10a: R1 = Bn; 88%
9b:   R1 = Me; 82%
10b: R1 = Bn; 86%
 
 
Scheme 73. Synthesis of chiral ferrocenyl P,N-ligands 9a-b and 10a-b 
 
The stereochemistry of the two ferrocenyl ethers 32a and 32b at the α-center was determined 
by X-ray analysis of the phosphine sulfide 32b. 
 
These chiral ferrocenyl P,N-ligands were applied successfully in Pd(0)-catalyzed asymmetric 
allylic alkylations of 27 and provided the desired product 28 in up to 97% ee (Scheme 74). 
 
Ph
OAc
Ph
27 28
PhPh
MeO2C CO2Me[Pd(C3H5)Cl]2 (0.5 mol%), 9a (1.0 mol%)
CH2(CO2Me)2, KOAc (1.0 mol%)
BSA (3.0 equiv.), solvent, 25 °C, 2-6 h
up to 97% ee
N
OMePh2P
Fe
9a
 
Scheme 74. Application of new P,N-ligands 9-10 in asymmetric allylic alkylations  
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Further, we applied these P,N-ligands 9a-g and 10a-g in Ir-catalyzed asymmetric 
hydrogenation of imines.  The P,N-ligands 9a, 10a, 9c, and 9d were found to be efficient 
ligands for the iridium catalyzed imine hydrogenation under mild conditions.  Iridium 
complexes based on these P,N-ligands 46a-d provided high enantioselectivities in the 
hydrogenation of various N-(3,5-dimethyl-4-methoxy)phenyl-1-phenyl ethylidene amines of 
type 56 that up to 99% ee (Scheme 75). 
 
N
OMePh2P
Ir(COD)
R1
R
N
Me
OMe
Me
56a-y
Fe
BARF
R1
(R)-57a-y
R
HN
Me
OMe
Me
46a (1 mol%), H2, 10 bar
Tol:MeOH (4:1), 2 h, 25 °C
up to 99% ee
>99.5% conversion
46a
 
Scheme 75. Hydrogenation of imine 56 using the Ir-catalysts 46a 
 
We also demonstrated the deprotection of N-(3,5-dimethyl-4-methoxy)phenyl group on the 
amines of type 57 under practical conditions which lead to the various chiral primary amines 
and lactams (Scheme 76). 
 
Me
HN
Me
OMe
Me
(R)-57
HN
Me
OMe
Me
CO2Me
R
(R)-58-62
HN
O
Me
NH2
CAN (4 equiv), 25 °C
MeOH:H2O (6:1), 12 h
CAN (4 equiv), 25 °C
MeOH:H2O (6:1), 12 h
n = 1: (R)-56u
n = 2: (R)-56v
n = 1: (R)-63; 74%; 92% ee
n = 2: (R)-64; 78%; 97% ee
n
78-87%; 92-95% ee
R
n
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Scheme 76. Deprotection of N-aromatic group and synthesis of chiral amines and lactams 
 
In the third project we described the synthesis of bis-ferrocenyl ligands of type 11 and their 
applications in asymmetric catalysis (Figure 16).  These ligands provided disappointing 
results in asymmetric hydrogenations and allylic alkylations. 
 
11a 11b
Fe
OMe
Ph2P
Ph2P
Fe Fe
OMe
Ph2P
Fur2P
Fe
 
Figure 16. New bis-ferrocenyl P,P-ligands 11a and 11b 
 
In the final project we demonstrated the synthesis of new paracyclophane phosphines 12a-d 
(Figure 17). 
 
PPh2
PAr2
CF3
CF3
F
12c
12b
O
12a
(R)-12a-d
Ar =
CH3
CH3
12d
 
Figure 17. New paracyclophane based diphosphines 12a-d 
 
The ligand 12d was synthesized as outlined in the scheme 77. 
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PPh2
Br
S
PPh2
PXyl2
S
S
PPh2
PXyl2
1. n-BuLi, THF, -78 °C
    1 h
2. ClPXyl2, -78 °C, 1 h
     RT, 1.5 h
3. S8, RT, 12 h
Raney-Ni, MeOH
RT, 12 h
78d: 87%
(R)-12d: 92%
77: 85%
PPh2
Br
S
(R)-76
1. n-BuLi, THF, -78 °C
    1 h
2. ClPPh2, -78 °C, 1 h
     RT, 1.5 h
3. S8, RT, 12 h
 
Scheme 77. Synthesis of new paracyclophane diphosphine 12d 
 
Among these P,P-ligands 12a-d, ligand 12d proved to be an efficient ligand for Ru-catalyzed 
hydrogenation of various prochiral ketones (Scheme 78).  The ruthenium-diamine complex 
80c which was derived from ligand 12d provided high conversions and enantioselectivities in 
the hydrogenation of different aromatic and hetero-aromatic ketones up to 97% ee (Scheme 
78). 
 
P
Ph2
Xyl2
P
Ru
H2
N
N
H2
Cl
Cl
Ph
Ph
Ar R
O t-BuOK, 25 °C
H2, 10 bar, S/C 2000
Ar R
OH
80c
up to 97% eefull conversion
 
Scheme 78. Asymmetric hydrogenation of aromatic and hetero-aromatic ketones using Ru-
catalyst 80c 
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Experimental Section  
 
1. General conditions 
 
All reactions were carried out with a magnetic stirring and, if air or moisture sensitive, in a 
flamed-dried glassware under a nitrogen or an argon atmosphere.  The syringes which were 
used to transfer the reagents and the solvents were purged with nitrogen or argon prior to use. 
 
Solvents 
 
The solvents were dried according to standard methods by distillation over drying agents as 
stated below and were stored under argon or nitrogen.  Dichloromethane and toluene were 
predried over calcium chloride and were distilled from calcium hydride.  DMF was heated at 
reflux for 14 h over calcium hydride and was distilled.  Diisopropylamine and i-PrOH were 
distilled from potassium hydride.  Ethanol was treated with phthalic anhydride (25 g/L) and 
sodium, heated at reflux for 6 h and distilled.  Methanol was treated with magnesium turnings 
(20 g/L), heated at reflux for 6 h and distilled.  Tetrahydrofuran (THF) was continuously 
heated at reflux and freshly distilled from sodiumbenzophenone ketyl under nitrogen. 
 
Reagents 
 
Reagents of >98% purity were used as obtained. 
n-Butyllithium was used as a solution in hexane. 
t-Butyllithium was used as a solution in pentane. 
Lithium Diisopropylamine was prepared by adding n-BuLi (1.5 M; 1.10 equiv.) to a 2.0 M 
solution of diisopropylamine (1.32 equiv.) in THF at -78 °C and then stirring at room 
temperature for 30 min. It was used, as it is in lithiation reactions. 
Phenyl lithium was prepared by adding n-BuLi (1.5 M; 1.10 equiv.) to a 0.2 M solution of 
iodobenzene (1.0 equiv) in diethyl ether at 0 °C and then stirred at room temperature for 30 
min.  It was used, as it is in exchange and lithiation reactions. 
The following reagents and substances were prepared according to the literature procedures: 
Sulfoxide (14), 1,3-Diphenyl-3-acetoxypropen (27),122 chloro dixylylphosphine,123 bis 2-
furylphsophine,124 and NaBARF125 
Content determination of organometallic reagents 
The organo lithium and organo magnesium solutions were titrated using the method of 
Paquette126 and Knochel127 prior to use. 
 
Chromatography 
 
Thin layer chromatography (TLC) was performed using aluminium plates covered with SiO2 
(Merck 60, F-254).  The chromatograms were developed under UV light and/or by treatment 
of the TLC plate with one of the solutions below followed by gentle heating with a heat gun: 
-KMnO4 (0.3 g), K2CO3 (20 g) and KOH (0.3 g) in water (300 mL) 
                                                 
122
 Hayashi, T. ; Yamamoto, A. ; Ito, Y.; Nishioka, E.; Miura, H.; Yanagi, K. J. Am. Chem. Soc. 1989, 111, 6301. 
123
 Wu, J.; Chen, H.; Kwok, H.; Lam, K. H.; Zhou, Z. Y.; Yeung, C. H.; Chan, A. S. C. Tetrahedron Lett. 2002, 
43, 1539. 
124
 Demay, S. Dissertation, Ludwig-Maximilins-Universität München, 2001 
125
 Reger, D. L.; Wright, T. D.; Little, C. A.; Lamba, J. J. S.; Smith, M. D. Inorg. Chem. 2001, 40, 3810 
126
 Lin, H.-S.; Paquette, L. A. Synth. Commun. 1994, 24, 2503. 
127
 Krasovskiy, A.; Knochel, P. Synthesis 2006, 5, 890. 
Experimental Section   74
-Phosphormolybdic acid (5.0 g), Ce(SO4)2 (2.0 g) and conc. H2SO4 (12 mL) in water (230 
mL) 
Flash column chromatography was performed using SiO2 60 (0.040-0.063 mm; 230-400 mesh 
ASTM) or Al2O3 (grade III) from Merck.  The diameters of the columns and the amount of 
silica gel were calculated according to the recommendations of W. C: Still.128 
 
Analytical data 
 
Melting points were uncorrected and measured on a Büchi B-540 apparatus. 
NMR spectra were recorded on Brucker ARX 200, AC 300 or WH 400 instruments.  
Chemical shifts are reported as δ-values in ppm relative to the deuterated solvent peak: CDCl3 
(δH: 7.27, δC: 77.0) and Benzene-d6 (δH: 7.16, δC: 128.0). 
For the characterization of the observed signal multiplicities the following abbreviations were 
applied: s (singlet), d (doublet), dd (double doublet), t (triplet), dt (double triplet), m 
(multiplet), br (broad). 
Optical rotation values were measured on the Perkin-Elmer 241 polarimeter. 
Infrared spectra were recorded from 4000-400 cm-1 on a Nicolet 510 FT-IR or a Perkin-
Elmer 281 IR spectrometer.  The absorption bands are reported in wave number (cm-1).  For 
the band characterization the following abbreviation were applied: br (broad), s (strong), m 
(medium), w (weak). 
Gas Chromatography (GC): Hewlett-Packard 6890.  Cjiral columns: Chirasil-Dex-CB (25 
mm x 0.25 nm), Chirasil-L-val (25 m x 0.12 µm x 0.22 mm fused silica WCOT)).  Carrier gas 
H2. 
High Performance Liquid Chromatography (HPLC) was performed using Gynkotec-
HPLC with a diode-array UV-VIS detector.  Chiral columns: OD-H, OD, OJ and AD (Diacel 
Chemical Industries) with n-heptane/i-propanol as a mobile phase.  Racemic compounds were 
used for optimizing the operating conditions for the resolution of the enantiomer and 
diastereomer peaks. 
Electron impact mass (EI, 70 ev) specta were recorded on Finnigan MAT 95Q or Finnigan 
90 instrument.  High resolution mass spectra (HRMS) were recorded on the same instrument.  
The combination of gas chromatography with mass spectroscopic detection, a GC/MS from 
Hewlett-Packard HP 6890/MSD 5973 was used. 
Elemental Analysis was carried out on a Heraeus CHN-Rapid-Elementanalyzer in the 
microanalytical laboratories of the Department für Chemie und Pharmazie, Ludwig-
Maxmilians Universität München. 
 
2. Typical Procedures 
 
Typical procedure for the diastereoselective ortho-lithiation of ferrocene 14 (TP 1) 
 
A 250 mL Schlenk flask under an argon atmosphere was charged with ferrocenyl sulfoxide 14 
(5 mmol, 1.0 equiv.) in THF (50 mL) and added freshly prepared lithium diisopropylamine 
(2.0 M in THF; 2.75 mL; 1.1 equiv) at -78 °C.  The reaction mixture was stirred at -78 °C for 
30 min and then electrophile (1.10-1.20 equiv) was added.  The reaction mixture was stirred 
at -78 °C for 1-1.5 h and then warm up to room temperature and stirred for 2 h.  The reaction 
mixture was quenched with a saturated aqueous NH4Cl solution (20 mL) and the aqueous 
layer was washed with Et2O (4 x 25 mL).  The combined organic extracts were washed with 
water, brine and then dried over MgSO4.  After evaporation of the solvents, the crude product 
was purified by column chromatography. 
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Typical procedure for the sulfoxide-lithium exchange on bromo ferrocenes of type 17 
using PhLi (TP 2) 
 
A 10 mL Schlenk flask under argon atmosphere, was charged with 1-bromo ferrocenyl 
sulfoxide 17 (1.0 mmol) was dissolved in THF (5.0 mL).  This solution was added to a freshly 
prepared solution of phenyllithium (0.2 M in diethylether; 1.20 equiv) at -78 °C.  After 
stirring the reaction mixture are -78 °C for 5 min, electrophile (1.10-1.20 equiv) was added 
and stirred for 30-45 min.  Then the reaction mixture was warmed to room temperature and 
stirred for 1-2 h.  Reaction mixture was quenched with saturated aqueous NH4Cl solution (5 
mL) and the aqueous layer was extracted with Et2O (4 x 10 mL).  The combined organic 
extracts were washed with water, brine and dried over MgSO4.  Evaporation of the solvents 
and purification by column chromatography afforded the desired bromoferrocenes of type 20. 
 
Typical procedure for the preparation of ferrocenyl alcohols through the sulfoxide-
lithium exchange (TP 3) 
 
A Schlenk flask under an argon atmosphere was charged with ferrocenyl sulfoxide 30 or 34 
(10 mmol, 1.0 equiv.) in THF and cooled to −78 °C. A solution of freshly prepared PhLi in 
ether (0.20 M in ether, 1.20 equiv.) was slowly added and the reaction mixture was stirred at 
−78 °C for 10 min. 2-Pyridinecarboxaldehyde (1.20 equiv) was added dropwise at −78 °C and 
reaction mixture was stirred for 1.5 h then at room temperature for 1.5 h-2 h. After quenching 
the reaction mixture with a saturated NH4Cl solution (25 mL), the aqueous layer was 
extracted with diethyl ether (4 x 30 mL). The combined organic layers were washed with 
water, brine, dried over MgSO4 and evaporated under reduced pressure. Purification of the 
residue by flash chromatography (silica gel, n-pentane:Et2O 1:1) afforded the two 
diastereomeric alcohols as a separable or inseparable mixture. 
 
Typical procedure for preparation of ferrocenyl ethers (TP 4): 
 
A 50 mL Schlenkflask under an argon atmosphere was charged with KH (1 30 equiv) in THF 
and cooled to 0 °C. A solution of ferrocenyl alcohol (1.0 equiv) in THF was slowly added and 
the mixture was stirred at room temperature for 1 h. Methyliodide (1.20 equiv) or 
benzylbromide (1.20 equiv.) was then added dropwise at 0 °C and the reaction mixture was 
stirred at this temperature for 10 min then at room temperature for 30 min. After quenching 
the reaction mixture with a saturated NH4Cl solution, aqueous layer was extracted with 
diethyl ether. The combined organic layers were washed with water, brine, dried over MgSO4 
and evaporated under reduced pressure. Crude product was purified by flash chromatography 
to furnish the ferrocenyl ethers as solids. 
 
Typical procedure for the desulfurization of phosphine sulfides (TP 5).  
 
An argon flushed 50 mL Schlenk flask was loaded with Raney Ni slurry (Raney Ni in water; 
(P,N-ligand: 10 equiv; P,P-ligand 25 equiv)). Raney Ni was washed with MeOH (4 × 15 mL). 
To this flask was then transferred a solution of the protected ligand in THF (2-4 mL), then 
added 25 mL MeOH and stirred at room temperature under argon atmosphere for 12 h 
(conversion was monitored by 31Pnmr). The reaction mixture was filtered under argon. The 
Raney Ni residue was washed with THF (4 × 10 mL). The combined filtrate was concentrated 
under reduced pressure to afford the pure product as a yellow solid and stored under argon. 
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Typical procedure for the preparation of ferrocenyl P,N-iridium complexes 46a-g and 
47a-g (TP 6). 
 
A 25 mL Schlenk flask under an argon atmosphere, was charged with P,N-ligand (0.50 
mmol), [Ir(cod)Cl]2 (0.25 mmol, 0.50 equiv.) in CH2Cl2 (5 mL) and stirred at room 
temperature for 1 h. NaBARF (0.75 mmol, 1.50 equiv.) was added followed by water (5 mL) 
and the resulting two-phase reaction mixture was stirred vigorously for 30 min. The separated 
aqueous layer was extracted with CH2Cl2 (4 × 15 mL). The combined organic extracts were 
washed with brine and dried over MgSO4. The residue was purified by column 
chromatography (CH2Cl2 as an eluent) yielding the Ir-complexes as a bright orange solid. 
 
Typical procedure for the preparation of N-arylimines (TP7). 
 
A 250 mL round-bottomed flask was filled with a ketone (10.0 mmol), an amine (12.0 mmol) 
and molecular sieves (4 Å, 8 g) in toluene (60 mL). The reaction mixture was refluxed until 
full conversion was reached (conversion was monitored by GC). The reaction mixture was 
filtered through celite, solvent was evaporated and the crude product was further purified by 
column chromatography or vacuum distillation or recrystallization to afford the desired 
product. 
 
Typical procedure for the Ir-catalyzed hydrogenation of the imines (TP 8): 
 
A 10 mL Schlenk flask under an argon atmosphere was loaded with Ir-complex (0.005 mmol) 
and imine (0.5 mmol) in Toluene:MeOH (4:1). The mixture was stirred at room temperature 
for 10-15 min. Then the solution was transferred under argon to an autoclave which was 
equipped with a glass tube and a stirring bar. The autoclave was then purged three times with 
hydrogen (5 bar) and finally pressurized to 10 bar. The reaction mixture was stirred for the 
indicated period of time until full conversion was achieved. Then the hydrogen gas was 
released, evaporated the solvents and filtered through a short pad of silica gel 
Conversion was checked by 1H-NMR/GC and enantioselectivity was determined using either 
Chiral GC or Chiral HPLC. 
 
Typical procedure for the preparation of chiral primary amines and lactams (TP 9) 
 
The secondary amine of type 57 (0.4 mmol) was dissolved in MeOH:H2O (6:1; 21 mL) and 
cerium ammonium nitrate (CAN; 4 equiv; 1.6 mmol) was added at 0 °C.  Then the reaction 
mixture was warmed to room temperature and stirred for overnight.  The reaction mixture 
washed with CH2Cl2 (5 mL) and the aqueous layer was made alkaline using aqueous NaOH 
solution (2.0 M).  The aqueous layer was washed with ethylacetate (4 x 15 mL) and the 
combined organic extracts were washed with water, brine, dried over MgSO4 and 
concentrated in vacuo.  Purification by chromatography afforded the primary amines and 
lactams. 
 
Typical procedure for the preparation of ruthenium-diamine complexes 79a-c and 80a-c 
of paracyclophane phosphines (TP 10) 
 
In a 10 mL Schlenk falsk P,P-ligand (0.01 mmol) and [Ru(C6H5)Cl]2 (0.005 mmol) were 
dissolved in a mixture of toluene (2 mL) and DMF (1.5 mL) under an argon atmosphere.  The 
mixture was heated at 115 °C for 4 h and then chiral diamine (0.01 mmol) was added and 
continued the stirring at 115 °C for 2 h.  The reaction mixture was cooled to room temperature 
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and stirred for overnight.  Evaporated the solvents under reduced pressure and the mixture 
was washed with CH2Cl2:Et2O (1:1; 4 mL) under argon.  Evaporation of the solvents, 
afforded the desired ruthenium-diamine complex of the paracyclophane phosphine (79a-c or 
80a-c).  These complexes are used in the ketone hydrogenation without any further 
purification. 
 
Typical procedure for the Ru-catalyzed hydrogenation of the ketones (TP 11) 
 
A 10 mL Schlenk flask was charged with the ruthenium precatalyst of type 79 or 80 (0.002 
mmol) and ketone (4 mmol) and dry iPrOH (4 mL) under argon atmosphere.  The mixture 
was stirred at room temperature for 15 min then transferred under argon to an autoclave which 
was equipped with a glass tube and a stirring bar. The autoclave was then purged three times 
with hydrogen (5 bar) and finally pressurized to 10 bar. The reaction mixture was stirred for 
the indicated period of time until full conversion was achieved. Then the hydrogen gas was 
released, evaporated the solvents and filtered through a short pad of silica gel 
Conversion was checked by 1H-NMR/GC and enantioselectivity was determined using either 
Chiral GC or Chiral HPLC. 
 
Typical procedure for the Pd(0)-catalyzed asymmetric alkylation on racemic 27 (TP 12) 
 
A 10 mL Schlenk flask was filled with ferrocenyl ligand (1.0 mol %), [Pd(C3H5)Cl]2 (1.0 mg; 
0.5 mol %) and CH2Cl2 (4 mL) under an argon atmosphere.  The mixture was stirred at room 
temperature for 10 min.  3-Acetoxy-1,3-diphenyl-propene 27 (126 mg; 0.5 mmol), 
dimethylmalonate (0.2 mL; 1.5 mmol), N,O-bistrimethylsilylacetamide (305 mg; 1.5 mmol) 
and potassium acetate (0.5 mg; 1.0 mol%) were added successively.  The reaction mixture 
was stirred for 1 h-12 h at room temperature.  The reaction was quenched with saturated 
aqueous NH4Cl (2 mL) and extracted with CH2Cl2 (4 x 10 mL).  The organic phase was 
washed with water, brine, dried over Na2SO4 and concentrated in vacuo.  Purification by flash 
chromatography yielded 28. 
 
Typical procedure for the Rh-catalyzed hydrogenations (TP 13) 
 
A 10 mL Schlenk flask was charged with the chiral ligand (1 mol %) and [Rh(nbd)2]BF4 (3.7 
mg, 1 mol %) in toluene/methanol (5:1).  Then added a solution of substarte 25 or 74 in 
methanol (4 mL) and stirred for 15 min at room temperature.  The mixture was transferred to 
an autoclave which was equipped with a glass tube and a stirring bar. The autoclave was then 
purged three times with hydrogen (5 bar) and finally pressurized to the required pressure. The 
reaction mixture was stirred for the indicated period of time until full conversion was 
achieved. Then the hydrogen gas was released, evaporated the solvents and filtered through a 
short pad of silica gel, afforded the desired product 26 or 75. 
Conversion was checked by 1H-NMR/GC and enantioselectivity was determined using either 
Chiral GC or HPLC. 
 
3. Preparation of new planar chiral ferrocenyl P,P-ligand 8 
 
(SFc, S)-[2-((2-Bromophenyl)dimethylsilyl)-ferrocen-1-yl]-p-tolylsulfoxide (16) 
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Prepared according to TP1 using sulfoxide 14 (1.62 g; 5.0 mmol), LDA (2.75 mL, 5.50 
mmol; 1.10 equiv.), and 2-bromophenyldimethylchlorosilane 15 (1.50 g, 6.0 mmol; 1.2 equiv) 
as an electrophile.  After the typical work-up, the crude product was purified by flash 
chromatography (silica gel, n-pentane:Et2O 1:1), provided the desired compound (2.50 g, 4.65 
mmol, 93 %) as a yellow solid. 
 
MP: 146.5-148.5 °C 
[α]D20 = +20.1 (c = 0.2, acetone) 
1H-NMR (600 MHz, CDCl3): δ = 7.59-7.58 (m, 2H), 7.45-7.44 (m, 2H), 7.27-7.24 (m, 3H), 
7.17-7.15 (m, 2H), 4.56 (s, 1H), 4.46 (s, 1H), 4.35 (s, 1H), 4.24 (s, 5H), 2.41 (s, 3H), 1.04 (s, 
3H), 0.79 (s, 3H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 140.9, 139.6, 137.9, 132.4, 130.6, 130.0, 129.2, 126.3, 
125.1, 78.7, 73.3, 71.6, 71.5, 70.1, 21.4, 0.74, -0.58 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3435 (br, s), 2920 (w), 1578 (w), 1411 (m), 1175 (m), 
1048 (m), 810 (s), 757 (m). 
MS (70 eV, EI): m/z (%) = 536 (M+, 68), 523 (47), 522 (100), 520 (90), 398 (11). 
HRMS (EI): m/z calcd. for: [C25H2579BrFe32SSiO] 535.9928,  found: 535..9912.  
 
(RFc, S)-[1-Bromo-2-ferrocen-1-yl]-p-tolylsulfoxide (17) 
 
SOTol
Fe
Br
 
 
Prepared according to TP1 using sulfoxide 14 (1.62 g, 5.0 mmol), LDA (2.75 mL, 5.50 
mmol; 1.10 equiv.), and 1,1,2,2-tetrafluorodibromoethane (1.56 g; 6.0 mmol; 1.20 equiv) as 
an electrophile.  After the typical work-up, the crude product was purified by flash 
chromatography (silica gel, n-pentane:Et2O 1:1), provided the desired compound (1.78 g, 4.41 
mmol, 88 %) as a brown solid 
 
MP: 85.8-88.9 °C 
[α]D20 = +9.5 (c = 0.2, acetone) 
1H-NMR (300 MHz, C6D6): δ = 7.72-7.69 (m, 2H), 6.90-6.88 (m, 2H), 4.18 (dd, J = 1.3 Hz, 
2.2 Hz, 1H), 4.05 (s, 5H), 3.85 (q, J = 1.3 Hz, 1H), 3.63 (t, J = 2.7 Hz, 1H), 1.98 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 142.2, 140.7, 129.4, 125.5, 93.6, 77.5, 73.5, 72.5, 68.4, 68.2 
ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (m), 3078 (w), 1641 (w), 1490 (w), 1191 (m), 1034 
(s), 813 (m), 627 (m). 
MS (70 eV, EI): m/z (%) = 402 (M+, 100), 386 (14), 324 (19), 250 (57), 217 (57), 185 (31). 
HRMS (EI): m/z calcd. for: [C17H1579BrFe32SO] 401.9376,  found: 401.9340. 
 
(RFc)-[2-Bromo-2-ferrocen-1-yl]-phenylsulfide (20a) 
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Prepared according to TP2, using sulfoxide 17 (403 mg; 1.0 mmol), phenyllithium (6 mL; 0.2 
M in Et2O; 1.20 equiv) and diphenyldisulfide (262 mg; 1.20 mmol; 1.20 equiv) as an 
electrophile.  After the typical work-up, the crude product was purified by column 
chromatography (silica gel, n-pentane), provided the desired compound (269 mg, 0.72 mmol, 
72 %) as a pale yellow solid. 
 
MP: 66.7-67.0 °C 
[α]D20 = −6.0 (c = 0.2, acetone) 
1H-NMR (300 MHz, C6D6): δ = 7.23-7.22 (m, 2H), 6.98-6.93 (m, 2H), 6.86-6.81 (m, 1H), 
4.34 (dd, J = 1.3 Hz, 2.6 Hz, 1H), 4.20 (dd, J = 1.7 Hz, 2.6 Hz, 1H), 4.04 (s, 5H), 3.77 (t, J = 
2.6 Hz, 1H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 139.9, 129.0, 126.7, 125.5, 85.9, 77.9, 73.8, 72.5, 72.4, 68.7 
ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3435 (s), 1627 (m), 1478 (m), 1394 (m), 1106 (w), 1024 
(m), 1001 (m), 827 (m), 740 (m). 
MS (70 eV, EI): m/z (%) = 372 (M+, 100), 292 (12), 258 (23), 203 (20), 171 (43). 
HRMS (EI): m/z calcd. for: [C16H1379BrFe32S] 371.9271,  found: 371.9273. 
 
(RFc)-[2-Bromo-2-ferrocen-1-yl]-phenylsulfone (21) 
 
SO2Ph
Fe
Br
 
 
To a 50 mL round-bottomed flask was added ferrocenylsulfide 20a (186 mg; 0.5 mmol) and 
CH2Cl2 (10 mL).  This solution was added slowly to a solution of mCPBA (345 mg, 2.0 
mmol; 4.0 equiv) in CH2Cl2 (5 mL).  After the addition the reaction mixture was warmed to 
room temperature and stirred for 2 h.  The reaction mixture was quenched with 2.0 M aqueous 
solution of NaHSO3 (20 mL) and the aqueous layer was extracted with CH2Cl2 (4 x 10 mL).  
The combined organic extracts were washed with water, brine, dried over MgSO4 and 
concentrated in vacum.  The residue was purified by flash chromatography (silica gel, n-
pentane), furnished the desired compound (190 mg, 0.47 mmol, 94 %) as a pale yellow solid. 
 
MP: 66.4-68.9 °C 
[α]D20 = −2.3 (c = 0.2, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 8.09-8.06 (m, 2H), 6.91-6.89 (m, 3H), 4.66 (dd, J = 1.7 Hz, 
2.7 Hz, 1H), 4.33 (s, 5H), 4.12-4.11 (m, 1H), 3.67 (t, J = 2.9 Hz, 1H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 143.2, 132.7, 128.9, 127.6, 89.3, 76.8, 74.6, 73.5, 70.0, 69.9 
ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (m), 1637 (w), 1445 (m), 1322 (s), 1200 (m), 1146 
(s), 1088 (m), 938 (m), 724 (s), 612 (s). 
MS (70 eV, EI): m/z (%) = 404 (M+, 62), 324 (100), 258 (5), 204 (28), 202 (25). 
HRMS (EI): m/z calcd. for: [C16H1379BrFe32SO2] 403.9169,  found: 403.9149. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.3 
mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C);  
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tr = 44.9 min [minor], tr = 51.0 min [major];  97% ee. 
 
(RFc)-[2-Bromo-2-ferrocen-1-yl]-aldehyde (20b) 
 
CHO
Fe
Br
 
 
Prepared according to TP2, using sulfoxide 17 (403 mg; 1.0 mmol), phenyllithium (6 mL; 0.2 
M in Et2O; 1.20 equiv), and DMF (1.0 mL; 1.30 equiv) as an electrophile.  After the typical 
work-up, the crude product was purified by column chromatography (silica gel, n-
pentane:Et2O (10:1)), provided the desired compound (202 mg, 0.69 mmol, 69 %) as a dark 
red oil. 
 
[α]D20 = −692 (c = 0.15, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 10.24 (s, 1H), 4.62 (s, 1H), 4.26 (s, 1H), 3.85 (s, 6H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 191.4, 80.3, 76.5, 74.6, 72.2, 70.9, 66.8 ppm. 
IR (neat): υmax (cm−1) = 3436 (w), 1681 (s), 1438 (m), 1224 (m), 987 (m), 828 (m), 749 (m). 
MS (70 eV, EI): m/z (%) = 292 (M+, 66), 212 (100), 184 (33), 156 (4), 128 (51). 
HRMS (EI): m/z calcd. for: [C11H979BrFeO] 291.9186,  found: 291.9179. 
 
(RFc)-[2-Bromo-2-ferrocen-1-yl]-Iodide (20c) 
 
I
Fe
Br
 
 
Prepared according to TP2, using sulfoxide 17 (403 mg; 1.0 mmol), phenyllithium (6 mL; 0.2 
M in Et2O; 1.2 equiv), and I2 (304 mg; 1.2 mmol; 1.2 equiv) as an electrophile.  After the 
typical work-up, the crude product was purified by column chromatography (silica gel, n-
pentane), provided the desired compound (274 mg, 0.70 mmol, 70 %) as a pale yellow solid. 
 
MP: 85.5-83.6 °C 
[α]D20 = −1.8 (c = 0.2, acetone) 
1H-NMR (600 MHz, C6D6): δ = 4.52 (s, 1H), 4.42 (s, 1H), 4.22 (s, 5H), 4.19 (s, 1H) ppm. 
13C-NMR (150 MHz, C6D6): δ = 84.5, 73.7, 73.6, 73.3, 69.6, 68.4 ppm. 
IR (KBr-pressling): υmax (cm−1) = 2900 (w), 1690 (m), 1633 (s), 1569 (m), 1468 (m), 1312 
(m), 1100 (m), 1028 (m), 845 (s), 779 (s). 
MS (70 eV, EI): m/z (%) = 390 (M+, 100), 183 (17), 128 (74), 127 (12). 
HRMS (EI): m/z calcd. for: [C10H879BrFeI] 389.8203,  found: 389.8188. 
 
(RFc)-[2-Bromo-2-ferrocen-1-yl]-trimethylsilane (20d) 
 
SiMe3
Fe
Br
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Prepared according to TP2, using sulfoxide 17 (403 mg; 1.0 mmol), phenyllithium (6.0 mL; 
0.2 M in Et2O; 1.20 equiv), and trimethylchlorosilane (0.2 mL; 1.20 mmol; 1.20 equiv) as an 
electrophile.  After the typical work-up, the crude product was purified by column 
chromatography (silica gel, n-pentane), provided the desired compound (236 mg, 0.70 mmol, 
70 %) as a pale yellow oil. 
 
[α]D20 = −1.0 (c = 0.2, acetone) 
1H-NMR (300 MHz, C6D6): δ = 4.41 (s, 1H), 4.40 (s, 1H), 4.18 (s, 5H), 4.17 (s, 1H), 0.21 (s, 
9H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 82.5, 73.7, 73.0, 72.8, 67.6, 67.2 ,-0.2 ppm. 
IR (neat): υmax (cm−1) = 2910 (w), 1600 (w), 1558 (m), 1468 (m), 1229 (m), 1100 (m), 1028 
(m), 845 (s), 779 (s), 698 (m). 
MS (70 eV, EI): m/z (%) = 335 (M+, 100), 258 (77), 195 (14), 121 (25). 
HRMS (EI): m/z calcd. for: [C13H1779BrFeSi] 335.9632,  found: 335.9640. 
 
(RFc)-[2-Bromo-2-ferrocen-1-yl]-trimethylsilane (20e) 
 
P(S)Ph2
Fe
Br
 
 
Prepared according to TP2, using sulfoxide 17 (403 mg; 1.0 mmol), phenyllithium (6.0 mL; 
0.2 M in Et2O; 1.20 equiv).  The reaction mixture was stirred at -78 °C for 5 min, and then 
ClPPh2 (0.2 mL; 1.20 mmol; 1.20 equiv) was added as an electrophile.  The reaction mixture 
was stirred 30 min at -78 °C and then at room temperature for 1 h.  A solution of sulphur (320 
mg; 10.0 equiv) in butylamine (1.0 mL) was added to the reaction mixture.  Then reaction 
mixture was stirred at room temperature for 4-5 h and added saturated aqueous NH4Cl 
solution (10 mL).  The aqueous layer was extracted with Et2O (4 x 15 mL) and the combined 
organic extracts were washed with HCl (2.0 M), water, brine, dried over MgSO4, and 
concentrated in vacum.  The crude product was purified by column chromatography (silica 
gel, n-pentane:Et2O (10:1)), furnished the desired compound (380 mg, 0.79 mmol, 70 %) as a 
pale yellow solid. 
 
MP: 125.5-123.6 °C 
[α]D20 = −4.2 (c = 0.2, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.64-7.54 (m, 4H), 7.15-7.10 (m, 6H), 4.64-4.62 (m, 1H), 
4.54-4.53 (m, 1H), 4.42 (s, 5H), 4.29 (s, 1H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 134.6 (d, J = 87.1 Hz), 132.8 (d, J = 85.6 Hz), 131.4 (d, J = 
11.0 Hz), 131.0 (d, J = 10.6 Hz), 129.2 (d, J = 2.9 Hz), 129.0 (d, J = 2.9 Hz), 127.6 (d, J = 
12.7 Hz), 127.1 (d, J = 13.0 Hz), 82.8 (d, J = 10.1 Hz), 79.2 (d, J = 90.2 Hz), 78.2 (d, J = 10.8 
Hz), 72.5 (d, J = 9.7 Hz), 72.0 (d, J = 7.6 Hz), 71.9 ppm. 
IR (KBr-pressling): υmax (cm−1) = 2914 (br, w), 1689 (w), 1646 (m), 1598 (m), 1219 (m), 
1109 (m), 898 (s), 778 (s), 645 (s). 
MS (70 eV, EI): m/z (%) = 480 (M+, 12), 448 (100), 337 (64), 183 (30). 
HRMS (EI): m/z calcd. for: [C22H1879BrFeP32S] 479.9400,  found: 479.9412. 
 
(SFc)-[2-((2-Bromophenyl)dimethylsilyl)]-1-phosphinothioylferrocene (22) 
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Prepared according to TP2, using sulfoxide 17 (538 mg; 1.0 mmol), phenyllithium (6 mL; 0.2 
M in Et2O; 1.20 equiv).  The reaction mixture was stirred at -78 °C for 10 min, and then 
ClPPh2 (0.2 mL; 1.20 mmol; 1.2 equiv) was added as an electrophile.  The reaction mixture 
was stirred 30 min at -78 °C and then at room temperature for 1 h.  A solution of sulfur (320 
mg; 10 equiv) in butylamine (1.0 mL) was added to the reaction mixture.  Then reaction 
mixture was stirred at room temperature for 4-5 h and added saturated aqueous NH4Cl 
solution (10 mL).  The aqueous layer was extracted with Et2O (4 x 15 mL) and the combined 
organic extracts were washed with HCl (2.0 M), water, brine, dried over MgSO4, and 
concentrated in vacum.  The crude product was purified by column chromatography (silica 
gel, n-pentane:Et2O (8:1)), furnished the desired compound (542 mg, 0.88 mmol, 88 %) as a 
yellow solid. 
 
MP: 121.4-122.8 °C 
[α]D20 = +9.2 (c = 0.2, acetone) 
1H-NMR (300 MHz, CDCl3): δ = 7.99-7.94 (m, 2H), 7.75-7.69 (m, 2H), 7.58 (dd, J = 7.5 
Hz, 1.8 Hz, 1H), 7.21 (d, J = 1.8 Hz, 1H), 7.02-6.99 (m, 3H), 6.92-6.90 (m, 4H), 6.70-6.66 
(m, 1H), 4.40-4.39 (m, 1H), 4.27 (s, 5H), 4.10-4.09 (m, 1H), 3.92-3.91 (m, 1H), 1.00 (s, 3H), 
0.86 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 140.8, 137.9, 135.7 (d, J = 16.0 Hz), 134.8 (d, J = 15.1 
Hz), 132.9, 132.7 (d, J = 10.3 Hz), 132.3 (d, J = 10.5 Hz), 131.3, 130.9 (d, J = 3.1 Hz), 130.7, 
128.1, 127.9 (d, J = 3.9 Hz), 127.8, 126.3, 82.8 (d, J = 12.8 Hz), 82.2 (d, J = 96.9 Hz), 78.3 
(d, J = 14.4 Hz), 74.5 (d, J = 18.2 Hz), 72.1 (d, J = 9.7 Hz), 70.7, 1.9, 1.4 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +41.33 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3435 (br, s), 2923 (w), 1628 (w), 1436 (w), 1101 (m), 811 
(m), 717 (m), 616 (w). 
MS (70 eV, EI): m/z (%) = 614 (M+, 63), 601 (18), 599 (17), 217 (100). 
HRMS (EI): m/z calcd. for: [C30H2879BrFeP32SSi] 613.9951,  found: 613.9950. 
 
(SFc)-[2-((2-Bromophenyl)dimethylsilyl)]-1-iodo-ferrocene (23) 
 
Si
Br
I
MeMe
Fe
 
 
Prepared according to TP2, using sulfoxide 17 (270 mg; 0.5 mmol), phenyllithium (3 mL; 0.2 
M in Et2O; 1.20 equiv) and I2 (152 mg, 0.6 mmol; 1.20 equiv) as an electrophile.  After the 
typical work-up, the crude product was purified by column chromatography (silica gel, n-
pentane), furnished the desired compound (234 mg, 0.45 mmol, 89 %) as a yellow solid. 
 
MP: 110.0-112.4 °C 
[α]D20 = +4.8 (c = 0.2, acetone) 
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1H-NMR (300 MHz, CDCl3): δ = 7.50-7.48 (m, 1H), 7.17-7.13 (m, 3H), 4.70 (q, J = 1.3 Hz, 
1H), 4.38 (t, J = 2.2 Hz, 1H), 4.22 (s, 5H), 4.18 (dd, J = 1.3 Hz, 2.6 Hz, 1H), 0.98 (s, 3H), 
0.72 )s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 139.7, 137.8, 132.6, 130.8, 126.2, 113.6, 88.7, 79.3, 73.6, 
72.8, 72.7, 71.2, 1.0, 0.2 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 2920 (m), 1628 (w), 1599 (m), 1346 (w), 1001 (m), 811 
(m), 707 (m). 
MS (70 eV, EI): m/z (%) = 524 (M+, 90), 318 (20), 303 (25), 181 (100), 121 (68). 
HRMS (EI): m/z calcd. for: [C18H1879BrFe127ISi] 523.8755,  found: 523.8767. 
 
(SFc)-[2-(((2-Phosphiothioyl)phenyl))dimethylsilyl)]-1-phosphinothioyl-ferrocene (24) 
 
Si
PPh2
PPh2
MeMe
Fe S
S
 
 
A 25 mL Schlenk flask was charged with phosphinesulfide 22 (616 mg; 1.0 mmol) and THF 
(5 mL) under argon atmosphere.  nBuLi (1.6 M; 0.70 mL; 1.10 mmol) was added at -78 °C 
dropwise to the above solution and stirred the resulted lithium species for 15 min.  ClPPh2 
(0.20 mL; 1.20 mmol; 1.20 equiv) was added as an electrophile and the reaction mixture was 
stirred 30 min at -78 °C and then at room temperature for 1 h.  A solution of sulfur (320 mg; 
10 equiv) in butylamine (1.0 mL) was added to the reaction mixture and the reaction mixture 
was stirred at room temperature for 4-5 h and added a saturated aqueous NH4Cl solution (10 
mL).  The aqueous layer was extracted with Et2O (4 x 15 mL) and the combined organic 
extracts were washed with HCl (2.0 M), water, brine, dried over MgSO4, and concentrated in 
vacum.  The crude product was purified by column chromatography (silica gel, n-
pentane:Et2O (6:1)), furnished the desired compound (670 mg, 0.89 mmol, 89%) as a yellow 
solid.  
 
MP: 212.4-213.8 °C 
[α]D20 = +2.9 (c = 0.2, acteone) 
1H-NMR (300 MHz, CDCl3): δ = 7.90-7.75 (m, 2H), 7.61-7.54 (m, 7H), 7.50-7.40 (m, 12H), 
732-7.26 (m, 3H), 4.38-4.36 (m, 2H), 4.29 (s, 5H), 3.83-3.81 (m, 1H), 0.66 (s, 3H), 0.18 (s, 
3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 145.4 (d, J = 18.3 Hz), 140.0 (d, J = 16.5 Hz), 138.4 (d, J = 
87.5 Hz), 135.4 (d, J = 9.9 Hz), 135.2 (d, J = 87.3 Hz), 134.8 (d, J = 3.6 Hz), 134.6 (d, J = 
87.5 Hz), 134.3 (d, J = 9.5 Hz), 133.7 (d, J = 3.1 Hz), 132.51 (d, J = 13.7 Hz), 132.5 (d, J = 
10.1 Hz), 132.4 (d, J = 14.5 Hz), 132.2 (d, J = 10.5 Hz), 128.1 (d, J = 3.5 Hz), 88.1 (d, J = 
87.6 Hz), 81.2 (d, J = 2.7 Hz), 80.0 (d, J = 2.9 Hz), 71.6 (d, J = 9.1 Hz), 70.4, 70.2 (d ; J = 8.9 
Hz), 4.6, 4.1 ppm 
31P-NMR (81 MHz, CDCl3): δ = +41.33 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3430 (br, s), 2910 (m), 1500 (m), 1460 (m), 1219 (w), 
1101 (m), 810 (m), 798 (m). 
MS (70 eV, EI): m/z (%) = 752 (M+, 13), 689 (25), 688 (50), 687 (100), 656 (8). 
HRMS (EI): m/z calcd. for: [C42H38FeP232S2Si] 752.1009,  found: 752.1013. 
 
(SFc)-[2-(((2-Diphynlphosphiono)phenyl))dimethylsilyl)]-1-diphenylphosphinoferrocene 
(8) 
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Si
PPh2
PPh2
MeMe
Fe
 
 
 
Prepared according to TP5, using the phosphinesulfide 24 (150 mg, 0.20 mmol) and Raney-Ni 
(765 mg, 13 mmol; 65.0 equiv.) in MeOH (25 mL).  After evaporation of the solvent, the 
diphosphine (127 mg, 0.18 mmol; 92%) obtained as a yellow solid. 
 
MP: 88.5-91.2 °C 
[α]D20 = +2.0 (c = 0.2, acteone) 
1H-NMR (300 MHz, CDCl3): δ = 7.90-7.75 (m, 2H), 7.61-7.54 (m, 7H), 7.50-7.40 (m, 12H), 
732-7.26 (m, 3H), 4.38-4.36 (m, 2H), 4.29 (s, 5H), 3.83-3.81 (m, 1H), 0.66 (s, 3H), 0.18 (s, 
3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 145.4 (d, J = 18.3 Hz), 140.0 (d, J = 16.5 Hz), 138.4 (d, J = 
87.5 Hz), 135.4 (d, J = 9.9 Hz), 135.2 (d, J = 87.3 Hz), 134.8 (d, J = 3.6 Hz), 134.6 (d, J = 
87.5 Hz), 134.3 (d, J = 9.5 Hz), 133.7 (d, J = 3.1 Hz), 132.51 (d, J = 13.7 Hz), 132.5 (d, J = 
10.1 Hz), 132.4 (d, J = 14.5 Hz), 132.2 (d, J = 10.5 Hz), 128.1 (d, J = 3.5 Hz), 88.1 (d, J = 
87.6 Hz), 81.2 (d, J = 2.7 Hz), 80.0 (d, J = 2.9 Hz), 71.6 (d, J = 9.1 Hz), 70.4, 70.2 (d ; J = 8.9 
Hz), 4.6, 4.1 ppm 
31P-NMR (81 MHz, CDCl3): δ = -21.60, -10.61 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3430 (br, s), 2910 (m), 1500 (m), 1460 (m), 1219 (w), 
1101 (m), 810 (m), 798 (m). 
MS (70 eV, EI): m/z (%) = 688 (M+, 13), 687 (25), 524 (100), 412 (45). 
HRMS (EI): m/z calcd. for: [C42H38FeP2Si] 688.1567,  found: 688.1573. 
 
4. Preparation of new ferrocenyl P,N-ligands 9-10  
 
(SFc)-1-((S)-p-Tolylsulfinyl)-2-(diphenylphosphinothioyl) ferrocene (30):  
 
S
OPh2P
S
Fe
 
 
Prepared according to the typical procedure TP1, using sulfoxide 14 (6.48 g, 20.0 mmol) in 
THF (200 mL) and LDA (11.0 mL; 22.0 mmol; 1.1 equiv.).  The reaction mixture was stirred 
for 30 min at –78 °C and chloro diphenylphosphine (5.30 g, 24.0 mmol, 1.20 equiv.) was 
added slowly at −78 °C. The reaction mixture was stirred at −78 °C for 1.5 h then warmed to 
room temperature and stirred for 1.5 h. A solution of sulfur (1.92 g, 60.0 mmol, 3.0 equiv.) in 
butylamine (3 mL) was added to the reaction mixture at room temperature and stirred for 2-4 
h (protection was monitored by 31P-NMR). After quenching the reaction mixture with a 
saturated NH4Cl solution, aqueous layer was extracted with dichloromethane (4 × 100 mL). 
The combined organic layers were washed with 2N HCl, water, brine, dried over MgSO4 and 
evaporated under reduced pressure. Purification by flash chromatography (silica gel, n-
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pentane:Et2O 1:1) of the residue provided the desired compound (9.50 g, 17.60 mmol, 88 %) 
as a pale brown solid. 
 
MP: 120.3-121.3 °C  
[α]D20 = −306 (c = 0.08, acetone). 
1H-NMR (300 MHz, C6D6): δ = 8.35-8.23 (m, 4H), 7.94 (d, J = 7.8 Hz, 2H) 7.24-7.15 (m, 
6H) 6.92 (d, J = 7.5 Hz, 2H) 4.56-4.51 (m, 1H) 4.24-4.21 (m, 1H) 4.20 (s, 5H), 4.14-4.00 (m, 
1H), 2.09 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 143.0, 141.6, 135.4 (d, J = 28.8 Hz), 134.2 (d, J = 28.2), 
133.52 (d, J = 24.1 Hz), 133.51 (d, J = 1.8 Hz), 132.1 (d, J = 3.5 Hz), 131.8 (d, J = 2.9 Hz), 
129.7, 128.8 (d, J = 1.8 Hz), 128.6 (d, J = 7.6 Hz), 81.3, 80.0, 77.4 (d, J = 12.9 Hz), 72.5, 72.0 
(d, J = 7.6 Hz), 71.9 (d, J = 10.0 Hz), 21.5 ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.45 ppm. 
IR(KBr): υmax (cm−1) = 3436 (br, s), 1630 (br, w), 1436 (w), 1041 (m), 717 (m). 
MS (70 eV, EI): m/z (%) = 540 (M+, 26), 524 (22), 401 (100). 
HRMS (EI): m/z calcd. for: [C29H25P56FeO32S2] 540.0434,  found: 540.0417 
 
Preparation of (RFc)-1-(Diphenylphosphinothioyl)-2-(α-hydroxypyridyl)methylferrocene 
(31): 
 
N
OHPh2P
S
Fe
 
 
 
Prepared according to the typical procedure TP3, using ferrocenyl sulfoxide 30 (10.0 mmol, 
5.40 g) in THF (10 mL), PhLi (0.20 M, 60 mM, 12.0 mmol, 1.20 equiv.) in diethylether, and 
2-Pyridinecarboxaldehyde (2.30 mL, 24.0 mmol, 1.20 equiv.) as an electrophile.  After the 
typical work-up, the residue was purified by flash chromatography (silica gel, n-pentane:Et2O 
1:1) afforded the two diastereomeric alcohols 31a and 31b (3.69 g, 7.20 mmol, 72 %) as an 
inseparable mixture 31 in 6:4 ratio (by 31P-NMR). 
 
1H-NMR (200 MHz, C6D6): δ = 8.29-8.19 (m, 1H), 7.93-7.86 (m, 4H), 7.76-7.72 (m, 1H), 
7.65-7.54 (m, 4H), 7.39-7.35 (m, 1H), 7.01-6.80 (m, 16H), 6.44-6.36 (m, 3H), 5.32 (d, J = 9.0 
Hz, 1H), 4.96 (d, J = 6.0 Hz, 1H), 4.65 (s, 1H), 4.48 (s, 5H), 4.32 (s, 6H), 3.93-3.91 (m, 2H), 
3.64-3.61 (m, 2H) ppm. 
31P-NMR (81 MHz, C6D6): +42.6 (minor, 40 %), +43.5 (major, 60%) ppm. 
 
Preparation of ferrocenyl methyl ethers 32a and 32 b: 
 
Prepared according to the typical procedure TP4, using KH (104 mg, 2.60 mmol, 1.30 equiv.) 
in THF (4 mL), ferrocenyl alcohol 31 (dr 6:4, 1.01 g, 2.0 mmol) in THF (20 mL) and CH3I 
(341 mg, 2.40 mmol, 1.20 equiv.).  The reaction mixture was quenched with a saturated 
NH4Cl solution (10 mL) and the aqueous layer was extracted with diethylether (4 x 20 mL).  
After the typical work-up, the residue was purified by flash chromatography (silica gel, n-
pentane:Et2O 1:1) to furnish the two methyl ethers 32a (566 mg, 1.07 mmol, 54 %) and 32b 
(367 mg, 0.70 mmol, 35 %) yellow solids. 
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(RFc)-1-(Diphenylphosphinothioyl)-2-((S)-α-methoxypyridyl)methylferrocene (32a): 
 
N
OMePh2P
S
Fe
 
 
MP: 217.9-218.4 °C 
[α]D20 = −25.8 (c = 0.22, acetone). 
1H-NMR (300 MHz, C6D6): δ = 8.50-8.42 (m, 1H), 8.08-7.95 (m, 4H), 7.46 (d, J = 7.9 Hz, 
1H), 7.13-7.03 (m, 7 H), 6.71-6.67 (m, 1 H), 6.64 (s, 1H), 4.35 (s, 5H), 4.10-4.08 (m, 1H), 
3.94 (dd, J = 2.2 Hz, 4.0 Hz, 1H), 3.77 (dd, J = 2.2 Hz, 4.0 Hz, 1H), 2.92 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 161.4, 149.1, 136.4 (d, J = 88.0 Hz), 135.7, 134.8 (d, J = 
87.0 Hz), 132.8 ( d, J = 4.7 Hz), 132.7 (d, J = 4.7 Hz), 130.9 (d, J = 2.9 Hz), 130.7 (d, J = 2.9 
Hz), 128.2, 127.9, 122.3, 122.2, 92.6 (d, J = 11.8 Hz), 80.8, 75.8 (d, J = 94.5 Hz), 75.5 (d, J = 
12.9 Hz), 72.9 (d, J = 8.8 Hz), 71.7, 69.1 (d, J = 10.5 Hz), 56.7 ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.74 ppm. 
IR(KBr): υmax (cm−1) = 3436 (br, s), 1630 (br, w), 1589 (s), 1436 (br, s), 3436 (m), 1099 (s), 
819 (w), 715 (s), 502 (s). 
MS (70 eV, EI): m/z (%) = 523 (M+, 28), 458 (68), 428 (100), 288 (14). 
HRMS (EI): m/z calcd. for: [C29H26P56FeNO32S] 523.0822,  found: 523.0837 
 
(RFc)-1-(Diphenylphosphinothioyl)-2-((R)-α-methoxypyridyl)methylferrocene (32b): 
 
N
OMePh2P
S
Fe
 
 
MP: 199.3-200.8 °C 
[α]D20 = −21.7 (c = 0.18, acetone). 
1H-NMR (300 MHz, C6D6): δ = 8.25-8.23 (m, 1H), 7.92-7.84 (m, 2H), 7.40-7.33 (m, 2H), 
7.20-7.17 (m, 1H), 7.04-6.95 (m, 3H), 6.84-6.79 (m, 1H), 6.73-6.63 (m, 3 H), 6.60 (s, 1 H), 
6.38-6.33 (m, 1H), 5.30 (dd, J = 1.8 Hz, 4.0 Hz, 1 H), 4.50 (s, 5 H), 4.02 (dd, J = 2.3 Hz, 4.0 
Hz, 1H), 3.57 (dd, J = 2.3 Hz, 4.0 Hz, 1H), 3.30 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 160.0, 149.6, 135.6 (d, J = 60.0 Hz), 134.8, 134.5 (d, J = 
60.0 Hz), 132.6 ( d, J = 10.6 Hz), 132.1 (d, J = 10.6 Hz), 131.0 ( d, J = 2.9 Hz), 130.2 (d, J = 
2.9 Hz), 127.8, 127.6, 124.1, 121.9, 95.5 (d, J = 11.8 Hz), 79.5, 74.4 (d, J = 12.3 Hz), 73.3 (d, 
J = 94.5 Hz), 72.4 (d, J = 9.5 Hz), 71.4, 69.5 (d, J = 10.2 Hz), 56.6 ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.59 ppm. 
IR(KBr): υmax (cm−1) = 3436 (br, m), 1588 (w), 1436 (s), 1158 (s), 1099 (s), 819 (m), 615 (s). 
MS (70 eV, EI): m/z (%) = 523 (M+, 25), 458 (60), 428 (100), 426(32). 
HRMS (EI): m/z calcd. for: [C29H26P56FeNO32S] 523.0822,  found: 523.0855 
 
Preparation of ferrocenyl benzyl ethers 33a and 33b:  
 
Experimental Section   87
Prepared according to the typical procedure TP4, using KH (104 mg, 2.60 mmol, 1.30 equiv.) 
in THF (4 mL), ferrocenyl alcohol 31 (dr 6:4, 1.01 g, 2.0 mmol) in THF (20 mL) and Benzyl 
bromide (411 mg, 2.40 mmol, 1.20 equiv).  The reaction mixture was quenched with a 
saturated NH4Cl solution (10 mL), the aqueous layer was extracted with diethylether (4 x 20 
mL).  After the typical work-up, the residue was purified by flash chromatography (silica gel, 
n-pentane:Et2O 1:1) to furnish the two benzyl ethers 33a (649 mg, 1.08 mmol, 54 %) and 33b 
(433 mg, 0.72 mmol, 36 %) as yellow solids. 
 
(RFc)-1-(Diphenylphosphinothioyl)-2-(((S)-α-benzyloxy)pyridyl))methylferrocene (33a):   
 
N
OCH2Ph
Ph2P
S
Fe
 
 
MP: 173.1-175.0 °C 
[α]D20 = −62.6 (c = 0.3, CH2Cl2). 
1H-NMR (300 MHz, CDCl3): δ = 8.36-8.27 (m, 1 H), 7.74-7.67 (m, 2 H), 7.47-7.26 (m, 8 
H), 7.20-7.12 (m, 4H), 7.06-6.96 (m, 3H), 6.82-6.74 (m, 1 H), 6.50 (s, 1H), 5.20 (s, 1H), 4.50 
(dd, J = 11.6 Hz, 22.0 Hz, 2H), 4.34 (s, 1H), 4.33 (s, 5 H), 3.60 (s, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 158.9, 138.4, 135.7, 134.3 (d, J = 49.6 Hz), 133.1 (d, J = 
49.2 Hz), 132.0 (d, J = 11.0 Hz), 131.6 (d, J = 11.0 Hz), 131.1 (d, J = 2.8 Hz), 130.4 (d, J = 
2.8 Hz), 128.2, 128.0, 127.9, 127.8, 127.6, 127.5, 124.1, 122.3, 94.2 (d, J = 11.9 Hz), 76.8, 
74.4 (d, J = 12.8 Hz), 72.6 (d, J  = 94.6 Hz), 71.4 (d, J = 9.4 Hz), 71.0, 70.9, 69.4 (d, J = 10.6 
Hz) ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.98 ppm. 
IR(KBr): υmax (cm−1) = 3436 (br, s), 3056 (br, w), 1589 (m), 1436 (s), 1102 (s), 1052 (s), 819 
(w), 750 (m), 715 (s), 695 (s).. 
MS (70 eV, EI): m/z (%) = 599 (M+, 36), 534 (38), 429 (100), 288 (41), 154 (40). 
HRMS (EI): m/z calcd. for: [C35H30P56FeNO32S] 599.1135,  found: 599.1120 
 
(RFc)-1-(Diphenylphosphinothioyl)-2-(((R)-α-benzyloxy)pyridyl))methylferrocene (33b):   
 
N
OCH2Ph
Ph2P
S
Fe
 
 
MP: 129.7-130.8 °C 
[α]D20 = −48.0 (c = 0.3, CH2Cl2). 
1H-NMR (300 MHz, CDCl3): δ = 8.34 (s, 1H), 7.79-7.68 (m, 2H), 7.53-7.29 (m, 8H), 7.21-
7.13 (m, 4H), 7.10-7.04 (m, 3H), 6.82 (s, 1H), 6.53 (s, 1H), 5.23 (s, 1H), 4.53 (q, J = 11.7 Hz, 
2H), 4.40-4.37 (m, 1H), 4.36 (s, 5H), 3.63 (s, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 159.2, 149.1, 138.7, 136.0, 134.5 (d, J = 49.8 Hz), 133.4 
(d, J = 49.8 Hz), 132.3 (d, J = 10.5 Hz), 131.9 (d, J = 10.5 Hz), 131.4 (d, J = 2.8 Hz), 130.7 
(d, J = 3.3 Hz), 128.5, 128.3, 128.1, 127.9, 127.8, 124.4, 122.5, 94.5 (d, J = 11.7 Hz), 77.1, 
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74.7 (d, J = 12.2 Hz), 72.9 (d, J = 94.5 Hz), 71.6 (d, J = 9.4 Hz), 71.3, 69.7 (d, J = 10.5 Hz) 
ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.96 ppm. 
IR(KBr): υmax (cm−1) = 3435 (b, s), 1629 (b, w), 1436 (s), 1101 (s), 821 (m), 714 (s), 694 (s). 
MS (70 eV, EI): m/z (%) = 599 (M+, 10), 534 (8), 429 (27), 428 (100), 427 (25) 
HRMS (EI): m/z calcd. for: [C35H30P56FeNO32S] 599.1122,  found: 599.1158 
 
(RFc)-1-(Diphenylphosphino)-2-(((S)-α-methoxy)pyridyl))methylferrocene (9a):   
 
N
OMePh2P
Fe
 
 
Prepared according to TP5 from Raney-Ni (1. 5 g, 24.0 mmol, 30 equiv.) and 32a (420 mg, 
0.80 mmol) in MeOH (50 mL) and obtained as a yellow solid (331 mg, 0.67 mmol, 84 %). 
 
MP: 120.3-122.4 °C  
[α]D20 = +234 (c = 0.1, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.69-8.68 (m, 1H) 7.75-7.69 (m, 2H), 7.63-7.51 (m, 4H), 
7.39-7.38 (m, 2H), 7.30-7.22 (m, 5H), 5.49 (d, J = 3.3 Hz, 1H), 4.23-4.20 (m, 1H), 4.03 (s, 
1H), 3.81 (s, 5H), 3.36 (s, 1H), 2.93 (s, 3H) ppm. 
13C-NMR (100 MHz, CDCl3): δ = 160.6, 148.7, 135.2 (d, J = 21.5 Hz), 132.4 (d, J = 18.3 
Hz), 132.3, 130.8, 129.0, 128.7, 128.0 (d, J = 8.0 Hz), 127.63 (d, J = 6.5 Hz), 127.4, 122.6, 
121.8, 95.6 (d, J = 24.0 Hz), 82.3, 73.8 (d, J = 9.5 Hz), 71.2, 70.5, 69.8, 69.2, 68.7 ppm. 
31P-NMR (81 MHz, CDCl3): δ = -21.17 ppm. 
IR(neat): υmax (cm−1) = 2920 (w), 1728 (w), 1586 (m), 1428 (m), 1126 (m), 1080 (s), 1105 
(s), 810 (s), 748 (s), 698 (s). 
MS (70 eV, EI): m/z (%) = 491 (M+, 39), 427 (28), 426 (100), 396 (32), 262 (30), 154 (37). 
HRMS (EI): m/z calcd. for: [C29H26P56FeNO] 491.1101,  found: 491.1108 
 
 
(RFc)-1-(Diphenylphosphino)-2-(((R)-α-methoxy)pyridyl))methylferrocene (9b):   
 
N
OMePh2P
Fe
 
 
Prepared according to TP4 from Raney-Ni (1.5 g, 24.0 mmol, 30 equiv.) and 32b (420 mg, 
0.80 mmol) in MeOH (50 mL), and obtained as a yellow solid (325 mg, 0.66 mmol, 82 %). 
 
MP: 140.2-144.0 °C 
[α]D20 = +214 (c = 0.1, CH2Cl2) 
1H-NMR (600 MHz, CDCl3): δ = 8.07 (m, 1H), 7.71-7.70 (m, 1H), 7.49 (br s, 2H), 7.33-7.28 
(m, 3H), 7.12-6.94 (m, 4H), 6.79-6.76 (m, 3H), 5.39 (s, 1H), 4.66 (s, 1H), 4.31-4.26 (m, 1H), 
4.10 (s, 5H), 3.65 (s, 1H), 3.34 (s, 3H) ppm. 
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13C-NMR (150 MHz, CDCl3): δ = 160.3, 148.5, 139.1 (d, J = 9.2 Hz), 137.5 (d, J = 9.2 Hz), 
135.8, 135.0 (d, J = 21.3 Hz), 131.9 (d, J = 18.5 Hz), 128.9, 127.9 (d, J = 8.0 Hz), 127.5 (d, J 
= 6.4 Hz), 127.0, 122.0, 121.7, 92.9 (d, J = 24.7 Hz), 82.8 (d, J = 9.8 Hz), 76.5 (d, J = 9.6 
Hz), 71.7 (d, J = 4.2 Hz), 70.0 (d, J = 3.4 Hz), 69.7, 68.7, 68.1 ppm. 
31P-NMR (81 MHz, CDCl3): δ = -21.25 ppm. 
IR(neat): υmax (cm−1) = 2928 (w), 1725 (w), 1586 (m), 1430 (m), 1162 (m), 1087 (s), 1104 
(s), 816 (s), 744 (s), 698 (s). 
MS (70 eV, EI): m/z (%) = 491 (M+, 47), 427 (28), 426 (100), 396 (37), 262 (38), 154 (50). 
HRMS (EI): m/z calcd. for: [C29H26P56FeNO] 491.1101,  found: 491.1110. 
 
(RFc)-1-(Diphenylphosphino)-2-(((S)-α-benzyloxy)pyridyl))methylferrocene (10a):   
 
N
OCH2Ph
Ph2P
Fe
 
 
Prepared according to TP4 from Raney-Ni (1.5 g, 24.0 mmol; 30 equiv.) and 33a (480 mg, 
0.80 mmol) in MeOH (50 mL), and obtained as a yellow solid (402 mg, 0.71 mmol, 88 %).  
 
MP: 49.8-53.5 °C 
[α]D20 = +230 (c = 0.1, CH2Cl2) 
1H-NMR (600 MHz, CDCl3): δ = 8.71-8.70 (m, 1H), 7.77-7.74 (m, 1H), 7.65-7.61 (m, 3H), 
7.39-7.38 (m, 3H), 7.30-7.28 (m, 1H), 7.24-7.16 (m, 5H), 7.08 (t, J = 7.3 Hz, 1H), 7.02 (t, J = 
7.4 Hz, 2H), 6.74-6.73 (m, 2H), 5.88 (s, 1H), 4.31 (d, J = 10.9 Hz, 1H), 4.26 (t, J = 2.6 Hz, 
1H), 4.22 (s, 1H), 4.13 (d, J = 10.9 Hz, 1H), 3.90 (s, 1H), 3.83 (s, 5H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 160.7, 140.5 (d, J = 10.0 Hz), 137.9 (d, J = 10.2 Hz), 
137.6, 135.4 (d, J = 22.0 Hz), 132.4 (d, J = 18.0 Hz), 129.1, 128.4, 128.1 (d, J = 1.7 Hz), 
128.0, 127.9, 127.8 (d, J = 1.7 Hz), 127.4, 127.4, 122.8, 122.3, 95.1 (d, J = 26 Hz), 76.5 (d, J 
= 10.6 Hz), 71.9 (d, J = 4.5 Hz), 71.7, 70.5, 70.49 (d, J = 3.4 Hz), 70.0, 69.8 ppm. 
31P-NMR (81 MHz, CDCl3): δ = -21.58 ppm. 
IR(KBr): υmax (cm−1) = 3054 (br, w), 2858 (br, w), 1587 (m), 1432 (m), 1047 (s), 817 (m), 
739 (s), 690 (s).  
MS (70 eV, EI): m/z (%) = 567 (M+, 38), 502 (87), 461 (57), 396 (100), 276 (33), 154 (34). 
HRMS (EI): m/z calcd. for: [C35H30P56FeNO] 567.1414,  found: 567.1389 
 
(RFc)-1-(Diphenylphosphino)-2-(((R)-α-benzyloxy)pyridyl))methylferrocene (10b):   
 
N
OCH2Ph
Ph2P
Fe
 
 
Prepared according to TP4 from Raney-Ni (1.5 g, 24.0 mmol; 30 equiv.) and 33b (482 mg, 
0.80 mmol) in MeOH (50 mL), and obtained as a yellow solid (390 mg, 0.69 mmol, 86 %). 
 
MP: 58.0-60.2 °C 
[α]D20 = +134 (c = 0.1, CH2Cl2) 
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1H-NMR (400 MHz, CDCl3): δ = 8.05-8.03 (m, 1H), 7.51-7.42 (m, 4H), 7.39-7.27 (m, 7H), 
7.20-7.18 (m, 1H), 7.04-7.01 (m, 1H), 6.95-6.91 (m, 2H), 6.79-6.71 (m, 3H), 5.71 (d, J = 2.1 
Hz, 1H), 4.80-4.79 (m, 1H), 4.53 (d, J = 11.7 Hz, 1H), 4.45 (d, J = 11.7 Hz, 1H), 4.28 (t, J = 
2.3 Hz, 1H), 4.05 (s, 5H), 3.70-3.69 (m, 1H) ppm. 
13C-NMR (100 MHz, CDCl3): δ = 160.7, 148.4, 139.3 (d, J = 9.2 Hz), 138.6, 137.6 (d, J = 
9.6 Hz), 135.9, 135.2 (d, J = 21.3 Hz), 131.9 (d, J = 18.2 Hz), 128.9 (d, J = 0.8 Hz), 128.3, 
127.9 (d, J = 7.8 Hz), 127.6, 127.5, 127.4 (d, J = 2.2 Hz), 127.0, 122.1, 121.8 (d, J = 1.5 Hz), 
95.9 (d, J = 24.3 Hz), 80.7 (d, J = 7.3 Hz), 73.8 (d, J = 10.5 Hz), 71.3 (d, J = 4.8 Hz), 70.8, 
69.9, 69.1, 69.0 (d, J = 4.5 Hz) ppm. 
31P-NMR (81 MHz, CDCl3): δ = -22.49 ppm. 
IR(KBr): υmax (cm−1) = 3050 (w), 2860 (w), 1586 (m), 1432 (m), 1066 (m), 1026 (m), 815 
(m), 740 (s), 692 (s), 614 (m). 
MS (70 eV, EI): m/z (%) = 568 ([M+H]+, 38), 567 (M+, 100), 502 (58), 461 (47), 385 (83), 
276 (41), 212 (72). 
HRMS (EI): m/z calcd. for: [C35H30P56FeNO] 567.1414,  found: 567.1436 
 
Preparation of (RFc)-1-Bis(3,5-dimethylphenylphosphinothioyl)-2-(α-hydroxypyridyl)me-
thylferrocene (35): 
 
N
OHXyl2P
S
Fe
 
 
 
Prepared according to the typical procedure TP3, using ferrocenyl sulfoxide 35 (6.00 g, 10.0 
mmol) in THF (10 mL), t-BuLi (1.50 M, 14.7 mL, 22.0 mmol, 2.20 equiv.), and 2-
pyridinecarboxaldehyde (2.30 mL, 24.0 mmol, 1.20 equiv.) as an electrophile.  After the 
typical work-up, the residue was purified by flash chromatography (silica gel, n-pentane:Et2O 
1:1) afforded the two diastereomeric alcohols 35a and 35b (3.69 g, 6.50 mmol, 65 %) as an 
inseparable mixture 35 in 5:5 ratio (by 31P-NMR). 
 
1H-NMR (200 MHz, C6D6): δ = 8.29-8.19 (m, 1H), 7.93-7.86 (m, 4H), 7.76-7.72 (m, 1H), 
7.65-7.54 (m, 4H), 7.39-7.35 (m, 1H), 7.01-6.80 (m, 16H), 6.44-6.36 (m, 3H), 5.32 (d, J = 9.0 
Hz, 1H), 4.96 (d, J = 6.0 Hz, 1H), 4.65 (s, 1H), 4.48 (s, 5H), 4.32 (s, 6H), 3.93-3.91 (m, 2H), 
3.64-3.61 (m, 2H) ppm. 
31P-NMR (81 MHz, C6D6): δ = 43.09 (51 %), 43.83 (49 %). 
 
Preparation of ferrocenyl methyl ethers 36a and 36 b: 
 
Prepared according to the typical procedure TP4, using KH (95 mg, 2.25 mmol, 1.50 equiv.) 
in THF (4 mL), ferrocenyl alcohol 35 (dr 5:5, 850 mg, 1.5 mmol) in THF (10 mL) and CH3I 
(0.12 mL, 1.80 mmol, 1.20 equiv.).  The reaction mixture was quenched with a saturated 
NH4Cl solution (10 mL) and the aqueous layer was extracted with diethylether (4 x 20 mL).  
After the typical work-up, the residue was purified by flash chromatography (silica gel, n-
pentane:Et2O 1:1) to furnish the two methyl ethers 36a (393 mg, 0.67 mmol, 45%) and 36b 
(256 mg, 0.66 mmol, 44%) as yellow solids. 
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(RFc)-1-Bis(3,5-dimethylphenylphosphinothioyl)-2-(((S)-α-methoxy)pyridyl))methyl-
ferrocene (36b):   
 
N
OMeXyl2P
S
Fe
 
 
MP: 88 °C (sublimation) 
[α]D20 = −25.8 (c = 0.22, acetone). 
1H-NMR (400 MHz, C6D6): δ = 8.54-8.52 (m, 1H), 7.93-7.91 (m, 2H), 7.83-7.80 (m, 2H), 
7.53 (tt, J = 1.0 Hz, 7.8 Hz, 1H), 7.12 (ddd, J = 1.9 Hz, 7.7 Hz, 1H), 6.78-6.77 (m, 2H), 6.68 
(dddd, J = 1.3 Hz, 4.8 Hz, 7.4 Hz, 1H), 6.64 (s, 1H), 4.35 (s, 5H), 4.33-4.32 (m, 1H), 4.03-
4.02 (m, 1H), 4.00-3.99 (m, 1H), 2.99 (s, 3H), 2.04 (s, 6H), 2.03 (s, 6H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 161.5, 149.2, 137.6 (d, J = 12.9 Hz), 137.4 (d, J = 13.0 Hz), 
136. 4 (d, J = 86.8 Hz), 135.7, 134.8 (d, J = 84.2 Hz), 132.9 (d, J = 3.0 Hz), 132.7 (d, J = 3.2 
Hz), 130.7 (d, J = 10.5 Hz), 130.6 (d, J = 10.9 Hz), 122.5, 122.3, 92.5 (d, J = 11.4 Hz), 80.6, 
76.3 (d, J = 93.6 Hz), 75.4 (d, J = 12.3 Hz), 73.1 (d, J = 8.9 Hz), 71.7, 69.2 (d, J = 10.3 Hz), 
56.7, 21.15 (d, J = 0.8 Hz), 21.1 (d, J = 0.8 Hz) ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.31 ppm.. 
IR(KBr): υmax (cm−1) = 3635 (w), 2920 (m), 1587 (m), 1431 (m), 1121 (m), 1073 (s), 846 
(m), 689 (s), 670 (s). 
MS (70 eV, EI): m/z (%) = 579 (M+, 32), 515 (27), 514 (80), 485 (31), 484 (100), 482 (22), 
154 (17). 
HRMS (EI): m/z calcd. for: [C33H34P56FeNO32S] 579.1448,  found: 579.1457 
 
(RFc)-1-Bis(3,5-dimethylphenylphosphinothioyl)-2-(((R)-α-methoxy)pyridyl))methyl-
ferrocene (36b):   
 
N
OMeXyl2P
S
Fe
 
 
MP: 99.3-100.1 °C 
[α]D20 = −21.7 (c = 0.18, acetone). 
1H-NMR (400 MHz, C6D6): δ = 8.32-8.30 (m, 1H), 7.75-7.72 (m, 2H), 7.27 (tt, J = 1.0 Hz, 
7.7 Hz, 1H), 7.14-7.12 (m, 2H), 6.74 (s, 1H), 6.66 (ddd, J = 1.8 Hz, 7.7 Hz, 2H), 6.53 (s, 1H), 
6.33 (dddd, J = 1.3 Hz, 4.7 Hz, 7.5 Hz, 1H), 5.36-5.35 (m, 1H), 4.58 (s, 5H), 4.06-4.05 (m, 
1H), 3.78-3.77 (m, 1H), 3.28 (s, 3H), 1.97 (s, 6H), 1.80 (s, 6H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 160.2, 149.5, 137.6 (d, J = 13.0 Hz), 137.3 (d, J = 13.3 Hz), 
135. 6 (d, J = 86.5 Hz), 134.8 (d, J = 84.8 Hz), 134.6, 132.9 (d, J = 3.2 Hz), 132.4 (d, J = 3.3 
Hz), 130.5 (d, J = 10.7 Hz), 130.0 (d, J = 10.7 Hz), 124.3, 121.9, 95.4 (d, J = 11.5 Hz), 79.5, 
74.6 (d, J = 12.1 Hz), 74.1 (d, J = 93.7 Hz), 72.4 (d, J = 9.2 Hz), 71.4, 69.3 (d, J = 10.4 Hz), 
56.5, 21.1 (d, J = 0.8 Hz), 21.0 (d, J = 0.8 Hz) ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.31 ppm. 
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IR(KBr): υmax (cm−1) = 3325 (w), 2918 (m), 1586 (m), 1467 (m), 1432 (m), 1122 (m), 1088 
(m), 848 (m), 814 (m), 690 (s), 662 (s). 
MS (70 eV, EI): m/z (%) = 523 (M+, 25), 458 (60), 428 (100), 426(32). 
HRMS (EI): m/z calcd. for: [C33H34P56FeNO32S] 579.1488,  found: 579.1467 
 
Preparation of ferrocenyl benzyl ethers 37a and 37b:  
 
Prepared according to the typical procedure TP4, using KH (95 mg, 2.25 mmol, 1.50 equiv.) 
in THF (4 mL), ferrocenyl alcohol 35 (dr 5:5, 850 mg, 1.5 mmol) in THF (10 mL) and 
PhCH2Br (312 mg, 1.80 mmol, 1.20 equiv.).  The reaction mixture was quenched with a 
saturated NH4Cl solution (10 mL) and the aqueous layer was extracted with diethylether (4 x 
20 mL).  After the typical work-up, the residue was purified by flash chromatography (silica 
gel, n-pentane:Et2O 1:1) to furnish the two methyl ethers 37a (455 mg, 0.69 mmol, 46%) and 
37b (435 mg, 0.66 mmol, 44%) yellow solids. 
 
(RFc)-1-Bis(3,5-dimethylphenylphosphinothioyl)-2-(((S)-α-benzyloxy)pyridyl))methyl-
ferrocene (37a):   
 
N
OCH2Ph
Xyl2P
S
Fe
 
 
MP: 222.6-223.9 °C 
[α]D20 = −10.8 (c = 0.2, acetone). 
1H-NMR (300 MHz, CDCl3): δ = 8.68 (s, 1H), 7.67 (s, 1H), 7.58 (s, 1H), 7.41-6.66 (m, 
10H), 6.63 (s, 2H), 6.47 (s, 1H), 4.31 (s, 1H), 4.18 (s, 2H), 4.05 (s, 5H), 3.89 (s, 1H), 3.75 (s, 
1H), 2.28 (s, 6H), 2.09 (s, 6H), ppm. 
13C-NMR (75 MHz, CDCl3): δ = 149.3, 138.5, 137.5 (d, J = 13.0 Hz), 136.2, 134.6 (d, J = 
89.2 Hz), 133.7 (d, J = 86.4 Hz), 132.9, 130.1 (d, J = 10.7 Hz), 129.9 (d, J = 11.6 Hz), 127.8, 
127.6, 126.8, 123.2, 122.8, 78.5, 75.3 (d, J = 12.2 Hz), 74.8 (d, J = 95 Hz), 73.2, 71.4, 71.1, 
69.5 (d, J = 11.2 Hz), 21.5, 21.4 ppm 
31P-NMR (81 MHz, C6D6): δ = +43.10 ppm. 
IR(KBr): υmax (cm−1) = 3345 (br, w), 2917 (w), 1588 (m), 1433 (m), 1195 (m), 1051 (s), 848 
(m), 690 (s), 675 (s). 
MS (70 eV, EI): m/z (%) = 655 (M+, 45), 590 (11), 564 (17), 485 (30), 484 (100). 
HRMS (EI): m/z calcd. for: [C39H38P56FeNO32S] 655.1761,  found: 655.1783 
 
(RFc)-1-Bis(3,5-dimethylphenylphosphinothioyl)-2-(((R)-α-benzyloxy)pyridyl))methyl-
ferrocene (37b):   
 
N
OCH2Ph
Xyl2P
S
Fe
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MP: 129.7-130.8 °C 
[α]D20 = −12.7 (c = 0.2, acetone). 
1H-NMR (600 MHz, CDCl3): δ = 8.33 (brs, 1H) 7.36 (s, 2H), 7.23-7.19 (m, 6H), 7.12 (s, 
1H), 7.02 (s, 1H), 6.98 (brs, 1H), 6.76 (s, 1H), 6.67 (m, 2H), 6.46 (s, 1H), 5.16 (brs, 1H), 
4.50-4.42 (m, 2H), 4.27 (s, 6H), 3.53 (s, 1H), 2.25 (s, 6H), 2.01 (s, 6H), ppm. 
13C-NMR (150 MHz, CDCl3): δ = 148.9, 138.6, 137.7 (d, J = 11.9 Hz), 137.3 (d, J = 12.2 
Hz), 134.0 (d, J = 86.0 Hz), 133.3 (d, J = 85.1 Hz), 133.2, 132.7, 129.9 (d, J = 11.2 Hz), 129.6 
(d, J = 10.7 Hz), 128.5, 128.4, 127.7, 124.5, 76.8, 74.8 (d, J = 12.1 Hz), 73.3 (d, J = 92.1 Hz), 
71.7, 71.2, 69.6 (d, J = 12.0 Hz), 21.5 ppm. 
31P-NMR (81 MHz, C6D6): δ = +43.08 ppm. 
IR(KBr): υmax (cm−1) = 3435 (b, s), 2912 (w), 1586 (m), 1433 (m), 1121 (m), 848 (m), 690 
(s), 661 (s). 
MS (70 eV, EI): m/z (%) = 655 (M+, 15), 485 (28), 484 (100), 483 (30), 154 (14). 
HRMS (EI): m/z calcd. for: [C39H38P56FeNO32S] 655.1761,  found: 655.1758 
 
(RFc)-1-Bis(3,5-dimethylphenylphosphino)-2-(((S)-α-methoxy)pyridyl))methylferrocene 
(9c): 
 
N
OMeXyl2P
Fe
 
 
Prepared according to TP5 from Raney-Ni (1.1 g, 18.0 mmol; 30 equiv.) and 36a (347 mg, 
0.60 mmol) in MeOH (40 mL), and obtained as a yellow solid (297 mg, 0.54 mmol, 90%). 
 
MP: 112.3-113.2 °C  
[α]D20 = +16.2 (c = 0.2, acetone) 
1H-NMR (400 MHz, CDCl3): δ = 8.55-8.47 (m, 1H) 7.42-7.31 (m, 2H), 6.83-6.66 (m, 3H), 
6.25-6.20 (m, 4H), 5.45 (s, 1H), 4.25-4.18 (m, 1H), 4.13 (s, 1H), 3.80 (s, 5H), 3.35 (s, 1H), 
2.85 (s, 3H), 2.31 (s, 6H), 2.28 (s, 6H) ppm. 
13C-NMR (100 MHz, CDCl3): δ = 161.2, 147.6, 133.5 (d, J = 22.1 Hz), 132.0 (d, J = 19.1 
Hz), 131.1, 129.8, 129.0, 127.9, 127.2 (d, J = 9.1 Hz), 126.6, 126.2 (d, J = 6.7 Hz), 121.5, 
120.2, 96.2 (d, J = 25.2 Hz), 81.3, 71.8 (d, J = 8.2 Hz), 71.2 (d, J = 9.8 Hz), 71.0, 68.5 (d, J = 
6.7 Hz), 69.2, 68.7, 23.5, 21.7 ppm. 
31P-NMR (81 MHz, CDCl3): δ = -20.46 ppm. 
IR(neat): υmax (cm−1) = 2911 (w), 1658 (w), 1522 (m), 1435 (s), 1246 (m), 1080 (s), 865 (s), 
724 (s), 695 (s). 
MS (70 eV, EI): m/z (%) = 547 (M+, 46), 482 (44), 480 (100), 260 (11). 
HRMS (EI): m/z calcd. for: [C33H34P56FeNO] 547.1727,  found: 547.1711 
 
 
(RFc)-1-Bis(3,5-dimethylphenylphosphino)-2-(((R)-α-methoxy)pyridyl))methylferrocene 
(9d):   
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N
OMeXyl2P
Fe
 
 
Prepared according to TP4 from Raney-Ni (1.1g, 18.0 mmol; 30 equiv.) and 36b (347 mg, 
0.60 mmol) in MeOH (40 mL), and obtained as a yellow solid (286 mg, 0.49 mmol, 82 %). 
 
MP: 140.2-144.0 °C 
[α]D20 = +22.1 (c = 0.2, acetone) 
1H-NMR (400 MHz, CDCl3): δ = 8.11-8.07 (m, 1H) 7.75-7.72 (m, 1H), 6.91-6.80 (m, 3H), 
6.77-6.72 (m, 1H), 6.21-6.19 (m, 4H), 5.40 (s, 1H), 4.85-4.80 (m, 1H), 4.43 (s, 1H), 4.05 (s, 
5H), 3.65-3.59 (m, 1H), 2.91 (s, 3H), 2.32 (s, 6H), 2.26 (s, 6H) ppm. 
13C-NMR (100 MHz, CDCl3): δ = 161.0, 146.6, 133.5 (d, J = 21.0 Hz), 133.2 (d, J = 18.2 
Hz), 132.1, 130.2, 130.0, 128.7 (d, J = 9.5 Hz), 127.9, 126.0 (d, J = 5.9 Hz), 124.2, 121.5, 
121.2, 94.1 (d, J = 25.0 Hz), 80.2, 71.8 (d, J = 8.1 Hz), 71.6, 71.0 (d, J = 8.8 Hz), 66.7, 68.2, 
67.5, 24.2, 23.2 ppm. 
31P-NMR (81 MHz, CDCl3): δ = -20.25 ppm. 
IR(neat): υmax (cm−1) = 2982 (w), 1754 (w), 1628 (m), 1545 (m), 1368 (m), 1022 (m), 1104 
(s), 964 (s), 728 (s), 699 (s). 
MS (70 eV, EI): m/z (%) = 547 (M+, 28), 482 (24), 480 (100), 365 (43), 260 (18). 
HRMS (EI): m/z calcd. for: [C33H34P56FeNO] 547.1727,  found: 547.1719. 
 
(RFc)-1-Bis(3,5-dimethylphenylphosphino)-2-(((S)-α-benzyloxy)pyridyl))methylferrocene 
(10c):   
 
N
OCH2Ph
Xyl2P
Fe
 
 
Prepared according to TP4 from Raney-Ni (1.1 g, 18.0 mmol, 30 equiv.) and 37a (395 mg, 
0.60 mmol) in MeOH (40 mL), and obtained as a yellow solid (335 mg, 0.53 mmol, 89 %).  
 
MP: 69.1-70.5 °C 
[α]D20 = +14.5 (c = 0.2, acetone) 
1H-NMR (600 MHz, CDCl3): δ = 8.75-8.72 (m, 1H), 7.71-7.66 (m, 4H), 7.54-7.48 (m, 3H), 
7.11-6.99 (m, 3H), 6.35-6.25 (m, 4H), 5.82-5.79 (m, 1H), 4.32-4.26 (m, 2H), 4.15 (s, 1H), 
4.05-3.96 (m, 2H), 3.81 (s, 5H), 2.31 (s, 6H), 2.30 (s, 6H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 160.6, 141.0 (d, J = 10.1 Hz), 138.2, 137.8 (d, J = 22.1 
Hz), 134.8 (d, J = 10.2 Hz), 132.2, 130.6 (d, J = 17.2 Hz), 128.4 (d, J = 2.1 Hz), 128.2, 127.9, 
127.5, 126.9, 126.4 (d, J = 2.1 Hz), 126.1, 125.8, 122.7, 122.1, 96.2 (d, J = 25.8 Hz), 75.9 (d, 
J = 11.2 Hz), 72.8 (d, J = 5.4 Hz), 71.8 (d, J = 4.5 Hz), 71.0, 70.8, 70.2, 69.8, 23.9, 22.1 ppm. 
31P-NMR (81 MHz, CDCl3): δ = -21.46 ppm. 
IR(KBr): υmax (cm−1) = 3065 (br, w), 2926 (br, w), 1648 (m), 1444 (s), 1168 (s), 954 (m), 
817 (m), 675 (s).  
MS (70 eV, EI): m/z (%) = 623 (M+, 38), 558 (25), 452 (100), 260 (35). 
HRMS (EI): m/z calcd. for: [C39H38P56FeNO] 623.2040,  found: 623.2039 
Experimental Section   95
 
(RFc)-1-Bis(3,5-dimethylphenylphosphino)-2-(((R)-α-benzyloxy)pyridyl))methylferrocene 
(10d):   
 
N
OCH2Ph
Xyl2P
Fe
 
 
Prepared according to TP4 from Raney-Ni (1.1 g, 18.0 mmol; 30 equiv.) and 33b (395 mg, 
0.60 mmol) in MeOH (40 mL), and obtained as a yellow solid (300 mg, 0.48 mmol, 80 %). 
 
MP: 55.6-60.9 °C 
[α]D20 = +14.3 (c = 0.2, acetone) 
1H-NMR (600 MHz, CDCl3): δ = 8.45-8.41 (m, 1H), 7.81-7.79 (m, 2H), 7.65-7.60 (m, 2H), 
7.58-7.46 (m, 4H), 7.10-6.90 (m, 3H), 6.29-6.25 (m, 3H), 5.64-5.60 (m, 1H), 4.82-4.77 (m, 
2H), 4.34-4.31 (m, 1H), 4.22-4.20 (m, 1H), 3.98 (s, 6H), 2.35 (s, 6H), 2.33 (s, 6H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 160.6, 145.2 (d, J = 11.2 Hz), 138.6 (d, J = 10.5 Hz), 
137.9 (d, J = 22.0 Hz), 135.2 (d, J = 10.8 Hz), 132.2, 131.2 (d, J = 16.9 Hz), 128.4,127.8 (d, J 
= 2.3 Hz), 126.8 (d, J = 8.2 Hz), 126.5, 126.0, 125.1 (d, J = 2.4 Hz), 125.9, 124.8, 122.1, 
122.0, 95.4 (d, J = 26.0 Hz), 76.2 (d, J = 13.0 Hz), 74.0, 72.7 (d, J = 4.4 Hz), 71.0, 70.2, 69.8, 
69.0, 24.2, 22.7 ppm. 
31P-NMR (81 MHz, CDCl3): δ = -22.49 ppm. 
IR(KBr): υmax (cm−1) = 3065 (w), 2925 (w), 1646 (m), 1538 (m), 1026 (s), 914 (m), 862 (m), 
699 (s), 672 (m). 
MS (70 eV, EI): m/z (%) = 623 (M+, 65), 558 (11), 452 (100), 260 (35), 155 (32). 
HRMS (EI): m/z calcd. for: [C39H38P56FeNO] 623.2040,  found: 623.2053 
 
2-Bromo-6-phenylpyridine 39a 
 
N PhBr
 
 
 
Under an argon atmosphere, a 250 mL Schlenk flask was charged with CuCN (2.35 g, 26.2 
mmol, 1.05 equiv) and THF (30 mL).  This suspension was treated with a solution of 
PhMgCl·LiCl (32 mL, 1.65 M, 52.8 mmol, 2.1 equiv) at –78 °C. After 20 minutes stirring, 
2,6-dibromopyridine 38 (5.92 g, 25 mmol, 1 equiv) in THF (30 mL) was slowly added.  When 
the addition was completed, the reaction mixture was warmed up to room temperature and 
stirring for 12 h. The reaction mixture was quenched with an aqueous solution of NH3:NH4Cl 
(6:4; 20 mL). Extracted the aqueous layer with Et2O (4 x 30 mL), the combined organic layers 
were washed with water, brine and dried over MgSO4. Purification of the crude mixture was 
was performed by flash chromatography (silica gel, n-pentan) and gave the desired product as 
a colourless oil (4.8 g, 20.5 mmol, 82 %). 
 
lH-NMR (300 MHz, CDCl3): δ = 7.95 (m, 2H), 7.67 (dd, J = 0.8 Hz, 7.7 Hz, 1H), 7.57 (t, J = 
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13C-NMR (75 MHz, CDCl3): δ = 158.5, 142.1, 138.9, 137.6, 129.6, 128.8, 126.9, 126.3, 
118.9 ppm.  
IR (KBr): νmax (cm-1) = 2850 (w), 1546 (m), 1429 (m), 1124 (m), 1051 (m), 982 (m), 781 (s).  
MS (70 eV, EI) m/z (%) = 233 (M+, 69), 154 (100), 127 (36). 
HRMS (EI): m/z calcd. for [C11H8N79Br] 232.9840, found: 232.9843.  
 
2-Bromo-6-tertButylpyridine 39a 
 
N tBuBr
 
 
 
Under an argon atmosphere, a 250 mL Schlenk flask was charged with CuCN (2.35 g, 26.2 
mmol, 1.05 equiv) and THF (30 mL).  This suspension was treated with a solution of 
tBuMgCl·LiCl (32 mL, 1.65 M, 52.8 mmol, 2.1 equiv) at –78 °C. After 20 minutes stirring, 
2,6-dibromopyridine 38 (5.92 g, 25 mmol, 1 equiv) in THF (30 mL) was slowly added.  When 
the addition was completed, the reaction mixture was warmed up to room temperature and 
stirring for 12 h. The reaction mixture was quenched with an aqueous solution of NH3:NH4Cl 
(6:4; 20 mL). Extracted the aqueous layer with Et2O (4 x 30 mL), the combined organic layers 
were washed with water, brine and dried over MgSO4. Purification of the crude mixture was 
performed by flash chromatography (silica gel, n-pentan) and gave the desired product as a 
colourless oil (17.8 mmol, 3.8 g, 68 %). 
 
lH-NMR (300 MHz, CDCl3): δ = 7.43 (t, J = 7.7 Hz, 1H), 7.26-7.23 (m, 2H), 1.33 (s, 9H) 
ppm. 
13C-NMR (75 MHz, CDCl3): δ = 171.2, 141.2, 138.4, 124.9, 117.8, 37.6, 30.0 ppm.  
IR (KBr): νmax (cm-1) = 2964 (s), 1580 (s), 1553 (s), 1398 (s), 1114 (s), 852 (m), 794 (s).  
MS (70 eV, EI) m/z (%) = 213 (M+, 23), 200 (99), 198 (100), 171 (18), 118 (14). 
HRMS (EI): m/z calcd. for [C9H12N79Br] 213.0153, found: 213.0142.  
 
Preparation of 6-Phenyl-2-pyridylcarboxaldehyde 40a 
 
NOHC Ph
 
 
A 100 mL Schlenk flask, under an argon atmosphere, was charged with 2-Bromo-6-
phenylpyridine 39a (4.37 g, 18.6 mmol, 1 equiv) and THF (20 mL).  The nBuLi (12.4 mL, 
1.58 M, 19.5 mmol, 1.05 equiv) was added slowly to the above solution at –78 °C. After 
stirring for 15 minutes, DMF (2.2 mL, 27.9 mmol, 1.5 equiv) was slowly added and the 
reaction mixture was stirred for 2 hours at -78 °C before warming to room temperature. The 
reaction mixture was quenched at room temperature with an aqueous solution of NH4Cl. The 
aqueous layer was extracted with Et2O (4 x 10 mL) and the combined organic layers were 
washed with water, brine and dried over MgSO4. Evaporation of the solvent and purification 
of the crude mixture by flash chromatography (silica gel, n-pentan:Et2O (10:1)), afforded the 
desired product as a colourless oil (15.8 mmol, 2.91 g, 85 %).  
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lH-NMR (300 MHz, CDCl3): δ = 10.17 (s, 1H), 8.09-8.06 (m, 2H), 7.97-7.88 (m, 3H), 7.54-
7.43 (m, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 193.9, 157.9, 152.7, 138.1, 137.8, 129.6, 128.9, 127.0, 
124.4, 119.7 ppm.  
IR (KBr): νmax (cm-1) = 3401 (br, w), 2849 (w), 1071 (s), 1452 (m), 1027 (s), 1217 (s), 761 
(s), 693 (m).  
MS (70 eV, EI) m/z (%) = 183 (M+, 81), 154 (100), 127 (34), 77 (16). 
HRMS (EI): m/z calcd. for [C12H9NO] 183.0684, found: 183.0692.  
 
Preparation of 6-tertButyl-2-pyridylcarboxaldehyde 40b 
 
N tBuOHC
 
 
A 100 mL Schlenk flask, under an argon atmosphere, was charged with 2-Bromo-6-
tertbutylpyridine 39b (3.3 g, 15.5 mmol, 1 equiv) and THF (20 mL).  The nBuLi (10.3 mL, 
1.58 M, 16.3 mmol, 1.05 equiv) was added slowly to the above solution at –78 °C. After 
stirring for 15 minutes, DMF (1.8 mL, 23.25 mmol, 1.5 equiv) was slowly added and the 
reaction mixture was stirred for 2 hours at -78 °C before warming to room temperature. The 
reaction mixture was quenched at room temperature with an aqueous solution of NH4Cl. The 
aqueous layer was extracted with Et2O (4 x 10 mL) and the combined organic layers were 
washed with water, brine and dried over MgSO4. Evaporation of the solvent and purification 
of the crude mixture by flash chromatography (silica gel, n-pentan:Et2O (10:1)), afforded the 
desired product as a colourless oil (13.2 mmol, 2.15 g, 85 %).  
 
lH-NMR (300 MHz, CDCl3): δ = 10.07 (s, 1H), 7.77-7.76 (m, 2H), 7.57-7.44 (m, 1H), 1.40 
(s, 9H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 194.5, 170.0, 151.9, 137.0, 123.4, 118.3, 37.6, 30.0 ppm.  
IR (KBr): νmax (cm-1) = 2961 (s), 1547 (s), 1502 (s), 1386 (s), 1114 (s), 830 (m), 760 (s).  
MS (70 eV, EI) m/z (%) = 163 (M+, 34), 148 (100), 118 (12), 91 (5). 
HRMS (EI): m/z calcd. for [C10H13NO] 163.0997, found: 163.0976.  
 
(RFc)-1-Diphenylphosphinothioyl-2-[α-hydroxy(6-phenylpyridyl)]-methylferrocene 41 
 
N
OHPh2P
S
Ph
Fe
 
 
Prepared according to the typical procedure TP3, using ferrocenyl sulfoxide 30 (10.0 mmol, 
5.40 g) in THF (10 mL), PhLi (0.20 M, 60 mM, 12.0 mmol, 1.20 equiv.) in diethylether, and 
6-phenyl-2-pyridinecarboxaldehyde 40a (2.20 g, 12.0 mmol, 1.1 equiv) as an electrophile.  
After the typical work-up, the residue was purified by flash chromatography (silica gel, n-
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pentane:Et2O 6:1) afforded the two diastereomeric alcohols 41a and 41b (3.79 g, 6.40 mmol, 
64%) as an inseparable mixture 41 in 6:4 ratio (by 31P-NMR). 
 
lH-NMR (200 MHz, C6D6): δ = 8.04-7.96 (m, 2H), 7.93-7.75 (m, 6H), 7.69-7.63 (m, 2H), 
7.58-7.47 (m; 3H), 7.26-7.13 (m, 6H), 7.04-6.93 (m, 9H), 6.82-6.72 (m, 10H), 6.37 (d, J = 
11.0 Hz, 1H), 5.87 (d, J = 10.0 Hz, 1H), 4.76 (d, J = 6.0 Hz, 1H), 4.68-4.63 (m, 1H), 4.45 (s, 
5H), 4.29 (s, 5H), 3.93-3.85 (m, 2H), 3.60-3.55 (m, 2H) ppm. 
31P-NMR (81 MHz, C6D6): δ = +43.6 (60 %), +42.6 (40 %) ppm. 
 
Preparation of ferrocenyl methyl ethers 42a and 42b 
Prepared according to the typical procedure TP4, using KH (60 mg, 1.50 mmol, 1.50 equiv.) 
in THF (3 mL), ferrocenyl alcohol 41 (576 mg, 0.98 mmol, 1.0 equiv.) in THF (3 mL) and 
CH3I (0.5 mL, 8.0 mmol, 8.0 equiv.).  The reaction mixture was quenched with a saturated 
NH4Cl solution (5 mL) and the aqueous layer was extracted with diethylether (4 x 15 mL).  
After the typical work-up, the residue was purified by flash chromatography (silica gel, n-
pentane:Et2O 6:1) to furnish the two methyl ethers 42a (322 mg, 0.54 mmol, 55 %) and 42b 
(198 mg, 0.33 mmol, 34 %) as yellow solids. 
 
(RFc)-1-Diphenylphosphinothioyl-2-[(S)-α-methoxy(6-phenylpyridyl)]-methylferrocene 
42a 
 
N
OMePh2P
S
Ph
Fe
 
 
MP: 141.2-143.8 °C 
[α]D20 = -28 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 8.25-8.23 (m, 2H), 8.08-7.98 (m, 4H), 7.45-7.19 (m, 5H), 
7.07-7.04 (m, 7H), 6.70 (s, 1H), 4.31 (s, 5H), 4.20-4.18 (m, 1H), 3.89 (dd, J = 2.1 Hz, 4.0 Hz, 
1H), 3.76-3.74 (m, 1H), 2.99 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 161.2, 156.6, 139.5, 136.9, 136.5 (d, J = 88.2 Hz), 134.8 (d, 
J = 84.6 Hz), 132.8 (d, J = 3.4 Hz), 132.7 (d, J = 3.7 Hz), 130.9 (d, J = 3.0 Hz), 130.7 (d, J = 
3.8 Hz), 129.2, 129.0, 127.9, 127.2, 120.8, 118.8, 92.6 (d, J = 11.6 Hz), 81.0, 75.8 (d, J = 94.6 
Hz), 75.5 (d, J = 12.3 Hz), 73.1 (d, J = 8.8 Hz), 71.6, 69.0 (d, J = 10.0 Hz), 56.8 ppm.  
31P-NMR (81 MHz, C6D6): δ = +42.8 ppm. 
IR (KBr): νmax (cm-1) = 3436 (m), 2925 (s), 1630 (w), 1446 (m), 1437 (m), 1101 (m), 759 
(m), 693 (m).  
MS (70 eV, EI) m/z (%) = 599 (M+, 100), 534 (22), 504 (100), 502 (16), 286 (16). 
HRMS (EI): m/z calcd. for [C32H32P56FeO32SN] 599.1135, found: 599.1129. 
 
(RFc)-1-Diphenylphosphinothioyl-2-[(S)-α-methoxy(6-phenylpyridyl)]-methylferrocene 
42b 
 
Experimental Section   99
N
OMePh2P
S
Ph
Fe
 
 
MP: 100-110 °C 
[α]D20 = -31 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 8.40-7.98 (m, 6H), 7.45-7.20 (m, 5H), 7.13-7.09 (m, 7H), 
6.72 (s, 1H), 5.32-5.30 (m, 1H), 4.50 (s, 5H), 4.25-4.20 (m, 1H), 3.81-3.79 (m, 1H), 3.20 (s, 
3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 162.4, 158.2, 140.5, 138.2, 137.2 (d, J = 87.2 Hz), 135.2 (d, 
J = 84.8 Hz), 133.2 (d, J = 3.8 Hz), 132.9 (d, J = 4.0 Hz), 132.6 (d, J = 3.9 Hz), 131.4 (d, J = 
4.0 Hz), 129.2, 128.4, 121.2, 119.2, 93.0 (d, J = 11.8 Hz), 81.5, 76.2 (d, J = 95.0 Hz), 76.1 (d, 
J = 13.2 Hz), 73.7 (d, J = 9.0 Hz), 72.4, 69.2 (d, J = 10.4 Hz), 61.2 ppm.  
31P-NMR (81 MHz, C6D6): δ = +41.2 ppm. 
IR (KBr): νmax (cm-1) = 3440 (m), 2900 (s), 1629 (w), 1446 (m), 1400 (m), 1100 (m), 792 
(m), 698 (s).  
MS (70 eV, EI) m/z (%) = 599 (M+, 100), 532 (20), 504 (82), 502 (20), 286 (36).  
HRMS (EI): m/z calcd. for [C32H32P56FeO32SN] 599.1135, found: 599.1130. 
 
(RFc)-1-diphenylphoshphino-2-[(S)-α-methoxy(6-phenylpyridyl)]methylferrocene 9e  
 
N
OMePh2P
Ph
Fe
 
 
Prepared according to TP5 from Raney-Ni (1.10 g, 18.0 mmol, 30 equiv.) and 42a (360 mg; 
0.6 mmol) in MeOH (40 mL), and obtained as a yellow solid (286 mg, 0.51 mmol, 84%). 
 
MP: 112-114 °C 
[α]D20 = -20 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 8.14-7.92 (m, 6H), 7.16-7.42 (m, 5H), 7.02-7.05 (m, 7H), 
6.68 (s, 1H), 4.32 (s, 5H), 4.21-4.22 (m, 1H), 3.88-3.91 (m, 1H), 3.76-3.78 (m, 1H), 2.96 (s, 
3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 157.2, 154.2, 137.2, 135.1, 134.5 (d, J = 80.0 Hz), 132.8 (d, 
J = 78.2 Hz), 131.4 (d, J = 3.2 Hz), 130.7 (d, J = 2.4 Hz), 129.4 (d, J = 3.1 Hz), 129.2 (d, J = 
2.2 Hz), 128.4, 128.1, 126.8, 126.7, 126.5, 118.2, 116.8, 91.2 (d, J = 10.4 Hz), 80.9, 74.6 (d, J 
= 88 Hz), 74.5 (d, J = 11.3 Hz), 72.8 (d, J = 8.0 Hz), 70.8, 68.5 (d, J = 10.8 Hz), 56.4 ppm.  
IR (KBr): νmax (cm-1) = 3421 (m), 2924 (s), 1572 (s), 1638 (m), 1512 (m), 1108 (m), 791 
(m), 698 (m). 
MS (70 eV, EI) m/z (%) = 567 (M+, 18), 534 (24), 504 (100), 501 (36). 
HRMS (EI): m/z calcd. for [C35H30P56FeON] 567.1414, found: 567.1428. 
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(RFc)-1-diphenylphoshphino-2-[(R)-α-methoxy(6-phenylpyridyl)]methylferrocene 9f 
 
N
OMePh2P
Ph
Fe
 
 
Prepared according to TP5 from Raney-Ni (1.1 g, 18.0 mmol; 30 equiv.) and 42b (360 mg; 
0.6 mmol) in MeOH (40 mL), and obtained as a yellow solid (274 mg, 0.48 mmol, 80 %). 
 
MP: 152-153 °C 
[α]D20 = -19 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 8.02-7.92 (m, 6H), 7.44-7.30 (m, 5H), 7.06-7.03 (m, 7H), 
6.70 (s, 1H), 4.92 (s, 1H), 4.40 (s, 5H), 3.92-3.91 (m, 1H), 3.78-3.77 (m, 1H), 3.10 (s, 3H) 
ppm. 
13C-NMR (100 MHz, C6D6): δ = 158.2, 156.1, 138.1, 135.4, 135.1 (d, J = 80.0 Hz), 132.4 (d, 
J = 81.0 Hz), 131.6 (d, J = 3.1 Hz), 131.1 (d, J = 2.8 Hz), 130.4 (d, J = 2.8 Hz), 130.1 (d, J = 
2.0 Hz), 128.6, 128.4, 127.9, 127.8, 127.6, 119.4, 118.2, 92.4 (d, J = 10.8 Hz), 81.2, 74.9 (d, J 
= 84 Hz), 74.8 (d, J = 11.4 Hz), 73.2 (d, J = 8.2 Hz), 70.9, 68.8 (d, J = 11.0 Hz), 58.2 ppm.  
IR (KBr): νmax (cm-1) = 3400 (m), 2947 (s), 1565 (s), 1600 (m), 1547 (m), 1100 (m), 790 
(m), 645 (m). 
MS (70 eV, EI) m/z (%) = 567 (M+, 48), 534 (25), 504 (100), 501 (86). 
HRMS (EI): m/z calcd. for [C35H30P56FeON] 567.1414, found: 567.1419. 
 
Preparation of ferrocenyl alcohols 43a and 43b 
 
Prepared according to the typical procedure TP3, using ferrocenyl sulfoxide 30 (5.40 g, 10.0 
mmol) in THF (10 mL), PhLi (0.20 M, 60 mL, 12.0 mmol, 1.20 equiv.) in diethylether, and 6-
(tert-butyl)-2-pyridylcarbaldehyde 40b (1.98 g, 12.0 mmol, 1.20 equiv) as an electrophile.  
After the typical work-up, the residue was purified by flash chromatography (silica gel, n-
pentane:Et2O 6:1) afforded the two diastereomeric alcohols 43a (1.54 g; 2.70 mmol, 27%) 
and 43b (2.67 g; 4.70 mmol, 47%) as yellow solids. 
 
(RFc)-1-Diphenylphosphinothioyl-2-[(S)-α-hydroxy(6-phenylpyridyl)]-methylferrocene 
43a 
 
N
OHPh2P
S
Fe
tBu
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MP: 111-112 °C 
[α]D20 = -68.2 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 7.96-7.90 (m, 2H), 7.73-7.67 (m, 2H), 7.54-7.52 (m, 1H), 
7.05-6.92 (m, 7H), 6.76 (dd, J = 0.8 Hz, 7.8 Hz, 1H), 6.47 (d, J = 9.2 Hz, 1H), 5.05 (d, J = 8.9 
Hz, 1H), 4.51-4.49 (m, 1H), 4.26 (s, 5H), 3.95-3.94 (m, 1H), 3.70-3.69 (m, 1H), 1.34 (s, 9H) 
ppm. 
13C-NMR (100 MHz, C6D6): δ = 167.4 161.6, 136.4, 135.8 (d, J = 87.4 Hz), 134.2 (d, J = 
85.8 Hz), 132.8 (d, J = 10.8 Hz), 132.3 (d, J = 10.8 Hz), 131.2 (d, J = 3.1 Hz), 130.9 (d, J = 
3.1 Hz), 128.1, 127.9, 118.9, 117.2, 97.1 (d, J = 11.8 Hz), 75.0 (d, J = 12.4 Hz), 74.2 (d, J = 
9.2 Hz), 74.1 (d, J = 92.7 Hz), 71.7, 71.4, 69.5 (d, J = 10.2 Hz), 37.4, 30.3 ppm.  
31P-NMR (81 MHz, C6D6): δ = +43.6 ppm. 
IR (KBr): νmax (cm-1) = 3435 (br, s), 2956 (m), 1575 (m), 1437 (s), 1104 (s), 750.4 (s), 714 
(s), 693 (s), 509 (s).  
MS (70 eV, EI) m/z (%) = 565 (M+, 65), 501 (31), 500 (100), 482 (97), 210 (20). 
HRMS (EI): m/z calcd. for [C32H32P56FeO32SN] 565.1292, found: 565.1301. 
 
(RFc)-1-diphenylphoshphinothioyl-2-[(R)-α-hydroxy(6-tert-butylpyridyl)]methyl 
ferrocene 43b 
 
N
OHPh2P
S
Fe
tBu
 
 
MP: 167-169 °C 
[α]D20 = -63.25 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 7.96-7.91 (m, 2H), 7.65-7.60 (m, 2H), 7.09-6.94 (m, 6H), 
6.89-6.85 (m, 2H), 6.76-6.71 (m, 2H), 5.13 (d, J = 5.6 Hz, 1H), 4.68-4.67 (m, 1H), 4.50 (s, 
5H), 3.97-3.96 (m, 1H), 3.64-3.63 (m, 1H), 1.24 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 167.5, 160.7, 136.3, 136.0 (d, J = 85.8 Hz), 135.2 (d, J = 
86.0 Hz), 132.6 (d, J = 10.5 Hz), 132.4 (d, J = 10.5 Hz), 131.1 (d, J = 3.3 Hz), 130.8 (d, J = 
3.0 Hz), 128.1, 127.9, 119.1, 117.2, 99.4 (d, J = 12.3 Hz), 74.3 (d, J = 11.9 Hz), 73.8 (d, J = 
94.9 Hz), 72.1 (d, J = 9.5 Hz), 71.4, 69.4 (d, J = 10.9 Hz), 68.5, 37.3, 30.1 ppm.  
31P-NMR (81 MHz, C6D6): δ = +42.5 ppm. 
IR (KBr): νmax (cm-1) = 3430 (br, s), 2963 (s), 1574 (s), 1436 (s), 1102 (s), 716 (s), 693 (s), 
490 (s).  
MS (70 eV, EI) m/z (%) = 565 (M+, 72), 501 (34), 500 (99), 482 (100). 
HRMS (EI): m/z calcd. for [C32H32P56FeO32SN] 565.1292, found: 565.1278. 
 
Preparation of ferrocenyl methyl ethers 44a and 44b 
 
(RFc)-1-Diphenylphoshphinothioyl-2-[(S)-α-methoxy(6-tert-butylpyridyl]methyl 
ferrocene 44a 
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N
OMePh2P
S
Fe
tBu
 
 
Prepared according to the typical procedure TP4, using KH (19 mg, 0.5 mmol, 1.5 equiv) in 
THF (1 mL), ferrocenyl alcohol 43a (170 mg, 0.30 mmol, 1.0 equiv) in THF (2 mL) and CH3I 
(0.1 mL, 1.6 mmol, 5.0 equiv).  After quenching the reaction mixture with a saturated NH4Cl 
solution (5 mL) and the aqueous layer was extracted with diethylether (4 x 10 mL).  After the 
typical work-up, the residue was purified by flash chromatography (silica gel, n-pentane:Et2O 
6:1) to furnish the methyl ether 44a (139 mg, 0.24 mmol, 80%) as a yellow solid. 
 
MP: 196-198 °C 
[α]D20 = -49 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ =  8.07-7.97 (m, 4H), 7.38-7.36 (m, 1H), 7.23-7.19 (m, 1H), 
7.06-7.04 (m, 6H), 6.99-6.97 (m, 1H), 6.52 (s, 1H), 4.35-4.33 (m, 1H), 4.32 (s, 5H), 3.95-3.94 
(m, 1H), 3.77-3.75 (m, 1H), 2.92 (s, 3H), 1.43 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.7, 160.0, 136.5 (d, J = 88.2 Hz), 136.3, 134.9 (d, J = 
85.0 Hz), 132.8 (d, J = 10.6 Hz), 132.7 (d, J = 10.7 Hz), 130.9 (d, J = 3.1 Hz), 130.6 (d, J = 
3.1 Hz), 127.9, 127.7, 120.0, 117.9, 92.6 (d, J = 11.8 Hz), 81.0, 75.9 (d, J = 94.2 Hz), 75.5 (d, 
J = 12.4 Hz), 73.1 (d, J = 9.1 Hz), 71.5, 69.1 (d, J = 10.3 Hz), 56.5, 37.8, 30.6 ppm.  
31P-NMR (81 MHz, C6D6): δ = +42.89 ppm. 
IR (KBr): νmax (cm-1) = 3436 (w), 2957 (m), 1575 (m), 1437 (s), 1162 (m), 1103 (s), 822 
(m), 751 (m), 693 (s), 513 (m).  
MS (70 eV, EI) m/z (%) = 580 ([M+H]+, 31), 579 (M+, 76), 564 (12), 514 (38), 485 (34), 484 
(100), 482 (35). 
HRMS (EI): m/z calcd. for [C33H34P56FeO32SN] 579.1448, found: 579.1440. 
 
(RFc)-1-Diphenylphoshphinothioyl-2-[(R)-α-methoxy(6-tert-butylpyridyl]methyl 
ferrocene 44b 
 
Prepared according to the typical procedure TP4, using KH (30 mg, 1.25 mmol, 1.5 equiv) in 
THF (1.5 mL), ferrocenyl alcohol 43b (284 mg, 0.50 mmol, 1.0 equiv) in THF (2 mL) and 
CH3I (0.1 mL, 1.8 mmol, 3.5 equiv).  After quenching the reaction mixture with a saturated 
NH4Cl solution (5 mL) and the aqueous layer was extracted with diethylether (4 x 15 mL).  
After the typical work-up, the residue was purified by flash chromatography (silica gel, n-
pentane:Et2O 6:1) to furnish the methyl ether 44b (239 mg, 0.41 mmol, 82%) as a yellow 
solid. 
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N
OCH3
Ph2P
S
Fe
tBu
 
 
MP: 159-161 °C 
[α]D20 = -41 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 7.90-7.84 (m, 2H), 7.31-7.26 (m, 2H), 7.03-6.92 (m, 4H), 
6.85-6.80 (m, 1H), 6.73-6.62 (m, 4H), 6.57 (s, 1H), 5.32-5.31 (m, 1H), 4.52 (s, 5H), 4.03 (q, J 
= 2.3 Hz, 1H), 3.55 (q, J = 2.1 Hz, 1H), 3.27 (s, 3H), 1.33 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.5, 158.2, 135.7 (d, J = 86.4 Hz), 135.4, 134.8 (d, J = 
85.7 Hz), 132.6 (d, J = 10.7 Hz), 132.0 (d, J = 10.3 Hz), 131.9 (d, J = 3.1 Hz), 130.1 (d, J = 
3.1 Hz), 127.9, 127.6, 121.3, 117.0, 95.5 (d, J = 11.9 Hz), 79.4, 74.3 (d, J = 12.2 Hz), 73.2 (d, 
J = 94.5 Hz), 72.6 (d, J = 9.2 Hz), 71.4, 69.3 (d, J = 10.4 Hz), 37.6, 30.3, 56.4 ppm.  
31P-NMR (81 MHz, C6D6): δ = +42.4 ppm. 
IR (KBr): νmax (cm-1) = 3436 (w), 2955 (m), 1575 (m), 1434 (s), 1158 (m), 1098 (s), 748 (s), 
693 (s), 519 (m).  
MS (70 eV, EI) m/z (%) = 579 (M+, 64), 515 (12), 514 (34), 484 (100), 482 (34). 
HRMS (EI): m/z calcd. for [C33H34P56FeO32SN] 579.1448, found: 579.1432. 
 
Preparation of ferrocenyl benzylethers 45a-b 
 
(RFc)-1-Diphenylphoshphinothioyl-2-[(S)-α-benzyloxy(6-tert-butylpyridyl]methyl 
ferrocene 45a 
 
N
OCH2Ph
Ph2P
S
Fe
tBu
 
 
Prepared according to the typical procedure TP4, using KH (19 mg, 0.5 mmol, 1.5 equiv) in 
THF (1 mL), ferrocenyl alcohol 43a (170 mg, 0.30 mmol, 1.0 equiv) in THF (2 mL) and 
PhCH2Br (260 mg, 1.6 mmol, 5.0 equiv).  After quenching the reaction mixture with a 
saturated NH4Cl solution (5 mL) and the aqueous layer was extracted with diethylether (4 x 
15 mL).  After the typical work-up, the residue was purified by flash chromatography (silica 
gel, n-pentane:Et2O 6:1) to furnish the benzyl ether 45a (169 mg, 0.25 mmol, 85%) as a 
yellow solid. 
 
MP: 165.3-166.3 °C  
[α]D20 = −85 (c = 0.2, acetone). 
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1H-NMR (400 MHz, C6D6): δ = 8.05-7.91 (m, 4H), 7.46-7.45 (m, 1H), 7.05-6.78 (m, 14H), 
4.68-4.61 (m, 1H), 4.39-4.38 (m, 1H), 4.31 (s, 5H), 4.18-4.12 (m, 1H), 3.98-3.96 (m, 1H), 
3.89-3.78 (m, 1H), 1.46 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.2, 157.6, 139.7, 138.9, 135.0 (d, J = 86.9 Hz), 134.8 (d, 
J = 86.3 Hz), 134.0, 132.0 (d, J = 10.8 Hz), 131.6 (d, J = 10.3 Hz), 130.8 (d, J = 10.8 Hz), 
130.2 (d, J = 10.8 Hz), 128.0, 127.9, 127.6 (d, J = 12.7 Hz), 127.4 (d, J = 11.4 Hz), 120.9, 
117.1, 94.5 (d, J = 11.7 Hz), 77.4, 74.0 (d, J = 12.1 Hz), 73.2 (d, J = 95.5 Hz), 72.6 (d, J = 9.1 
Hz), 70.9, 70.4, 69.5 (d, J = 10.4 Hz), 37.4, 30.0 ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.71 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 2958 (w), 1629 (w), 1575 (m), 1479 (m), 
1437 (m), 1103 (m), 1101 (s), 823 (m), 750 (m), 715 (m), 694 (m). 
MS (70 eV, EI): m/z (%) = 655 (M+, 19), 565 (19), 564 (47), 485 (28), 484 (100). 
HRMS (EI): m/z calcd. for: [C39H38P56FeO32SN] 655.1761,  found: 655.1742 
 
(RFc)-1-Diphenylphoshphinothioyl-2-[(R)-α-benzyloxy(6-tert-butylpyridyl]methyl 
ferrocene 45b 
 
Prepared according to the typical procedure TP4, using KH (19 mg, 0.5 mmol, 1.5 equiv) in 
THF (1 mL), ferrocenyl alcohol 43b (170 mg, 0.30 mmol, 1.0 equiv) in THF (2 mL) and 
PhCH2Br (260 mg, 1.6 mmol, 5.0 equiv).  After quenching the reaction mixture with a 
saturated NH4Cl solution (5 mL) and the aqueous layer was extracted with diethylether (4 x 
15 mL).  After the typical work-up, the residue was purified by flash chromatography (silica 
gel, n-pentane:Et2O 6:1) to furnish the benzyl ether 45b (169 mg, 0.25 mmol, 85%) as a 
yellow solid. 
 
N
OCH2Ph
Ph2P
S
Fe
tBu
 
 
MP: 181.0-181.9 °C  
[α]D20 = −80 (c = 0.2, acetone). 
1H-NMR (400 MHz, C6D6): δ = 7.89-7.84 (m, 2H), 7.41 (d, J = 7.2 Hz, 2H), 7.33-7.28 (m, 
2H), 7.20 (t, J = 7.7 Hz, 2H), 7.11-6.95 (m, 5H), 6.85-6.82 (m, 2H), 6.74-6.65 (m, 4H), 5.32-
5.31 (m, 1H), 4.56 (d, J = 11.2 Hz, 1H), 4.47 (d, J = 11.4 Hz, 1H), 4.44 (s, 5H), 4.05-4.04 (m, 
1H), 3.59-3.58 (m, 1H), 1.34 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.5, 158.5, 139.7, 139.6, 135.8 (d, J = 86.8 Hz), 135.4, 
134.7 (d, J = 86.3 Hz), 132.6 (d, J = 10.8 Hz), 132.0 (d, J = 10.8 Hz), 130.9 (d, J = 10.8 Hz), 
130.1 (d, J = 10.8 Hz), 128.4, 128.3, 127.8 (d, J = 12.3 Hz), 127.6 (d, J = 11.4 Hz), 121.3, 
117.1, 95.5 (d, J = 11.5 Hz), 77.6, 74.3 (d, J = 12.1 Hz), 73.2 (d, J = 94.5 Hz), 72.6 (d, J = 9.1 
Hz), 71.4, 70.9, 69.3 (d, J = 10.3 Hz), 37.6, 30.3 ppm. 
31P-NMR (81 MHz, C6D6): δ = +42.31 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 2956 (m), 1574 (m), 1160 (m), 1101 (s), 821 
(m), 749 (s), 713 (s), 694 (s). 
MS (70 eV, EI): m/z (%) = 655 (M+, 10), 485 (32), 484 (100), 483 (84), 427 (11). 
HRMS (EI): m/z calcd. for: [C39H38P56FeO32SN] 655.1761,  found: 655.1757 
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(RFc)-1-Diphenylphoshphino-2-[(S)-α-methoxy(6-tert-butylpyridyl]methylferrocene 9g  
 
N
OCH3
Ph2P
Fe
tBu
 
 
Prepared according to the typical procedure TP5, using Raney-Ni (720 mg, 12.0 mmol; 30 
equiv.) and 44a (232 mg, 0.40 mmol) in MeOH (30 mL), and obtained as a yellow solid (175 
mg, 0.32 mmol, 80 %). 
 
MP: 55-57 °C 
[α]D20 = +29 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ =  7.78-7.74 (m, 2H), 7.54-7.50 (m, 2H), 7.36-7.34 (m, 1H), 
7.25-7.22 (m, 1H), 7.14-7.07 (m, 5H), 7.05-6.98 (m, 2H), 5.89 (d, J = 2.9 Hz, 1H), 4.20-4.19 
(m, 1H), 4.08 (t, J = 2.6 Hz, 1H), 4.00 (s, 5H), 3.95-3.94 (m, 1H), 2.99 (s, 3H), 1.46 (s, 9H) 
ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.4, 160.4, 141.6 (d, J = 10.9 Hz), 139.0 (d, J = 9.9 Hz), 
136.4, 136.0 (d, J = 22.1 Hz), 132.9 (d, J = 18.2 Hz), 129.2, 128.3, 127.9, 127.5, 119.3, 117.9, 
93.9 (d, J = 24.8 Hz), 83.7 (d, J = 8.8 Hz), 72.4 (d, J = 4.9 Hz), 70.9 (d, J = 3.9 Hz), 70.3, 
69.7, 69.4 (d, J = 59.0 Hz), 56.5, 37.7, 30.6 ppm.  
IR (KBr): νmax (cm-1) = 3436 (m), 2955 (m), 1576 (m), 1433 (m), 1085 (m), 820 (m), 742 
(m), 696 (m), 489 (m).  
MS (70 eV, EI) m/z (%) = 548 ([M+H]+, 38), 547 (M+, 100), 532 (53), 395 (19), 347 (22), 
210 (22). 
HRMS (EI): m/z calcd. for [C33H34P56FeON] 547.1727, found: 547.1719. 
 
(RFc)-1-Diphenylphoshphino-2-[(R)-α-methoxy(6-tert-butylpyridyl]methylferrocene 9h 
 
N
OCH3
Ph2P
tBu
Fe
 
 
Prepared according to the typical procedure TP5, using Raney-Ni (1.1 g, 18.0 mmol; 30 
equiv.) and 44b (348 mg, 0.60 mmol) in MeOH (40 mL), and obtained as a yellow solid (273 
mg, 0.50 mmol, 83%). 
 
MP: 142-144 °C 
[α]D20 = +21 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ = 7.66-7.61 (m, 2H), 7.10-7.07 (m, 4H), 7.04-7.00 (m, 1H), 
6.87-6.73 (m, 6H), 5.70 (d, J = 2.1 Hz, 1H), 4.93-4.92 (m, 1H), 4.17 (s, 5H), 4.14-4.11 (m, 
1H), 3.77-3.76 (m, 1H), 3.20 (s, 3H), 1.25 (s, 9H) ppm. 
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13C-NMR (100 MHz, C6D6): δ = 168.0, 160.1, 141.0 (d, J = 11.7 Hz), 139.1 (d, J = 11.2 Hz), 
136.2, 135.8 (d, J = 22.3 Hz), 132.2 (d, J = 17.6 Hz), 129.1, 128.2, 127.7, 127.0, 119.2 (d, J = 
0.8 Hz), 117.3, 97.0 (d, J = 24.0 Hz), 82.9 (d, J = 8.0 Hz), 74.8 (d, J = 12.0 Hz), 71.4 (d, J = 
4.9 Hz), 70.3, 69.7, 69.4 (d, J = 58.4 Hz), 56.6, 37.4, 30.2 ppm.  
31P-NMR (81 MHz, C6D6): δ = -20.5 ppm. 
IR (KBr): νmax (cm-1) = 3436 (w), 2956 (m), 1574 (m), 1449 (m), 1156 (m), 1093 (s), 821 
(m), 749 (m), 698 (m), 504 (m).  
MS (70 eV, EI) m/z (%) = 548 ([M+H]+, 40), 547 (M+, 100), 532 (46), 394 (44), 332 (26), 
210 (39). 
HRMS (EI): m/z calcd. for [C33H34P56FeON] 547.1727, found: 547.1737. 
 
(RFc)-1-Diphenylphoshphino-2-[(S)-α-benzyloxy(6-tert-butylpyridyl]methylferrocene 10e  
 
N
OCH2Ph
Ph2P
tBu
Fe
 
 
Prepared according to the typical procedure TP5, using Raney-Ni (720 mg, 12.0 mmol; 30 
equiv.) and 45a (265 mg, 0.40 mmol) in MeOH (30 mL), and obtained as a yellow solid (224 
mg, 0.36 mmol, 89 %). 
 
MP: 112.8-114.2 °C  
[α]D20 = +209 (c = 0.30, CH2Cl2). 
1H-NMR (400 MHz, C6D6): δ = 7.76-7.62 (m, 2H), 7.46-7.40 (m, 3H), 7.22 (t, J = 7.7 Hz, 
1H), 7.12-7.11 (m, 3H), 7.01-6.97 (m, 7H), 6.82-6.80 (m, 2H), 6.20 (d, J = 3.2 Hz, 1H), 4.52-
4.49 (m, 1H), 4.24-4.22 (m, 2H), 4.11 (t, J = 2.2 Hz, 1H), 3.99 (s, 6H), 1.48 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.4, 160.5, 141.5 (d, J = 10.3 Hz), 139.1 (d, J = 11.5 Hz), 
138.7, 136.5, 136.0 (d, J = 22.3 Hz), 133.0 (d, J = 17.4 Hz), 129.2 (d, J = 0.8 Hz), 128.4, 
128.3, 128.1 (d, J = 5.8 Hz), 128.0, 127.5, 127.1, 119.7, 118.0, 93.7 (d, J = 25.7 Hz), 82.1 (d, 
J = 8.9 Hz), 77.3 (d, J = 11.4 Hz), 72.5 (d, J = 5.3 Hz), 71.6, 71.2 (d, J = 3.8 Hz), 70.3, 70.0, 
37.8, 30.6 ppm. 
31P-NMR (81 MHz, C6D6): δ = -21.22 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, m), 2956 (m), 1573 (m), 1452 (m), 1434 (m), 
1087 (m), 1062 (m), 820 (m), 748 (s), 696 (s). 
MS (70 eV, EI): m/z (%) = 623 (M+, 30), 532 (19), 518 (34), 517 (100), 439 (13), 347 (13), 
332 (51). 
HRMS (EI): m/z calcd. for: [C39H38P56FeON] 623.2040,  found: 623.2021 
 
(RFc)-1-Diphenylphoshphino-2-[(R)-α-benzyloxy(6-tert-butylpyridyl]methylferrocene 10f 
 
N
OCH2Ph
Ph2P
tBu
Fe
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Prepared according to the typical procedure TP5, using Raney-Ni (720 mg, 12.0 mmol; 30 
equiv.) and 45b (265 mg, 0.40 mmol) in MeOH (30 mL), and obtained as a yellow solid (212 
mg, 0.34 mmol, 85%). 
 
MP: 120.5-121.7 °C  
[α]D20 = +105 (c = 0.26, CH2Cl2). 
1H-NMR (400 MHz, C6D6): δ = 7.65-7.60 (m, 2H), 7.46-7.44 (m, 2H), 7.24-7.20 (m, 2H), 
7.14-7.10 (m, 6H), 6.85-6.74 (m, 6H), 5.97 (d, J = 2.4 Hz. 1H), 4.92-4.90 (m, 1H), 4.50 (s, 
2H), 4.15-4.13 (m, 1H), 4.12 (s, 5H), 3.80-3.79 (m, 1H), 1.27 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.0, 160.3, 141.5 (d, J = 12.0 Hz), 139.4, 139.1 (d, J = 
11.5 Hz), 136.3, 135.8 (d, J = 22.1 Hz), 132.2 (d, J = 17.6 Hz), 129.1 (d, J = 0.8 Hz), 128.5, 
128.2 (d, J = 0.8 Hz), 128.2, 127.8, 127.6, 127.0, 119.4, 117.4, 97.0 (d, J = 27.4 Hz), 81.0 (d, 
J = 8.4 Hz), 74.8 (d, J = 12.6 Hz), 71.4 (d, J = 4.6 Hz), 71.0, 70.4, 69.9 (d, J = 4.2 Hz), 69.7, 
37.4, 30.2 ppm. 
31P-NMR (81 MHz, C6D6): δ = -20.61 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, m), 2950 (m), 1585 (m), 1476 (m), 1434 (m), 
1049 (m), 818 (m), 747 (m), 709 (m). 
MS (70 eV, EI): m/z (%) = 623 (M+, 96), 532 (44), 518 (38), 517 (100), 451 (41), 394 (41), 
332 (84). 
HRMS (EI): m/z calcd. for: [C39H38P56FeON] 623.2040,  found: 623.2040 
 
(RFc)-1-Diphenylphoshphino-2-[(S)-α-hydroxy(6-tert-butylpyridyl]methylferrocene 10g  
 
N
OHPh2P
tBu
Fe
 
 
Prepared according to the typical procedure TP5, using Raney-Ni (720 mg, 12.0 mmol; 30 
equiv.) and 43a (226 mg, 0.40 mmol) in MeOH (30 mL), and obtained as a yellow solid (182 
mg, 0.34 mmol, 85%). 
 
MP: 98-100 °C 
[α]D20 = -41.2 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ =  7.96-7.91 (m, 2H), 7.69-7.52 (m, 3H), 7.06-6.96 (m, 6H), 
6.77-6.74 (m, 1H), 6.42 (s, 1H), 5.04 (s, 1H), 4.48-4.40 (m, 1H), 4.28 (s, 5H), 3.94-3.92 (m, 
1H), 3.69-3.65 (m, 1H), 1.32 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 169.2, 161.2, 142.6 (d, J = 10.9 Hz), 140.1 (d, J = 11.8 Hz), 
138.2, 137.1 (d, J = 23.1 Hz), 133.2 (d, J = 20 Hz), 130.1, 129.6, 128.1, 127.4, 120.1 (d, J = 
1.1 Hz), 116.9, 96.9 (d, J = 25.2 Hz), 83.1 (d, J = 8.5 Hz), 75.2 (d, J = 12.2 Hz), 71.7 (d, J = 
5.0 Hz), 70.8, 70.1, 69.6 (d, J = 58.2 Hz), 37.2, 30.3 ppm.  
31P-NMR (81 MHz, C6D6): δ = -20.0 ppm. 
IR (KBr): νmax (cm-1) = 3436 (br, s), 2882 (s), 1572 (s), 1409 (s), 1112 (m), 747 (m), 698 (s). 
MS (70 eV, EI) m/z (%) = 533 (M+, 40), 501 (28), 500 (66), 482 (100). 
HRMS (EI): m/z calcd. for [C32H32P56FeON] 533.1571, found: 533.1578. 
Experimental Section   108
 
(RFc)-1-Diphenylphoshphino-2-[(R)-α-hydroxy(6-tert-butylpyridyl]methylferrocene 10h 
 
N
OHPh2P
tBu
Fe
 
 
Prepared according to the typical procedure TP5, using Raney-Ni (720 mg, 12.0 mmol; 30 
equiv.) and 43b (226 mg, 0.40 mmol) in MeOH (30 mL), and obtained as a yellow solid (171 
mg, 0.32 mmol, 80%). 
 
MP: 101-104 °C 
[α]D20 = -49.8 (c = 0.3, CH2Cl2) 
lH-NMR (400 MHz, C6D6): δ =  7.95-7.91 (m, 2H), 7.70-7.61 (m, 2H), 7.08-7.00 (m, 6H), 
6.91-6.88 (m, 2H), 6.75-6.70 (m, 2H), 5.14 (s, 1H), 4.69-4.67 (m, 1H), 4.20 (s, 5H), 3.96-3.90 
(m, 1H), 3.62-3.60 (m, 1H), 1.20 (s, 9H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.8, 160.1, 141.5 (d, J = 12.1 Hz), 139.5 (d, J = 11.2 Hz), 
135.9, 136.2 (d, J = 21.9 Hz), 132.4 (d, J = 18 Hz), 129.9, 128.5, 127.9, 127.2, 119.5 (d, J = 
1.0 Hz), 116.8, 96.5 (d, J = 24.1 Hz), 82.5 (d, J = 8.0 Hz), 75.0 (d, J = 12.0 Hz), 71.5 (d, J = 
4.9 Hz), 70.4, 69.5, 69.4 (d, J = 58.0 Hz), 37.4, 30.1 ppm.  
31P-NMR (81 MHz, C6D6): δ = -23.4 ppm. 
IR (KBr): νmax (cm-1) = 3449 (br, s), 2990 (m), 1570 (s), 1400 (s), 1100 (s), 726 (s), 699 (s). 
MS (70 eV, EI) m/z (%) = 533 (M+, 30), 501 (32), 500 (48), 482 (100). 
HRMS (EI): m/z calcd. for [C32H32P56FeON] 533.1571, found: 533.1577. 
 
5. Preparation of iridium complexes 46a-g and 47a-g 
 
Iridium complex (46a):  
N
OMePh2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 9a (246 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol, 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) afforded the iridium complex 46a (746 mg, 90%) as a 
bright orange solid. 
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MP: 184.3-185.4 °C 
[α]D20 = +69 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.78-8.77 (m, 1H), 8.17-8.06 (m, 2H), 7.94-7.84 (m, 3H), 
7.74-7.69 (m, 7H), 7.64-7.45 (m, 7H), 7.33-7.30 (m, 3H), 6.95-6.82 (m, 3H), 4.96-4.91 (m, 
1H), 4.48 (t, J = 2.6 Hz, 1H), 4.15-4.08 (m, 3H), 3.79-3.68 (m, 1H), 3.70 (s, 2H), 3.13 (s. 4H), 
2.66-2.29 (m, 5H), 2.16-1.80 (m, 3H), 1.68-1.27 (m, 4H), ppm. 
13C-NMR (100 MHz, CDCl3): δ = 164.9, 161.7 (q, J = 53.7 Hz), 149.8, 137.1 (q, J = 291.2 
Hz), 135.6 (d, J = 14.4 Hz), 134.8, 132.7 (d, J = 2.9 Hz), 130.8 (d, J = 2.8 Hz), 129.9 (d, J = 
58.8 Hz), 129.2 (d, J = 11.2 Hz), 129.1 (q, J = 2.7 Hz), 128.7 (q, J = 2.9 Hz), 128.6, 128.4 (q, 
J = 2.7 Hz), 126.2, 125.9, 123.6, 123.2, 120.5, 117.5 (q, J = 4.0 Hz), 94.0-93.6 (m), 81.9 (d, J 
= 1.9 Hz), 73.3 (d, J = 2.3 Hz), 71.5 (d, J = 55.4 Hz), 70.4, 70.1 (d, J = 6.3 Hz), 69.9 (d, J = 
8.5 Hz), 67.4, 65.1, 58.4, 36.2 (d, J = 4.1 Hz), 32.9 (d, J = 1.9 Hz), 28.5 (d, J = 1.8 Hz), 26.6 
(d, J = 2.2 Hz) ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.7 ppm. 
IR (neat): υmax (cm−1) = 2930 (w), 1272 (w), 1354 (s), 1273 (s), 1111 (s), 1096 (s), 887 (m), 
716 (m), 668 (s). 
MS (FAB): 793 ([M+H]+, 41), 792 (M+, 100), 791 (63), 650 (21). 
HRMS (EI): m/z calcd. for: [C37H38PNO193Ir56Fe]:  792.1660,  found  792.1658 
 
Iridium complex (47a):  
 
N
OMePh2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 9b (246 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) afforded the iridium complex 47a (736 mg, 89%) as a 
bright orange solid. 
 
MP: 189.3-190.9 °C 
[α]D20 = +50 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 7.71-7.70 (m, 7H), 7.56-7.33 (m, 12H), 7.55-7.20 (m, 1H), 
7.12-7.07 (m, 2H), 6.81 (s, 1H), 6.77-6.73 (m, 2H), 6.64-6.61 (m, 1H), 5.04-5.03 (m, 1H), 
4.66-4.63 (m, 1H), 4.56-4.47 (m, 2H), 4.38 (s, 4H), 4.24-4.14 (m, 2H), 3.67-3.66 (m, 1H), 
3.56 (s, 3H), 2.62-2.40 (m, 5H), 2.18-2.13 (m, 1H), 1.84-1.74 (m, 2H), 1.55 (s, 1H), , 1.26 (s, 
1H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 161.8, 161.7 (q, J = 50.1 Hz), 149.2, 138.8, 134.5, 132.8 
(d, J = 10.0 Hz), 131.9 (d, J = 2.6 Hz), 131.4, 131.3 (d, J = 11.3 Hz), 130.9, 130.7 (d, J = 2.4 
Hz), 129.4 (d, J = 2.7 Hz), 129.0 (q, J = 2.9 Hz), 128.8 (d, J = 6.5 Hz), 128.7-128.0 (m), 
128.6, 125.7 (d, J = 32.0 Hz), 125.0, 124.5, 123.2, 121.8, 120.5, 117.4, 92.8 (d, J = 13.3 Hz), 
91.7 (d, J = 16.2 Hz), 88.6 (d, J = 11.6 Hz), 85.5 (d, J = 1.7 Hz), 73.2 (d, J = 1.9 Hz), 71.8 (d, 
J = 6.1 Hz), 71.2, 69.4 (d, J = 6.7 Hz), 67.4, 66.9, 60.6, 58.0, 35.1 (d, J = 4.0 Hz), 32.3 (d, J = 
2.2 Hz), 31.0 (d, J = 2.3 Hz), 27.4 (d, J = 1.9 Hz) ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.6 ppm 
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IR (neat): υmax (cm−1) = 2925 (w), 1609 (w), 1353 (m), 1273 (s), 1156 (s), 1122 (s), 1095 (s), 
887 (m), 838 (m), 715 (m), 668 (m). 
MS (ESI): 793 ([M+H]+, 41), 792 (M+, 100), 790 (65), 452 (11). 
HRMS (ESI): m/z calcd. for: [C37H38P56FeNO193Ir] 792.1670,  found: 792.1639 
 
Iridium complex (46b):  
 
N
OBnPh2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 10a (284 mg, 0.50 mmol), [Ir(COD)Cl]2 (168 
mg, 0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) provided the iridium complex 46b (780 mg, 90%) as a 
bright orange solid. 
 
MP: 178.1-180.7 °C 
[α]D20 = +54 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.77-8.75 (m, 1H), 8.13-8.09 (m, 2H), 8.03-8.02 (m, 1H), 
7.96-7.92 (m, 1H), 7.78-7.72 (m, 8H), 7.61-7.60 (m, 3H), 7.52 (br, s, 3H), 7.48-7.44 (m, 1H), 
7.41-7.34 (m, 8H), 6.95-6.87 (m, 3H), 5.05-5.04 (m, 1H), 4.87-4.86 (m, 2H), 4.51 (t, J = 2.6 
Hz, 1H), 4.22-4.19 (m, 1H), 4.07 (t, J = 2.6 Hz, 1H), 3.98-3.97 (m, 1H), 3.65-3.64 (m, 1H), 
3.13 (s, 4H), 2.52-2.48 (m, 2H), 2.35-2.29 (m, 1H), 2.09-2.00 (m, 2H), 1.79-1.75 (m, 1H), 
1.57-1.52 (m, 3H), 1.23 (m, 2H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 165.1, 161.7 (q, J = 50.1 Hz), 149.7, 136.4, 135.5 (d, J = 
14.0 Hz), 134.8-134.7 (m), 133.4 (q, J = 360.1 Hz), 132.7 (d, J = 2.2 Hz), 130.8 (d, J = 2.6 
Hz), 130.0 (d, J = 58.7 Hz), 129.2 (d, J = 11.0 Hz), 129.1 (q, J = 2.9 Hz), 128.9, 128.7 (q, J = 
2.8 Hz), 128.6, 127.2, 126.1, 125.9, 123.8, 123.2, 120.5, 117.5-117.4 (m), 94.6 (d, J = 14.2 
Hz), 94.0 (d, J = 6.8 Hz), 93.9, 78.6 (d, J = 1.8 Hz), 73.3 (d, J = 2.2 Hz), 72.3, 71.7 (d, J = 
55.0 Hz), 70.4, 70.2 (q, J = 8.2 Hz), 67.0, 65.5, 35.7 (d, J = 4.5 Hz), 32.2 (d, J = 1.9 Hz), 28.7 
(d, J = 2.1 Hz), 26.9 (d, J = 2.3 Hz) ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.6 ppm 
IR (neat): υmax (cm−1) = 2927 (w), 1608 (w), 1353 (m), 1272 (s), 1117 (s), 1000 (w), 886 (m), 
838 (m), 712 (m), 668 (m), 681 (m). 
MS (ESI): 869 ([M+H]+, 44), 868 (M+, 100), 866 (49), 584 (10), 391 (5). 
HRMS (ESI): m/z calcd. for: [C43H42P56FeNO193Ir] 868.1938,  found: 868.1964 
 
Iridium complex (47b):  
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N
OBnPh2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 10b (284 mg, 0.5 mmol), [Ir(COD)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.).  Flash chromatographical 
purification (silica gel, CH2Cl2) provided the iridium complex 47 (763 mg, 88%) as a bright 
orange solid. 
 
MP: 71.5-75.7 °C 
[α]D20 = +27 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 7.72-7.70 (m, 8H), 7.57-7.40 (m, 16H), 7.24-7.20 (m, 1H), 
7.12-7.08 (m, 2H), 6.96 (s, 1H), 6.78-6.73 (m, 2H), 6.64-6.60 (m, 1H), 5.18-5.17 (m, 1H), 
4.80-4.77 (m, 1H), 4.66-4.57 (m, 3H), 4.53-4.48 (m, 1H), 4.34 (s, 4H), 4.29-4.23 (m, 1H), 
4.20-4.15 (m, 1H), 3.71-3.69 (m, 1H), 2.54-2.13 (m, 7H), 1.92-1.77 (m, 3H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 161.8, 161.7 (q, J = 50.0 Hz), 149.3, 138.9, 136.4, 134.8 
(br, s), 132.8 (d, J = 9.8 Hz), 131.9 (d, J = 2.5 Hz), 131.27 (d, J = 11.3 Hz), 131.26 (d, J = 
54.0 Hz), 130.8 (d, J = 2.5 Hz), 129.4-129.3 (m), 129.1 (t, J = 3.0 Hz), 129.0, 128.9-128.7 
(m), 128.5-128.4 (m), 127.5, 126.8 (q, J = 365.0 Hz), 125.9, 125.6, 123.2, 122.2, 117.5-117.4 
(m), 93.4 (d, J = 13.0 Hz), 91.9 (d, J = 15.7 Hz), 88.7 (d, J = 12.1 Hz), 82.9, 73.2 (d, J = 1.4 
Hz), 72.3, 71.7 (d, J = 6.3 Hz), 71.2, 69.8 (d, J = 7.2 Hz), 67.3, 66.7 (d, J = 57.0 Hz), 61.2, 
34.5 (d, J = 3.5 Hz), 31.7 (d, J = 2.3 Hz), 31.6 (d, J = 2.3 Hz), 27.9 (d, J = 2.2 Hz) ppm. 
31P-NMR (81 MHz, CDCl3): δ = +5.71 ppm. 
IR (neat): υmax (cm−1) = 2928 (w), 1609 (m), 1353 (m), 1273 (s), 1117 (s), 1001 (m), 839 
(m), 669 (m), 682 (m). 
MS (ESI): 869 ([M+H]+, 44), 868 (M+, 100), 866 (46), 584 (18). 
HRMS (ESI): m/z calcd. for: [C43H42P56FeNO193Ir] 868.1938,  found: 868.1948 
 
Iridium complex (46c):  
N
OMeXyl2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 9c (275 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol, 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) afforded the iridium complex 46c (787 mg, 0.46 mmol; 
92%) as a bright orange solid. 
 
MP: 189.3-191.4 °C 
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[α]D20 = +60 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.75-8.72 (m, 1H), 8.15-8.10 (m, 4H), 7.79-7.68 (m, 6H), 
7.54-7.42 (m, 6H), 7.00-6.75 (m, 4H), 6.45-6.40 (m, 3H), 4.80-4.75 (m, 2H), 4.22-4.18 (m, 
4H), 3.80-3.65 (m, 2H), 3.75 (s, 1H), 3.18 (s, 3H), 2.65-2.25 (m, 6H), 2.45 (s, 6H), 2.38 (s, 
6H), 2.20-1.80 (m, 3H), 1.67-1.25 (m, 4H), ppm. 
13C-NMR (100 MHz, CDCl3): δ = 165.9, 162.7 (q, J = 54.2 Hz), 150.1, 135.2 (q, J = 290.7 
Hz), 135.0, 134.8, 132.7 (d, J = 3.1 Hz), 130.8 (d, J = 3.1 Hz), 130.2 (d, J = 61.2 Hz), 129.2 
(d, J = 11.2 Hz), 129.1 (q, J = 3.7 Hz), 128.7-128.6 (m), 127.8 (q, J = 3.2 Hz), 125.2, 125.0, 
123.6-121.0 (m), 116.8 (q, J = 3.6 Hz), 94.0-93.6 (m), 82.5 (d, J = 1.9 Hz), 73.5 (d, J = 2.3 
Hz), 71.8 (d, J = 58.5 Hz), 70.4, 70.1 (d, J = 6.3 Hz), 70.0, 68.2, 66.2, 58.2, 36.5 (d, J = 3.8 
Hz), 33.2 (d, J = 2.1 Hz), 28.9 (d, J = 2.1 Hz), 26.6 (d, J = 2.2 Hz), 25.4, 23.5 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.2 ppm. 
IR (neat): υmax (cm−1) = 2945 (w), 1445 (w), 1345 (s), 1269 (m), 1156 (s), 1009 (s), 716 (m), 
668 (s). 
MS (FAB): 849 ([M+H]+, 22), 848 (M+, 100), 782 (63), 620 (22). 
HRMS (EI): m/z calcd. for: [C41H46PNO193Ir56Fe]:  848.2296,  found  848.2305 
 
Iridium complex (47c):  
 
N
OMeXyl2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 9d (275 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol, 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) afforded the iridium complex 47c (804 mg, 0.47 mmol; 
93%) as a bright orange solid. 
 
MP: 192.6-193.0 °C 
[α]D20 = +61.0 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.05-7.97 (m, 1H), 7.77-7.65 (m, 4H), 7.58-7.40 (m, 7H), 
6.90-6.65 (m, 6H), 6.58-6.32 (m, 5H), 5.11-5.01 (m, 1H), 4.48-4.01 (m, 4H), 3.80-3.68 (m, 
2H), 3.22 (s, 3H), 2.66-2.26 (m, 6H), 2.45 (s, 6H), 2.38 (s, 6H), 2.18-1.81 (m, 2H), 1.67-1.18 
(m, 5H), ppm. 
13C-NMR (100 MHz, CDCl3): δ = 165.0, 161.4 (q, J = 50.8 Hz), 152.1, 133.7 (q, J = 297.4 
Hz), 133.0, 132.9 (d, J = 3.1 Hz), 132.7, 131.8 (d, J = 1.8 Hz), 131.0 (d, J = 58.5 Hz), 129.8 
129.4 (q, J = 4.1 Hz), 128.7 (d, J = 11.2 Hz), 127.0 (q, J = 4.0 Hz), 125.2-124.8 (m), 123.0-
120.8 (m), 114.2 (q, J = 2.7 Hz), 95.4-93.0 (m), 82.5 (d, J = 1.9 Hz), 75.4 (d, J = 2.3 Hz), 72.1 
(d, J = 55.8 Hz), 71.0 (d, J = 6.3 Hz), 70.4, 70.0, 69.2, 68.5, 58.2, 36.5 (d, J = 3.9 Hz), 33.1 
(d, J = 2.2 Hz), 29.2 (d, J = 2.9 Hz), 26.7 (d, J = 2.4 Hz), 25.4, 23.5 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.0 ppm 
IR (neat): υmax (cm−1) = 3006 (w), 2825 (m), 1611 (w), 1345 (m), 1229 (s), 1198 (m), 1010 
(s), 967 (m), 875 (m), 668 (m). 
MS (FAB): 849 ([M+H]+, 21), 848 (M+, 100), 782 (22). 
HRMS (EI): m/z calcd. for: [C41H46PNO193Ir56Fe]:  848.2296,  found  848.2292 
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Iridium complex (46d):  
 
N
OBnXyl2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 10c (312 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) provided the iridium complex 46d (796 mg, 0.45 mmol; 
89%) as a bright orange solid. 
 
MP: 188.2-190.1 °C 
[α]D20 = +48.9 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.68-8.64 (m, 1H), 8.44-7.99 (m, 10H), 7.95-7.82 (m, 4H), 
7.80-7.70 (m, 4H), 7.60-7.32 (m, 6H), 6.95-6.87 (m, 3H), 4.90-4.88 (m, 1H), 4.87-4.86 (m, 
1H), 4.78-4.55 (m, 2H), 4.22-4.19 (m, 1H), 4.00-3.95 (m, 2H), 3.13 (s, 5H), 2.50-2.48 (m, 
2H), 2.39 (s, 6H), 2.37 (s, 6H), 2.30-2.00 (m, 2H), 1.75-1.44 (m, 4H), 1.23 (s, 2H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 165.0, 160.7 (q, J = 52.5 Hz), 150.1, 135.2, 135.0-134.0 
(m), 133.2 (q, J = 287.0 Hz), 132.1 (d, J = 2.8 Hz), 131.8 (d, J = 2.6 Hz), 130.0 (d, J = 60.1 
Hz), 129.5, 129.2 (q, J = 2.9 Hz), 128.9 (d, J = 11.2 Hz), 128.7 (q, J = 2.8 Hz), 128.2, 127.9, 
126.8, 126.2, 124.2, 123.7, 121.2, 119.5-116.4 (m), 94.5 (d, J = 13.1 Hz), 93.8 (d, J = 7.0 Hz), 
93.5, 78.6, 73.2 (d, J = 2.8 Hz), 72.1, 71.0 (d, J = 56.3 Hz), 70.8, 70.3 (q, J = 8.2 Hz), 69.2, 
67.5, 35.7 (d, J = 2.9 Hz), 32.7 (d, J = 1.9 Hz), 28.6 (d, J = 2.7 Hz), 26.9 (d, J = 2.1 Hz), 23.3, 
22.8 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.4 ppm 
IR (neat): υmax (cm−1) = 2918 (w), 1765 (m), 1644 (w), 1482 (m), 1399 (m), 1186 (s), 992 
(w), 886 (m), 742 (s), 698 (s), 681 (s). 
MS (ESI): 925 ([M+H]+, 64), 924 (M+, 100), 825 (19), 620 (10).. 
HRMS (ESI): m/z calcd. for: [C47H50P56FeNO193Ir] 924.2609,  found: 924.2629 
 
Iridium complex (47d):  
N
OBnXyl2P
Ir(COD)
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 10d (312 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) provided the iridium complex 47d (804 mg, 0.45 mmol; 
90%) as a bright orange solid. 
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MP: 154.2-155.7 °C 
[α]D20 = +42.8 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.08-8.01 (m, 1H), 8.44-7.90 (m, 12H), 7.88-7.66 (m, 7H), 
7.55-7.48 (m, 5H), 6.95-6.85 (m, 3H), 5.11-5.08 (m, 1H), 4.89-4.85 (m, 1H), 4.64 (s, 2H), 
4.38-4.15 (m, 2H), 3.83 (s, 6H), 2.55-2.50 (m, 2H), 2.35 (s, 6H), 2.32 (s, 6H), 2.30-1.58 (m, 
6H), 1.28-1.20 (m, 2H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 161.4, 160.2 (q, J = 54.1 Hz), 149.2, 135.2-134.8 (m), 
133.2 (q, J = 275.8 Hz), 132.0 (d, J = 3.1 Hz), 131.2 (d, J = 3.8 Hz), 129.8 (d, J = 60.1 Hz), 
129.4, 128.9 (q, J = 3.2 Hz), 128.9, 128.2 (q, J = 3.1 Hz), 127.9 (d, J = 12.1 Hz), 127.9-123.5 
(m), 120.9-115.2 (m), 95.4 (d, J = 12.8 Hz), 94.2 (d, J = 6.8 Hz), 93.0, 78.6 (d, J = 2.2 Hz), 
73.0, 72.1, 71.0 (d, J = 58.1 Hz), 70.9, 70.2 (q, J = 8.2 Hz), 68.7, 67.2, 36.5 (d, J = 2.8 Hz), 
32.6 (d, J = 1.9 Hz), 28.6 (d, J = 2.2 Hz), 27.4 (d, J = 2.1 Hz), 24.2, 23.8 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +8.56 ppm. 
IR (neat): υmax (cm−1) = 3008 (w), 1609 (m), 1425 (m), 1365 (s), 1135 (s), 981 (s), 839 (m), 
785 (s), 670 (m), 654 (s). 
MS (ESI): 925 ([M+H]+, 12), 924 (M+, 100), 825 (22), 620 (25).. 
HRMS (ESI): m/z calcd. for: [C47H50P56FeNO193Ir] 924.2609,  found: 924.2608 
 
Iridium complex (46e):  
N
OMePh2P
Ir(COD)
Fe
BARF
Ph
 
 
Prepared according to TP6 from P,N-ligand 9e (350 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol, 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) afforded the iridium complex 46e (764 mg, 0.41 mmol; 
82%) as a bright orange solid. 
 
MP: 221.8-223.4 °C 
[α]D20 = +28.8 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.70-8.67 (m, 1H), 8.11-7.88 (m, 8H), 7.81-7.55 (m, 10H), 
7.45-7.33 (m, 11H), 6.95-6.82 (m, 1H), 4.96-4.90 (m, 1H), 4.45 (t, J = 2.2 Hz, 1H), 4.11-4.00 
(m, 3H), 3.79-3.68 (m, 3H), 3.21 (s. 5H), 2.67-2.29 (m, 5H), 2.15-1.81 (m, 2H), 1.68-1.27 (m, 
3H), ppm. 
13C-NMR (100 MHz, CDCl3): δ = 165.2, 160.9 (q, J = 51.2 Hz), 150.2, 135.0 (q, J = 278.9 
Hz), 135.0, 134.8 (d, J = 14.2 Hz), 132.7, 130.8 (d, J = 2.8 Hz), 130.2 (d, J = 55.4 Hz), 129.2-
127.8 (m), 126.2 (d, J = 11.4 Hz), 125.0 (d, J = 2.8 Hz), 123.8, 122.9, 121.2, 116.7 (q, J = 5.9 
Hz), 94.8-93.0 (m), 81.9, 73.0 (d, J = 2.8 Hz), 71.2 (d, J = 56.2 Hz), 70.2, 70.0 (d, J = 5.8 Hz), 
69.5 (d, J = 7.2 Hz), 66.8, 64.3, 56.7, 36.2 (d, J = 4.1 Hz), 33.8 (d, J = 3.1 Hz), 28.5 (d, J = 
1.8 Hz), 26.6 (d, J = 2.2 Hz) ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.7 ppm. 
IR (neat): υmax (cm−1) = 2998 (w), 1465 (m), 1542 (m), 1268 (m), 1225 (s), 1165 (s), 1028 
(s), 912 (m), 878 (m), 792 (m), 765 (m). 
MS (ESI): 869 ([M+H]+, 2), 868 (M+, 100), 852 (18), 782 (15), 685 (22). 
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HRMS (ESI): m/z calcd. for: [C43H42PNO193Ir56Fe]:  868.1938,  found  868.1922 
 
Iridium complex (47e):  
 
N
OMePh2P
Ir(COD)
Fe
BARF
Ph
 
 
Prepared according to TP6 from P,N-ligand 9f (350 mg, 0.50 mmol), [Ir(cod)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol, 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) afforded the iridium complex 47e (745 mg, 0.40 mmol; 
80%) as a bright orange solid. 
 
MP: 199.0-201.2 °C 
[α]D20 = +24.3 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.10-8.07 (m, 1H), 7.98-7.71 (m, 10H), 7.69-7.48 (m, 
11H), 7.40-7.10 (m, 7H), 6.88-6.86 (m, 2H), 5.11-5.06 (m, 1H), 4.52-4.47 (m, 1H), 4.32-4.22 
(m, 3H), 3.91-3.88 (m, 2H), 3.80-3.75 (m, 1H), 3.43 (s. 5H), 2.65-2.25 (m, 4H), 2.15-1.80 (m, 
3H), 1.68-1.27 (m, 3H), ppm. 
13C-NMR (100 MHz, CDCl3): δ = 161.0, 160.0 (q, J = 52.7 Hz), 148.5, 134.3 (q, J = 282.1 
Hz), 134.0, 134.2 (d, J = 14.6 Hz), 133.7 (d, J = 2.9 Hz), 133.3 (d, J = 11.4 Hz), 132.7-130.2 
(m), 130.4-126.6 (m), 125.8 (d, J = 2.8 Hz), 125.0 (d, J = 10.8 Hz), 124.2, 123.2, 121.8, 118.2 
(q, J = 6.1 Hz), 95.2-93.1 (m), 82.5 (d, J = 11.8 Hz), 73.0 (d, J = 2.8 Hz), 71.0 (d, J = 55.4 
Hz), 70.8, 70.0 (d, J = 5.8 Hz), 69.4 (d, J = 6.7 Hz), 67.4, 65.8, 57.2, 37.4 (d, J = 3.8 Hz), 32.1 
(d, J = 3.2 Hz), 28.5 (d, J = 1.9 Hz), 27.2 (d, J = 2.5 Hz) ppm. 
31P-NMR (81 MHz, CDCl3): δ = +9.6 ppm 
IR (neat): υmax (cm−1) = 3002 (br, w), 2999 (w), 1676 (w), 1556 (m), 1344 (m), 1298 (s), 
1199 (s), 1009 (s), 965 (s), 898 (m), 856 (m), 695 (m). 
MS (ESI): 869 ([M+H]+, 12), 868 (M+, 100), 852 (11), 625 (22). 
HRMS (ESI): m/z calcd. for: [C43H42PNO193Ir56Fe]:  868.1938,  found  868.1935 
 
Iridium complex (46f):  
 
N
OMePh2P
Ir(COD)
Fe
BARF
tBu
 
 
Prepared according to TP6 from P,N-ligand 9g (302 mg, 0.50 mmol), [Ir(COD)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.). Purification by flash 
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chromatography (silica gel, CH2Cl2) provided the iridium complex 46f (790 mg, 0.45 mmol; 
89%) as a bright orange solid. 
 
MP: 128.1-129.7 °C 
[α]D20 = +63.4 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.76-8.66 (m, 2H), 8.24-8.05 (m, 3H), 7.98-7.75 (m, 9H), 
7.60-7.54 (m, 6H), 7.40-7.32 (m, 4H), 6.95-6.87 (m, 3H), 5.00-4.88 (m, 3H), 4.50 (t, J = 2.2 
Hz, 1H), 4.12-4.05 (m, 2H), 3.98-3.95 (m, 1H), 3.65-3.64 (m, 2H), 3.25 (s, 3H), 2.50-2.47 (m, 
2H), 2.34-2.29 (m, 1H), 2.09-2.00 (m, 1H), 1.79-1.75 (m, 1H), 1.57-1.52 (m, 3H), 1.98 (s, 
9H), 1.23 (m, 2H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 166.2, 162.1 (q, J = 50.1 Hz), 151.7, 138.2, 135.5 (d, J = 
14.0 Hz), 135.0 (q, J = 371.1 Hz), 134.5-133.6 (m), 132.5 (t, J = 2.1 Hz), 130.8 (d, J = 2.6 
Hz), 129.8 (d, J = 57.6 Hz), 129.2 (d, J = 10.9 Hz), 129.0, 128.8 (q, J = 3.2 Hz), 128.7 (q, J = 
2.8 Hz), 128.2, 127.7, 126.2, 125.9-121.0 (m), 117.5-117.0 (m), 95.6 (d, J = 14.0 Hz), 94.2 (d, 
J = 7.1 Hz), 93.5, 78.8 (s), 73.0 (d, J = 2.1 Hz), 72.8, 71.0 (d, J = 54.0 Hz), 70.2, 70.0 (q, J = 
8.0 Hz), 68.2, 66.5, 34.8 (d, J = 5.2 Hz), 31.0 (d, J = 1.9 Hz), 28.7 (d, J = 2.1 Hz), 26.9 (d, J = 
2.3 Hz), 14.5, 11.8 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +8.45 ppm 
IR (neat): υmax (cm−1) = 3008 (br, w), 2998 (w), 1665 (w), 1592 (m), 1156 (m), 1222 (s), 
1177 (s), 980 (m), 886 (m), 728 (m), 662 (m). 
MS (ESI): 849 ([M+H]+, 40), 848 (M+, 100), 820 (15), 657 (24). 
HRMS (ESI): m/z calcd. for: [C41H46P56FeNO193Ir] 848.2283,  found: 848.2275 
 
Iridium complex (47f):  
N
OMePh2P
Ir(COD)
Fe
BARF
tBu
 
 
Prepared according to TP6 from P,N-ligand 9h (302 mg, 0.50 mmol), [Ir(COD)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) provided the iridium complex 47f (774 mg, 0.44 mmol; 
88%) as a bright orange solid. 
 
MP: 167.5-171.2 °C 
[α]D20 = +38.0 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 7.65-7.68 (m, 9H), 7.57-7.50 (m, 2H), 7.24-7.22 (m, 3H), 
7.20-6.99 (m, 8H), 6.96 (s, 1H), 6.75-6.70 (m, 1H), 6.64-6.60 (m, 1H), 5.19-5.16 (m, 1H), 
4.75-4.77 (m, 1H), 4.64-4.55 (m, 2H), 4.54-4.47 (m, 2H), 4.30 (s, 4H), 4.29-4.23 (m, 2H), 
4.22-4.20 (m, 1H), 3.71-3.69 (m, 1H), 2.54-2.13 (m, 7H), 2.01 (s, 9H), 1.92-1.77 (m, 2H) 
ppm.  
13C-NMR (100 MHz, CDCl3): δ = 161.8, 161.0 (q, J = 51.2 Hz), 148.7, 139.2-136.4 (m), 
134.5, 132.7 (d, J = 10.2 Hz), 131.9 (d, J = 2.7 Hz), 131.2 (d, J = 52.2 Hz), 131.0 (d, J = 10.8 
Hz), 130.8 (d, J = 2.5 Hz), 129.4-129.0 (m), 128.9-128.7 (m), 128.5, 128.0, 128.2, 127.5, 
126.8 (q, J = 366.1 Hz), 126.2, 125.2, 122.8, 122.2, 120.0-118.4 (m), 93.2 (d, J = 12.2 Hz), 
92.1 (d, J = 14.2 Hz), 89.2 (d, J = 11.7 Hz), 82.0 (d, J = 1.4 Hz), 73.2, 72.3, 71.7 (d, J = 6.8 
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Hz), 71.0, 69.7 (d, J = 7.0 Hz), 67.0, 66.7 (d, J = 57.0 Hz), 58.4, 32.9 (d, J = 3.2 Hz), 31.7 (d, 
J = 2.3 Hz), 31.2 (d, J = 2.3 Hz), 27.9 (d, J = 2.2 Hz) 16.2, 14.8 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +5.66 ppm. 
IR (neat): υmax (cm−1) = 3002 (br, w), 2918 (w), 1542 (m), 1655 (m), 1292 (m), 1212 (s), 
1156 (s), 1045 (m), 925 (s), 839 (m), 798 (m). 
MS (ESI): 849 ([M+H]+, 50), 848 (M+, 100), 817 (10), 620 (11). 
HRMS (ESI): m/z calcd. for: [C41H46P56FeNO193Ir] 848.2283,  found: 848.2285 
 
Iridium complex (46g):  
 
N
OBnPh2P
Ir(COD)
tBu
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 10g (340 mg, 0.50 mmol), [Ir(COD)Cl]2 (168 
mg, 0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.). Purification by flash 
chromatography (silica gel, CH2Cl2) provided the iridium complex 46g (811 mg, 0.44 mmol, 
88%) as a bright orange solid. 
 
MP: 164.2-169.5 °C 
[α]D20 = +48.4 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 8.88-8.82 (m, 2H), 8.15-8.00 (m, 4H), 7.95-7.82 (m, 6H), 
7.75-7.60 (m, 6H), 7.42-7.22 (m, 4H), 7.12-6.90 (m, 6H), 6.75-6.62 (m, 3H), 5.11-5.06 (m, 
1H), 4.88-4.80 (m, 2H), 4.50-4.48 (m, 1H), 4.22 (s, 4H), 3.98-3.97 (m, 1H), 3.65-3.64 (m, 
1H), 2.52-2.40 (m, 2H), 2.32-2.29 (m, 2H), 2.09-2.00 (m, 2H), 11.79-1.75 (m, 1H), 1.64 (s, 
9H), 1.57-1.50 (m, 3H), 1.22 (m, 2H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 163.2, 160.6 (q, J = 50.1 Hz), 149.7, 136.4, 135.5 (d, J = 
14.0 Hz), 134.8-134.7 (m), 133.4 (q, J = 360.1 Hz), 132.7 (d, J = 2.2 Hz), 130.8 (d, J = 2.6 
Hz), 130.0 (d, J = 58.7 Hz), 129.2 (d, J = 11.0 Hz), 129.1 (q, J = 2.9 Hz), 128.9, 128.7 (q, J = 
2.8 Hz), 128.6, 127.2, 126.1, 125.9, 123.8, 123.2, 120.5, 117.5-117.4 (m), 94.6 (d, J = 14.2 
Hz), 94.0 (d, J = 6.8 Hz), 93.9, 78.6 (d, J = 1.8 Hz), 73.3 (d, J = 2.2 Hz), 72.3, 71.7 (d, J = 
55.0 Hz), 70.4, 70.2 (q, J = 8.2 Hz), 67.0, 65.5, 35.7 (d, J = 4.5 Hz), 32.2 (d, J = 1.9 Hz), 28.7 
(d, J = 2.1 Hz), 26.9 (d, J = 2.3 Hz), 16.5, 14.2 ppm. 
31P-NMR (81 MHz, CDCl3): δ = +8.4 ppm 
IR (neat): υmax (cm−1) = 2914 (w), 1608 (w), 1554 (m), 1275 (s), 1192 (s), 1024 (w), 925 (m), 
886 (m), 768 (m), 681 (m). 
MS (ESI): 925 ([M+H]+, 11), 924 (M+, 100), 902 (12), 789 (27), 584 (10). 
HRMS (ESI): m/z calcd. for: [C47H50P56FeNO193Ir] 924.2596,  found: 9242595 
 
Iridium complex (47g):  
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N
OBnPh2P
Ir(COD)
tBu
Fe
BARF
 
 
Prepared according to TP6 from P,N-ligand 10f (340 mg, 0.50 mmol), [Ir(COD)Cl]2 (168 mg, 
0.25 mmol) and NaBARF (665 mg, 0.75 mmol; 1.50 equiv.).  Flash chromatographical 
purification (silica gel, CH2Cl2) provided the iridium complex 47g (740 mg, 0.40 mmol; 80%) 
as a bright orange solid. 
 
MP: 122.5-128.7 °C 
[α]D20 = +42.1 (c = 0.2, CH2Cl2) 
1H-NMR (400 MHz, CDCl3): δ = 7.66-7.64 (m, 6H), 7.55-7.45 (m, 12H), 7.22-7.20 (m, 4H), 
7.10-6.99 (m, 3H), 6.78-6.70 (m, 5H), 6.64-6.60 (m, 1H), 5.20-5.15 (m, 1H), 4.80-4.78 (m, 
2H), 4.66-4.57 (m, 1H), 4.53-4.48 (m, 1H), 4.34 (s, 4H), 3.72-3.69 (m, 1H), 2.54-2.10 (m, 
7H), 1.92-1.75 (m, 3H), 1.68 (s, 9H), 1.22 (m, 2H) ppm.  
13C-NMR (100 MHz, CDCl3): δ = 160.5, 160.0 (q, J = 50.0 Hz), 149.3, 138.9, 136.4, 134.8 
(br, s), 132.8 (d, J = 9.8 Hz), 131.9 (d, J = 2.5 Hz), 131.27 (d, J = 11.3 Hz), 131.26 (d, J = 
54.0 Hz), 130.8 (d, J = 2.5 Hz), 129.4-129.3 (m), 129.1 (t, J = 3.0 Hz), 129.0, 128.9-128.7 
(m), 128.5-128.4 (m), 127.5, 126.8 (q, J = 365.0 Hz), 125.9, 125.6, 123.2, 122.2, 117.5-117.4 
(m), 93.4 (d, J = 13.0 Hz), 91.9 (d, J = 15.7 Hz), 88.7 (d, J = 12.1 Hz), 82.9, 73.2 (d, J = 1.4 
Hz), 72.3, 71.7 (d, J = 6.3 Hz), 71.2, 69.8 (d, J = 7.2 Hz), 67.3, 66.7 (d, J = 57.0 Hz), 61.2, 
34.5 (d, J = 3.5 Hz), 31.7 (d, J = 2.3 Hz), 31.6 (d, J = 2.3 Hz), 27.9 (d, J = 2.2 Hz) 17.2, 15.3 
ppm. 
31P-NMR (81 MHz, CDCl3): δ = +7.601 ppm. 
IR (neat): υmax (cm−1) = 3002 (br, w), 2999 (w), 1642 (m), 1554 (m), 1456 (m), 1275 (s), 
1122 (s), 966 (m), 888 (m), 768 (m), 742 (m), 681 (m). 
MS (ESI): 925 ([M+H]+, 21), 924 (M+, 100), 902 (16), 789 (30), 584 (11). 
HRMS (ESI): m/z calcd. for: [C47H50P56FeNO193Ir] 924.2596,  found: 924.2612 
 
6. Synthesis of N-arylimines  
 
N-phenyl-1-phenylethylideneamine (50a)129 
 
N
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and aniline 
(12.0 mmol, 1.12 g, 1.1 mL; 1.20 equiv.). Recrystallisation from n-pentane, afforded the 
desired imine (1.42 g, 7.30 mmol, 73%) as a yellow crystalline solid. 
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MP: 38-39 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.98 (dd, J = 7.5 Hz, 2.1 Hz, 2H), 7.44-7.40 (m, 3H), 7.33 
(t, J = 7.4 Hz, 2H), 7.08 (t, J = 7.4 Hz, 1H), 6.79 (d, J = 7.3 Hz, 2H), 2.18 (s, 3H) ppm. 
 
N-(4-methoxy)phenyl-1-phenylethylideneamine (50b)130 
 
N
OMe
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 4-methoxy 
aniline (12.0 mmol, 1.48 g; 1.20 equiv.). Recrystallisation from n-pentane:EtOAc, afforded 
the desired imine (1.42 g, 6.29 mmol, 63%) as a yellow crystalline solid. 
 
MP: 87.3-87.9 °C. 
1H-NMR (300 MHz, CDCl3): δ = 7.98-7.95 (m, 2H) 7.45-7.43 (m, 3H), 6.91 (d, J = 8.9 Hz, 
2H), 6.76 (d, J = 8.8 Hz, 2H), 3.80 (s, 3H), 2.30 (s, 3H) ppm. 
 
N-(4-methyl)phenyl-1-phenylethylideneamine (50c)2: 
 
N
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 4-methyl 
aniline (12.0 mmol, 1.29 g; 1.20 equiv.). Recrystallisation from n-pentane:EtOAc, afforded 
the desired imine (1.57 g, 7.50 mmol, 75%) as a yellow solid. 
 
MP: 41-42 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.98-7.96 (m, 2H), 7.49-7.44 (m, 3H), 7.16 (d, J = 8.0 Hz, 
2H), 6.72 (d, J = 8.0 Hz, 2H), 2.35 (s, 3H), 2.20 (s, 3H) ppm. 
 
N-(3,4-Dioxymethylene)phenyl-1-phenylethylideneamine (50d) 
 
N
O
O
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Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 3,4-
dioxymethylene aniline (12.0 mmol, 1.65 g; 1.20 equiv.). Recrystallisation from MeOH, 
afforded the desired imine (1.82 g, 7.61 mmol, 76%) as a pale brown solid. 
 
MP: 118.3-120.0 °C. 
1H-NMR (300 MHz, CDCl3): δ = 7.96-7.93 (m, 2H), 7.48-7.39 (m, 3H), 6.79 (d, J = 8.1 Hz, 
1H), 6.37 (d, J = 2.2 Hz, 1H), 6.24 (dd, J = 2.2 Hz, 8.1 Hz, 1H), 5.90 (s, 2H), 2.26 (s, 3H) 
ppm. 
13C-NMR (75 MHz, CDCl3): δ = 166.3, 150.0, 146.0, 143.7, 139.4, 130.5, 128.4, 127.1, 
111.8, 108.3, 101.6, 101.0, 17.4 ppm. 
IR (neat): υmax (cm−1) = 3065 (w), 2889 (w), 1616 (m), 1481 (s), 1339 (m), 1240 (s), 1177 
(s), 1031 (s), 938 (s), 848 (s). 
MS (70 eV, EI): m/z (%) = 239 (M+, 57), 224 (100), 225 (15), 162 (8), 121 (9). 
HRMS (EI): m/z calcd. for: [C15H13NO2] 239.0946,  found: 239.0958. 
 
N-(3,4,5-Trimethoxy)phenyl-1-phenylethylideneamine (50e) 
 
N
OMe
OMe
OMe
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 3,4,5-
trimethoxy aniline (12.0 mmol, 2.20 g; 1.20 equiv.). Recrystallisation from n-pentane:EtOAc, 
afforded the desired imine (2.25 g, 7.89 mmol, 79%) as a yellow solid. 
 
MP: 96.1-97.9 °C. 
1H-NMR (300 MHz, CDCl3): δ = 7.97-7.94 (m, 2H), 7.45-7.42 (m, 3H), 6.02 (s, 2H), 3.86 
(s, 3H), 3.83 (s, 6H), 2.28 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 166.0, 153.6, 147.8, 139.2, 130.5, 128.5, 128.3, 127.1, 
96.6, 61.0, 56.0, 17.4 ppm. 
IR (neat): υmax (cm−1) = 3855 (w), 3752 (w), 2951 (w), 1636 (m), 1581 (s), 1496 (s), 1411 
(s), 1233 (s), 1119 (s), 1011 (s), 768 (s), 696 (s). 
MS (70 eV, EI): m/z (%) = 285 (M+, 66), 270 (100), 242 (3), 226 (3), 146 (3), 103 (5). 
HRMS (EI): m/z calcd. for: [C17H19NO3] 285.1365,  found: 285.1361. 
 
N-(3,4-Dimethyl)phenyl-1-phenyl ethylidene amine (50f) 
 
N
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 3,4-
dimethyl aniline (12.0 mmol, 1.45 g; 1.20 equiv.). Purification by vacuum distillation (160 
°C, 0.1 mbar) afforded the desired imine (1.70 g, 7.58 mmol, 76%) as a yellow oil. 
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1H-NMR (300 MHz, CDCl3): δ = 7.98-7.95 (m, 2H), 7.46-7.43 (m, 3H), 7.10 (d, J = 8.0 Hz, 
1H), 6.60-6.53 (m, 2H), 2.27 (s, 3H), 2.26 (s, 3H), 2.25 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 165.3, 149.3, 139.6, 137.1, 131.2, 130.3, 130.0, 128.3, 
127.1, 120.8, 116.7, 19.9, 19.1, 17.3 ppm. 
IR (neat): υmax (cm−1) = 3866 (w), 3745 (w), 2920 (w), 1631 (s), 1602 (m), 1491 (s), 1450 
(m), 1365 (m), 1241 (s), 1204 (m), 819 (m), 758 (s), 685 (s). 
MS (70 eV, EI): m/z (%) = 223 (M+, 72), 208 (100), 146 (4), 105 (8). 
HRMS (EI): m/z calcd. for: [C16H17N] 223.1361,  found: 223.1352. 
 
N-(3,4-Dimethoxy)phenyl-1-phenylethylideneamine (50g) 
 
N
OMe
OMe
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 3,4-
dimethoxy aniline (12.0 mmol, 1.84 g; 1.20 equiv.). Recrystallisation from n-pentane:EtOAc, 
afforded the desired imine (1.91 g, 7.50 mmol, 75%) as a yellow solid. 
 
MP: 91.6-92.6 °C. 
1H-NMR (300 MHz, CDCl3): δ = 7.98-7.93 (m, 2H), 7.48-7.41 (m, 3H), 6.85 (d, J = 8.4 Hz, 
1H), 6.43 (d, J = 2.4 Hz, 1H), 6.32 (dd, J = 2.7 Hz, 8.8 Hz, 1H), 3.88 (s, 3H), 3.86 (s, 3H), 
2.27 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 166.0, 149.4, 145.2, 139.5, 133.0, 130.4, 128.3, 127.1, 
111.7, 110.7, 104.3, 56.1, 55.8, 17.3 ppm. 
IR (neat): υmax (cm−1) = 3855 (w), 3075 (w), 2842 (w), 1700 (w), 1623 (m), 1576 (m), 1501 
(s), 1228 (s), 1133 (s), 1024 (s), 856 (s), 770 (s), 704 (s). 
MS (70 eV, EI): m/z (%) = 255 (M+, 97), 240 (100), 196 (3), 122 (4), 103 (4). 
HRMS (EI): m/z calcd. for: [C16H17NO2] 255.1259,  found: 255.1255. 
 
N-(3,5-Dimethyl)phenyl-1-phenylethylideneamine (50h) 
 
N
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 
2,4.dimethyl aniline (12.0 mmol, 1.45 g, 1.48 mL; 1.20 equiv.). Purification by vacuum 
distillation (85 °C, 0.1 mbar), afforded the desired imine (1.75 g, 7.80 mmol, 78%) as a 
yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.45-7.28 (m, 5H), 7.21-7.18 (m, 1H), 6.92 (s, 2H), 2.38 
(s, 3H), 2.34 (s, 3H), 2.32 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 165.2, 150.5, 138.5, 132.1, 132.0, 130.3, 128.3, 127.1, 
124.9, 117.0, 21.3, 17.4, 16.8 ppm. 
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IR (neat): υmax (cm−1) = 2924 (w), 1682 (w), 1633 (s), 1589 (s), 1450 (m), 1367 (m), 1274 
(s), 1150 (m), 1029 (m), 845 (s), 763 (s), 672 (s). 
MS (70 eV, EI): m/z (%) = 223 (M+, 44), 207 (88), 208 (100), 105 (25), 103 (9). 
HRMS (EI): m/z calcd. for: [C16H17N] 223.1361,  found: 223.1371. 
 
N-(3,5-Dimethyl)phenyl-1-phenylethylideneamine (50i)131 
 
N
MeO
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 2-methoxy 
aniline (12.0 mmol, 1.48 g; 1.20 equiv.). Purification by vacuum distillation (140 °C, 0.1 
mbar), afforded the desired imine (1.58 g, 7.00 mmol, 70%) as a yellow solid. 
 
MP: 42.4 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.99-7.94 (m, 3H), 7.41-7.34 (m, 2H), 7.01 (dd, J = 2.0 
Hz, 7.9 Hz, 1H), 6.93-6.85 (m, 2H), 6.77 (dd, J = 2.0 Hz, 7.7 Hz, 1H), 3.71 (s, 3H), 2.13 (s, 
3H) ppm. 
 
N-(3,5-Dimethyl)phenyl-1-phenylethylideneamine (52a) 
 
N
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 
3,5.dimethyl aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Purification by vacuum 
distillation (120 °C, 0.1 mbar), afforded the desired imine (1.72 g, 7.79 mmol, 78%) as a 
yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.98-7.95 (m, 2H), 7.49-7.43 (m, 3H), 6.73 (s, 1H), 6.43 
(s, 2H), 2.32 (s, 6H), 2.24 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 165.2, 151.5, 138.5, 133.1, 130.3, 128.3, 127.1, 124.9, 
117.0, 21.3, 17.4 ppm. 
IR (neat): υmax (cm−1) = 2915 (w), 1682 (w), 1633 (s), 1589 (s), 1450 (m), 1367 (m), 1274 
(s), 1150 (m), 1029 (m), 845 (s), 763 (s), 672 (s). 
MS (70 eV, EI): m/z (%) = 223 (M+, 84), 208 (100), 105 (15), 103 (6), 77 (11). 
HRMS (EI): m/z calcd. for: [C16H17N] 223.1361,  found: 223.1364. 
 
N-(3,5-Dimethyl)phenyl-1-(4-methoxylphenyl)ethylideneamine (52b) 
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Experimental Section   123
N
MeO
 
 
Prepared according to TP7 from 4-methoxy acetophenone (10.0 mmol, 1.50 g) and 3,5-
dimethyl aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Purification by recrystalliation (n-
pentane:MeOH), afforded the desired imine (1.90 g; 7.50 mmol, 75%) as a orange yellow 
solid. 
 
MP: 62.3-64.6°C 
1H-NMR (300 MHz, CDCl3): δ = 7.96-7.92 (m, 2H), 6.96-6.91 (m, 2H), 6.72 (s, 1H), 6.43 
(s, 2H), 3.85 (s, 3H), 2.30 (s, 6H), 2.21 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.8, 161.7, 151.0, 138.9, 138.5, 129.0, 124.9, 117.4, 
113.6, 55.4, 21.3, 17.2 ppm. 
IR (neat): υmax (cm−1) = 2915 (w), 1631 (s), 1592 (s), 1512 (m), 1365 (m), 1246 (s), 1171 (s), 
1026 (s), 827 (s), 688 (s). 
MS (70 eV, EI): m/z (%) = 253 (M+, 49), 239 (13), 238 (100), 105 (5). 
HRMS (EI): m/z calcd. for: [C17H19N] 253.1467   found: 253.1479. 
 
N-(3,5-Dimethyl)phenyl-1-(4-methylphenyl)ethylideneamine (52c) 
 
N
H3C
 
 
Prepared according to TP7 from 4-methylacetophenone (1.34 g; 1.33 mL, 10.0 mmol,) and 
3,5-dimethyl aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Purification by vacuum 
distillation (120 °C, 0.1 mbar), afforded the desired imine (1.71 g; 7.20 mmol, 72%) as a 
yellow solid. 
 
MP: 59.1-61.7 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.91-7.87 (m, 2H), 7.29-7.27 (m, 2H), 6.75 (s, 1H), 6.50 
(s, 2H), 2.43 (s, 3H), 2.33 (s, 6H), 2.25 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 165.2, 151.3, 140.7, 138.5, 136.6, 129.0, 127.2, 124.9, 
117.2, 26.5, 21.3, 17.3 ppm. 
IR (neat): υmax (cm−1) = 3029 (w), 1635 (s), 1588 (s), 1364 (s), 1272 (s), 1149 (m), 1031 (m), 
841 (s), 810 (s), 736 (m), 688 (s). 
MS (70 eV, EI): m/z (%) = 237 (M+, 64), 222 (100), 105 (8). 
HRMS (EI): m/z calcd. for: [C17H19N] 237.1517   found: 237.1522. 
 
N-(3,5-Dimethyl)phenyl-1-(3-methoxyphenyl)ethylideneamine (52d) 
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N
MeO
 
 
Prepared according to TP7 from 3-methoxy acetophenone (10.0 mmol, 1.50 g, 1.38 mL) and 
3,5-dimethyl aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Recrystallisation of the crude 
product in methnaol, afforded the desired imine (1.87 g; 7.40 mmol, 74%) as a yellow solid. 
 
MP: 57.7-59.0 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.59-7.57 (m, 1H), 7.51-7.48 (m, 1H), 7.34 (t, J = 7.9 Hz, 
1H), 7.01 (dddd, J = 7.9 Hz, 2.6 Hz, 0.9 Hz, 1H), 6.73 (s, 1H), 6.43 (s, 2H), 3.87 (s, 3H), 2.31 
(s, 6H), 2.23 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 165.0, 159.7, 151.4, 140.9, 139.0, 138.6, 129.2, 124.9, 
119.8, 117.0, 111.8, 55.4, 21.3, 17.5 ppm. 
IR (neat): υmax (cm−1) = 3008 (w), 2910 (w), 1633 (s), 1584 (s), 1447 (m), 1277 (s), 1029 (s), 
848 (s), 794 (s), 672 (s). 
MS (70 eV, EI): m/z (%) = 253 (M+, 66), 238 (100), 146 (5), 105 (6). 
HRMS (EI): m/z calcd. for: [C17H19NO] 253.1467,  found: 253.1469. 
 
N-(3,5-Dimethyl)phenyl-1-(4-chlorophenyl)ethylideneamine (52e) 
 
N
Cl
 
 
Prepared according to TP7 from 4-chloro acetophenone (10.0 mmol, 1.54 g, 1.29 mL) and 
3,5-dimethyl aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Purification by vacuum 
distillation (120 °C, 0.1 mbar), afforded the desired imine (2.29 g; 8.90 mmol; 89%) as a pale 
yellow crystalline solid. 
 
MP: 105.3-107.4 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.91-7.88 (m, 2H), 7.42-7.38 (m, 2H), 6.73 (s, 1H), 6.40 
(s, 2H), 2.31 (s, 6H), 2.21 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 163.8, 151.3, 138.6, 137.9, 136.5, 128.5, 125.0, 116.9, 
21.3, 17.2 ppm. 
IR (neat): υmax (cm−1) = 2919 (br, w), 1635 (s), 1587 (s), 1399 (m), 1270 (m), 1152 (m), 1008 
(s), 840 (s), 768 (s), 676 (s). 
MS (70 eV, EI): m/z (%) = 259 (M+, 22), 257 (63), 242 (100), 105 (22), 79 (10). 
HRMS (EI): m/z calcd. for: [C16H16NCl] 257.0971,  found: 257.0975. 
 
N-(3,5-Dimethyl)phenyl-1-(4-phenylphenyl)ethylideneamine (52f) 
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N
Ph
 
 
Prepared according to TP7 from 4-phenyl acetophenone (10.0 mmol, 1.96 g) and 3,5-
dimethyl aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Recrystallisation of the crude 
product in n-pentane, afforded the desired imine (1.95 g; 6.50 mmol, 65%) as a pale yellow 
solid. 
 
MP: 121.9-123.1 °C 
1H-NMR (300 MHz, CDCl3): δ = 8.07-8.02 (m, 2H), 7.70-7.64 (m, 4H), 7.49-7.44 (m, 3H), 
6.75 (s, 1H), 6.45 (s, 2H), 2.33 (s, 6H), 2.28 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.8, 151.4, 143.1, 140.4, 138.3, 135.8, 128.8, 127.7, 
127.6, 127.1, 127.0, 124.9, 117.1, 21.3, 17.4 ppm. 
IR (neat): υmax (cm−1) = 3860 (w), 3747 (m), 3039 (br, w), 2915 (br, w), 1773 (w), 1625 (s), 
1558 (s), 1540 (s), 1458 (s), 1398 (m), 1272 (m), 843 (s), 763 (s), 685 (s). 
MS (70 eV, EI): m/z (%) = 299 (M+, 52), 284 (100), 152 (3), 105 (7). 
HRMS (EI): m/z calcd. for: [C22H21N] 299.1674,  found: 299.1667. 
 
N-(3,5-Dimethyl)phenyl-1-phenylpropylideneamine (52h) 
 
N
 
 
Prepared according to TP7 from propiophenone (10.0 mmol, 1.34 g, 1.34 mL) and 3,5-
dimethyl aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Purification by vacuum 
distillation (120 °C, 0.1 mbar), afforded the desired imine (1.66 g; 7.00 mmol, 70%) as a pale 
yellow oil. 
 
1H-NMR (300 MHz, C6D6): δ = 8.04-8.02 (m, 2H), 7.26-7.19 (m, 3H), 6.75 (s, 1H), 6.45 (s, 
2H), 2.50 (q, J = 7.1 Hz, 2H), 2.31 (s, 6H), 0.89 (t, J = 7.1 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 165.1, 151.0, 138.2, 133.2, 130.4, 128.2, 127.6, 126.5, 117.4, 
21.0, 17.2, 13.0 ppm. 
IR (neat): υmax (cm−1) = 2920 (w), 1705 (m), 1600 (s), 1290 (s), 1029 (m), 848 (m), 795 (m), 
699 (m). 
MS (70 eV, EI): m/z (%) = 237 (M+, 25), 223 (100), 209 (90), 121 (70), 91 (19). 
HRMS (EI): m/z calcd. for: [C17H19N] 237.3395,  found: 237.3404. 
 
N-(3,5-Dimethyl)phenyl-1-(1,2,3,4-tertahydro)naphthyliedeneamine (52h) 
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N
 
 
Prepared according to TP7 from α-tetralone (10.0 mmol, 1.46 g, 1.33 mL) and 3,5-dimethyl 
aniline (12.0 mmol, 1.45 g, 1.49 mL; 1.20 equiv.). Recrystallisation of the crude product (n-
pentane:ethylacetate (10:1)), afforded the desired imine (1.79 g; 7.20 mmol, 72%) as a brown 
solid. 
 
MP: 83.5-84.6 °C 
1H-NMR (300 MHz, CDCl3): δ = 8.33-8.30 (m, 1H), 7.36 (ddd, J = 7.5 Hz, 1.6 Hz, 1H), 
7.31-7.26 (m, 1H), 7.20-7.18 (m, 1H), 6.70 (s, 1H), 6.40 (s, 2H), 2.90 (t, J = 6.2 Hz, 2H), 2.54 
(dd, J = 7.2 Hz, 6.2 Hz, 2H), 2.30 (s, 6H), 1.96-1.87 (m, 2H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 165.4, 151.4, 141.3, 138.5, 133.8, 133.3, 130.6, 128.6, 
126.4, 124.7, 117.1, 30.0, 29.9, 22.9, 21.3 ppm. 
IR (neat): υmax (cm−1) = 2921 (w), 1631 (s), 1588 (s), 1454 (m), 1290 (s), 1035 (m), 840 (s), 
765 (s), 662 (s). 
MS (70 eV, EI): m/z (%) = 249 (M+, 100), 221 (61), 121 (7), 105 (8), 77 (13). 
HRMS (EI): m/z calcd. for: [C18H19N] 249.1517   found: 249.1513. 
 
Preparation of 2,6-Dimethyl-4-amino anisole (55) 
 
NH2
OMe
 
 
A 1.0 L flask was charged with 2,6-dimethyl-4-nitro anisole (180 mmol, 32.6 g), active 
charcoal (20%, 36.0 mmol, 434 mg), FeCl3.6H2O (10%, 18.0 mmol, 4.90 g), MeOH (500 mL) 
and refluxed. While the reaction mixture was refluxing, NH2NH2·H2O (1.8 mol, 57.5 g, 55.8 
mL) was added slowly and continued stirring for overnight. Reaction mixture was cooled to 
room temperature, filtered and washed with MeOH (3 × 100 mL). Evaporated the filtrate 
under reduced pressure, filtered the residue through a short pad of silica gel and washed with 
ether to afford the amine in 96 % yield as a pale yellow crystalline solid. 
 
MP: 62-64 °C 
1H-NMR (300 MHz, CDCl3): δ = 6.45-6.45 (m, 2H), 4.02 (br, 2H, NH), 3.68 (s, 3H), 2.25-
2.21 (m, 6H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 150.5, 140.9, 131.8, 116.1, 60.2, 16.3 ppm. 
IR (neat): υmax (cm−1) = 3400 (s), 2955 (m), 1623 (w), 1472 (m), 1212 (m), 1013 (s), 796 
(m). 
MS (70 eV, EI): m/z (%) = 151 (M+, 88), 137 (26), 136 (100), 108 (47), 93 (28). 
HRMS (EI): m/z calcd. for: [C9H13NO] 151.0997,  found  151.0999. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenylethylideneamine (56a) 
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N
OMe
 
 
Prepared according to TP7 from acetophenone (10.0 mmol, 1.20 g, 1.16 mL) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by vacuum 
distillation (140 °C, 0.1 mbar), afforded the desired imine (1.90 g, 7.50 mmol, 75%) as a 
yellow solid. 
 
MP: 65.5-66.7 °C. 
1H-NMR (300 MHz, CDCl3): δ = 7.98-7.95 (m, 2H) 7.46-7.43 (m, 3H), 6.48 (s, 2H), 3.70 (s, 
3H), 2.28 (s, 6H), 2.27 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.6, 150.2, 140.4, 133.1, 130.6, 128.5, 128.4, 127.3, 
119.8, 59.9, 17.5, 16.2 ppm. 
IR (neat): υmax (cm−1) = 2945 (m), 2822 (w), 1686 (w), 1629 (s), 1471 (m), 1448 (s), 1278 
(s), 1213 (s), 1007 (s), 874 (m), 766 (s), 692 (s). 
MS (70 eV, EI): m/z (%) = 253 (M+, 32), 238 (100), 223 (2), 194 (2), 91 (10). 
HRMS (EI): m/z calcd. for: [C17H19NO] 253.1467,  found: 253.1462. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-methyl)phenylethylideneamine (56b) 
 
N
OMe
Me
 
 
Prepared according to TP7 from 4-methyl acetophenone (1.34 g; 1.33 mL, 10.0 mmol,) and 
3,5-dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g, 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  20:1 (2% Et3N) ), furnished the desired 
imine (1.85 g, 6.9 mmol, 69 %) as a yellow oil. 
 
1H-NMR (300 MHz, C6D6): δ = 8.02-7.99 (m, 2H), 7.07-7.04 (m, 2H), 6.51 (s, 2H), 3.44 (s, 
3H), 2.23 (s, 3H), 2.12 (s, 6H), 1.97 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 164.0, 153.4, 148.4, 140.3, 137.6, 131.3, 129.1, 127.6, 119.9, 
59.4, 21.2, 16.8, 16.3 ppm. 
IR (neat): υmax (cm−1) = 2921 (br, w), 1631 (m), 1594 (m), 1477 (m), 1364 (m), 1275 (m), 
1216 (s), 1182 (m), 1010 (s), 872 (m), 816 (s). 
MS (70 eV, EI): m/z (%) = 267 (M+, 42), 253 (15), 252 (100), 119 (2), 117 (2). 
HRMS (EI): m/z calcd. for: [C18H21NO] 267.1623,  found: 267.1631. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-methyl)phenylethylideneamine (56c) 
 
Experimental Section   128
N
OMe
 
 
Prepared according to TP7 from 3-methyl acetophenone (10.0 mmol, 1.34 g, 1.33 mL) and 
3,5-dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether 40:1 (2% Et3N) ) afforded the desired 
imine (1.95 g, 7.29 mmol, 73%) as a yellow oil. 
 
1H-NMR (300 MHz, C6D6): δ = 7.99 (s, 1H) 7.84-7.81 (m, 1H), 7.18-7.16 (m, 1H), 7.07-
7.04 (m, 1H), 6.52 (s, 2H), 3.43 (s, 3H), 2.24 (s, 6H), 2.17 (s, 3H), 1.97 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 164.3, 153.5, 148.3, 140.2, 137.8, 131.3, 131.2, 128.3, 128.2, 
124.9, 119.9, 59.4, 21.4, 16.9, 16.3 ppm. 
IR (neat): υmax (cm−1) = 2922 (w), 1631 (m), 1477 (m), 1282 (m), 1217 (s), 1010 (m), 875 
(m), 694 (s). 
MS (70 eV, EI): m/z (%) = 267 (M+, 42), 252 (100), 133 (2), 118 (4).  
HRMS (EI): m/z calcd. for: [C18H21NO] 267.1623,  found: 267.1628. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(2-methylphenyl) ethylidene amine (56d):  
 
N
OMe
 
 
Prepared according to TP7 from 2-methyl acetophenone (10.0 mmol, 1.34 g, 1.30 mL) and 
3,5-dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether 40:1 (2% Et3N) ), afforded the desired 
imine (1.98 g, 7.40 mmol, 74%) as a yellow oil.  
 
1H-NMR (300 MHz, CDCl3): δ = 7.33-7.30 (m, 1H), 7.12-7.10 (m, 2H), 6.87-6.86 (m, 1H), 
6.55 (s, 2H), 3.44 (s, 3H), 2.24 (s, 6H), 2.06 (s, 3H), 1.92 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 168.1, 153.7, 148.0, 140.1, 135.9, 131.5, 129.6, 128.6, 
127.8, 125.8, 119.5, 59.4, 29.2, 20.5, 16.3 ppm. 
IR (neat): υmax (cm−1) = 2925 (w), 1641 (m), 1479 (s), 1217 (s), 1009 (s), 871 (m), 744 (s). 
MS (70 eV, EI): m/z (%) = 268 ([M+H]+, 12), 267 (M+, 88), 252 (100), 135 (15), 130 (31), 
91 (56). 
HRMS (EI): m/z calcd. for: [C18H21NO]  267.1623,  found: 267.1614. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-carbomethoxy)phenylethylideneamine (56e) 
 
Experimental Section   129
N
OMe
MeO2C
 
 
Prepared according to TP7 from methyl 4-acetyl-benzoate (10.0 mmol, 1.78 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  40:1 (2% Et3N) ), provided the desired 
imine (2.33 g, 7.50 mmol, 75%) as a bright yellow solid. 
 
MP: 90.0-92.4 °C. 
1H-NMR (300 MHz, C6D6): δ = 8.21-8.19 (m, 2H), 7.97-7.95 (m, 2H), 6.46 (s, 2H), 3.52 (s, 
3H), 3.43 (s, 3H), 2.20 (s, 6H), 1.84 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 166.4, 163.6, 153.8, 147.7, 143.8, 132.1, 131.4, 129.8, 127.5, 
119.8, 59.4, 51.7, 16.8, 16.3 ppm. 
IR (neat): υmax (cm−1) = 2955 (w), 1718 (s), 1627 (m), 1437 (m), 1272 (s), 1112 (s), 1007 (s), 
768 (s), 696 (s) ppm. 
MS (70 eV, EI): m/z (%) = 311 (M+, 56), 296 (100), 132 (11). 
HRMS (EI): m/z calcd. for: [C19H21NO3] 311.1521,  found: 311.1515. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-trifluoromethyl)phenylethylideneamine (56f) 
 
N
OMe
F3C
 
 
Prepared according to TP7 from 4-trifluoromethyl acetophenone (10.0 mmol, 1.88 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by vacuum 
distillation (160 °C, 0.1 mbar), afforded the desired imine (2.70 g, 8.40 mmol, 84%) as a 
yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.98-7.95 (m, 2H), 7.46-7.43 (m, 2H), 6.48 (s, 2H), 3.70 
(s, 3H), 2.28 (s, 6H), 2.27 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.0, 152.3, 146.7, 132.0 (q, J = 16.8 Hz), 131.3, 128.6, 
127.5 (q, J = 283.3 Hz), 127.4, 125.2 (q, J = 3.6 Hz), 119.3, 59.9, 17.4, 16.2 ppm. 
IR (neat): υmax (cm−1) = 2935 (br, w), 1633.2 (m), 1478 (m), 1326 (s), 1220 (s), 1124 (s), 
1111 (s), 1011 (s), 843 (s), 605 (m). 
MS (70 eV, EI): m/z (%) = 321 (M+, 48), 306 (100), 302 (2), 171 (2), 91 (5). 
HRMS (EI): m/z calcd. for: [C18H18NF3O] 321.1340,  found: 321.1329. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-methoxy)phenylethylideneamine (56g) 
 
Experimental Section   130
N
OMe
MeO
 
 
Prepared according to TP3 from 4-methoxy acetophenone (10.0 mmol, 1.50 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Recrystallisation from MeOH, 
afforded the desired imine (1.98 g, 6.99 mmol, 70%) as a yellow solid. 
 
MP: 62.3-64.6 °C. 
1H-NMR (400 MHz, C6D6): δ = 7.96-7.92 (m, 2H), 6.96-6.91 (m, 2H), 6.40 (s, 2H), 3.85 (s, 
3H), 3.45 (s, 3H), 2.24 (s, 6H), 2.00 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 165.9, 160.8, 151.4, 145.6, 133.4, 129.4, 127.8, 120.6, 
114.6, 55.9, 55.6, 16.6, 16.2 ppm. 
IR (neat): υmax (cm−1) = 2915 (w), 1631 (s), 1592 (s), 1512 (m), 1365 (m), 1246 (s), 1171 (s), 
1026 (s), 827 (s), 688 (s). 
MS (70 eV, EI): m/z (%) = 283 (M+, 49), 268 (100), 105 (10). 
HRMS (EI): m/z calcd. for: [C18H21NO2] 283.1572,  found: 283.1571. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-methoxy)phenylethylideneamine (56h) 
 
N
OMe
OMe
 
 
Prepared according to TP7 from 3-methoxy acetophenone (10.0 mmol, 1.50 g, 1.38 mL) and 
3,5-dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  20:1 (2% Et3N) ), furnished the desired 
imine (1.98 g, 7.0 mmol, 70%) as a yellow oil. 
 
1H-NMR (400 MHz, C6D6): δ = 7.59-7.57 (m, 1H), 7.51-7.48 (m, 1H), 7.34 (t, J = 7.9 Hz, 
1H), 7.01 (dddd, J = 0.9 Hz, 2.6 Hz, 7.9 Hz, 1H), 6.60 (s, 2H), 3.80 (s, 3H), 3.65 (s, 3H), 2.41 
(s, 6H), 2.20 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 164.3, 153.5, 148.3, 140.2, 137.8, 131.3, 131.2, 128.3, 
128.2, 124.9, 119.9, 60.1, 55.4, 17.2, 16.6 ppm. 
IR (neat): υmax (cm−1) = 3001 (w), 2910 (w), 1633 (s), 1584 (s), 1447 (m), 1277 (s), 1029 (s), 
848 (s), 794 (s), 672 (s). 
MS (70 eV, EI): m/z (%) = 283 (M+, 59), 268 (100), 105 (11). 
HRMS (EI): m/z calcd. for: [C18H21NO2] 283.1572,  found: 283.1584. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl propylidene amine (56i) 
 
Experimental Section   131
N
OMe
F
 
 
Prepared according to TP7 from 3-fluoro acetophenone (10.0 mmol, 1.38 g, 1.23 mL) and 
3,5-dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  40:1 (2% Et3N) ), provided the desired 
imine (2.06 g, 7.59 mmol, 76%) as a yellow oil. 
 
1H-NMR (300 MHz, C6D6): δ = 7.84-7.79 (m, 1H), 7.65-7.62 (m, 1H), 7.00-6.84 (m, 2H), 
6.44 (s, 2H), 3.43 (s, 3H), 2.22 (s, 6H), 1.81 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 163.4 ( d, J = 245.0 Hz), 163.0 (d, J = 3.0 Hz), 153.7, 147.6, 
142.5 (d, J = 7.5 Hz), 131.4, 129.9 (d, J = 7.7 Hz), 123.1 (d, J = 2.8 Hz), 119.8, 117.1 ( d, J = 
22.0 Hz), 114.4 (d, J = 23.0 Hz), 59.4, 16.7, 16.3 ppm. 
IR (neat): υmax (cm−1) = 2937 (br, w), 1691 (w), 1633 (m), 1585 (m), 1481 (m), 1440 (s), 
1266 (s), 1217 (s), 1010 (m), 867 (s), 784 (s), 686 (s). 
MS (70 eV, EI): m/z (%) = 271 (M+, 44), 256 (100), 120 (5). 
HRMS (EI): m/z calcd. for: [C17H18NFO] 271.1372,  found:271.1363. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-chloro)phenylethylideneamine (56j) 
 
N
OMe
Cl
 
 
Prepared according to TP7 from 4-chloro acetophenone (10.0 mmol, 1.54 g, 1.29 mL) and 
3,5-dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  40:1 (2% Et3N) ), afforded the desired 
imine (2.16 g, 7.51 mmol, 75%) as a yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.90-7.87 (m, 2H), 7.44-7.37 (m, 2H), 6.40 (s, 2H), 3.70 
(s, 3H), 2.27 (s, 6H), 2.20 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.0, 153.1, 146.9, 138.0, 136.4, 131.2, 128.4, 119.4, 
59.8, 17.2, 16.1 ppm. 
IR (neat): υmax (cm−1) = 2936 (br, w), 1631 (m), 1589 (m), 1477 (m), 1398 (w), 1272 (w), 
1219 (s), 1091 (s), 1011 (s), 830 (s), 756 (m). 
MS (70 eV, EI): m/z (%) = 287 (M+, 38), 274 (30), 272 (100), 91 (5). 
HRMS (EI): m/z calcd. for: [C17H18N35ClO] 287.1077,  found: 287.1078. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-chloro)phenylethylideneamine (56k) 
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Prepared according to TP7 from 3-chloro acetophenone (10.0 mmol, 1.54 g, 1.29 mL) and 
3,5-dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  40:1 (2% Et3N) ), afforded the desired 
imine (2.16 g, 7.51 mmol, 75%) as a yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.90-7.84 (m, 2H), 7.65-7.60 (m, 1H), 7.00-6.88 (m, 1H), 
6.40 (s, 2H), 3.48 (s, 3H), 2.22 (s, 6H), 1.80 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.0, 152.8, 146.2, 138.1, 136.0, 130.4, 129.4, 129.0, 
128.6, 126.2, 119.4, 59.6, 17.0, 16.1 ppm. 
IR (neat): υmax (cm−1) = 2912 (br, w), 1615 (m), 1509 (s), 1382 (m), 1272 (m), 1206 (m), 
1091 (m), 868 (s), 790 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 287 (M+, 30), 274 (55), 272 (100), 91 (15). 
HRMS (EI): m/z calcd. for: [C17H18N35ClO] 287.1077,  found: 287.1066. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-phenyl)phenylethylideneamine (56l) 
 
N
OMe
Ph
 
 
Prepared according to TP7 from 4-phenyl acetophenone (10.0 mmol, 1.96 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Recrystallisation from n-
pentane, afforded the desired imine (2.47 g, 7.50 mmol, 75%) as a yellow solid. 
 
MP: 96.3-97.3 °C 
1H-NMR (400 MHz, C6D6): δ = 8.12-8.09 (m, 2H), 7.55-7.53 (m, 2H), 7.51-7.48 (m, 2H), 
7.25-7.18 (m, 3H), 6.55 (s, 2H), 3.45 (s, 3H), 2.26 (s, 6H), 2.00 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 163.9, 153.6, 148.2, 143.3, 140.9, 139.0, 131.4, 129.1, 
128.1, 127.8, 127.5, 127.2, 120.0, 59.4, 16.8, 16.4 ppm. 
IR (neat): υmax (cm−1) = 2929 (w), 1623 (m), 1595 (m), 1214 (s), 1066 (s), 870 (s), 765 (s), 
693 (s). 
MS (70 eV, EI): m/z (%) = 329 (M+, 52), 314 (100), 207 (6), 157 (5). 
HRMS (EI): m/z calcd. for: [C23H23NO] 329.1780,  found: 329.1765. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(2-naphthyl) ethylidene amine (56m) 
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Prepared according to TP7 from 2-acetyl naphthalene (10.0 mmol, 1.70 g) and 3,5-dimethyl-
4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash chromatography 
(silica gel; n-pentane:diethyl ether 80:1 (2% Et3N) ), afforded the desired imine (1.94 g, 6.39 
mmol, 64%) as a yellow oil.  
 
1H-NMR (300 MHz, CDCl3): δ = 8.56 (dd, J = 1.8 Hz, 8.8 Hz, 1H) 8.23-8.22 (m, 1H), 7.74-
7.62 (m, 3H), 7.37-7.30 (m, 2H), 6.56 (s, 2H), 3.45 (s, 3H), 2.26 (s, 6H), 2.05 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.1, 153.6, 148.3, 137.6, 134.9, 133.5, 131.4, 129.1, 
128.2, 128.1, 128.0, 127.2, 126.4, 124.9, 119.9, 59.4, 16.7, 16.4 ppm. 
IR (neat): υmax (cm−1) = 2912 (w), 1641 (m), 1489 (s), 1207 (s), 1109 (s), 789 (m), 690 (s). 
MS (70 eV, EI): m/z (%) = 304 ([M+H]+, 11), 303 (M+, 48), 288 (100), 151 (6). 
HRMS (EI): m/z calcd. for: [C21H21NO]  303.1623,  found: 303.1622. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(2-acetylphenyl) ethylidene amine (56n) 
 
N
OMe
COCH3
 
 
Prepared according to TP7 from 1,3-diacetyl benzene (10.0 mmol, 1.62 g) and 3,5-dimethyl-
4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash chromatography 
(silica gel; n-pentane:diethyl ether  20:1 (2% Et3N) ), furnished the desired imine (2.07 g, 7.0 
mmol 70%) as a yellow oil.  
 
1H-NMR (300 MHz, CDCl3): δ = 8.13-8.08 (m, 1H), 7.98-7.69 (m, 2H), 7.39-7.38 (m, 1H), 
6.52 (s, 2H), 3.43 (s, 3H), 2.61 (s, 3H), 2.24 (s, 3H), 2.20 (s, 6H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 199.6, 164.3, 153.6, 148.8, 140.2, 137.9, 131.6, 131.4, 
128.4, 128.3, 125.0, 119.5, 59.4, 26.9, 16.9, 16.2 ppm. 
IR (neat): υmax (cm−1) = 2924 (w), 1611 (m), 1497 (s), 1207 (s), 1109 (m), 870 (m), 764 (s). 
MS (70 eV, EI): m/z (%) = 295 (M+, 78), 280 (100), 263 (29), 136 (30). 
HRMS (EI): m/z calcd. for: [C19H21NO2]  295.1572,  found: 295.1577. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(1,2,3,4-tetrahydro) naphthylidene amine (56o) 
 
Experimental Section   134
N
OMe
 
 
Prepared according to TP7 from α-tetralone (10.0 mmol, 1.46 g, 1.33 mL) and 3,5-dimethyl-
4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Recrystallisation from n-pentane:EtOAc, 
afforded the desired imine (1.79 g, 6.41 mmol, 64%) as a brown solid. 
 
MP: 85.3-86.4 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.32-8.29 (m, 1H), 7.35 (ddd, J = 7.5 Hz, 1.7 Hz, 1H), 
7.30-7.27 (m, 1H), 7.20-7.16 (m, 1H), 6.46 (s, 2H), 3.70 (s, 3H), 2.89 (t, J = 6.2 Hz, 2 H), 
2.58-2.54 (m, 2H), 2.27 (s, 6H), 1.93-1.87 (m, 2H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 165.8, 153.0, 141.3, 133.8, 133.4, 131.2, 130.7, 128.7, 
126.4, 119.7, 59.8, 30.0, 29.9, 23.0, 16.2 ppm. 
IR (neat): υmax (cm−1) = 2927 (m), 1625 (s), 1596 (m), 1453 (m), 1219 (s), 1004 (s), 872 (s), 
766 (s). 
MS (70 eV, EI): m/z (%) = 279 (M+, 48), 264 (100), 129 (8). 
HRMS (EI): m/z calcd. for: [C19H21NO] 279.1623,  found: 279.1634. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-(1,2,3,4-tetrahydro) naphthylidene amine (56p) 
 
N
Me
OMe
Me
 
 
Prepared according to TP7 from α-indanone (10.0 mmol, 1.38 g) and 3,5-dimethyl-4-
methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash chromatography 
(silica gel; n-pentane:diethyl ether  20:1 (2% Et3N) ), furnished the desired imine (1.86 g, 7.00 
mmol 70%) as a dark brown oil.  
 
1H-NMR (300 MHz, CDCl3): δ = 8.28-8.19 (m, 1H), 7.35 (ddd, J = 7.4 Hz, 1.6 Hz, 1H), 
7.28-7.25 (m, 1H), 7.11-7.10 (m, 1H), 6.42 (s, 2H), 3.68 (s, 3H), 2.89 (t, J = 6.2 Hz, 2H), 2.56 
(t, J = 6.7 Hz, 2H), 2.24 (s, 6H), 1.93-1.87 (m, 2H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 164.2, 152.0, 141.3, 133.2, 133.0, 131.4, 130.8, 128.2, 
125.9, 120.0, 59.6, 30.6, 29.4, 16.2 ppm. 
IR (neat): υmax (cm−1) = 2907 (m), 1600 (s), 1575 (s), 1386 (m), 1112 (m), 1005 (m), 985 
(m), 862 (s). 
MS (70 eV, EI): m/z (%) = 265 (M+, 18), 250 (100), 129 (12), 116 (72). 
HRMS (EI): m/z calcd. for: [C18H19NO] 265.1467,  found: 265.1488. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl propylidene amine (56q) 
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Prepared according to TP7 from propiophenone (10.0 mmol, 1.34 g, 1.34 mL) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  80:1 (2% Et3N) ), afforded the desired 
imine in (2.09 g, 7.81 mmol, 78%) as a yellow oil.  
 
1H-NMR (400 MHz, C6D6): δ = 8.02-8.00 (m, 2H), 7.24-7.19 (m, 3H), 6.53 (s, 2H), 3.43 (s, 
3H), 2.52 (q, J = 7.7 Hz, 2H), 2.23 (s, 6H), 0.89 (t, J = 7.7 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 169.4, 153.4, 148.2, 138.6, 131.4, 130.2, 128.6, 128.0, 
119.4, 59.4, 23.0, 16.4, 13.1 ppm. 
IR (neat): υmax (cm−1) = 2980 (w), 1705 (m), 1600 (s), 1220 (m), 1110 (m), 795 (m), 699 (m). 
MS (70 eV, EI): m/z (%) = 267 (M+, 75), 252 (100), 238 (99), 111 (20), 91 (29). 
HRMS (EI): m/z calcd. for: [C18H21NO] 267.1623,  found: 267.1629. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl hexylidene amine (56r) 
 
N
OMe
 
 
Prepared according to TP7 from n-hexanophenone (10.0 mmol, 1.76 g) and 3,5-dimethyl-4-
methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash chromatography 
(silica gel; n-pentane:diethyl ether  100:1 (2% Et3N) ), afforded the desired imine (2.23 g, 
7.21 mmol, 72%) as a yellow oil.  
 
1H-NMR (400 MHz, C6D6): δ = 7.27-7.25 (m, 2H), 7.19-7.15 (m, 2H), 7.07-7.03 (m, 1H), 
6.66 (s, 2H), 3.37 (s, 3H), 2.42-2.38 (m, 2H), 2.17 (s, 6H), 1.59-1.57 (m, 2H), 1.20-1.17 (m, 
4H), 0.85 (t, J = 7.7 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 169.5, 153.6, 149.5, 144.0, 131.1, 128.7, 127.2, 126.7, 
116.2, 59.5, 39.3, 32.1, 28.6, 22.9, 16.7, 15.3 ppm. 
IR (neat): υmax (cm−1) = 2990 (w), 1745 (m), 1600 (s), 1225 (m), 1010 (m), 699 (m). 
MS (70 eV, EI): m/z (%) = 309 (M+, 40), 294 (18), 253 (99), 238 (100), 151 (30). 
HRMS (EI): m/z calcd. for: [C21H27NO] 309.2093,  found: 309.2094. 
 
N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl hexylidene amine (56s) 
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Prepared according to TP7 from 1,3-diphenylpropiophenone (10.0 mmol, 2.54 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether  100:1 (2% Et3N) ), afforded the desired 
imine (2.11 g, 7.41 mmol, 74%) as a yellow oil.  
 
1H-NMR (400 MHz, C6D6): δ = 7.28-7.15 (m, 6H), 7.10-6.90 (m, 4H), 6.50 (s, 2H), 3.41 (s, 
3H), 2.62-2.58 (m, 2H), 2.31-2.29 (m, 2H), 2.20 (s, 6H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 168.5, 164.4, 148.5, 144.0, 132.0, 131.1, 129.8, 129.4, 
129.3, 128.6, 127.2, 126.7, 116.2, 59.5, 27.6, 22.9, 16.7 ppm. 
IR (neat): υmax (cm−1) = 2982 (w), 1815 (m), 1643 (s), 1460 (m), 1225 (m), 1125 (m), 814 
(m), 765 (m), 699 (m). 
MS (70 eV, EI): m/z (%) = 343 (M+, 20), 267 (40), 253 (19), 238 (100), 151 (10). 
HRMS (EI): m/z calcd. for: [C24H25NO] 343.1936,  found: 343.1954. 
 
5-[(N-(3,5-Dimethyl-4-methoxy)phenyl)imino]-1,5-diphenylpentan-1-one (56t) 
 
N
COPh
OMe
 
 
Prepared according to TP7 from 1,5-diphenyl-1,5-pentanedione (10.0 mmol, 2.52 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g;, 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether 4:1 (2% Et3N) ), provided the desired 
imine (2.70 g, 7.0 mmol, 70%) as a dark brown oil.  
 
1H-NMR (400 MHz, C6D6): δ = 7.76-7.74 (m, 2H), 7.22-6.99 (m, 8H), 6.82 (s, 2H), 3.32 (s, 
3H), 3.09-3.04 (m, 2H), 2.11 (s, 6H), 1.82-1.75 (m, 2H), 1.60-1.53 (m, 2H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 198.7, 161.7, 153.8, 149.5, 144.0, 137.5, 134.4, 132.7, 
131.1, 130.7, 128.8, 128.2, 127.0, 114.0, 59.5, 38.6, 34.6, 23.8, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3360 (m), 2949 (w), 1700 (s), 1680 (s), 1635 (m), 1189 (s), 1100 (s), 
760 (s), 685 (s). 
MS (70 eV, EI): m/z (%) = 385 (M+, 42), 280 (45), 266 (80), 253 (88), 238 (100). 
HRMS (EI): m/z calcd. for: [C26H27NO2] 385.2042,  found: 385.2038. 
 
Methyl 4-[(N-(3,5-dimethyl-4-methoxyphenyl))imino]-4-phenylbutanoate (56u) 
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Prepared according to TP7 from methyl 3-benzoylpropionate (10.0 mmol, 1.92 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether 5:1 (2% Et3N) ), provided the desired 
imine (2.24 g, 6.89 mmol, 69%) as a dark brown oil.  
 
1H-NMR (400 MHz, C6D6): δ = 7.19-7.17 (m, 2H), 7.10-7.00 (m, 3H), 6.50 (s, 2H), 3.39 (s, 
3H), 3.34 (s, 3H), 2.52 (t, J = 6.4 Hz, 2H), 2.31-2.29 (m, 2H), 2.20 (s, 6H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 172.8, 166.8, 153.6, 147.7, 138.3, 130.4, 128.7, 128.2, 
127.9, 119.3, 59.4, 51.2, 33.4, 32.3, 16.3 ppm. 
IR (neat): υmax (cm−1) = 2950 (w), 1735 (s), 1686 (s), 1219 (s), 1165 (s), 1009 (m), 758 (s), 
690 (s). 
MS (70 eV, EI): m/z (%) = 325 (M+, 99), 310 (43), 266 (28), 250 (45), 238 (100). 
HRMS (EI): m/z calcd. for: [C20H23NO] 325.1678,  found: 325.1662. 
 
Methyl 5-[(N-(3,5-dimethyl-4-methoxyphenyl))imino]-5-phenylpentanoate (56v) 
 
N
CO2Me
OMe
 
 
Prepared according to TP7 from methyl 4-benzoylbutanoate (10.0 mmol, 2.06 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethyl ether 5:1 (2% Et3N) ), provided the desired 
imine (2.37 g, 6.99 mmol, 70%) as a dark brown oil.  
 
1H-NMR (400 MHz, C6D6): δ = 7.80-7.77 (m, 2H), 7.13-7.03 (m, 3H), 6.90 (s, 2H), 3.32 (s, 
3H), 3.28 (s, 3H), 2.55 (t, J = 6.4 Hz, 2H), 2.23 (s, 6H), 2.17-2.13 (m, 2H), 2.00-1.94 (m, 2H) 
ppm. 
13C-NMR (100 MHz, C6D6): δ = 173.1, 167.0, 153.0, 145.9, 137.4, 132.7, 130.0, 128.5, 
127.8, 120.2, 59.7, 50.9, 33.4, 33.0, 19.5, 18.6 ppm. 
IR (neat): υmax (cm−1) = 2945 (w), 1700 (s), 1686 (s), 1189 (s), 1165 (s), 798 (s), 650 (s). 
MS (70 eV, EI): m/z (%) = 339 (M+, 60), 324 (25), 308 (27), 266 (65), 253 (55), 238 (100). 
HRMS (EI): m/z calcd. for: [C21H25NO3] 339.1834,  found: 339.1845. 
 
N-(3,5-dimethyl-4-methoxyphenyl)-1-(3,4-dimethoxy)phenyl ethylideneamine (56W) 
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Prepared according to TP7 from 3,4-dichlorocetophenone (10.0 mmol, 1.89 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g, 1.20 equiv.). Purification by recrystallisation 
from methanol provided the desired imine (2.29 g, 7.11 mmol, 71 %) as a yellow oil.  
 
1H-NMR (400 MHz, C6D6): δ = 8.24 (d, J = 2.8 Hz, 1H), 7.94 (dd, J = 8.4 Hz, 2.1 Hz, 1H), 
7.09-7.01 (m, 1H), 6.60 (s, 2H), 3.51 (s, 3H), 2.27 (s, 6H), 2.05 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 164.0, 148.5, 146.2, 140.1, 138.5, 135.2, 134.4, 128.3, 
121.0, 120.1, 111.2, 59.4, 17.0, 16.7 ppm. 
IR (neat): υmax (cm−1) = 2925 (w), 1620 (w), 1562 (m), 1418 (s), 1366 (s), 1299 (m), 1007 
(m), 808 (s), 712 (s). 
MS (70 eV, EI): m/z (%) = 321 (M+, 25), 307 (10), 306 (100), 171 (27). 
HRMS (EI): m/z calcd. for: [C17H17Cl2NO] 321.0687,  found: 313.1665. 
 
N-(3,5-dimethyl-4-methoxyphenyl)-1-(3,4-dimethoxy)phenyl ethylideneamine (56x) 
 
N
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MeO
 
 
Prepared according to TP7 from 3,4-dimethoxyacetophenone (10.0 mmol, 1.80 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by recrystallisation 
from methanol provided the desired imine (2.23 g, 7.22 mmol, 72%) as a white solid.  
 
MP: 115.9-117.1 °C 
1H-NMR (400 MHz, C6D6): δ = 8.05 (d, J = 2.1 Hz, 1H), 7.40 (dd, J = 8.3 Hz, 2.1 Hz, 1H), 
6.61 (d, J = 8.4 Hz, 1H), 6.58 (s, 2H), 3.49 (s, 3H), 3.43 (s, 3H), 3.40 (s, 3H), 2.25 (s, 6H), 
2.05 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 163.5, 157.5, 152.3, 150.1, 148.5, 133.1, 131.4, 128.3, 
121.0, 120.1, 110.8, 59.4, 55.44, 55.41, 16.7, 16.4 ppm. 
IR (neat): υmax (cm−1) = 2935 (w), 2959 (w), 1620 (w), 1594 (m), 1583 (s), 1510 (s), 1452 
(m), 1414 (s), 1267 (s), 1217 (s), 1153 (s), 1018 (s), 867 (s), 765 (m). 
MS (70 eV, EI): m/z (%) = 314 ([M+H]+, 12), 339 (M+, 55), 299 (18), 298 (100), 268 (6). 
HRMS (EI): m/z calcd. for: [C19H23NO3] 313.1678,  found: 313.1665. 
 
N-(3,5-dimethyl-4-methoxyphenyl)-1-(3,4-dimethoxy)phenyl ethylideneamine (56y) 
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Prepared according to TP7 from 3,4-dimethylacetophenone (10.0 mmol, 1.48 g) and 3,5-
dimethyl-4-methoxy aniline (12.0 mmol, 1.81 g; 1.20 equiv.). Purification by flash 
chromatography (silica gel; n-pentane:diethylether 60:1 (2% Et3N) ), provided the desired 
imine (1.83 g, 6.50 mmol, 65%) as a yellow oil.  
 
 
1H-NMR (400 MHz, C6D6): δ = 7.38-7.22 (m, 2H), 6.91-6.82 (m, 1H), 6.61 (s, 2H), 3.40 (s, 
3H), 2.33 (s, 3H), 2.30 (s, 3H), 2.25 (s, 6H), 2.05 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 163.0, 158.5, 150.3, 149.2, 148.5, 132.8, 131.9, 128.3, 
121.0, 120.2, 111.2, 59.4, 17.4, 17.2, 16.7, 16.4 ppm. 
IR (neat): υmax (cm−1) = 2912 (w), 1645 (w), 1600 (m), 1512 (m), 1478 (m), 1400 (s), 1297 
(s), 1125 (m), 1008 (m), 875 (m), 795 (s). 
MS (70 eV, EI): m/z (%) = 281 (M+, 65), 266 (100), 265 (10), 151 (16), 146 (70). 
HRMS (EI): m/z calcd. for: [C19H23NO] 281.1780,  found: 281.1781. 
 
7. Asymmetric Hydrogenation of Imines  
 
(R)-N-phenyl-1-phenyl ethyl amine (51a)132 
 
HN
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50a (98 mg; 0.50 mmol) and obtained as a yellow oil (95 mg, 0.48 mmol, 
96%). 
 
[α]D20 = −3.9 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.36 (d, J = 7.4 Hz, 2H), 7.33 (t, J = 8.1 Hz, 2H), 7.22 (t, J 
= 7.4 Hz, 1H), 7.06 (dd, J = 8.9 Hz, 7.4 Hz, 2H), 6.65 (t, J = 7.4 HZ, 1H), 6.50 (d, J = 7.9 Hz, 
2H), 4.48 (q, J = 6.9 Hz, 1H), 3.95 (br, NH), 1.50 (d, J = 7.1 HZ, 3H) ppm. 
The enantiomer ratio was determined by Chiral GC DEX-CB Column (100 °C (5 min), 5 
°C/min 160 °C (50 min)); tr = 20.9 min [minor], tr = 21.1 min [major];  84% ee. 
 
(R)-N-(4-methoxy)phenyl-1-phenyl ethylidene amine (51b)3 
 
                                                 
132
 Iwadate, N.; Yoshida, K.; Imamoto, T. Org. Lett. 2006, 8, 2289;  
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HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50a (113 mg; 0.50 mmol) and obtained as a yellow oil (108 mg, 0.47 mmol, 
95%) 
[α]D20 = +1.3 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, C6D6): δ = 7.21-7.10 (m, 4H), 7.05-7.00 (m, 1H), 6.69-6.64 (m, 2H), 
6.73-6.72 (m, 2H), 4.17 (q, J = 6.6 Hz, 1H), 3.54 (s, 3H), 3.31 (br, 1H, -NH), 1.13 (d, J = 6.85 
Hz, 3H) ppm. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
ml/min, heptane/iPrOH: 90/10, λ = 215 nm, 25 °C); tr = 14.9 min [major], tr = 16.2 min 
[minor];  88% ee. 
 
N-(4-methyl)phenyl-1-phenyl ethyl amine (51c)133 
 
HN
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50c (105 mg; 0.50 mmol) and obtained as a yellow oil (100 mg, 0.48 mmol, 
95%). 
 
[α]D20 = +48.2 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, C6D6): δ = 7.35-7.30 (m, 2H), 7.25-7.20 (m, 3H), 6.88 (d, J = 8.0 Hz, 
2H), 6.45 (d, J = 8.0 Hz, 2H), 4.42 (q, J = 6.7 Hz, 1H), 3.52 (br, NH), 2.20 (s, 3H), 1.52 (d, J 
= 6.8 Hz, 3H) ppm. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
ml/min, heptane/iPrOH: 90/10, λ = 215 nm, 25 °C); tr = 13.0 min [major], tr = 14.5 min 
[minor];  85% ee. 
 
N-(3,4,-Dioxymethylene)phenyl-1-phenyl ethyl amine (51d) 
 
HN
O
O
*
 
 
                                                 
133
 Kwong, F. Y.; Buchwald, S. L. Org. Lett, 2003, 5, 793. 
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Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50d (120 mg; 0.50 mmol) and obtained as a pale white solid. (111 mg, 0.46 
mmol, 92%) 
 
MP: 104.2-106.1 °C. 
[α]D20 = −11.4 (c = 0.6, CH2Cl2) 
1H-NMR (300 MHz, CDCl3): δ = 7.34-7.12 (m, 5H), 6.50 ( d, J = 8.4 Hz, 1H), 6.10 (d, J = 
2.1 Hz, 1 H), 5.91 (dd, J = 2.1 Hz, 8.2 Hz, 1 H), 5.72 (s, 2H), 4.31 (q, J = 6.6 Hz, 1H), 1.43 
(d, J = 6.8 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 147.8, 144.2, 141.7, 139.6, 128.3, 126.7, 125.6, 108.1, 
105.6, 100.2, 96.6, 54.6, 24.3 ppm. 
IR (neat): υmax (cm−1) = 3421 (m), 2956 (w), 1638 (w), 1519 (m), 1481 (s), 1352 (m), 1292 
(m), 1204 (s), 1036 (s), 928 (s), 789 (m), 696 (s). 
MS (70 eV, EI): m/z (%) = 241 (M+, 92), 226 (54), 137 (100), 105 (86), 79 (17). 
HRMS (EI): m/z calcd. for: [C15H15NO2] 241.1103,  found: 241.1084. 
The enantiomer ratio was determined by Chiral GC DEX-CB Column (160 °C, const; 100 
min); tr = 40.2 min [minor], tr = 41.0 min [major];  90% ee. 
 
N-(3,4,5-trimrthoxy)phenyl-1-phenyl ethyl amine (51e)  
 
HN
OMe
OMe
OMe
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50e (143 mg; 0.50 mmol) and obtained as a viscous oil. (135 mg, 0.47 
mmol, 94%) 
 
[α]D20 = −30.2 (c = 0.50, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.18-7.17 (m, 1H), 7.11-7.10 (m, 3H), 7.02-6.98 (m, 1H), 
5.64 (s, 2H), 4.18 (q, J = 6.8 Hz, 1H), 3.75 (s, 3H), 3.47 (br, 1H, NH), 3.36 (s, 6H), 1.16 (d, J 
= 6.7 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 154.7, 146.0, 144.2, 131.7, 128.8, 127.1, 126.1, 92.5, 60.7, 
55.8, 54.1, 24.9 ppm. 
IR (neat): υmax (cm−1) = 3376 (br, w), 2933 (w), 1609 (m), 1507 (m), 1420 (m), 1231 (s), 
1117 (s), 1005 (m), 764 (m), 700 (s). 
MS (70 eV, EI): m/z (%) = 287 (M+, 84), 272 (72), 182 (21), 168 (97), 105 (100). 
HRMS (EI): m/z calcd. for: [C17H21NO3] 287.1521,  found: 287.1498. 
The enantiomer ratio was determined by HPLC using Chiralcel OJ column (flow rate 1.0 
mL/min, heptane/iPrOH: 85/15, λ= 215 nm, 25 °C); tr = 44.2 min [major], tr = 55.2 min 
[minor];  89% ee. 
 
N-(3,4,-Dimethyl)phenyl-1-phenyl ethyl amine (51f) 
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HN
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50f (112 mg; 0.50 mmol) and obtained as a yellow oil (108 mg, 0.48 mmol, 
92%) 
 
[α]D20 = −20.9 (c = 1.0, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.17-7.16 (m, 1H), 7.10-7.06 (m, 3H), 7.00-6.96 (m, 1H), 
6.80 (d, J = 8.8 Hz, 1H), 6.24-6.21 (m, 2H), 4.23 (q, J = 6.8 Hz, 1H), 3.40 (br, 1H, NH), 1.97 
(s, 3H), 1.96 (s, 3H), 1.12 (d, J = 6.6 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 145.9, 145.8, 136.7, 130.3, 128.6, 126.8, 126.0, 124.9, 
115.6, 112.3, 53.5, 18.7, 24.8, 20.0 ppm. 
IR (neat): υmax (cm−1) = 3406 (br, w), 2964 (m), 2920 (m), 1617 (s), 1500 (s), 1447 (m), 1317 
(m), 801 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 225 (M+, 51), 210 (100), 121 (32), 120 (10), 106 (13), 105 (46). 
HRMS (EI): m/z calcd. for: [C16H19N] 225.1517,  found: 225.1510. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 14.4 min [minor], tr = 17.5 min 
[major];  90% ee. 
 
N-(3,4,-Dimethoxy)phenyl-1-phenyl ethyl amine (51g) 
 
HN
OMe
OMe
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50g (128 mg; 0.50 mmol) and obtained as a yellow oil (122 mg, 0.47 mmol, 
95%) 
 
[α]D20 = −34.2 (c = 0.55, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.19-7.18 (m, 1H), 7.12-7.08 (m, 3H), 7.02-6.98 (m, 1H), 
6.52 ( d, J = 8.7 Hz, 1H), 5.97 (d, J = 2.7 Hz, 1H), 5.93 (dd, J = 2.7 Hz, 8.6 Hz, 1H), 4.20 (br, 
1H, NH), 4.17 (q, J = 6.6 Hz, 1H), 3.40 (s, 3H), 3.36 (s, 3H), 1.14 (d, J = 6.8 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 151.2, 146.0, 142.8, 142.5, 128.7, 126.9, 126.0, 115.3, 
104.9, 100.6, 57.0, 55.4, 54.1, 24.9 ppm. 
IR (neat): υmax (cm−1) = 3384 (m), 2961 (m), 2829 (m), 1616 (m), 1511 (s), 1448 (m), 1223 
(s), 1165 (s), 1023 (m), 760 (m). 
MS (70 eV, EI): m/z (%) = 257 (M+, 100), 242 (73), 153 (20), 138 (43), 105 (54). 
HRMS (EI): m/z calcd. for: [C16H19NO2] 257.1416,  found: 257.1415. 
The enantiomer ratio was determined by HPLC using Chiralcel OJ column (flow rate 1.0 
mL/min, heptane/iPrOH: 85/15, λ= 215 nm, 25 °C); tr = 34.5 min [minor], tr = 39.5 min 
[major];  81% ee. 
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N-(2,4,-Dimethyl)phenyl-1-phenyl ethyl amine (51h) 
 
HN
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50h (112 mg; 0.50 mmol) and obtained as a yellow oil (95 mg, 0.42 mmol, 
84%) 
 
[α]D20 = −10.1 (c = 0.40, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.22-7.18 (m, 2H), 7.16-7.06 (m, 3H), 6.45 (s, 2H), 6.16 (s, 
1H), 4.17 (q, J = 7.0 Hz, 1H), 3.87 (brs, NH, 1H), 1.98 (s, 3H), 1.96 (s, 3H), 1.14 (d, J = 7.0 
Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 145.4, 142.6, 131.2, 129.5, 129.2, 128.5, 127.6, 126.4, 
121.2, 54.5, 25.6, 24.9, 16.4 ppm. 
IR (neat): υmax (cm−1) = 3362 (m), 2928 (m), 1624 (m), 1500 (s), 1464 (m), 1165 (s), 1082 
(m), 760 (m), 673 (s). 
MS (70 eV, EI): m/z (%) = 225 (M+, 22), 210 (100), 121 (12), 105 (64). 
HRMS (EI): m/z calcd. for: [C16H19N] 225.1517,  found: 225.1520. 
The enantiomer ratio was determined by HPLC using Chiralcel OJ column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 10.3 min [minor], tr = 16.3 min 
[major];  83% ee. 
 
(R)-N-(2-methoxy)phenyl-1-phenyl ethyl amine (51i)134 
 
HN
MeO
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 50i (114 mg; 0.50 mmol) and obtained as a yellow oil (57 mg, 0.25 mmol, 
50%) 
 
[α]D20 = +4.2 (c = 0.20, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.37 (d, J = 7.7 Hz, 2H), 7.30 (d, J = 7.4 Hz, 2H), 7.21 (t, J 
= 7.4 Hz, 1H), 6.77 (d, J = 7.9 Hz, 1H), 6.65 (t, J = 7.9 Hz, 1H), 6.60 (t, J = 7.8 Hz, 1H), 6.35 
(d, J = 7.9 Hz, 1H), 4.60 (brs, NH, 1H), 4.47 (q, J = 6.7 Hz, 1H), 3.88 (s, 3H), 1.57 (s, 3H) 
ppm. 
The enantiomer ratio was determined by GC using Chiralsil DEX-CB column (100 °C (7 min) 
5 °C/min 160 °C (60 min), const;); tr = 14.9 min [major], tr = 16.2 min [minor];  54% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1-phenyl ethyl amine (53a)135 
                                                 
134
 Pei, D.; Wang, Z.; Wei, S.; Zhang, Y.; Sun, J. Org. Lett. 2006, 8, 5413. 
135
 Kwong, F. Y.; Buchwald, S. L. Org. Lett. 2003, 5, 793. 
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HN
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52a (112 mg; 0.50 mmol) and obtained as a pale yellow oil (106 mg, 0.47 
mmol, 94%) 
 
[α]D20 = −12.8 (c = 0.5, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.25-7.23 (m, 2H), 7.18-7.13 (m, 2H), 7.08-7.06 (m, 1H), 
6.37 (s, 1H), 6.16 (s, 2H), 4.32 (q, J = 7.0 Hz, 1H), 3.71 (br, 1H, NH), 2.13 (s, 6H), 1.21 (d, J 
= 7.1 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 147.6, 145.8, 138.5, 128.8, 127.0, 126.1, 120.0, 112.0, 53.5, 
24.8, 21.6 ppm. 
IR (neat): υmax (cm−1) = 3406 (br, w), 2914 (w), 1597 (s), 1512 (m), 1452 (m), 1336 (m), 
1184 (m), 822 (m), 696 (m). 
MS (70 eV, EI): m/z (%) = 225 (M+, 39), 210 (100), 121 (34), 120 (10), 105 (42). 
HRMS (EI): m/z calcd. for: [C16H19N] 225.1517,  found: 225.1511. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 9.7 min [minor], tr = 11.0 min 
[major];  94% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1(4-methoxyphenyl)ethyl amine (53b) 
 
HN
MeO
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52b (120 mg; 0.50 mmol) and obtained as a yellow oil (112 mg, 0.47 mmol, 
94%). 
 
[α]D20 = +10.8 (c = 0.5, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.29-7.23 (m, 2H), 6.91-6.85 (m, 2H), 6.47 (s, 1H), 6.28 (s, 
2H), 4.90-4.40 (m, 1H), 3.63 (brs, 1H), 3.40 (s, 3H), 2.25 (s, 6H), 1.33 (d, J = 6.6 Hz, 3H) 
ppm. 
13C-NMR (75 MHz, C6D6): δ = 157.7, 146.6, 137.1, 136.5, 125.8, 118.4, 112.9, 110.6, 53.3, 
51.5, 23.6, 20.3 ppm. 
IR (neat): υmax (cm−1) = 3390 (m), 2961 (w), 1602 (s), 1507 (s), 1341 8s), 1029 (s), 825 (s). 
MS (70 eV, EI): m/z (%) = 255 (M+, 16), 135 (100), 121 (11), 105 (8). 
HRMS (EI): m/z calcd. for: [C17H21NO] 255.1618,  found: 255.1609. 
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The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 13.9 min [minor], tr = 15.7 min 
[major];  94% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1(4-methylphenyl)ethyl amine (53c) 
 
HN
H3C
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52c (119 mg; 0.50 mmol) and obtained as a yellow oil (115 mg, 0.48 mmol, 
96%). 
 
[α]D20 = +12.3 (c = 0.6, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.13 (d, J = 8.0 Hz, 2H), 6.95 (d, J = 7.7 Hz, 2H), 6.33 (s, 
1H), 6.13 (s, 2H), 4.31 (q, J = 6.2 Hz, 1H), 3.50 (brs, 1H), 2.10 (s, 6H), 2.06 (s, 3H), 1.24 (d, 
J = 6.9 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 147.8, 142.9, 138.3, 136.1, 129.4, 126.0, 119.6, 111.8, 53.1, 
24.8, 21.5, 20.9 ppm. 
IR (neat): υmax (cm−1) = 3395 (br, w), 2920 (br, w), 1597 (s), 1507 (m), 1473 (m), 1336 (m), 
1184 (m), 1109 (w), 814 (s), 721 (w), 690 (m). 
MS (70 eV, EI): m/z (%) = 239 (M+, 89), 225 (14), 224 (100), 121 (48), 119 (72). 
HRMS (EI): m/z calcd. for: [C17H21N] 239.1674,  found: 239.1678. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 9.2 min [minor], tr = 10.3 min 
[major];  93% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1(3-methoxyphenyl)ethyl amine (53d) 
 
HN
MeO
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52d (127 mg; 0.50 mmol) and obtained as a pale yellow oil (121 mg, 0.47 
mmol, 95%). 
 
[α]D20 = +10.5 (c = 0.5, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.07 (t, J = 8.0 Hz, 1H), 6.99-6.97 (m, 1H), 6.87-6.85 (m, 
1H), 6.61 (dddd, J = 0.9 Hz, 2.7 Hz, 8.0 Hz, 1H), 6.32 (s, 1H), 6.13 (s, 2H), 4.33-4.25 (m, 
1H), 3.50 (brs, 1H), 3.30 (s, 3H), 2.10 (s, 6H), 1.17 (d, J = 6.8 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 160.5, 147.8, 147.7, 138.4, 129.7, 119.7, 118.3, 112.1, 112.0, 
111.8, 54.5, 53.4, 24.8, 21.5 ppm. 
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IR (neat): υmax (cm−1) = 3403 (br, w), 2918 (w), 1600 (s), 1482 (m), 1335 (m), 1251 (s), 1043 
(s), 820 (s), 690 (s). 
MS (70 eV, EI): m/z (%) = 255 (M+, 45), 240 (100), 135 (32), 121 (40), 105 (16), 91 (8). 
HRMS (EI): m/z calcd. for: [C17H21NO] 255.1623,  found: 255.1624. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 17.4 min [minor], tr = 19.9 min 
[major];  94% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1(4-chlorophenyl)ethyl amine (53e) 
 
HN
Cl
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52e (129 mg, 0.50 mmol) and obtained as a yellow crystalline solid (122 
mg, 0.47 mmol, 94%). 
 
MP: 44.2-46.4 °C 
[α]D20 = +8.0 (c = 0.6, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.07-7.03 (m, 2H), 6.91-6.86 (m, 2H), 6.33 (s, 1H), 6.04 (s, 
2H), 4.12 (q, J = 6.6 Hz, 1H), 3.40 (brs, 1H), 2.10 (s, 6H), 1.02 (d, J = 6.6 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 147.3, 144.3, 138.5, 132.5, 128.8, 127.4, 119.9, 111.8, 52.6, 
24.6, 21.5 ppm. 
IR (neat): υmax (cm−1) = 3390 (m), 2853 (w), 1597 (m), 1486 (m), 1336 (m), 1207 (m), 1184 
(m), 1086 (m), 1011 (m), 817 (s), 781 (m), 690 (m). 
MS (70 eV, EI): m/z (%) = 259 (M+, 73), 244 (100), 139 (42), 121 (58), 103 (21). 
HRMS (EI): m/z calcd. for: [C16H18N35Cl] 259.1128,  found: 259.1128. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 10.6 min [minor], tr = 13.7 min 
[major];  91% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1(4-phenylphenyl)ethyl amine (53f) 
 
HN
Ph
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52f (150 mg; 0.50 mmol) and obtained as a yellow oil (142 mg, 0.47 mmol, 
94%). 
 
[α]D20 = +8.0 (c = 0.6, CH2Cl2) 
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1H-NMR (300 MHz, C6D6): δ = 7.44-7.39 (m, 3H), 7.26-7.22 (m, 1H), 7.20-7.05 (m, 5H), 
6.30 (s, 1H), 6.20 (s, 2H), 4.35 (q, J = 6.6 Hz, 1H), 3.50 (brs, 1H), 2.10 (s, 6H), 1.20 (d, J = 
6.6 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 147.8, 145.0, 141.5, 140.2, 138.6, 128.9, 127.7, 127.4, 127.3, 
126.6, 120.0, 111.9, 53.1, 24.9, 21.7 ppm. 
IR (neat): υmax (cm−1) = 3392 (m), 2863 (w), 1590 (m), 1470 (s), 1330 (m), 1107 (m), 1100 
(m), 1011 (m), 897 (s), 780 (m), 690 (m). 
MS (70 eV, EI): m/z (%) = 301 (M+, 55), 286 (54), 181 (100), 165 (16), 121 (18). 
HRMS (EI): m/z calcd. for: [C22H23N] 301.1830,  found: 301.1832. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 16.3 min [minor], tr = 13.6 min 
[major];  88% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1phenyl-propylamine (53g) 
 
HN
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52g (119 mg; 0.50 mmol) and obtained as a brown oil (115 mg, 0.48 mmol, 
96%). 
 
[α]D20 = +12.0 (c = 0.5, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.28-7.20 (m, 2H), 7.18-7.05 (m, 3H), 6.25 (s, 1H), 6.16 (s, 
2H), 4.31 (t, J = 6.7 Hz, 1H), 3.71 (br, 1H, NH), 2.10 (s, 6H), 1.55-1.50 (m, 2H), 0.81 (t, J = 
7.4 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 147.8, 145.8, 139.1, 128.7, 127.0, 126.7, 120.1, 112.7, 55.2, 
25.0, 23.2, 21.2 ppm. 
IR (neat): υmax (cm−1) = 3390 (br, w), 2920 (m), 1600 (m), 1455 (m), 1120 (m), 1009 (s), 845 
(m), 765 (m), 690 (s). 
MS (70 eV, EI): m/z (%) = 239 (M+, 20), 210 (100), 165 (29), 121 (18). 
HRMS (EI): m/z calcd. for: [C17H21N] 239.1674,  found: 239.1680. 
The enantiomer ratio was determined by HPLC using Chiralcel AD column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 9.2 min [major], tr = 10.2 min 
[minor];  94% ee. 
 
(R)-N-(3,5,-Dimethyl)phenyl-1(1,2,3,4-dihydro)naphthylamine (53h) 
 
HN
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Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 52h (125 mg; 0.50 mmol) and obtained as a brown oil (118 mg, 0.47 mmol, 
94%). 
 
[α]D20 = +20.8 (c = 0.5, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.40-7.37 (m, 1H), 7.09-7.03 (m, 2H), 6.97-6.95 (m, 1H), 
6.43 (s, 1H), 6.20 (s, 2H), 4.49-4.46 (m, 1H), 3.38-3.36 (m, 1H), 2.62-2.49 (m, 2H), 2.22 (s, 
6H), 1.81-1.74 (m, 1H), 1.70-1.58 (m, 2H), 1.47-1.42 (m, 1H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 148.1, 138.9, 138.7, 137.6, 129.7, 129.1, 127.3, 126.3, 119.6, 
111.4, 51.3, 29.6, 29.2, 21.7, 19.7 ppm. 
IR (neat): υmax (cm−1) = 3402 (br, w), 3019 (m), 2919 (m), 1595 (s), 1510 (m), 1447 (m), 
1337 (m), 1183 (m), 817 (s), 742 (s), 689 (s). 
MS (70 eV, EI): m/z (%) = 251 (M+, 63), 249 (12), 131 (70), 129 (12), 121 (100), 105 (6), 91 
(17). 
HRMS (EI): m/z calcd. for: [C18H21N] 251.1674,  found: 251.1670. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 9.4 min [major], tr = 10.3 min [minor];  
84% ee. 
 
(R)-N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl ethyl amine (57a) 
 
HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56a (127 mg; 0.50 mmol) and obtained as a pale yellow solid (121 mg, 0.47 
mmol, 95%). 
 
[α]D20 = −6.3 (c = 0.6, CH2Cl2) 
MP: 86.3 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.39-7.29 (m, 4H), 7.25-7.22 (m, 1H), 6.21 (s, 2H), 4.41 
(q, J = 6.7 Hz, 1H), 3.62 (s, 3H), 2.15 (s, 6H), 1.49 (d, J = 6.7 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 149.0, 145.2, 143.0, 131.2, 128.6, 126.8, 125.9, 113.6, 
59.9, 54.1, 24.7, 16.2 ppm. 
IR (neat): υmax (cm−1) = 3381 (m), 2924 (br, m), 1609 (m), 1487 (s), 1190 (s), 1006 (s), 830 
(m), 701 (m). 
MS (70 eV, EI): m/z (%) = 255 (M+, 100), 240 (87), 136 (77), 105 (98). 
HRMS (EI): m/z calcd. for: [C17H21NO] 255.1623,  found: 255.1627. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 1.0 
mL/min, heptane/iPrOH: 80/20, λ= 215 nm, 25 °C); tr = 6.4 min [minor], tr = 7.6 min [major];  
94% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-methyl)phenyl ethyl amine (57b) 
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HN
OMe
Me
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56b (134 mg; 0.50 mmol) and obtained as a viscous oil (128 mg, 0.47 
mmol, 95%). 
 
[α]D20 = + 3.8 (c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.19-7.15 (m, 2H), 7.00-6.97 (m, 2H), 6.17 (s, 2H), 4.29 (q, 
J = 6.6 Hz, 1H), 3.40 (br, 1H, NH), 3.38 (s, 3H), 2.09 (s, 6H), 2.12 (s, 3H), 1.23 (d, J = 6.7 
Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.5, 143.8, 143.1, 136.2, 131.0, 129.5, 126.1, 114.0, 59.5, 
53.5, 25.0, 21.0, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3392 (br, w), 2923 (w), 1608 (m), 1487 (m), 1340 (w), 1219 (s), 
1135 (w), 1044 (m), 1009 (s), 835 (m), 815 (s). 
MS (70 eV, EI): m/z (%) = 269 (M+, 85), 253 (47), 151 (24), 136 (50), 119 (100). 
HRMS (EI): m/z calcd. for: [C18H23NO] 269.1780,  found: 269.1783. 
The enantiomer ratio was determined by HPLC using Chiralcel AD column (flow rate 0.5 
mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 11.4 min [minor], tr = 12.5 min 
[major];  86% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-methyl)phenyl ethyl amine (57c):  
 
HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56c (134 mg; 0.50 mmol) and obtained as a viscous yellow oil (129 mg, 
0.48 mmol, 96%). 
 
[α]D20 = +4 (c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.12-7.10 (m, 3H), 6.90-6.88 (m, 1H), 6.18 (s, 2H), 4.29 (q, 
J = 6.9 Hz, 1H), 3.42 (br, 1H, NH), 3.37 (s, 3H), 2.17 (s, 6H), 2.11 (s, 3H), 1.23 (d, J = 6.9 
Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.5, 146.2, 143.8, 138.2, 131.1, 128.8, 127.8, 126.7, 
123.3, 114.0, 59.5, 53.9, 25.1, 21.5, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3396 (br, w), 2923 (w), 1607 (s), 1486 (s), 1222 (s), 1189 (m), 1009 
(m), 835 (m), 784 (m). 
MS (70 eV, EI): m/z (%) = 271 ([M+2H]+, 9), 270 ([M+H]+, 100), 213 (5). 
HRMS (EI): m/z calcd. for: [C18H24NO]; [M+H]+:  270.1858,  found: 270.1846 
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The enantiomer ratio was determined by HPLC using Chiralcel AD column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 10.2 min [major], tr = 11.8 min 
[minor];  94% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(2-methyl)phenyl ethyl amine (57d):  
 
HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56d (134 mg; 0.50 mmol) and obtained as a viscous yellow oil (128 mg, 
0.47 mmol, 95%). 
 
[α]D20 = +1.8 (c = 0.6, CH2Cl2) 
1H-NMR (300 MHz, C6D6): δ = 7.41-7.39 (m, 1H), 7.10-7.05 (m, 1H), 7.03-7.01 (m, 2H), 
6.09 (s, 2H), 4.50 (q, J = 6.7 Hz, 1H), 3.37 (brs, 4H), 2.22 (s, 3H), 2.16 (s, 6H), 1.18 (d, J = 
6.7 Hz, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 149.5, 143.7, 143.5, 134.8, 131.1, 130.8, 126.9, 126.8, 125.1, 
113.7, 59.5, 50.1, 22.7, 18.9, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3406 (br, w), 2964 (m), 2920 (m), 1617 (s), 1500 (s), 1447 (m), 1317 
(m), 801 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 269 (M+, 100), 254 (72), 151 (35), 136 (51), 119 (68), 91 (13). 
HRMS (EI): m/z calcd. for: [C18H23NO] 269.1780,  found: 269.1774. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 13.9 min [major], tr = 15.7 min 
[minor];  94% ee. 
 
(R)-(+)-N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-carbomethoxy)phenyl ethyl amine (57e)  
 
HN
OMe
MeO2C
 
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56e (156 mg; 0.50 mmol) and obtained as a yellow solid (150 mg, 0.48 
mmol, 96%). 
 
MP: 113.7-115.2 °C 
[α]D20 = +23.3 (c = 0.6, CH2Cl2) 
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1H-NMR (400 MHz, C6D6): δ = 8.09-8.07 (m, 2H), 7.15-7.14 (m, 2H), 6.08 (s, 2H), 4.18 (q, 
J = 6.8 Hz, 1H), 3.47 (s, 3H), 3.36 (s, 3H), 3.34 (br, 1H, NH), 2.16 (s, 6H), 1.08 (d, J = 6.8 
Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 166.5 151.4, 149.7, 143.4, 131.2, 130.3, 129.5, 126.1, 
114.0, 59.5, 53.6, 51.4, 24.6, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3350 (m), 2994 (w), 1713 (s), 1605 (m), 1431 (m), 1279 (s), 1220 
(s), 1114 (s), 1009 (s), 831 (s), 764 (s), 712 (s). 
MS (70 eV, EI): m/z (%) = 313 (M+, 94), 298 (90), 163 (100), 136 (80), 150 (41). 
HRMS (EI): m/z calcd. for: [C19H23NO3] 313.1678,  found: 313.1679. 
 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 25.2 min [minor], tr = 28.9 min 
[major];  94% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-trifluoromethyl)phenyl ethyl amine (57f)  
 
HN
OMe
F3C
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56f (161 mg; 0.50 mmol) and obtained as a yellow oil (155 mg, 0.48 mmol, 
96%). 
 
[α]D20 = +10.2 (c = 0.5, CH2Cl2) 
1H-NMR (300 MHz, CDCl3): δ = 7.57 (d, J = 8.4 Hz, 2H), 7.48 (d, J = 8.4 Hz, 2H), 6.20 (s, 
2H), 4.45 (q, J = 6.7 Hz, 1H), 3.60 (s, 3H), 2.14 (s, 6H), 1.50 (d, J = 6.7 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 149.4, 149.3, 142.3, 131.4, 129.6 ( q, J = 32.3 Hz), 126.3, 
125.6 (q, J = 3.8 Hz), 124.2 (q, J = 271.0 Hz), 113.8, 59.9, 54.1, 24.7, 16.2 ppm. 
IR (neat): υmax (cm−1) = 3349 (m), 2966 (w), 1605 (m), 1488 (m), 1323 (s), 1222 (s), 1155 
(s), 1062 (s), 1005 (s), 835 (s), 607 (m). 
MS (70 eV, EI): m/z (%) = 323 (M+, 100), 308 (77), 293 (11), 173 (33), 150 (21), 136 (4). 
HRMS (EI): m/z calcd.for: [C18H20F3NO] 323.1497,  found: 323.1481. 
 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 14.4 min [minor], tr = 18.5 min 
[major];  89% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-methoxy)phenyl ethyl amine (57g) 
 
HN
OMe
MeO
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Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56g (142 mg; 0.50 mmol) and obtained as a viscous yellow oil (136 mg, 
0.48 mmol, 96%). 
 
[α]D20 = +6.4 (c = 0.5, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.26-7.21 (m, 2H), 6.74-6.72 (m, 2H), 6.02 (s, 2H), 4.04 (q, 
J = 6.8 Hz, 1H), 3.85 (br, 1H, NH), 3.75 (s, 3H), 3.60 (s, 3H), 2.12 (s, 6H), 1.32 (d, J = 6.6 
Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 158.5, 151.6, 138.0, 136.4, 129.5, 122.4, 120.9, 114.1, 59.7, 
55.2, 52.4, 24.9, 16.6 ppm. 
IR (neat): υmax (cm−1) = 3406 (br, w), 2964 (m), 2920 (m), 1617 (s), 1500 (s), 1447 (m), 1317 
(m), 801 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 285 (M+, 50), 270 (20), 151 (30), 135 (100). 
HRMS (EI): m/z calcd. for: [C18H23NO2] 285.1729,  found: 285.1719. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 11.3 min [minor], tr = 12.9 min 
[major];  85% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-methoxy)phenyl ethyl amine (57h):  
 
HN
OMe
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56h (142 mg; 0.50 mmol) and obtained as a viscous oil (133 mg, 0.47 
mmol, 94%). 
 
[α]D20 = −4.6 (c = 0.5, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.23-7.11 (m, 1H), 6.98-6.71 (m, 2H), 6.67-6.60 (m, 1H), 
6.10 (s, 2H), 4.04 (q, J = 7.1 Hz, 1H), 3.71 (br, 1H, NH), 3.66 (s, 3H), 3.46 (s, 3H), 2.10 (s, 
6H), 1.46 (d, J = 7.0 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 158.1, 153.0, 138.2, 136.9, 130.1, 125.0, 122.4, 121.0, 
113.9, 112.8, 59.2, 55.1, 53.8, 25.7, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3416 (br, w), 2954 (m), 2922 (m), 1607 (s), 1487 (s), 1319 (m), 801 
(m), 689 (s). 
MS (70 eV, EI): m/z (%) = 285 (M+, 41), 270 (80), 151 (10), 135 (100). 
HRMS (EI): m/z calcd. for: [C18H23NO2] 285.1729,  found: 285.1731. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 18.7 min [minor], tr = 21.5 min 
[major];  86% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-fluoro)phenyl ethyl amine (57i)  
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HN
OMe
F
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56i (136 mg; 0.50 mmol) and obtained as a yellow oil (128 mg, 0.47 mmol, 
94%). 
 
[α]D20 = −12 (c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.03-7.00 (m, 1H), 6.91-6.88 (m, 2H), 6.72-6.67 (m, 1H), 
6.08 (s, 2H), 4.14 (q, J = 6.8 Hz, 1H), 3.37 (s, 3H), 3.28 (br, 1H, NH), 2.16 (s, 6H), 1.07 (d, J 
= 6.8 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 163.7 (d, J = 245.5 Hz), 149.7, 149.6 (d, J = 6.1 Hz), 143.4, 
131.2, 130.3 (d, J = 7.9 Hz), 121.7 (d, J = 2.6 Hz), 113.9, 113.8 (d, J = 21.3 Hz), 113.0 (d, J = 
21.6 Hz), 59.5, 53.4 (d, J = 1.8 Hz), 24.7, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3389 (br, w), 2927 (w), 1608 (m), 1485 (s), 1222 (s), 1009 (s), 835 
(m), 784 (s), 696 (s). 
MS (70 eV, EI): m/z (%) = 275 ([M+2H]+, 7), 274 ([M+H]+, 100), 193 (5). 
HRMS (EI): m/z calcd. for: [C17H21NFO]; [M+H]+ : 274.1607,  found: 274.1595 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 14.6 min [minor], tr = 18.0 min 
[major];  93% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-chloro)phenyl ethyl amine (57j) 
 
HN
OMe
Cl
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56j (144 mg; 0.50 mmol) and obtained as a yellow oil (139 mg, 0.48 mmol, 
96%). 
 
[α]D20 = +8.3 (c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.13-7.08 (m, 2H), 6.95-6.91 (m, 2H), 6.07 (s, 2H), 4.10 (q, 
J = 6.6 Hz, 1H), 3.38 (s, 3H), 3.27 (br, 1H, NH), 2.17 (s, 6H), 1.06 (d, J = 7.1 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.7, 144.5, 143.4, 132.6, 131.2, 128.9, 127.5, 114.0, 59.5, 
53.1, 24.8, 16.5 ppm. 
IR (neat): υmax (cm−1) = 2926 (w), 1608 (m), 1487 (s), 1337 (w), 1222 (s), 1090 (m), 1010 
(s), 825 (s), 730 (m), 695 (m). 
MS (70 eV, EI): m/z (%) = 289 (M+, 87), 276 (20), 274 (69), 150 (28), 139 (100), 136 (83). 
HRMS (EI): m/z calcd. for: [C17H20N35ClO] 289.1233,  found: 289.1227. 
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The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 13.7 min [minor], tr = 17.1 min 
[major];  92% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-chloro)phenyl ethyl amine (57k) 
 
HN
OMe
Cl
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56k (144 mg; 0.50 mmol) and obtained as a yellow oil (139 mg, 0.48 mmol, 
96%). 
 
[α]D20 = +11.2 (c = 0.4, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.06-7.01 (m, 1H), 6.90-6.71 (m, 2H), 6.69-6.60 (m, 1H), 
6.10 (s, 2H), 4.15 (q, J = 7.1 Hz, 1H), 3.36 (s, 3H), 3.21 (br, 1H, NH), 2.11 (s, 6H), 1.04 (d, J 
= 6.9 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 151.2, 137.6, 136.4, 132.8, 130.9, 127.9, 127.4, 127.0, 
125.9, 112.6, 59.6, 53.8, 25.4, 16.6 ppm. 
IR (neat): υmax (cm−1) = 2926 (w), 1606 (s), 1412 (m), 1262 (s), 1191 (m), 1010 (s), 945 (s), 
781 (m), 695 (m). 
MS (70 eV, EI): m/z (%) = 289 (M+, 61), 274 (32), 150 (22), 139 (100), 121 (26). 
HRMS (EI): m/z calcd. for: [C17H20N35ClO] 289.1233,  found: 289.1228. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 14.2 min [minor], tr = 18.4 min 
[major];  90% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(4-phenyl)phenyl ethyl amine (57l) 
 
HN
OMe
Ph
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56l (165 mg; 0.50 mmol) and obtained as a pale yellow powder (157 mg, 
0.47 mmol, 95%). 
 
MP: 156.2-157.9 °C 
[α]D20 = +48.7 (c = 0.6, CH2Cl2) 
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1H-NMR (400 MHz, C6D6): δ = 7.47-7.43 (m, 4H), 7.31-7.27 (m, 2H), 7.21-7.17 (m, 2H), 
7.13-7.09 (m, 1H), 6.20 (s, 2H), 4.34 (q, J = 6.7 Hz, 1H), 3.43 (br, 1H, NH), 3.38 (s, 3H), 2.19 
(s, 6H), 1.24 (d, J = 6.7 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.6, 145.2, 143.7, 141.5, 140.2, 131.2, 129.0, 127.7, 
127.4, 127.3, 126.6, 114.0, 59.5, 53.5, 25.0, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3354 (w), 2924 (w), 1604 (m), 1484 (s), 1217 (s), 998 (s), 827 (s), 
767 (s), 699 (s). 
MS (70 eV, EI): m/z (%) = 331 (M+, 41), 316 (24), 181 (100), 165 (19), 151 (26), 136 (32). 
HRMS (EI): m/z calcd. for: [C23H25NO] 331.1936,  found: 331.1930. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 17.5 min [minor], tr = 23.1 min 
[major];  92% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(2-naphthyl) ethyl amine (57m) 
 
HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56m (152 mg; 0.50 mmol) and obtained as a pale yellow oil (144 mg, 0.47 
mmol, 94%). 
 
[α]D20 = −22.4 (c = 0.6, CH2Cl2) 
1H-NMR (600 MHz, C6D6): δ = 7.73 (s, 1H), 7.63-7.60 (m, 3H), 7.35 (dd, J = 8.4 Hz, 1.6 
Hz, 1H), 7.24-7.21 (m, 2H), 6.20 (s, 2H), 4.43 (q, J = 6.7 Hz, 1H), 3.53 (br, NH, 1H), 3.35 (s, 
3H), 2.14 (s, 6H), 1.27 (d, J = 6.7 Hz, 3H) ppm. 
13C-NMR (150 MHz, C6D6): δ = 149.6, 143.8, 143.6, 134.2, 133.3, 131.2, 128.7, 128.1, 
127.9, 126.2, 125.6, 124.8, 124.6, 114.0, 59.5, 54.0, 24.9, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3405 (br, w), 2864 (m), 2910 (m), 1687 (s), 1510 (s), 1477 (m), 1297 
(m), 891 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 305 (M+, 56), 290 (30), 155 (100), 136 (35). 
HRMS (EI): m/z calcd. for: [C21H23NO] 305.1780,  found: 305.1785. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 9.1 min [minor], tr = 10.2 min 
[major];  92% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(3-acetyl)phenyl ethyl amine (57n)  
 
HN
OMe
COCH3
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Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56n (148 mg; 0.50 mmol) and obtained as a dark brown oil (138 mg, 0.46 
mmol, 92%). 
 
[α]D20 =  −14.8 (c = 0.50, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.94-7.90 (m, 2H), 7.82-7.54 (m, 3H), 7.29-7.25 (m, 2H), 
6.10 (s, 2H), 4.10 (q, J = 7.0 Hz, 1H), 3,54 (br, NH, 1H), 3.38 (s, 3H), 2.18 (s, 6H), 1.26 (d, J 
= 7.0 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 196.5, 151.2, 137.6, 134.6, 131.5, 128.2, 127.4, 127.0, 
126.8, 112.5, 59.4, 53.5, 26.5, 25.4, 16.6 ppm. 
IR (neat): υmax (cm−1) = 3405 (br, w), 2864 (m), 2910 (m), 1687 (s), 1510 (s), 1477 (m), 1297 
(m), 891 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 297 (M+, 100), 282 (91), 267 (10), 178 (13), 147 (85), 136 (90). 
HRMS (EI): m/z calcd. for: [C19H23NO2] 297.1729,  found: 297.1735. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 17.2 min [minor], tr = 19.5 min 
[major];  80% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(1,2,3,4-tetrahydro)naphthyl amine (57o) 
 
HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56o (139 mg; 0.50 mmol) and obtained as a brown oil (129 mg, 0.46 mmol, 
92%). 
 
[α]D20 = +18.4 (c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.44-7.42 (m, 1H), 7.10-7.06 (m, 2H), 6.98-6.95 (m, 1H), 
6.20 (s, 2H), 4.46-4.39 (m, 1H), 3.50 (s, 3H), 3.23 (br, 1H, NH), 2.63-2.46 (m, 2H), 2.26 (s, 
6H), 1.81-1.59 (m, 3H), 1.52-1.42 (m, 1H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.5, 144.0, 139.0, 137.5, 131.3, 129.7, 129.1, 127.3, 
126.3, 113.6, 59.6, 51.8, 29.6, 29.1, 19.6, 16.5 ppm. 
IR (neat): υmax (cm−1) = 2929 (w), 1605 (m), 1487 (m), 1222 (s), 1010 (s), 835 (m), 742 (s). 
MS (70 eV, EI): m/z (%) = 281 (M+, 62), 151 (46), 131 (100), 129 (12), 91 (18). 
HRMS (EI): m/z calcd. for: [C19H23NO] 281.1780,  found: 281.1780. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 9.2 min [major], tr = 10.2 min 
[minor];  84% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-(1,2,3,4-tetrahydro)naphthyl amine (57p) 
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HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56p (133 mg; 0.50 mmol) and obtained as a dark brown oil (73 mg, 0.27 
mmol, 54%). 
 
[α]D20 = +4.9 (c = 0.4, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.46-7.43 (m, 1H), 7.10-6.99 (m, 3H), 6.20 (s, 2H), 4.44-
4.40 (m, 1H), 3.52 (s, 3H), 3.23 (br, 1H, NH), 2.66-2.44 (m, 2H), 2.28 (s, 6H), 1.81-1.52 (m, 
2H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 150.1, 144.2, 140.0, 137.5, 131.4, 129.9, 129.1, 127.3, 
125.9, 112.6, 59.6, 51.8, 29.6, 19.6, 16.5 ppm. 
IR (neat): υmax (cm−1) = 2949 (w), 1622 (m), 1475 (s), 1298 (m), 1010 (m), 895 (m), 694 (m). 
MS (70 eV, EI): m/z (%) = 267 (M+, 35), 165 (31), 131 (100), 129 (12), 91 (18). 
HRMS (EI): m/z calcd. for: [C18H21NO] 267.1623,  found: 267.1630. 
The enantiomer ratio was determined by HPLC using Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 19.2 min [major], tr = 20.1 min 
[minor];  70% ee. 
 
(R)−N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl propyl amine (57q) 
 
HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56q (134 mg; 0.50 mmol) and obtained as a pale yellow oil (129 mg, 0.48 
mmol, 96%). 
 
[α]D20 = +2.0 (c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.18-7.17 (m, 1H), 7.13-7.09 (m, 3H), 7.02-6.98 (m, 1H), 
6.10 (s, 2H), 4.04 (t, J = 6.6 Hz, 1H), 3.43 (br, 1H, NH), 3.30 (s, 3H), 2.10 (s, 6H), 1.55-1.48 
(m, 2H), 0.75 (t, J = 7.4 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.5, 144.8, 144.0, 131.1, 128.7, 127.0, 126.7, 114.0, 60.1, 
59.5, 31.9, 16.5, 10.9 ppm. 
IR (neat): υmax (cm−1) = 3394 (br, w), 2930 (m), 1608 (m), 1487 (s), 1220 (s), 1009 (s), 835 
(m), 750 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 269 (M+, 21), 240 (100), 136 (9), 91 (15). 
HRMS (EI): m/z calcd. for: [C18H23NO] 269.1780,  found: 269.1791. 
The enantiomer ratio was determined by HPLC using Chiralcel AD column (flow rate 0.5 
mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 10.4 min [major], tr = 12.4 min 
[minor];  94% ee. 
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(R)-N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl-hexylamine (57r) 
 
HN
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56r (155 mg; 0.50 mmol) and obtained as a yellow oil (153 mg, 0.49 mmol, 
98%). 
 
[α]D20 = +2.4 (c = 0.5, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.24-7.22 (m, 2H), 7.14-7.12 (m, 2H), 7.04-7.00 (m, 1H), 
6.18 (s, 2H), 4.18 (t, J = 7.1 Hz, 1H), 3.52 (br, NH), 3.34 (s, 3H), 2.14 (s, 6H), 1.58-1.52 (m, 
2H), 1.32-1.15 (m, 6H), 0.82 (t, J = 7.0 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.5, 145.3, 144.0, 131.1, 128.7, 127.0, 126.7, 114.0, 59.5, 
58.8, 39.3, 32.1, 26.4, 22.9, 16.5, 14.2 ppm. 
IR (neat): υmax (cm−1) = 2928 (m), 1608 (m), 1488 (m), 1222 (s), 1011 (m), 832 (m), 755 
(m), 698 (s). 
MS (70 eV, EI): m/z (%) = 327 (M+, 37), 241 (100), 226 (8), 117 (17). 
HRMS (EI): m/z calcd. for: [C21H29NO] 311.2249,  found: 311.2248. 
The enantiomer ratio was determined by HPLC using a Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 11.0 min [minor], tr = 12.3 min 
[major];  95% ee. 
 
(R)-N-(3,5-Dimethyl-4-methoxy)phenyl-1-phenyl-hexylamine (57s) 
 
HN
Ph
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56s (172 mg; 0.50 mmol) and obtained as a yellow oil (169 mg, 0.49 mmol, 
98%). 
 
[α]D20 = +6.9 (c = 0.5, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.44-7.14 (m, 6H), 7.00-6.82 (m, 4H), 6.18 (s, 2H), 4.16 (t, J 
= 7.1 Hz, 1H), 3.50 (br, NH, 1H), 3.43 (s, 3H), 2.80-2.69 (m, 2H) 2.34 (s, 6H), 2.12 (t, J = 7.0 
Hz, 2H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 149.5, 146.5, 145.3, 144.0, 138.2, 131.1, 130.3, 128.7, 
127.0, 126.7, 125.4, 114.2, 59.5, 58.8, 26.4, 24.2, 16.5, ppm. 
IR (neat): υmax (cm−1) = 2918 (m), 1600 (m), 1425 (m), 1202 (s), 1142 (m), 864 (m), 698 (s). 
MS (70 eV, EI): m/z (%) = 345 (M+, 41), 241 (100), 226 (22), 117 (71). 
HRMS (EI): m/z calcd. for: [C24H27NO] 345.2093,  found: 345.2081. 
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The enantiomer ratio was determined by HPLC using a Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 11.0 min [minor], tr = 12.3 min 
[major];  95% ee. 
 
(R) −5-[(N-(3,5-Dimethyl-4-methoxy)phenyl)amino]-1,5-diphenylpentan-1-one (57t) 
 
HN O
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56t (193 mg; 0.50 mmol) and obtained as a dark brown oil (184 mg, 0.47 
mmol, 95%). 
 
[α]D20 = −11 (c = 0.4, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.82-7.80 (m, 2H), 7.28-7.26 (m, 2H), 7.18-7.17 (m, 1H), 
7.14-7.11 (m, 2H), 7.09-7.02 (m, 3H), 6.24 (s, 2H), 4.25 (t, J = 6.7 Hz, 1H), 3.83 (br, NH), 
3.37 (s, 3H), 2.48-2.46 (m, 2H), 2.17 (s, 6H), 1.87-1.81 (m, 1H), 1.68-1.59 (m, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 198.7, 149.5, 145.1, 144.0, 137.5, 132.7, 131.1, 128.8, 
128.6, 128.2, 127.0, 126.7, 114.0, 59.5, 58.7, 38.6, 37.8, 21.0, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3010 (w), 1788 (m), 1685 (s), 1129 (m), 1155 (s), 1009 (m), 795 
(m). 
MS (70 eV, EI): m/z (%) = 389 ([M+2H]+, 22), 388 ([M+H]+, 100), 237 (15). 
HRMS (EI): m/z calcd. for: [C26H30NO2] 388.2270,  found: 388.2277. 
The enantiomer ratio was determined by HPLC using a Chiralcel AD column (flow rate 0.2 
mL/min, heptane/iPrOH: 80/20, λ= 215 nm, 25 °C); tr = 57.0 min [major], tr = 64.5 min 
[minor];  99% ee. 
 
(R)-Methyl 4-[(N-(3,5-dimethyl-4-methoxy)phenyl)amino]-4-phenyl butanoate (57u) 
 
HN
OMe
O
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56u (163 mg; 0.50 mmol) and obtained as a brown oil (154 mg, 0.47 mmol, 
94%). 
 
[α]D20 = +21 ( c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.17 (s, 1H), 7.13-7.09 (m, 2H), 7.04-7.00 (m, 2H), 6.19 (s, 
2H), 4.24 (t, J = 6.8 Hz, 1H), 3.72 (br, NH), 3.35 (s, 3H), 3.30 (s, 3H), 2.80 (t, J = 6.8 Hz, 
1H), 2.53 (t, J = 6.4 Hz, 1H), 2.21-2.16 (m, 2H), 2.15 (s, 6H) ppm. 
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13C-NMR (100 MHz, C6D6): δ = 173.5, 149.6, 143.7, 132.8, 131.1, 128.8, 128.5, 126.6, 
114.0, 59.4, 58.1, 51.1, 33.6, 31.1, 16.5 ppm. 
IR (neat): υmax (cm−1) = 3393 (br, w), 2949 (w), 1732 (s), 1488 (s), 1220 (s), 1162 (s), 1009 
(s), 837 (m), 750 (s), 700 (s). 
MS (70 eV, EI): m/z (%) = 327 (M+, 37), 241 (100), 226 (8), 117 (17). 
HRMS (EI): m/z calcd. for: [C20H25NO3] 327.1834,  found: 327.1825. 
The enantiomer ratio was determined by HPLC using a Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 80/20, λ= 215 nm, 25 °C);  
tr = 19.5 min [major], tr = 25.3 min [minor];  92% ee. 
 
(R)-Methyl 5-[(N-(3,5-dimethyl-4-methoxy)phenyl)amino]-4-phenyl pentanoate (57v) 
 
HN
CO2Me
OMe
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56v (170 mg; 0.50 mmol) and obtained as a yellow oil (164 mg, 0.48 mmol, 
96%). 
 
[α]D20 = +8 (c = 0.6, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.21-7.19 (m, 2H), 7.16-7.12 (m, 2H), 7.05-7.03 (m, 1H), 
6.19 (s, 2H), 4.17 (t, J = 6.2 Hz, 1H) 3.62 (br, NH), 3.37 (s, 3H), 3.30 (s, 3H), 2.17 (s, 6H), 
2.04-2.01 (m, 2H), 1.68-1.64 (m, 1H), 1.53-1.51 (m, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 173.1, 149.5, 144.8, 143.8, 131.1, 128.7, 127.1, 126.6, 
113.9, 59.5, 58.4, 50.9, 38.4, 33.6, 22.0, 16.5 ppm. 
IR (neat): υmax (cm−1) = 2949 (w), 1732 (s), 1684 (m), 1488 (m), 1222 (s), 1152 (m), 1010 
(m), 753 (m), 700 (s). 
MS (70 eV, EI): m/z (%) = 341 (M+, 100), 310 (13), 241 (45), 240 (46), 225 (18). 
HRMS (EI): m/z calcd. for: [C21H27NO3] 341.1991,  found: 341.1979. 
The enantiomer ratio was determined by HPLC using a Chiralcel OD-H column (flow rate 0.5 
mL/min, heptane/iPrOH: 80/20, λ= 215 nm, 25 °C); tr = 16.1 min [minor], tr = 17.3 min 
[major];  98% ee. 
 
N-(3,5-dimethyl-4-methoxyphenyl)-1-(3,4-dimethyl)phenyl ethylamine (57w) 
 
HN
OMe
Cl
Cl
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 57w (162 mg; 0.50 mmol) and obtained as a yellow oil (156 mg, 0.48 
mmol, 96%) 
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[α]D20 = +18.2 (c = 0.5, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.51-7.45 (m, 2H), 6.94 (s, 1H), 6.10 (s, 2H), 4.11 (q, J = 
6.8 Hz, 1H), 3.88 (brs, NH, 1H), 3.43 (s, 3H), 2.22 (s, 6H), 2.00 (d, J = 7.0 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 152.2, 145.2, 140.5, 136.2, 135.2, 134.1, 132.2, 130.5, 
125.2, 114.0, 56.6, 55.5, 16.7, 16.0 ppm. 
IR (neat): υmax (cm−1) = 2992 (w), 1664 (m), 1592 (m), 1434 (m), 1325 (m), 1212 (m), 1062 
(s), 879 (s), 76o (m), 654 (s). 
MS (70 eV, EI): m/z (%) = 323 (M+, 59), 268 (19), 253 (100), 151 (16). 
HRMS (EI): m/z calcd. for: [C17H19NOCl2] 323.0844,  found: 323.0852. 
 
N-(3,5-dimethyl-4-methoxyphenyl)-1-(3,4-dimethoxy)phenyl ethylamine (57x) 
 
HN
OMe
MeO
MeO
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56x (157 mg; 0.50 mmol) and obtained as a yellow oil (149 mg, 0.47 mmol, 
94%) 
 
[α]D20 = +12.7 (c = 0.5, CH2Cl2) 
1H-NMR (400 MHz, C6D6): δ = 7.21 (d, J = 2.2 Hz, 1H), 7.18 (d, J = 8.3 Hz, 1H), 7.10-7.05 
(m, 1H), 6.11 (s, 2H), 4.25 (q, J = 7.1 Hz, 1H), 3.90 (brs, NH, 1H), 3.51 (s, 3H), 3.43 (s, 3H), 
3.40 (s, 3H), 2.25 (s, 6H), 1.08 (d, J = 6.9 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 152.5, 147.2, 145.2, 141.0, 135.6, 132.4, 126.2, 124.2, 
120.4, 112.8, 56.8, 56.6, 56.3, 56.2, 23.7, 16.6 ppm. 
IR (neat): υmax (cm−1) = 2935 (w), 2959 (w), 1620 (w), 1594 (m), 1583 (s), 1510 (s), 1452 
(m), 1414 (s), 1267 (s), 1217 (s), 1153 (s), 1018 (s), 867 (S), 765 (m). 
MS (70 eV, EI): m/z (%) = 314 ([M+H]+, 12), 339 (M+, 55), 299 (18), 298 (100), 268 (6). 
HRMS (EI): m/z calcd. for: [C19H25NO3] 313.1678,  found: 313.1665. 
 
N-(3,5-dimethyl-4-methoxyphenyl)-1-(3,4-dimethyl)phenyl ethylamine (57y) 
 
HN
OMe
*
 
 
Prepared according to the typical procedure TP8, using the iridium catalyst 46a (9.0 mg; 0.05 
mmol) and imine 56y (140 mg; 0.50 mmol) and obtained as a yellow oil (134 mg, 0.47 mmol, 
94%) 
 
[α]D20 = +4.5 (c = 0.5, CH2Cl2) 
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1H-NMR (400 MHz, C6D6): δ = 7.22-7.18 (m, 1H), 7.10-7.06 (m, 1H), 6.94 (d, J = 8.2 Hz, 
1H), 6.32 (s, 2H), 4.12 (q, J = 7.0 Hz, 1H), 3.85 (brs, NH, 1H), 3.42 (s, 3H), 2.34 (s, 3H), 2.30 
(s, 3H), 2.25 (s, 6H), 1.00 (d, J = 7.0 Hz, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 151.2, 140.2, 139.2, 135.4, 128.3, 124.2, 120.1, 111.2, 59.4, 
55.2, 23.2, 21.5, 16.7, 16.4 ppm. 
IR (neat): υmax (cm−1) = 2912 (w), 1645 (w), 1585 (m), 1464 (m), 1398 (m), 1208 (m), 1118 
(s), 1002 (s), 879 (s), 765 (m). 
MS (70 eV, EI): m/z (%) = 283 (M+, 25), 268 (21), 253 (100), 151 (12). 
HRMS (EI): m/z calcd. for: [C19H25NO] 283.1936,  found: 283.1665. 
 
8. Synthesis of Chrial Primary Amines and Lactams 
 
(R)−α-methyl benzylamine (58)136 
 
NH2
 
 
Prepared according to the typical procedure TP9, using the chiral secondary amine 57a (102 
mg; 0.40 mmol) and cerium ammonium nitrate (880 mg; 1.6 mmol; 4.0 equiv) and obtained 
as a yellow oil (42 mg, 0.34 mmol, 85%). 
 
[α]D20 = +28.9 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 1.58 (d, J = 6.8 Hz, 3H), 1.68 (br, 2H), 4.25 (q, J = 6.8 Hz, 
1H), 7.30-7.43 (m, 5H) ppm. 
 
(R)−α-methyl benzylamine (59)137 
 
NH2
Cl
 
 
Prepared according to the typical procedure TP9, using the chiral secondary amine 57j (116 
mg; 0.40 mmol) and cerium ammonium nitrate (880 mg; 1.6 mmol; 4.0 equiv) and obtained 
as a yellow oil (51 mg; 0.33 mmol, 82%). 
 
[α]D20 = +18.9 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 1.48 (d, J = 7.0 Hz, 3H), 1.62 (br, 2H), 4.21 (q, J = 6.9 Hz, 
1H), 7.15-7.17 (m, 2H), 7.87-7.99 (m, 2H) ppm. 
 
(R)−Methyl-4-(1-aminoethyl)benzoate ester (60)138  
                                                 
136
 Chi, Y.; Zhou, Y.; Zhang, X. J. Org. Chem. 2003, 10, 4120. 
137
 Mereyala, H. B.; Pola, P. Tetrahedron: Asymmetry 2003, 14, 2683. 
138
 Shawn, I. P.; McWilliams, J.; Secord, C.; Elizabeth, A.; Dale, M. R.; Todd, N. D.; Kress, M. H. Tetrahedron 
Lett. 2006, 47, 6409. 
Experimental Section   163
NH2
O
MeO
 
 
Prepared according to the typical procedure TP9, using the chiral secondary amine 57e (126 
mg; 0.40 mmol) and cerium ammonium nitrate (880 mg; 1.6 mmol; 4.0 equiv) and obtained 
as a yellow oil (63 mg; 0.35 mmol, 87%). 
 
[α]D20 = +21.9 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.99-7.87 (m, 2H), 7.17-7.15 (m, 2H), 4.20 (q, J = 6.9 Hz, 
1H), 3.38 (s, 3H), 1.60 (br, 2H), 1.48 (d, J = 7.0 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 166.8, 151.4, 129.1, 127.0, 126.1, 52.6, 51.8, 25.8 ppm. 
MS (70 eV, EI): m/z (%) = 179 (M+, 18), 121 (20), 107 (18), 106 (100), 91 (2). 
HRMS (EI): m/z calcd. for: [C10H13NO2] 179.2158,  found: 179.2165. 
 
(R)-1-Phenyl-1-propylamine (61)7 
 
NH2
 
 
Prepared according to the typical procedure TP9, using the chiral secondary amine 57q (108 
mg; 0.40 mmol) and cerium ammonium nitrate (880 mg; 1.6 mmol; 4.0 equiv) and obtained 
as a yellow oil (44 mg; 0.32 mmol, 80%). 
 
1H-NMR (300 MHz, CDCl3): 7.39-7.15 (m, 5H), 3.80 (t, J = 6.8 Hz, 1H), 1.75 (m, 2H), 1.60 
(s, 2H), 0.88 (t, J = 7.1 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): 144.2, 131.1, 127.0, 126.4, 55.0, 32.5, 12.5 ppm. 
[α]D20 = + 10.8 (c = 1.0, EtOH) 
MS (70 eV, EI): m/z (%) = 135 (M+, 2), 121 (10), 106 (100), 91 (40). 
HRMS (EI): m/z calcd. for: [C9H13N]  135.1048  found   135.1040 
 
(R)-(+)-1-Phenyl-1-hexanamine (62)139 
 
NH2
 
 
Prepared according to the typical procedure TP9, using the chiral secondary amine 57r (125 
mg; 0.40 mmol) and cerium ammonium nitrate (880 mg; 1.6 mmol; 4.0 equiv) and obtained 
as a pale yellow oil (55 mg; 0.31 mmol, 78%). 
 
[α]D20 = +4.8 (c = 1.6, EtOH) 
1H-NMR (300 MHz, CDCl3): 7.32-7.10 (m, 5H), 3.85 (t, J = 6.8 Hz, 1H), 1.80-1.00 (m, 
10H), 0.84 (t, J = 7.0 Hz, 1H) ppm. 
                                                 
139
 Bataille, P.; Paterne, M.; Brown, E. Tetrahedron: Asymmetry 1998, 9, 2181. 
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13C-NMR (75 MHz, CDCl3): 144.0, 131.1, 127.0, 126.7, 55.1, 14.1, 38.5, 32.6, 27.1, 22.5 
ppm. 
MS (70 eV, EI): m/z (%) = 177 (M+, 5), 160 (6), 118 (12), 106 (100), 91 (36). 
HRMS (EI): m/z calcd. for: [C12H19N]  177.1517  found   177.1521 
 
(R)-5-Phenylpyrrolidin-2-one (63)140 
 
HN
O
 
 
 
Prepared according to the typical procedure TP9, using the chiral secondary amine 57u (131 
mg; 0.40 mmol) and cerium ammonium nitrate (880 mg; 1.6 mmol; 4.0 equiv) and obtained 
as a pale yellow oil (46 mg; 0.29 mmol, 72%). 
 
[α]D20 = +41.0 (c = 0.4, CH2Cl2) 
1H-NMR (300 MHz, CDCl3): δ = 1.97-2.11 (m, 1H), 2.40-2.72 (m, 3H), 4.82 (t, J = 7.0 Hz, 
1H), 6.70 (brs, NH), 7.34-7.48 (m, 5H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 30.9, 31.4, 58.2, 125.8, 127.8, 128.9, 143.0, 178.9 ppm. 
MS (70 eV, EI): m/z (%) = 161 (M+, 67), 117 (100), 104 (8), 77 (17). 
HRMS (EI): m/z calcd. for: [C10H11NO] 161.0841,  found: 161.0843. 
The enantiomer ratio was determined by Chiral GC using a Chiral DEX-CB column (100 °C 
(5), 5 °C/min to 160 °C (60) )tr = 36.7 min [major], tr = 41.0 min [minor];  92% ee. 
 
(R)-6-Phenylpiperidin-2-one (64)141 
 
HN
O
 
 
Prepared according to the typical procedure TP9, using the chiral secondary amine 57v (137 
mg; 0.40 mmol) and cerium ammonium nitrate (880 mg; 1.6 mmol; 4.0 equiv) and obtained 
as a yellow oil (55 mg; 0.31 mmol, 78%). 
 
MP: 118-119 °C 
[α]D20 = +40.0 (c = 2.0, CHCl3) 
1H-NMR (400 MHz, C6D6): δ = 1.19-1.27 (m, 2H), 1.42-1.48 (m, 2H), 2.04-2.11 (m, 1H), 
2.15-2.22 (m, 1H), 3.94-3.97 (m, 1H), 6.80 (br, s, NH), 6.98-7.06 (m, 3H), 7.09-7.13 (m, 2H) 
ppm. 
13C-NMR (100 MHz, C6D6): δ = 19.6, 31.2, 32.1, 57.3, 126.4, 127.5, 128.7, 143.7, 171.4 
ppm. 
IR (neat): υmax (cm−1) = 3266 (br, w), 2955 (w), 1655 (s), 1623 (s), 1478 (s), 1355 (s), 1175 
(m), 737 (s), 695 (s). 
                                                 
140
 Ramachandran, P. V.; Burghardt, T. E. Chem. Eur. J. 2005, 11, 4387. 
141
 Davis, F. A.; Chao, B.; Fang, T.; Szewczyk, J. M. Org. Lett. 2000, 2, 1041. 
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MS (70 eV, EI): m/z (%) = 176 ([M+H]+, 12), 175 (M+, 100), 119 (26), 106 (34), 98 (10), 77 
(11). 
HRMS (EI): m/z calcd. for: [C11H13NO]  175.0997  found   175.0989 
The enantiomer ratio was determined by Chiral GC using a Chiral DEX-CB column (100 °C 
(5), 5 °C/min to 160 °C (60) ) 
tr = 38.7 min [minor], tr = 40.8 min [major];  97% ee. 
 
9. Synthesis of bisferrocenyl P,P-ligands  
 
(SFc, S)-[2-(Formyl)-ferrocen-1-yl]-p-tolylsulfoxide (65) 
 
CHO
SOTol
Fe
 
 
Prepared according to the TP1 using sulfoxide 14 (1.30 g; 4.0 mmol), THF (40 mL), LDA 
(2.2 mL, 4.4 mmol).  The reaction mixture stirred at -78 °C for 30 min and added DMF (0.45 
mL; 6.0 mmol; 1.5 equiv) as an electrophile and stirred for 1h at -78 °C.  The reaction mixture 
was warmed to room temperature and stirred for 1 h before quenching with a Sat. NH4Cl 
solution (20 mL).  After the typical work-up, the crude product was purified by flash 
chromatography (silica gel, n-pentane:Et2O 1:1), provided the desired compound (1.13 g, 3.20 
mmol, 80 %) as a red solid. 
 
MP: 149.1-149.8 °C  
[α]D20 = −188 (c = 0.1, acetone). 
1H-NMR (300 MHz, C6D6): δ = 11.05 (s, 1H), 7.47 (d, J = 8.4 Hz, 2H), 6.78 (d, J = 8.4 Hz, 
2H), 4.81 (s, 1H), 4.34 (s, 1H), 4.17 (s, 5H), 3.98-3.97 (m, 1H), 1.89 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 191.7, 144.4, 140.6, 129.9, 124.0, 98.5, 79.4, 73.8, 72.5, 
71.7, 70.3, 21.0 ppm. 
IR(KBr): υmax (cm−1) = 3436 (br, w), 3093 (w), 1673 (s), 1435 (m), 1227 (m), 1033 (s), 817 
(m), 754 (m). 
MS (70 eV, EI): m/z (%) = 352 (M+, 100), 335 (21), 244 (54), 211 (20). 
HRMS (EI): m/z calcd. for: [C18H1656FeO232S] 352.0220,  found: 352.0211 
 
(SFc)-1-[(S)-p-Tolylsulfinyl]-2-[α-hydroxy-((SFc)-1-((S)-p-tolylsulfinyl))ferrocenyl]met- -
hylferrocene (66)  
 
Fe
OH
SOTol
SOTol
Fe
 
 
 
Prepared according to the TP1 using sulfoxide 14 (260 mg; 0.80 mmol), THF (8 mL), LDA 
(0.44 mL; 0.88 mmol, 1.1 equiv).  The reaction mixture stirred at -78 °C for 30 min and added 
ferrocenyl aldehyde 65 (340 mg; 0.96 mmol; 1.2 equiv) as an electrophile and stirred for 1.5 h 
at -78 °C.  The reaction mixture was warmed to room temperature and stirred for 1 h before 
quenching with a saturated aquesous NH4Cl solution (15 mL).  After the typical work-up, the 
crude product was purified by flash chromatography (silica gel, Et2O), provided the 
bisferrocenyl alcohol 66 (243 mg, 0.48 mmol, 60 %) as a yellow solid. 
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MP: 129.1-130.2 °C  
[α]D20 = −4.2 (c = 0.1, acetone) 
1H-NMR (300 MHz, C6D6): δ = 8.26-8.24 (m, 2H), 7.95-7.92 (m, 2H), 7.11-7.04 (m, 4H), 
6.01 (d, J = 12.0 Hz, 1H), 5.90 (d, J = 11.5 Hz, 1H), 4.94-4.90 (m, 2H), 4.20 (s, 5H), 4.09-
4.06 (m, 1H), 3.99 (s, 5H), 3.89-3.80 (m, 2H), 3.77-3.74 (m, 1H), 2.10 (s, 3H), 2.06 (s, 3H) 
ppm. 
13C-NMR (75 MHz, C6D6): δ = 148.5, 147.2, 146.8, 145.4, 135.2, 134.7, 130.2, 127.8, 99.9, 
99.0, 85.4, 84.7, 77.8, 76.2, 76.0, 74.5, 73.2, 72.4, 71.9, 71.2, 70.9, 24.2, 23.8 ppm. 
IR (KBr): υmax (cm−1) = 3463 (br, w), 2793 (m), 1665 (m), 1598 (m), 1435 (m), 1389 (m), 
1212 (m), 1063 (s), 817 (m), 754 (m). 
MS (70 eV, EI): m/z (%) = 676 (M+, 60), 659 (100), 324 (55), 211 (10). 
HRMS (EI): m/z calcd. for: [C35H3256Fe2O332S2] 676.0492,  found: 676.0500 
 
(SFc)-1-[(S)-p-Tolylsulfinyl]-2-[α-methoxy-((SFc)-1-((S)-p-tolylsulfinyl))ferrocenyl]met- -
hylferrocene (67)  
 
Fe
OMe
SOTol
SOTol
Fe
 
 
 
Prepared according to the typical procedure TP4, using KH (19 mg, 0.45 mmol, 1.50 equiv.) 
in THF (2.0 mL), bisferrocenyl alcohol 66 (203 mg, 0.3 mmol) in THF (1.0 mL) and CH3I 
(135 mg; 0.05 mL, 0.90 mmol, 3.0 equiv).  After quenching the reaction mixture with a 
saturated aqueous NH4Cl solution (5 mL) and typical work-up, the residue was purified by 
flash chromatography (silica gel, Et2O) to furnish the methyl ether 68 (176 mg, 0.26 mmol, 85 
%) as a yellow solid. 
 
MP: 140.6-142.1 °C  
[α]D20 = −6.4 (c = 0.1, acetone). 
1H-NMR (300 MHz, C6D6): δ = 8.16 (d, J = 8.8 Hz, 2H), 7.84 (d, J = 8.0 Hz, 2H), 6.94 (d, J 
= 8.0 Hz, 4H), 5.91 (s, 1H), 4.92-4.90 (m, 1H), 4.40-4.36 (m, 1H), 4.17 (s, 5H), 4.40-3.97 (m, 
1H), 3.90 (s, 5H), 3.88-3.86 (m, 1H), 3.82-3.81 (m, 1H), 3.77-3.75 (m, 1H), 3.74 (s, 3H), 2.04 
(s, 3H), 2.01 (s, 3H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 146.2, 144.2, 141.3, 141.1, 130.2, 130.1, 125.6, 124.2, 99.1, 
98.8, 80.2, 79.4, 75.4, 74.8, 74.2, 72.5, 72.0, 71.9, 71.0, 70.2, 70.0, 59.7, 23.0, 21.2 ppm 
IR(KBr): υmax (cm−1) = 3436 (br, w), 3086 (w), 1632 (w), 1492 (w), 1108 (m), 1089 (s), 
1039 (s), 813 (s). 
MS (70 eV, EI): m/z (%) = 690 (M+, 7), 628 (17), 625 (19), 507 (32), 506 (98), 384 (30), 383 
(100). 
HRMS (EI): m/z calcd. for: [C36H3456Fe2O332S2] 690.0648,  found: 690.0608 
 
(RFc)-1-(Diphenylphosphinothioyl)-2-ferrocenylcarboxaldehyde (68) 
 
P(S)Ph2
CHO
Fe
 
 
Prepared according to the TP3 using sulfoxide 30 (1.62 g; 3.0 mmol), THF (40 mL), PhLi (18 
mL, 3.6 mmol).  The reaction mixture stirred at -78 °C for 10 min and added DMF (0.35 mL; 
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6.0 mmol; 1.5 equiv) as an electrophile and stirred for 1h at -78 °C.  The reaction mixture was 
warmed to room temperature and stirred for 1 h before quenching with a Sat. NH4Cl solution 
(20 mL).  After the typical work-up, the crude product was purified by flash chromatography 
(silica gel, n-pentane:Et2O 1:1), provided the desired compound (840 mg, 1.95 mmol, 65 %) 
as a red oil. 
 
[α]D20 = +68.1 (c = 0.1, acetone). 
1H-NMR (300 MHz, C6D6): δ = 11.25 (s, 1H), 7.88-7.80 (m, 2H), 7.72-7.65 (m, 2H), 7.05-
7.00 (m, 3H), 6.92-6.89 (m, 3H), 5.17-5.15 (m, 1H), 4.21 (s, 5H), 4.04-4.03 (m, 1H), 3.82-
3.80 (m, 1H) ppm. 
13C-NMR (75 MHz, C6D6): δ = 193.4, 135.7 (d, J = 87.1 Hz), 133.9 (d, J = 85.6 Hz, 1H), 
132.4 (d, J = 11.0 Hz), 132.0 (d, J = 10.6 Hz), 131.4 (d, J = 2.9 Hz), 131.4 (d, J = 2.9 Hz), 
128.6 (d, J = 12.7 Hz), 128.1 (d, J = 13.0 Hz), 83.9 (d, J = 10.1 Hz), 80.2 (d, J = 90.2 Hz), 
79.2 (d, J = 10.8 Hz), 72.8 (d, J = 9.7 Hz), 72.3 (d, J = 7.6 Hz), 72.0 ppm. 
IR(neat): υmax (cm−1) = 3436 (br, w), 2921 (w), 1664 (s), 1437 (m), 1243 (m), 1101 (m), 830 
(w), 717 (m), 656 (m). 
MS (70 eV, EI): m/z (%) = 430 (M+, 100), 402 (39), 365 (29), 338 (17), 337 (82). 
HRMS (EI): m/z calcd. for: [C23H1956FeOP32S] 430.0244,  found: 430.0239 
 
(RFc)-1-Diphenylphosphinothioyl-2-[α-hydroxy-((RFc)-1-(diphenylphosphinothioyl)) 
ferrocenyl]methylferrocene (69)  
 
Fe
OH
Ph2P
Ph2P
S
S
Fe
 
 
Prepared according to the TP3 using sulfoxide 30 (270 mg; 0.5 mmol), THF (5 mL), PhLi ( 3 
mL; 0.6 mmo, 1.2 equiv).  The reaction mixture stirred at -78 °C for 10 min and 
ferrocenylaldehyde 68 (259 mg; 0.6 mmol; 1.2 equiv) as an electrophile and stirred for 1.5 h 
at -78 °C.  The reaction mixture was warmed to room temperature and stirred for 2 h before 
quenching with a saturated aqueous NH4Cl solution (10 mL).  After the typical work-up, the 
crude product was purified by flash chromatography (silica gel, n-pentane:Et2O 10:1), 
provided the desired compound (230 mg, 0.28 mmol, 55 %) as a yellow solid. 
 
MP: 281 °C (decomposed) 
[α]D20 = +12 (c = 0.1, acetone). 
1H-NMR (400 MHz, C6D6): δ = 7.74-7.60 (m, 4H), 7.48-7.25 (m, 16H), 6.20 (d, J = 12.5 Hz, 
1H), 5.81 (d, J = 11.5 Hz, 1H), 4.74-4.73 (m, 2H), 4.66-4.65 (m, 2H), 4.30 (s, 5H), 4.27 (s, 
5H), 3.31-3.28 (m, 2H), 3.19-3.15 (m, 2H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 139.1 (d, J = 86.8 Hz), 137.4 (d, J = 87.9 Hz), 137.3 (d, J = 
86.3 Hz), 135.9 (d, J = 86.0 Hz), 133.7 (d, J = 10.9 Hz), 133.5 (d, J = 7.9 Hz), 132.6 (d, J = 
8.0 Hz), 131.7 (d, J = 11.4 Hz), 131.2 (d, J = 2.8 Hz), 130.9 (d, J = 3.8 Hz), 130.0 (d, J = 2.9 
Hz), 129.1 (d, J = 3.2 Hz), 128.9 (d, J = 9.9 Hz), 126.9 (d, J = 11.1 Hz), 98.6 (d, J = 13.2 Hz), 
96.0 (d, J = 10.5 Hz), 76.9 (d, J = 13.1 Hz), 75.4 (d, J = 9.2 Hz), 75.0, 74.8 (d, J = 94.9 Hz), 
73.7 (d, J = 11.2 Hz), 73.0 (d, J = 9.9 Hz), 72.9 (d, J = 9.8 Hz), 71.9 (d, J = 5.4 Hz), 71.8 (d, J 
= 92.8 Hz), 71.9, 71.2, 69.9 (d J = 11.9 Hz), 69.1 (d, J = 10.6 Hz) ppm 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 1619 (m), 1452 (m), 1338 (m), 1100 (m), 
828 (m), 797 (m), 714 (m), 694 (m). 
MS (70 eV, EI): m/z (%) = 832 (M+, 40), 817 (100), 695 (14), 445 (29). 
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HRMS (EI): m/z calcd. for: [C18H1656FeO232S] 832.0538,  found: 832.0530 
 
(RFc)-1-Bromo-2-[α-hydroxy-((RFc)-1-(diphenylphosphinothioyl)) ferrocenyl]methyl- 
ferrocene (70) 
 
Fe
OH
Ph2P
Br
Fe
S
 
 
Prepared according to the TP3 using sulfoxide 30 (1.10 g; 2.0 mmol), THF (10 mL), PhLi (11 
mL; 2.2 mmol).  The reaction mixture stirred at -78 °C for 10 min and added 1-bromo-2-
ferrocenylcarboxaldehyde 20b (645 mg; 2.2 mmol; 1.2 equiv) as an electrophile and stirred 
for 1h at -78 °C.  The reaction mixture was warmed to room temperature and stirred for 2 h 
before quenching with a saturated aqueous NH4Cl solution (20 mL).  After the typical work-
up, the crude product was purified by flash chromatography (silica gel, n-pentane:Et2O 8:1), 
provided the desired compound (807 mg, 1.16 mmol, 58%) as a yellow solid. 
 
MP: 171-172.8 °C 
[α]D20 = +61.2 (c = 0.2, acetone). 
1H-NMR (400 MHz, C6D6): δ = 7.74-7.60 (m, 4H), 7.48-7.25 (m, 16H), 6.20 (d, J = 12.5 Hz, 
1H), 5.81 (d, J = 11.5 Hz, 1H), 4.74-4.73 (m, 2H), 4.66-4.65 (m, 2H), 4.30 (s, 5H), 4.27 (s, 
5H), 3.31-3.28 (m, 2H), 3.19-3.15 (m, 2H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 138.7 (d, J = 89.5 Hz), 136.4 (d, J = 85.2 Hz), 134.2 (d, J = 
10.5 Hz), 134.0 (d, J = 10.7 Hz), 132.0 (d, J = 3.0 Hz), 131.4 (d, J = 2.8 Hz), 129.2 (d, J = 
12.1 Hz), 128.5 (d, J = 13.1 Hz), 95.2 (d, J = 12.1 Hz), 91.4, 81.2, 77.2 (d, J = 12.2 Hz), 75.2 
(d, J = 95.2 Hz), 73.8, 73.0 (d, J = 9.1 Hz), 72.1, 71.9, 70.5, 70.0 (d, J = 10.5 Hz), 67.2, 66.7 
ppm 
31P-NMR (81 MHz, C6D6): δ =+43.19 ppm 
IR (KBr-Pressling): υmax (cm−1) = 3440 (br, w), 2972 (w), 1678 (m), 1629 (w), 1400 (m), 
1378 (m), 1101 (s), 925 (s), 832 (s), 797 (s), 614 (s) 
MS (70 eV, EI): m/z (%) = 694 (M+, 100), 677 (70), 382 (10). 
HRMS (EI): m/z calcd. for: [C33H28Fe2P32SO79Br] 693.9481,  found: 693.9491. 
 
(RFc)-1-Bromo-2-[α-methoxy-((RFc)-1-(diphenylphosphinothioyl)) ferrocenyl]methyl- 
ferrocene (71) 
 
Fe
OMe
Ph2P
Br
Fe
S
 
 
Prepared according to the typical procedure TP4, using KH (60 mg, 1.50 mmol, 1.50 equiv.) 
in THF (2 mL), ferrocenyl alcohol 70 (698 mg, 1.0 mmol) in THF (3 mL) and CH3I (215 mg; 
0.1 mL, 1.50 mmol, 1.50 equiv.).  After quenching the reaction mixture with a saturated 
NH4Cl and typical work-up, the residue was purified by flash chromatography (silica gel, n-
pentane:Et2O 4:1) to furnish the methyl ether 71 (597 mg, 0.84 mmol, 84%) as a yellow solid. 
 
MP: 181.6-182.6 °C 
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[α]D20 = +85 (c = 0.2, acetone). 
1H-NMR (400 MHz, C6D6): δ = 8.07-7.98 (m, 4H), 7.06-7.03 (m, 6H), 6.43 (s, 1H), 4.33-
4.29 (m, 2H), 4.21 (s, 5H), 4.20-4.19 (m, 1H), 4.09 (s, 5H), 3.99-3.97 (m, 1H), 3.88-3.87 (m, 
2H), 3.12 (s, 3H) ppm. 
13C-NMR (100 MHz, C6D6): δ = 136.5 (d, J = 86.8 Hz), 135.3 (d, J = 84.7 Hz), 132.8 (d, J = 
10.7 Hz), 132.7 (d, J = 10.7 Hz), 130.9 (d, J = 2.8 Hz), 130.8 (d, J = 2.9 Hz), 127.93 (d, J = 
12.1 Hz), 127.9 (d, J = 12.8 Hz), 94.3 (d, J = 11.9 Hz), 91.2, 79.1, 75.3 (d, J = 12.2 Hz), 74.5 
(d, J = 94.2 Hz), 72.9, 72.8 (d, J = 8.5 Hz), 71.9, 71.4, 69.6, 69.3 (d, J = 10.5 Hz), 66.2, 65.7, 
56.3 ppm 
31P-NMR (81 MHz, C6D6): δ = +41.90 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 2930 (w), 1629 (w), 1436 (m), 1231 (m), 
1101 (s), 823 (s), 717 (s), 694 (s) 
MS (70 eV, EI): m/z (%) = 708 (M+, 100), 413 (20), 382 (60). 
HRMS (EI): m/z calcd. for: [C33H28Fe2P32SO79Br] 707.9637,  found: 707.9613. 
 
(RFc)-1-Diphenylphosphinothioyl-2-[α-methoxy-((RFc)-1-(diphenylphosphinothioyl)) 
ferrocenyl]methylferrocene (72) 
 
Fe
OMe
Ph2P
Ph2P
Fe
S
S
 
 
A 25 mL Schlenk flask was charged with bisferrocenylether 71 (355 mg; 0.5 mmol) and THF 
(3 mL).  The reaction mixture was cooled to -78 °C and nBuLi (1.6 M solution in pentane; 
0.35 mL, 0.55 mmol, 1.1 equiv) and stirred for 15 min.  Chlorodiphenylphosphine (168 mg; 
0.15 mL, 0.75 mmol, 1.5 equiv) was added and at -78 °C and the reaction mixture was stirred 
for 1 h before warming to the room temperature.  The reaction mixture was stirred at room 
temperature for 1 h and then sulfur (S8; 160 mg; 5.0 mmol, 10 equiv) was added a solution in 
butylamine (2 mL) and the reaction mixture was stirred for 12 h at room temperature.  Sat. 
Nh4Cl was added to the reaction mixture and the aqueous layer was extracted with 
diethylether (4 x 15 mL).  The combined organic layers were washed with water, brine, dried 
over MgSO4 and concentrated in vacuum.  The residue was purified by flash chromatography 
(silica gel, n-pentane:Et2O 4:1) to furnish bisphsophne sulfide 72 (323 mg, 0.38 mmol, 76%) 
as a yellow solid. 
 
MP: 223.4-225.0 °C 
[α]D20 = +57.6 (c = 0.2, acetone) 
1H-NMR (400 MHz, C6D6): δ = 8.11-7.70 (m, 8H), 7.20-6.85 (m, 12H), 6.33 (s, 1H), 4.61-
4.42 (m, 2H), 4.25 (s, 5H), 4.07 (s, 5H), 3.87 (s, 3H), 3.66-3.56 (m, 2H), 3.48-3.30 (m, 2H) 
ppm. 
13C-NMR (150 MHz, C6D6): δ = 137.1 (d, J = 85.4 Hz), 136.4 (d, J = 87.5 Hz), 136.3 (d, J = 
85.3 Hz), 134.8 (d, J = 86.2 Hz), 132.8 (d, J = 10.6 Hz), 132.7 (d, J = 8.3 Hz), 132.6 (d, J = 
8.0 Hz), 132.4 (d, J = d, 10.5 Hz), 130.95 (d, J = 3.6 Hz), 130.9 (d, J = 3.8 Hz), 130.44 (d, J = 
3.6 Hz), 130.4 (d, J = 2.6 Hz), 128.3 (d, J = 9.6 Hz), 127.6 (d, J = 11.3 Hz), 98.6 (d, J = 12.9 
Hz), 96.0 (d, J = 10.5 Hz), 75.9 (d, J = 12.9 Hz), 75.0 (d, J = 9.0 Hz), 74.9, 74.5 (d, J = 92.9 
Hz), 73.7 (d, J = 12.2 Hz), 73.0 (d, J = 9.9 Hz), 72.6 (d, J = 9.8 Hz), 71.4 (d, J = 4.7 Hz), 71.1 
(d, J = 98.8 Hz), 71.3, 71.2, 68.9 (d J = 10.9 Hz), 68.1 (d, J = 10.6 Hz), 59.8 ppm 
31P-NMR (81 MHz, CDCl3): δ = +43.98, +41.46 ppm. 
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IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 1629 (m), 1436 (m), 1101 (m), 1004 (m), 
820 (m), 717 (m), 694 (m). 
MS (70 eV, EI): m/z (%) = 846 (M+, 100), 782 (3), 695 (5), 630 (87), 445 (25), 324 (46). 
HRMS (EI): m/z calcd. for: [C46H40Fe2P2O32S2] 846.0695,  found: 846.0668. 
 
(RFc)-1-Diphenylphosphinothioyl-2-[α-methoxy-((RFc)-1-(bis(2-furylphosphinothioyl)) 
ferrocenyl]methylferrocene (73) 
 
Fe
OMe
Ph2P
Fur2P
Fe
S
S
 
 
A 25 mL Schlenk flask was charged with bisferrocenylether 71 (355 mg; 0.5 mmol) and THF 
(3 mL).  The reaction mixture was cooled to -78 °C and nBuLi (1.6 M solution in pentane; 
0.35 mL, 0.55 mmol, 1.1 equiv) and stirred for 15 min.  Chlorobis(2-furyl)phosphine (152 
mg; 0.75 mmol, 1.5 equiv) was added and at -78 °C and the reaction mixture was stirred for 1 
h before warming to the room temperature.  The reaction mixture was stirred at room 
temperature for 1 h and then sulfur (160 mg; 5.0 mmol, 10 equiv) was added a solution in 
butylamine (2 mL) and the reaction mixture was stirred for 12 h at room temperature.  Sat. 
NH4Cl was added to the reaction mixture and the aqueous layer was extracted with 
diethylether (4 x 15 mL).  The combined organic layers were washed with water, brine, dried 
over MgSO4 and concentrated in vacuum.  The residue was purified by flash chromatography 
(silica gel, n-pentane:Et2O 4:1) to furnish bisphsophne sulfide 73 (332 mg, 0.40 mmol, 80%) 
as a red solid. 
 
MP: 206.9-207.6 °C 
[α]D20 = +35.8 (c = 0.2, acetone) 
1H-NMR (400 MHz, C6D6): δ = 8.01-7.98 (m, 2H), 7.86-7.82 (m, 2H), 7.25 (t, J = 3.3 Hz, 
1H), 7.13 (t, J = 2.8 Hz, 1H), 7.08-7.01 (m, 8H), 6.41 (s, 1H), 5.93-5.91 (m, 2H), 4.56-4.52 
(m, 3H), 4.39 (s, 5H), 4.12 (s, 5H), 3.83-3.82 (m, 1H), 3.76 (s, 3H), 3.71-3.70 (m, 1H), 3.54-
3.53 (m, 1H) ppm. 
13C-NMR (100 MHz, CDCl3): δ = 151.3 (d, J = 98.0 Hz), 150.0 (d, J = 92.2 Hz), 147.3 (d, J 
= 7.0 Hz), 147.2 (d, J = 7.0 Hz), 137.0 (d, J = 85.0 Hz), 136.6 (d, J = 87.8 Hz), 132.8 (d, J = 
8.1 Hz), 132.7 (d, J = 8.4 Hz), 130.4 (d, J = 2.8 Hz), 130.3 (d, J = 3.0 Hz), 127.9 (d, J = 2.8 
Hz), 127.7 (d, J = 13.2 Hz), 122.3 (d, J = 13.3 Hz), 122.1 (d, J = 11.4 Hz), 111.4 (d, J = 9.1 
Hz), 111.1 (d, J = 9.5 Hz), 98.5 (d, J = 15.6 Hz), 96.3 (d, J = 10.3 Hz), 75.9 (d, J = 13.5 Hz), 
74.5 (d, J = 92.8 Hz), 74.9 (d, J = 92.7 Hz), 74.4 (d, J = 9.3 Hz), 74.4, 73.3 (d, J = 13.5 Hz), 
72.3 (d, J = 10.9 Hz), 71.48, 71.47, 69.7 (d, J = 11.6 Hz), 68.4 (d, J = 10.6 Hz), 59.4 ppm 
31P-NMR (81 MHz, CDCl3): δ = +44.04, +10.81 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 1631 (m), 1436 (m), 1158 (m), 1101 (m), 
1003 (m), 757 (s), 691 (s), 658 (m). 
MS (70 eV, ESI): m/z (%) = 826 (M+, 27), 795 (100), 645 (55), 397 (7). 
HRMS (EI): m/z calcd. for: [C42H3656Fe2P232S2O3] 826.0280,  found: 826. 0293. 
 
(RFc)-1-Diphenylphosphino-2-[α-methoxy-((RFc)-1-(diphenylphosphino))ferrocenyl]met- 
ylferrocene (11a) 
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Fe
OMe
Ph2P
Ph2P
Fe
 
 
A 25 mL Schlenk flask was charged with bisferrocenylether 71 (355 mg; 0.5 mmol) and THF 
(3 mL).  The reaction mixture was cooled to -78 °C and nBuLi (1.6 M solution in pentane; 
0.35 mL, 0.55 mmol, 1.1 equiv) and stirred for 15 min.  Chlorodiphenylphosphine (168 mg; 
0.15 mL, 0.75 mmol, 1.5 equiv) was added and at -78 °C and the reaction mixture was stirred 
for 1 h before warming to the room temperature.  The reaction mixture was stirred at room 
temperature for 1 h and then sulfur (S8; 160 mg; 5.0 mmol, 10 equiv) was added a solution in 
butylamine (2 mL) and the reaction mixture was stirred for 12 h at room temperature.  Sat. 
Nh4Cl was added to the reaction mixture and the aqueous layer was extracted with 
diethylether (4 x 15 mL).  The combined organic layers were washed with water, brine, dried 
over MgSO4 and concentrated in vacuum.  The residue was purified by flash chromatography 
(silica gel, n-pentane:Et2O 4:1) to furnish bisphsophne sulfide 72 (323 mg, 0.38 mmol, 76%) 
as a yellow solid. 
 
MP: 123.0-124.0 °C 
[α]D20 = +17.6 (c = 0.2, acetone) 
1H-NMR (400 MHz, C6D6): δ = 7.80-7.71 (m, 2H), 7.62-7.39 (m, 6H), 7.15-7.05 (m, 12H), 
5.63-5.61 (m, 1H), 4.34-4.29 (m, 2H), 3.95-3.94 (m, 2H), 3.91 (s, 5H), 3.80 (s, 8H), 3.67-3.66 
(m, 1H), 2.99-2.96 (m, 1H) ppm. 
13C-NMR (150 MHz, C6D6): δ = 139.1 (d, J = 13.0 Hz), 137.2(d, J = 12.1 Hz), 137.0 (d, J = 
2.1 Hz), 136.5 (d, J = 13.0 Hz), 134.8 (d, J = 22.1 Hz), 132.0 (d, J = 11.8 Hz), 129.6 (d, J = 
11.2 Hz), 129.0 (d, J = 22.1 Hz), 128.9 (d, J = 5.5 Hz), 128.6 (d, J = 21.8 Hz), 127.4 (d, J = 
6.2 Hz), 126.2 (d, J = 22.6 Hz), 126.0 (d, J = 3.2 Hz), 122.1 (d, J = 3.4 Hz), 111.6 (d, J = 10.2 
Hz), 106.0 (d, J = 10.5 Hz), 74.5 (d, J = 24.2 Hz), 74.0 (d, J = 22.9 Hz), 73.9 (d, J = 13.1 Hz), 
, 73.5 (d, J = 12.9 Hz), 72.7 (d, J = 13.1 Hz), 72.2 (d, J = 5.6 Hz), 72.0 (d, J = 6.0 Hz), 71.0 
70.5 (d, J = 14.9 Hz), 69.7, 69.2, 67.3 (d J = 5.9 Hz), 67.1 (d, J = 4.2 Hz), 57.6 ppm 
31P-NMR (81 MHz, CDCl3): δ = -19.58 (d, J = 7.6 Hz), -23.95 (d, J = 6.9 Hz) ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 3068 (w), 1629 (w), 1434 (m), 1107 (m), 
1002 (m), 818 (m), 742 (s), 698 (s). 
MS (70 eV, EI): m/z (%) = 782 (M+, 14), 717 (15), 630 (90), 446 (30), 445 (100), 379 (8). 
HRMS (EI): m/z calcd. for: [C46H40Fe2OP2] 782.1253,  found: 782.1241. 
 
(RFc)-1-Diphenylphosphino-2-[α-methoxy-((RFc)-1-(bis(2-furylphosphino))ferrocenyl]  
methylferrocene (11b) 
 
Fe
OMe
Ph2P
Fur2P
Fe
 
 
Prepared according to TP5, using bisferrocenylsulfide 73 (165 mg; 0.20 mmol) in THF (2 
mL) and Raney-Ni (Raney Ni in water; 704 mg; 12 mmol, 60 equiv) in MeOH (25 mL) and 
obtained the desired product 11b (130 mg, 0.17 mmol, 85%) as a yellow solid. 
 
MP: 126.3-129.0 °C 
[α]D20 = +27.0 (c = 0.2, acetone) 
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1H-NMR (600 MHz, C6D6): δ = 7.64 (t, J = 7.6 Hz, 2H), 7.51 (t, J = 7.3 Hz, 2H), 7.27 (d, J = 
5.9 Hz, 2H), 7.13-7.04 (m, 7H), 6.84 (s, 1H), 6.14 (s, 1H), 6.04 (s, 1H), 5.67 (t, J = 4.7 Hz, 
1H), 5.00 (s, 1H), 4.56 (s, 1H), 4.53 (s, 1H), 4.29-4.25 (m, 1H), 4.08 (s, 5H), 4.06 (s, 1H), 
3.79-3.77 (s, 1H), 3.57 (s, 5H), 3.15 (s, 3H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 154.0 (d, J = 12.9 Hz), 153.4 (d, J = 11.8 Hz), 146.3 (d, J 
= 1.9 Hz), 140.6 (d, J = 11.8 Hz), 139.2 (d, J = 13.0 Hz), 135.3 (d, J = 21.1 Hz), 133.8 (d, J = 
19.9 Hz), 128.7 (d, J 0 1.8 Hz), 128.3 (d, J = 6.0 Hz), 128.2 (d, J = 6.9 Hz), 128.0 (d, J = 21.2 
Hz), 120.7 (d, J = 29.3 Hz), 120.7 (d, J = 3.4 Hz), 120.6 (d, J = 3.4 Hz), 110.8 (d, J = 8.5 Hz), 
110.7 (d, J = 6.5 Hz), 101.7 (d, J = 33.0 Hz), 97.2 (d, J = 24.3 Hz), 76.1 (d, J = 13.4 Hz), 74.3 
(d, J = 12.9 Hz), 74.2 (d, J = 13.0 Hz), 73.0 (d, J = 6.0 Hz), 72.3 (d, J = 2.2 Hz), 70.4 (d, J = 
6.0 Hz), 70.3, 70.2, 69.2 (d, J = 15.2 Hz), 68.5 (d, J = 5.6 Hz), 65.9, 57.3 ppm 
31P-NMR (81 MHz, CDCl3): δ = -10.07, -17.68 ppm. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, s), 3050 (m), 1630 (w), 1434 (m), 1251 (m), 
1001 (m), 807 (s), 742 (s), 696 (s). 
MS (70 eV, EI): m/z (%) = 752 (M+, 13), 689 (25), 688 (50), 687 (100), 656 (8). 
HRMS (EI): m/z calcd. for: [C42H38FeP232S2Si] 752.1009,  found: 752.1013. 
IR (KBr-Pressling): υmax (cm−1) = 3436 (br, m), 2926 (m), 1434 (m), 1154 (w), 1108 (m), 
1085 (s), 1004 (s), 817 (m), 744 (s), 698 (m). 
MS (70 eV, EI): m/z (%) = 762 (M+, 27), 610 (13), 446 (35), 445 (100), 425 (23). 
HRMS (EI): m/z calcd. for: [C42H3656Fe2P2O3] 762.0838,  found: 762.0821. 
 
10. Synthesis of new paracyclophane based diphsophines 
 
(R)-4-Bromo-12-diphenylphosphinothioyl[2.2]paracyclophane (77):   
 
PPh2
Br
S
 
 
Dibromide 76 (1.83 g; 5.0 mmol) and THF (15 mL) were added to a 50 mL Schlenk flask 
under argon atmosphere.  nBuLi (1.5 M in pentane; 3.70 mL, 5.50 mmol) was added slowly to 
the above solution at -78 °C and stirred for 1 h.  ClPPh2 (1.33 g; 6.0 mmol, 1.20 equiv) was 
added and stirred for 1 h at -78 °C.  The reaction mixture was warned to room temperature 
and stirred for 1.5 h.  Sulfur (1.60 g; 50.0 mmol, 10 equiv) was added to the reaction mixture 
and stirred for overnight at room temperature.  The reaction mixture was quenched with a 
saturated NH4Cl solution (20 mL) and the aqueous layer was extracted with CH2Cl2 (4 x 30 
mL).  The combined organic layers were washed with water, brine, dried over MgSO4 and 
concentrated in vacuo.  The crude product was purified by flash chromatography (silicagel, 
npentane:Et2O (10:1)), afforded the desired compound as a white solid (2.14 g; 4.25 mmol, 
85%). 
 
MP: 148.1-148.9 °C 
[α]D20 = −22.9 (c = 0.4, CH2Cl2) 
1H-NMR (600 MHz, CDCl3): δ = 7.83-7.71 (m, 5H), 7.48-7.35 (m, 6H), 6.65-6.53 (m, 5H), 
3.60-3.49 (m, 2H), 3.39-3.35 (m, 1H), 3.01-2.97 (m, 1H), 2.90-2.71 (m, 4H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 145.0 (d, J = 8.6 Hz) 141.6, 138.6 (d, J = 13.0 Hz), 138.5, 
136.9 (d, J = 3.1 Hz), 136.3, 135.5 (d, J = 11.8 Hz), 134.6 (d, J = 86.2 Hz), 133.4, 132.9 (d, J 
= 10.6 Hz), 132.8 (d, J = 11.8 Hz), 132.2 (d, J = 84.6 Hz), 131.9 (d, J = 10.2 Hz), 131.3 (d, J 
= 3.1 Hz), 131.2 (d, J = 3.0 Hz), 131.1, 128.1 (d, J = 12.4 Hz), 128.0, (d, J = 12.4 Hz), 127.8 
(d, J = 87.2 Hz), 127.2, 35.4, 34.7 (d, J = 4.9 Hz), 33.7 (d, J = 1.1 Hz), 31.92 ppm. 
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31P-NMR (81 MHz, CDCl3): δ = +40.44 ppm. 
IR(neat): υmax (cm−1) = 3440 (br, w), 2912 (w), 1629 (s), 1425 (m), 1325 (m), 1102 (m), 789 
(s), 656 (s). 
MS (70 eV, EI): m/z (%) = 504 (37), 502 (M+, 34), 321 (18), 320 (100), 319 (16), 209 (10), 
183 (11). 
HRMS (EI): m/z calcd. for: [C28H2479BrP32S] 502.0520,  found: 502.0512 
 
(R)-4-Bis(3,5-dimethylphenyl)phosphinothioyl-12-diphenylphosphinothioyl[2.2]paracyc-
-lophane (78d) 
 
PPh2
PXyl2
S
S
 
 
Monophosphine sulfide 77 (755 mg; 1.50 mmol) and THF (5 mL) were added to a 25 mL 
Schlenk flask under argon atmosphere.  nBuLi (1.5 M in pentane; 1.2 mL, 1.70 mmol) was 
added slowly to the above solution at -78 °C and stirred for 2 h.  chlorobis(3,5-
dimethylphenyl)phosphine (500 mg; 1.80 mmol, 1.20 equiv) was added and stirred for 1 h at -
78 °C.  The reaction mixture was warned to room temperature and stirred for 1.5 h.  Sulfur 
(482 mg; 15.0 mmol, 10 equiv) was added to the reaction mixture and stirred for overnight at 
room temperature.  The reaction mixture was quenched with a sat. NH4Cl solution (10 mL) 
and the aqueous layer was extracted with CH2Cl2 (4 x 15 mL).  The combined organic layers 
were washed with water, brine, dried over MgSO4 and concentrated in vacuo.  The crude 
product was purified by flash chromatography (silicagel, npentane:Et2O (5:1)), afforded the 
desired compound as a white solid (910 mg; 1.30 mmol, 87%). 
 
MP: 291 °C 
[α]D20 = −20.9 (c = 0.4, CH2Cl2) 
1H-NMR (600 MHz, CDCl3): δ = 7.96-7.93 (m, 2H), 7.73-7.69 (m, 2H), 7.51-7.47 (m, 5H), 
7.33-7.31 (m, 4H), 7.26-7.23 (m, 2H), 7.10-7.08 (m, 2H), 7.02 (brs, 1H), 6.72-6.69 (m, 2H), 
6.66-6.63 (m, 2H), 3.42-3.47 (m, 2H), 3.33-3.26 (m, 2H), 2.86-2.80 (m, 2H), 2.71-2.66 (m, 
2H), 2.31 (s, 6H), 2.23 (s, 6H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 144.93 (d, J = 9.6 Hz), 144.9 (d, J = 9.6 Hz), 139.6 (d, J 
= 13.3 Hz), 139.4 (d, J = 13.2 Hz), 137.5 (d, J = 12.9 Hz), 137.3 (d, J = 13.2 Hz), 136.6 (d, J 
= 3.6 Hz), 136.5 (d, J = 3.7 Hz), 136.1 (d, J = 11.7 Hz), 135.9 (d, J = 12.3 Hz), 135.7 (d, J = 
83.3 Hz), 135.0 (d, J = 83.8 Hz), 134.7 (d, J = 11.8 Hz), 134.4 (d, J = 12.0 Hz), 133.2 (d, J = 
10.5 Hz), 133.0 (d, J = 3.1 Hz) 132.7 (d, J = 3.5 Hz), 131.6 (d, J = 10.3 Hz), 131.5 (d, J = 
84.8 Hz), 131.2 (d, J = 84.8 Hz), 131.1 (d, J = 3.1 Hz), 130.9 (d, J = 10.1 Hz ), 130.9 (d, J = 
2.8 Hz), 129.3 (d, J = 10.1 Hz), 127.9 (d, J = 12.5 Hz), 127.8 (d, J = 87.7 Hz), 127.8 (d, J = 
12.5 Hz), 127.7 (d, J = 88.7 Hz), 35.4 (t, J = 5.2 Hz), 33.8 (d, J = 16.0 Hz), 21.8 (d, J = 0.9 
Hz), 21.5 (d, J = 0.9 Hz) ppm  
31P-NMR (81 MHz, CDCl3): δ = +38.71, +38.39 ppm. 
IR(neat): υmax (cm−1) = 3441 (br, w), 2785 (w), 1594 (m), 1447 (m), 1389 (m), 1101 (m), 874 
(s), 725 (s), 696 (s). 
MS (70 eV, EI): m/z (%) = 696 (M+, 45), 521 (28), 320 (100), 309 (12), 183 (21). 
HRMS (EI): m/z calcd. for: [C44H42P232S2] 696.2203,  found: 696.2211 
 
(R)-4-Bis(3,5-dimethylphenyl)phosphino-12-diphenylphosphino[2.2]paracyclophane 
(12d):   
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PPh2
PXyl2
 
 
Prepared according to TP5, by using bisphosphinesulfide 78d (698 mg; 1.0 mmol) and 
Raney-Ni (3.8 g; Raney-Ni in water) in MeOH (60 mL) and the bisphosphine 13d was 
obtained as a white solid (583 mg; 0.92 mmol, 92%). 
 
MP: 211.0-212.2 °C 
[α]D20 = −22.4 (c = 0.4, CH2Cl2) 
1H-NMR (600 MHz, CDCl3): δ = 7.47-7.44 (m, 2H), 7.41-7.36 (m, 5H), 7.24-7.20 (m, 5H), 
7.04-7.02 (m, 3H), 6.65-6.63 (m, 1H), 6.57-6.48 (m, 6H), 3.02-2.89 (m, 6H), 2.63-2.54 (m, 
2H), 2.35 (s, 6H), 2.18 (s, 6H) ppm. 
13C-NMR (150 MHz, CDCl3): δ = 143.3 (d, J = 14.7 Hz), 143.1 (d, J = 15.1 Hz), 139.5 (d, J 
= 12.1 Hz), 139.4 (d, J = 13.9 Hz), 139.3 (d, J = 6.1 Hz), 138.9 (d, J = 7.1 Hz), 138.2 (d, J = 
12.2 Hz), 138.1 (d, J = 12.6 Hz), 137.5 (d, J = 17.5 Hz), 137.4 (d, J = 16.9 Hz), 137.3 (d, J = 
7.9 Hz), 137.2 (d, J = 8.7 Hz), 135.9 (d, J = 0.9 Hz), 135.7 (d, J = 0.9 Hz), 134.2 (d, J = 6.8 
Hz), 134.1 (d, J = 6.1 Hz), 133.4 (d, J = 22.8 Hz), 133.3 (d, J = 22.8 Hz), 133.0 (d, J = 20.4 
Hz), 132.7 (d, J = 8.7 Hz), 132.3 (d, J = 6.8 Hz), 131.3 (d, J = 1.1 Hz), 130.6 (d, J = 20.9 
Hz), 130.3 (d, J = 0.9 Hz), 129.3 (d, J = 0.8 Hz), 128.5 (d, J = 0.8 Hz), 128.3 (d, J = 22.7 
Hz), 128.2 (d, J = 22.0 Hz), 35.8 (d, J = 18.7 Hz), 35.7 (d, J = 19.0 Hz), 33.2 (d, J = 2.6 Hz), 
33.0 (d, J = 2.5 Hz), 21.4, 21.2 ppm. 
31P-NMR (81 MHz, CDCl3): δ = 0.69, 0.03 ppm 
IR(neat): υmax (cm−1) = 3444 (br, w), 2019 (w), 1655 (s), 1450 (s), 1210 (s), 876 (s), 765 (m), 
667 (m), 586 (m). 
MS (70 eV, EI): m/z (%) = 632 (M+, 14), 428 (32), 320 (100), 309 (11). 
HRMS (EI): m/z calcd. for: [C44H42P2] 632.2762,  found: 632.2777 
 
11. Preparation of ruthenium-diamine complexes 79a-c and 80a-c 
 
Prepartation of ruthenium-diamine complexes of 12b 
 
Prparation of the ruthenium complex 79a: 
 
P
Ph2
Ar2
P
Ru
H2
N
N
H2
Cl
Cl
Ph
Ph
Ar = 4-F-phenyl
 
 
Prepared according to TP10, using the ligand 12b (25 mg; 0.041 mmol; 1.0 equiv), 
[RuCl(C6H6)]2 (9.4 mg; 0.021 mmol) and (S,S)-1,2-diphenylethylenediamine (8.9 mg; 0.041 
mmol; 1.0 equiv) and obtained as a purple coloured solid in quantitative yield.  The residue 
was used for hydrogenations without any further purification. 
 
1H-NMR (200 MHz, CDCl3): 8.45-7.82 (m, 21H), 7.32-6.44 (m, 13 H), 4.50-3.51 (m, 5H), 
2.53-1.80 (m, 9H) ppm. 
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31P-NMR (81 MHz, CDCl3): +43.65 (d, J = 25.0 Hz), +40.36 (d, J = 25.2 Hz) ppm. 
 
Prparation of the ruthenium complex 80a: 
 
P
Ph2
Ar2
P
Ru
H2
N
N
H2
Cl
Cl
Ph
Ph
Ar = 4-F-phenyl
 
 
Prepared according to TP10, using the ligand 12b (25 mg; 0.041 mmol; 1.0 equiv), 
[RuCl(C6H6)]2 (9.4 mg; 0.021 mmol) and (S,S)-1,2-diphenylethylenediamine (8.9 mg; 0.041 
mmol; 1.0 equiv) and obtained as a purple coloured solid in quantitative yield.  The residue 
was used for hydrogenations without any further purification. 
 
1H-NMR (200 MHz, CDCl3): 8.54-8.00 (m, 20H), 7.50-6.65 (m, 14H), 4.55-3.55 (m, 5H), 
2.60-2.48 (m, 4H), 2.10-1.88 (m, 5H) ppm. 
31P-NMR (81 MHz, CDCl3): +44.11 (d, J = 25.1 Hz), +41.88 (d, J = 24.2 Hz) ppm. 
 
Prepartation of ruthenium-diamine complexes of 12c 
 
Prparation of the ruthenium complex 79c: 
 
P
Ph2
Ar2
P
Ru
H2
N
N
H2
Cl
Cl
Ph
Ph
Ar = 3,5-(CF3)2-phenyl
 
 
Prepared according to TP10, using the ligand 12c (20 mg; 0.024 mmol; 1.0 equiv), 
[RuCl(C6H6)]2 (5.5 mg; 0.012 mmol) and (S,S)-1,2-diphenylethylenediamine (5.2 mg; 0.024 
mmol; 1.0 equiv) and obtained as a purple coloured solid in quantitative yield.  The residue 
was used for hydrogenations without any further purification. 
 
1H-NMR (200 MHz, CDCl3): 8.55-8.08 (m, 12H), 8.00-7.95 (m, 4H), 7.75-6.60 (m, 14H), 
6.60-6.51 (m, 2H), 4.48-4.30 (m, 2H), 2.85-2.46 (m, 6H), 1.81-1.64 (m, 6H) ppm. 
31P-NMR (81 MHz, CDCl3): +48.16 (d, J = 28.9 Hz), +45.79 (d, J = 27.0 Hz) ppm. 
 
Prparation of the ruthenium complex 80b: 
 
P
Ph2
Ar2
P
Ru
H2
N
N
H2
Cl
Cl
Ph
Ph
Ar = 3,5-(CF3)2-phenyl
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Prepared according to TP10, using the ligand 12c (20 mg; 0.024 mmol; 1.0 equiv), 
[RuCl(C6H6)]2 (5.5 mg; 0.012 mmol) and (S,S)-1,2-diphenylethylenediamine (5.2 mg; 0.024 
mmol; 1.0 equiv) and obtained as a purple coloured solid in quantitative yield.  The residue 
was used for hydrogenations without any further purification. 
 
1H-NMR (200 MHz, CDCl3): 8.68-7.98 (m, 16H), 7.80-6.90 (m, 14H), 6.66-6.54 (m, 2H), 
4.55-4.38 (m, 2H), 3.01-2.67 (m, 4H), 2.60-2.55 (m, 2H), 2.00-1.60 (m, 6H) ppm. 
31P-NMR (81 MHz, CDCl3): +46.10 (d, J = 26.1 Hz), +43.20 (d, J = 26.2 Hz) ppm. 
 
Prepartation of ruthenium-diamine complexes of 12d 
 
Prparation of the ruthenium complex 79c: 
 
P
Ph2
Xyl2
P
Ru
H2
N
N
H2
Cl
Cl
Ph
Ph
 
 
Prepared according to TP10, using the ligand 12d (50 mg; 0.07 mmol; 1.0 equiv), 
[RuCl(C6H6)]2 (16 mg; 0.035 mmol) and (R,R)-1,2-diphenylethylenediamine (15 mg; 0.07 
mmol; 1.0 equiv) and obtained as a purple coloured solid in quantitative yield.  The residue 
was used for hydrogenations without any further purification. 
 
1H-NMR (200 MHz, CDCl3): 8.46-8.20 (m, 3H), 8.01-7.45 (m, 3H), 7.40-7.25 (m, 4H), 
7.20-7.11 (m, 7H), 7.00-6.85 (m, 7H), 6.70-6.68 (m, 1H), 6.60-6.58 (m, 1H), 6.50-6.39 (m, 
6H), 4.50-4.48 (m, 1H), 4.11-4.10 (m, 1H), 2.76-2.69 (m, 2H), 2.62-2.50 (m, 2H), 2.29 (s, 
6H), 2.12 (s, 6H), 1.94-1.87 (m, 2H), 1.71-1.66 (m, 2H). 
31P-NMR (81 MHz, CDCl3): +48.16 (d, J = 28.9 Hz), +44.79 (d, J = 27.0 Hz) ppm. 
 
Prparation of the ruthenium complex 80c: 
 
P
Ph2
Xyl2
P
Ru
H2
N
N
H2
Cl
Cl
Ph
Ph
 
 
Prepared according to TP10, using the ligand 12d (50 mg; 0.07 mmol; 1.0 equiv), 
[RuCl(C6H6)]2 (16 mg; 0.035 mmol) and (S,S)-1,2-diphenylethylenediamine (15 mg; 0.07 
mmol; 1.0 equiv) and obtained as a purple coloured solid in quantitative yield.  The residue 
was used for hydrogenations without any further purification. 
 
1H-NMR (200 MHz, CDCl3): 8.36-8.34 (m, 2H), 8.30-8.26 (m, 1H), 8.10-8.05 (m, 1H), 
8.00-7.92 (m, 1H), 7.40-7.25 (m, 4H), 7.20-7.10 (m, 8H), 7.05-6.90 (m, 7H), 6.76 (s, 1H), 
6.60-6.54 (m, 2H), 6.47-6.36 (m, 5H), 4.50-4.48 (m, 1H), 4.19-4.12 (m, 1H), 2.86-2.70 (m, 
2H), 2.60-2.55 (m, 2H), 2.23 (s, 6H), 2.02 (s, 6H), 1.95-1.86 (m, 2H), 1.71-1.66 (m, 2H) ppm. 
31P-NMR (81 MHz, CDCl3): +47.46 (d, J = 28.1 Hz), +44.19 (d, J = 27.1 Hz) ppm. 
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12. Asymmetric hydrogenation of ketones and olefins 
 
(R)-1-Phenylethanol (82a):   
 
OH
 
 
[α]D20 = +40.4 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.20-7.29 (m, 5H), 4.66 (q, J = 6.5 Hz, 1H), 2.80 (brs, 
1H), 1.30 (d, J = 6.4 Hz, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 146.4, 128.8, 127.7, 125.9, 70.6, 25.6 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (7 min), 
30 °C/min 160 °C (30 min)); 8.5 min (R), 8.9 (S).   97% ee. 
 
(R)-1-(4-Methoxyphenyl)ethanol (82b):   
 
OH
MeO
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 4-methoxy-acetophenone 81b (600 mg; 4.0 mmol) and obtained as 
colourless oil (584 mg; 3.84 mmol, 96%) 
 
[α]D20 = +43.6 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.31-7.26 (m, 2H), 6.89-6.86 (m, 2H), 4.84 (q, J = 6.4Hz, 
1H), 3.79 (s, 3H), 1.47 (d, J = 6.4 Hz, 3H), 1.83 (brs, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 159.0, 138.0, 126.6, 113.8, 69.9, 55.3, 25.0 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (110 °C (60 min), 
Const.); 26.0 min (R), 30.0 (S).   96% ee. 
 
(R)-1-(3-Methylphenyl)ethanol (82c):   
 
OH
CH3
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3- methyl-acetophenone 81c (537 mg; 0.54 mL, 4.0 mmol) and obtained as 
colourless oil (523 mg; 3.84 mmol, 96%) 
 
[α]D20 = +64.2 (c= 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.27-7.22 (m, 1H), 7.19-7.15 (m, 2H), 7.08 (d, J = 7.5 Hz, 
1H), 4.85 (q, J = 6.5 Hz, 1H), 2.36 (s, 3H), 1.88 (s, 1H), 1.48 (d, J = 6.5 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 145.8, 138.1, 128.4, 128.2, 126.1, 122.4, 70.4, 25.1, 21.4 
ppm. 
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Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (7 min), 
30 °C/min 160 °C (30 min)); 9.5 min (R), 9.7 (S).   97% ee. 
 
(R)-1-(2-Methylphenyl)ethanol (82d):   
 
OHCH3
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 81d (537 mg; 0.52 mL, 4.0 mmol) and obtained as 
colourless oil (534 mg; 3.92 mmol, 98%) 
 
[α]D20 = +48.2 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.52-7.49 (m, 1H), 7.26-7.21 (m, 1H), 7.19-7.13 (m, 2H), 
5.12 (q, J = 6.4 Hz, 1H), 2.34 (s, 3H), 1.82 (s, 1H), 1.46 (d, J = 6.4 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 143.8, 134.2, 130.3, 127.1, 126.3, 124.4, 66.8, 23.9, 18.9 
ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (15 min), 
5 °C/min 160 °C (30 min)); 20.1 min (R), 22.1 (S).   94% ee. 
 
(R)-1-(3-Methoxyphenyl)ethanol (82e):   
 
OH
OMe
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3- methoxy-acetophenone 81e (601 mg; 0.55 mL, 4.0 mmol) and obtained 
as colourless oil (584 mg; 3.84 mmol, 96%) 
 
[α]D20 = +54.8 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.29 (d, J = 8.2 Hz, 1H), 6.97-6.95 (m, 2H), 6.83 (dddd, J 
= 1.0 Hz, 2.6 Hz, 8.2 Hz, 1H), 4.88 (q, J = 6.5 Hz, 1H), 3.83 (s, 3H), 2.00 (brs, 1H), 1.50 (d, J 
= 6.5 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 159.7, 147.6, 129.5, 117.6, 112.8, 110.1, 70.3, 55.2, 25.1 
ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (60) 
const; 29.8 min (R), 34.7 (S).   97% ee. 
 
(R)-1-(3-Chlorophenyl)ethanol (82f):   
 
OH
Cl
 
 
Experimental Section   179
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3- chloro-acetophenone 81f (618 mg; 0.52 mL, 4.0 mmol) and obtained as 
colourless oil (601 mg; 3.84 mmol, 96%) 
 
[α]D20 = +42.4 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.37-7.36 (m, 1H), 7.26-7.21 (m, 3H), 4.89-4.82 (m, 1H), 
1.98 (d, J = 3.5 Hz, 1H), 1.47 (d, J = 6.5 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 147.8, 134.3, 129.7, 127.5, 125.6, 123.5, 69.8, 25.2 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (110 °C (10 min), 
50 °C/min 160 °C (30 min)); 12.9 min (R), 13.2 (S).   97% ee. 
 
(R)-1-(4-Chlorophenyl)ethanol (82g):   
 
OH
Cl
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 4- chloro-acetophenone 81g (618 mg; 0.52 mL, 4.0 mmol) and obtained as 
colourless oil (614 mg; 3.92 mmol, 98%) 
 
[α]D20 = +26.8 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.30-7.28 (m, 2H), 6.90-6.87 (m, 2H), 4.82 (q, J = 6.7 Hz, 
1H), 1.24 (brs, 1H), 1.30 (d, J = 6.8 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 158.2, 136.5, 124.8, 112.1, 68.2, 24.5 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (130 °C (60 min), 
Const.); 9.2 min (R), 10.7 (S).   96% ee. 
 
(R)-1-(4-Trifluoromethylphenyl)ethanol (82h):   
 
OH
F3C
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 4- trifluoromethyl-acetophenone 81h (753 mg; 4.0 mmol) and obtained as 
colourless oil (715 mg; 3.76 mmol, 94%) 
 
[α]D20 = +34.9 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.61-7.59 (m, 2H), 7.49-7.46 (m, 2H), 4.98-4.91 (m, 1H), 
1.98 (d, J = 3.3 Hz, 1H), 1.49 (d, J = 6.3 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 149.7 (q, J = 1.4 Hz), 129.6 (q, J = 32.3 Hz), 125.6, 125.4 
(q, J = 3.9 Hz), 124.1 (q, J = 271.6 Hz), 69.8, 25.4 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (7 min), 
30 °C/min 160 °C (30 min)); 9.3 min (R), 9.7 (S).   94% ee. 
 
(R)-1-(3-Fluorophenyl)ethanol (82i):   
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OH
F
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3- fluoro-acetophenone 81i (552 mg; 0.49 mL, 4.0 mmol) and obtained as 
colourless oil (532 mg; 3.80 mmol, 95%) 
 
[α]D20 = +42.4 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.23-7.19 (m, 1H), 7.05-7.00 (m, 2H), 6.90-6.85 (m, 1H), 
4.81 (q, J = 6.5 Hz, 1H), 1.96 (brs, 1H), 1.40 (d, J = 6.5 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 163.0 (d, J = 246.1 Hz), 148.5 (d, J = 6.4 Hz), 129.9 (d, J = 
7.7 Hz), 120.9 (d, J = 2.6 Hz), 114.2 (d, J = 21.2 Hz), 112.3 (d, J = 21.2 Hz), 69.7 (d, J = 2.1 
Hz), 25.2 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (110 °C (10 min), 
50 °C/min 160 °C (20 min)); 8.5 min (R), 10.1 (S).   96% ee. 
 
(R)-1-(1’-Naphtyhl)ethanol (82j):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 81j (681 mg; 0.61 mL, 4.0 mmol) and obtained as 
colourless oil (661 mg; 3.84 mmol, 96%) 
 
[α]D20 = +68.8 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 8.13-8.12 (m, 1H), 7.89-7.86 (m, 1H), 7.77 (d, J = 8.2 Hz, 
1H), 7.67 (d, J = 7.2 Hz, 1H), 7.55-7.45 (m, 3H), 5.70-5.62 (m, 1H), 2.02 (d, J = 2.8 Hz, 1H), 
1.67 (d, J = 6.57 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 141.3, 133.8, 130.2, 128.9, 127.9, 126.0, 125.6, 125.5, 
123.1, 122.0, 67.1, 24.3 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (115 °C (15 min), 
15 °C/min 160 °C (60 min)); 26.8 min (S), 27.4 (R).   96% ee. 
 
(R)-1-(2’-Naphthyl)ethanol (82k):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 1- naphthyl-acetophenone 81k (681 mg; 0.52 mL, 4.0 mmol) and obtained 
as colourless oil (675 mg; 3.92 mmol, 98%) 
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[α]D20 = +60.4 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.84-7.80 (m, 4H), 7.51-7.44 (m, 3H), 5.05 (q, J = 6.5 Hz, 
1H), 1.98 (brs, 1H), 1.58 (d, J = 6.2 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 143.2, 133.3, 132.9, 128.3, 127.9, 127.6, 126.1, 125.8, 
123.8, 123.7, 70.5, 25.1 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (115 °C (15 min), 
15 °C/min 160 °C (60 min)); 25.5 min (R), 26.3 (S).   97% ee. 
 
(R)-1-(4-Phenylphenyl)ethanol (82l):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 4- phenyl-acetophenone 81l (785 mg; 4.0 mmol) and obtained as colourless 
oil (769 mg; 3.88 mmol, 97%) 
 
[α]D20 = +51.0 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.60-7.57 (m, 4H), 7.46-7.41 (m, 4H), 7.37-7.32 (m, 1H), 
4.95 (q, J = 6.5 Hz, 1H), 1.87 (brs, 1H), 1.54 (d, J = 6.5 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 144.8, 140.8, 140.4, 128.7, 127.2, 127.1, 125.8, 70.1, 25.1 
ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (7 min), 5 
°C/min 160 °C (60 min)); 40.6 min (R), 42.7 (S).   94% ee. 
 
(R)-1-Phenylpropanol (84a):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and propiophenone 83a (537 mg; 0.54 mL, 4.0 mmol) and obtained as 
colourless oil (523 mg; 3.84 mmol, 96%) 
 
[α]D20 = +32.4 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.36-7.26 (m, 5H), 4.60 (t, J = 6.5 Hz, 1H), 1.94 (brs, 1H), 
1.84-1.76 (m, 2H), 0.93 (t, J = 6.5 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 144.6, 128.4, 127.4, 125.9, 76.0, 31.9, 10.1 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (110 °C (60 min), 
Const.); 11.9 min (R), 13.2 (S).   97% ee. 
 
(R)-1-Phenylpentanol (84b):   
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OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 83b (649 mg; 0.66 mL, 4.0 mmol) and obtained as 
a colourless oil (624 mg; 3.80 mmol, 95%) 
 
[α]D20 = +28.9 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.31-7.29 (m, 4H), 7.25-7.21 (m, 1H), 4.61 (t. J = 7.2 Hz, 
1H), 1.84 (brs, 1H), 1.78-1.62 (m, 2H), 1.38-1.16 (m, 4H), 0.85 (t, J = 7.1 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 144.9, 128.4, 127.4, 125.9, 74.7, 38.8, 28.0, 22.6, 14.0 
ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (15 min), 
5 °C/min 160 °C (45)); 24.3 min (S), 24.4 (R).   97% ee. 
 
(R)-1-Phenylhexanol (84c):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 83c (713 mg; 4.0 mmol) and obtained as a 
colourless oil (714 mg; 3.84 mmol, 96%) 
 
[α]D20 = +36.0 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.34-7.24 (m, 5H), 4.63-4.62 (m, 1H), 1.86 (d, J = 3.1 Hz, 
1H), 1.79-1.60 (m, 2H), 1.45-1.27 (m, 6H), 0.89-0.84 (m, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 145.0, 128.4, 127.4, 125.9, 74.5, 39.1, 31.7, 25.5, 22.5, 
14.0 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (15 min), 
5 °C/min 160 °C (45)); 26.6 min (S), 26.7 (R).   94% ee. 
 
(R)-1,3-Diphenylpropanol (84d):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 83d (841 mg; 4.0 mmol) and obtained as colourless 
oil (815 mg; 3.84 mmol, 96%) 
 
[α]D20 = +41.2 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.36-7.19 (m, 10H), 4.72-4.66 (m, 1H), 2.76-2.67 (m, 2H), 
2.20-1.98 (m, 2H), 1.90 (d, J = 3.6 Hz, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 144.5, 141.7, 128.5, 128.4, 128.3, 127.6, 125.9, 125.8, 
73.9, 40.4, 32.0 ppm. 
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Enantiomeric excess was determined by chiral HPLC using a chiracel OD-H column (flow 
rate 0.5 mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 22.7 min [minor], tr = 25.5 
min [major];  90% ee. 
 
(R)-1-Phenyl-2-methylpropanol (84e):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 83e (593 mg; 0.60 mL, 4.0 mmol) and obtained as 
colourless oil (541 mg; 3.60 mmol, 90%) 
 
[α]D20 = +12.8 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.35-7.23 (m, 5H), 4.34 (d, J = 7.1 Hz, 1H), 1.98-1.89 (m, 
2H), 0.99 (d, J = 7.0 Hz, 3H), 0.79 (d, J = 7.0 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 143.6, 128.1, 127.3, 126.5, 80.0, 35.2, 19.0, 18.2 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (110 °C (30 min), 
5 °C/min 160 °C (45)); 17.9 min (R), 18.6 (S).   38% ee. 
 
(R)-(E)-4-Phenyl-3-buten-2-ol (86a):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 85a (585 mg; 4.0 mmol) and obtained as colourless 
oil (563 mg; 3.80 mmol, 90%) 
 
[α]D20 = +36.8 (c=1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.41-7.30 (m, 4H), 7.28-7.22 (m, 1H), 6.58 (dd, J = 0.9 
Hz, 15.9 Hz, 1H), 6.27 (dd, J = 6.4 Hz, 15.8 Hz, 1H), 4.55-4.46 (m, 1H), 1.71 (brs, 1H), 1.39 
(d, J = 6.4 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 136.7, 133.5, 129.4, 128.5, 127.6, 126.4, 68.9, 23.4 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (115 °C (20 min), 
5 °C/min 160 °C (30)); 18.8 min (R), 19.7 (S).   94% ee. 
 
(R)-(E)-1,3-Diphenyl-2-propen-1-ol (86b):   
 
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 85b (833 mg; 0.52 mL, 4.0 mmol) and obtained as 
colourless oil (816 mg; 3.88 mmol, 98%) 
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[α]D20 = +2.0 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.46-7.21 (m, 10H), 6.69 (d, J = 0.9 Hz, 15.8 Hz, 1H), 
6.38 (d, J = 6.4 Hz, 15.8 Hz, 1H), 5.38 (d, J = 6.4 Hz, 1H), 2.12 (brs, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 142.7, 136.5, 131.5, 130.5, 128.6, 128.5, 127.8, 127.7, 
126.6, 126.3, 75.1 ppm. 
Enantiomeric excess was determined by chiral HPLC using a chiracel OD column (flow rate 
0.5 mL/min, heptane/iPrOH: 90/10, λ= 215 nm, 25 °C); tr = 14.8 min [minor], tr = 19.1 min 
[major];  37% ee. 
 
(R)-1-(3-Pyridyl)ethanol (88):   
 
N
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 87 (484 mg; 0.44 mL, 4.0 mmol) and obtained as 
colourless oil (483 mg; 3.92 mmol, 98%) 
 
[α]D20 = +21.8 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 8.50-8.42 (m, 2H), 7.71 (tt, J = 7.9 Hz, 1.7 Hz, 1H), 7.27-
7.23 (m, 1H), 4.91 (q, J = 6.6 Hz, 1H), 2.98 (brs, 1H), 1.49 (d, J = 6.5 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 148.4, 147.2, 141.3, 133.3, 123.5, 67.8, 25.2 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (40 °C (15 min), 3 
°C/min 160 °C (60 min)); 45.8 min (R), 46.8 (S).   96% ee. 
 
(R)-1-(2-Thienyl)ethanol (90):   
 
OH
S
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 89 (505 mg; 0.43 mL, 4.0 mmol) and obtained as 
colourless oil (502 mg; 3.92 mmol, 98%) 
 
[α]D20 = +16.4 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.22 (dd, J = 1.6 Hz, 4.6 Hz, 1H), 6.98-6.94 (m, 2H), 5.16-
5.08 (m, 1H), 2.06 (brs, 1H), 1.59 (d, J = 6.4 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 149.8, 126.6, 124.4, 123.1, 66.2, 25.2 ppm. 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (15 min), 
5 °C/min 160 °C (60 min)); 12.4 min (R), 14.5 (S).   92% ee. 
 
(R)-1-Ferrocenylethanol (92):   
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Fe
OH
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 2- methyl-acetophenone 91 (912 mg; 4.0 mmol) and obtained as colourless 
oil (865 mg; 3.76 mmol, 94%) 
 
[α]D20 = −30.2 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 4.58-4.50 (m, 1H), 4.22-4.20 (m, 2H), 4.18 (s, 5H), 4.15 (t, 
J = 1.9 Hz, 2H), 1.85 (d, J = 4.7 Hz, 1H), 1.43 (d, J = 6.3 Hz, 1H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 94.5, 68.3, 67.9, 67.8, 66.1, 66.1, 65.6, 23.7 ppm. 
Enantiomeric excess was determined by chiral HPLC using a chiracel OJ column (flow rate 
0.6 mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 34.8 min [major], tr = 37.2 min 
[minor];  94% ee. 
 
1-(3’, 4’- Dichlorophenyl)ethanol (94a)142:   
 
OH
Cl
Cl
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3,4-dichloroacetophenone 93a (756 mg; 4.0 mmol) and obtained as 
colourless oil (745 mg; 3.92 mmol, 98%) 
 
[α]D20 = +35.8 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.45 (d, J = 2.1 Hz, 1H), 7.39 (d, J = 8.3 Hz, 1H), 7.18 
(dddd, J = 0.6 Hz, 2.1 Hz, 8.3 Hz, 1H), 4.84 (q, J = 6.5 Hz, 1H), 1.91 (brs, 1H), 1.45 (d, J = 
6.6 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 146.0, 132.5, 131.2, 130.4, 127.5, 124.7, 69.2, 25.3 ppm. 
MS (70 eV, EI): m/z (%) = 190 (M+, 35), 175 (100), 147 (47), 111 (70). 
HRMS (EI): m/z calcd. for: [C8H8OCl2] 189.9952,  found: 189.9953 
Enantiomeric excess was determined by chiral GC using DEX-CB column (160 °C (60 min), 
const.); 6.6 min (R), 7.1 (S).   97% ee. 
 
1-(3’, 4’- Dioxymethylenephenyl)ethanol (94b)143:   
 
OH
O
O
 
 
                                                 
142
 Mao, J.; Wan, B.; Wu, F.; Lu, S. Tetrahedron Lett. 2005, 46, 7341. 
143
 Koul, S.; Koul, J. L.; Sing, B.; Kapoor, M.; Parshad, R.; Manhas, K. S.; Taneja, S. C.; Qazi, G. N. 
Tetrahedron: Asymmetry 2005, 16, 2575. 
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Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3,4-dioxymethyleneacetophenone 93b (657 mg; 4.0 mmol) and obtained as 
colourless oil (625 mg; 3.76 mmol, 94%) 
 
[α]D20 = +42.6 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 6.87 (d, J = 1.8 Hz, 1H), 6.80 (dddd, J = 0.5 Hz, 1.8 Hz, 
8.0 Hz, 1H), 6.75 (d, J = 8.0 Hz, 1H), 5.92 (s, 2H), 6.80 (q, J = 6.4 Hz, 1H), 1.90 (brs, 1H), 
1.44 (d, J = 6.40 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 147.7, 146.8, 139.9, 118.6, 108.0, 106.0, 100.9, 70.2, 25.1 
ppm. 
MS (70 eV, EI): m/z (%) = 166 (M+, 71), 151 (97), 148 (12), 123 (27), 93 (100). 
HRMS (EI): m/z calcd. for: [C9H10O3] 166.0630,  found: 166.0623 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (7 min), 5 
°C/min 160 °C (60)); 19.7 min (R), 20.1 (S).   90% ee. 
 
1-(3’, 4’- Dimethylphenyl)ethanol (94c)144:   
 
OH
H3C
H3C
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3,4-dimethyl-acetophenone 93c (593 mg; 0.59 mL, 4.0 mmol) and obtained 
as colourless oil (583 mg; 3.88 mmol, 97%) 
 
[α]D20 = +50.0 (c = 1.0, CHCl3) 
1H-NMR (300 MHz, CDCl3): δ = 7.15 (brs, 1H), 7.12-7.09 (m, 2H), 4.84 (q, J = 6.7 Hz, 1H), 
2.27 (s, 3H), 2.26 (s, 3H), 1.85 (brs, 1H), 1.48 (d, J = 6.4 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 143.3, 136.6, 135.7, 129.7, 126.7, 122.7, 70.2, 25.0, 19.8, 
19.4 ppm. 
MS (70 eV, EI): m/z (%) = 150 (M+, 43), 135 (82), 107 (100), 91 (49). 
HRMS (EI): m/z calcd. for: [C10H14O] 150.1045,  found: 150.1035 
Enantiomeric excess was determined by chiral GC using DEX-CB column (100 °C (7 min), 5 
°C/min 160 °C (60)); 15.4 min (R), 15.7 (S).   96% ee. 
 
1-(3’, 4’- Di´methoxyphenyl)ethanol (94d)145 
 
OH
MeO
MeO
 
 
Prepared according to the typical procedure TP11, using ruthenium catalysts 80c (2.1 mg; 
0.002 mmol) and 3,4-dimethoxy-acetophenone 93d (721 mg; 4.0 mmol) and obtained as 
colourless oil (714 mg; 3.92 mmol, 98%) 
 
[α]D20 = +49.6 (c = 1.0, CDCl3) 
                                                 
144
 Kagechika, H.; Himi, T.; Namikawa, K.; Kawachi, E.; Hashimoto, Y.; Shudo, K. J. Med. Chem. 1989, 32, 
1098. 
145
 Zaitsev, A. B.; Adolfsson, H. Org. Lett. 2006, 8, 5129. 
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1H-NMR (300 MHz, CDCl3): δ = 6.92 (d, J = 2.0 Hz, 1H), 6.87-6.86 (m, 1H), 6.83 (s, 1H), 
4.86-4.79 (m, 1H), 3.88 (s, 3H), 3.85 (s, 3H), 1.86 (d, J = 2.2 Hz, 1H), 1.47 (d, J = 6.7 Hz, 
3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 149.0, 148.3, 138.5, 117.5, 111.0, 108.6, 70.2, 55.9, 55.8, 
25.0 ppm. 
MS (70 eV, EI): m/z (%) = 182 (M+, 59), 167 (100), 139 (81), 124 (13). 
HRMS (EI): m/z calcd. for: [C10H14O3] 182.0943,  found: 182.0923 
Enantiomeric excess was determined by chiral GC using DEX-CB column (120 °C (120 min), 
const); 46.5 min (R), 50.5 (S).   94% ee. 
 
Synthesis of trans-(S)-methyl2-carbomethoxy-3,5-diphenylpent-4-enolate (28) 
 
CH(CO2Me)2
 
 
Preared according to TP12, using ligand 9h (3 mg, 0.0055 mmol) and 3-Acetoxy-1,3-
diphenyl-propene 27 (126 mg; 0.5 mmol), dimethylmalonate (0.2 mL; 1.5 mmol) and (S)-28 
obtained as a white solid (149 mg, 0.46 mmol; 92%). 
 
MP: 94.1-94.8 °C 
1H-NMR (300 MHz, CDCl3): δ = 7.25-7.00 (m, 10H), 6.40 (d, J = 15.8 Hz, 1H), 6.25 (dd, J 
= 15.8 Hz, 8.4 Hz, 1H), 4.15 (dd, J = 10.5, 8.8 Hz, 1H), 3.88 (d, J = 10.5 Hz, 1H), 3.55 (s, 
3H), 3.45 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 168.1, 167.5, 139.9, 136.0, 131.5, 129.1, 128.7, 128.1, 
127.5, 127.3, 126.9, 126.3, 57.9, 52.8, 52.0, 49.1ppm. 
Enantiomeric excess was determined by chiral HPLC using a chiracel OD-H column (flow 
rate 0.6 mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 34.8 min (R), tr = 37.2 min (S);  
94% ee. 
 
Synthesis of N-acetylphenylalaninmethylester (26)146 
 
CO2Me
NHAc
 
 
Preared according to TP13, using ligand 13d (6.4 mg, 0.0011 mmol) in MeOH (1 mL) and 2-
acetamidoacrylicacidmethylester 25 (219 mg, 1.0 mmol) in MeOH (4 mL) at 5 bar H2 
pressure and obtained the desired compound 26 as colourless solid (211 mg, 0.95 mmol; 
95%). 
 
1H-NMR (300 MHz, CDCl3): δ = 7.32-7.17(m, 3H), 7.13-7.04 (m, 2H), 6.06 (brs, 1H), 4.87 
(brs, 1H), 3.70 (s, 3H), 3.20-3.00 (m, 2H), 1.97 (s, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 172.0, 169.7, 135.8, 129.2, 128.5, 127.0, 53.1, 52.3, 37.8, 
23.2 ppm. 
Enantiomeric excess was determined by GC using a chirlsil L-Val column (140 °C const;) tr = 
11.6 min (R), tr = 12.5 min (S);  90% ee. 
 
Synthesis of 2-methylsuccinicaciddimethylester (75)147 
                                                 
146
 Glaser, R.; Vainas, B. J. Organomet. Chem. 1976, 121, 249. 
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MeO2C
CO2Me
Me
 
 
Preared according to TP13, using ligand 13d (6.4 mg, 0.0011 mmol) in MeOH (1 mL) and 2-
acetamidoacrylicacidmethylester 74 (158 mg, 1.0 mmol) in MeOH (4 mL) at 5 bar H2 
pressure and obtained the desired compound 75 as colourless oil (144 mg, 0.90 mmol; 90%). 
 
1H-NMR (300 MHz, CDCl3): δ = 3.66 (s, 3H), 3.64 (s, 3H), 2.99-2.85 (m, 1H), 2.74-2.65 
(m, 1H), 2.40-2.38 (m, 1H), 1.20 (d, J = 7.1 Hz, 3H) ppm. 
13C-NMR (75 MHz, CDCl3): δ = 176.1, 172.7, 52.0, 51.8, 37.8, 36.1, 16.5 ppm. 
Enantiomeric excess was determined by chiral HPLC using a chiracel OD-H column (flow 
rate 0.6 mL/min, heptane/iPrOH: 95/5, λ= 215 nm, 25 °C); tr = 34.8 min (R), tr = 37.2 min (S);  
60% ee. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                        
147
 Behrens, U.; Burk, M. J.; Gerlach, A.; Hems, W. Angew. Chem. Int. Ed. 2000, 39, 1981. 
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13. Data for the x-ray crystallography analysis 
 
Crystallographic data of 4b: 
 
Empirical Formula :     C29H26FeNOPS 
 
Formular weight         :     523.39 
 
Temperature [°C]      :     295 (2)K 
 
Wavelength                :    0.71073 Å 
 
Crystal system           :     Monoclinic 
 
Space group            :     P21 
 
Unit cell dimensions :     a = 9.0830 (18) Å  alpha = 90 deg. 
 
     b = 9.7040 (18) Å  beta  = 102.60(3) deg. 
 
     c = 15.6420 (3) Å  gamma = 90 deg. 
 
Volume                            :    1262.3 (5) Å3 
 
Z                                       :    2 
 
Density (calculated)          :   1.377 Mg/m3 
 
Absorption coefficient       :   0.766 mm-1 
 
F(000)                                :    544 
 
Crystal size                         :   0.57 x 0.53 x 0.20 mm 
 
Theta range for data collection: 2.60 to 26.30 
 
Index ranges                             : -11<=h<=11, -11<=k<=11, -19<=l<=19 
 
Reflections collected                : 5121 
 
Independent reflections            : 4649 
 
Absorption correction               : Semi-empirical by psi-scan 
 
Max 
no of parameters                        : 308    
 
R1 (I>2σ(I))                                 : 0.0363 
 
wR2 (all data)                               : 0.0975 
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goodness of fit                                : 1.099 
 
 
14. ABBREVIATIONS 
 
Ac   acetyl 
Ar   aryl 
Bn   benzyl 
br.   Broad 
brs   Broadsinglet 
BARF   Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 
calcd.   Calculated 
CAN   Cerium Ammonium Nitrate 
CH2Cl2  dichloromethane 
COD   1,4-Cyclooctadiene 
Conv.   Conversion 
d   double 
dec.   decomposition 
DMF   N,N-dimethylformamide 
ee   enantiomeric excess 
equiv.   equivalent 
EI   electron-impact 
Et   ethyl 
FAB   fast-atom bombardment 
Fc   Ferrocenyl 
Fur   2-furyl 
GC   gas chromatography 
h   hour 
HRMS   high resolution mass spectroscopy 
Hz   Hertz 
n-Bu   n-butyl 
i-Pr   isopropyl 
IR   infra-red 
J   coupling constant (NMR) 
M   molarity 
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m   meta 
m   multiplet 
Me   methyl 
min   minute 
mol.   mole  
mL   Millilitre 
mp.   melting point 
MS   mass spectroscopy 
nbd   nonbornadiene 
NMR   nuclear magnetic resonance 
o   ortho 
p   para 
Pent   pentyl 
Ph   phenyl 
Pyr   Pyridyl 
q   quartet 
rt   room temperature 
rac.   racemic 
s   singlet 
t   triplet 
t-Bu   tert-butyl 
THF   tetrahydrofuran 
TLC   thin layer chromatography 
TMS   trimethylsilyl 
Tol   4-methylphenyl (tolyl) 
TP   typical procedure 
Xyl   3,5-Dimethylphenyl (xylyl) 
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